[go: up one dir, main page]

TWI912365B - Resin compositions, cured materials, laminates, manufacturing methods of cured materials, and semiconductor devices - Google Patents

Resin compositions, cured materials, laminates, manufacturing methods of cured materials, and semiconductor devices

Info

Publication number
TWI912365B
TWI912365B TW110134213A TW110134213A TWI912365B TW I912365 B TWI912365 B TW I912365B TW 110134213 A TW110134213 A TW 110134213A TW 110134213 A TW110134213 A TW 110134213A TW I912365 B TWI912365 B TW I912365B
Authority
TW
Taiwan
Prior art keywords
preferred
compounds
groups
group
acid
Prior art date
Application number
TW110134213A
Other languages
Chinese (zh)
Other versions
TW202222912A (en
Inventor
浅川大輔
山内晃
Original Assignee
日商富士軟片股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商富士軟片股份有限公司 filed Critical 日商富士軟片股份有限公司
Publication of TW202222912A publication Critical patent/TW202222912A/en
Application granted granted Critical
Publication of TWI912365B publication Critical patent/TWI912365B/en

Links

Abstract

本發明提供一種樹脂組成物、將上述樹脂組成物硬化而成之硬化物、包含上述硬化物之積層體、上述硬化物之製造方法及包含上述硬化物或上述積層體之半導體元件,該樹脂組成物包含環化樹脂的前驅物及藉由鹼的作用而產生鹼之化合物B。The present invention provides a resin composition, a cured product formed by curing the resin composition, a laminate containing the cured product, a method for manufacturing the cured product, and a semiconductor device containing the cured product or the laminate, wherein the resin composition comprises a precursor of a cyclized resin and a compound B that generates an alkali by the action of an alkali.

Description

樹脂組成物、硬化物、積層體、硬化物之製造方法及半導體元件Resin compositions, cured materials, laminates, manufacturing methods of cured materials, and semiconductor devices

本發明係有關一種樹脂組成物、硬化物、積層體、硬化物之製造方法及半導體元件。 This invention relates to a resin composition, a cured material, a laminate, a method for manufacturing the cured material, and a semiconductor device.

聚醯亞胺等環化樹脂的耐熱性及絕緣性等優異,因此適用於各種用途。作為上述用途並無特別限定,但是若舉出實際安裝用半導體元件為例,則可以舉出作為絕緣膜或密封材料的材料或保護膜的利用。又,亦可以用作撓性基板的基底膜或覆蓋膜等。 Cyclic resins such as polyimide possess excellent heat resistance and insulation properties, making them suitable for a wide range of applications. While there are no particular limitations on these applications, for example, in the practical installation of semiconductor components, they can be used as insulating films, sealing materials, or protective films. Furthermore, they can also be used as base films or cover films for flexible substrates.

例如,在上述用途中,聚醯亞胺等環化樹脂以包含聚醯亞胺前驅物等環化樹脂的前驅物之樹脂組成物的形態使用。 For example, in the above-described applications, cyclic resins such as polyimide are used in the form of resin compositions comprising precursors of cyclic resins such as polyimide precursors.

將該種樹脂組成物例如藉由塗佈等適用於基材上而形成感光膜,之後依據需要進行曝光、顯影、加熱等,從而能夠將硬化物形成於基材上。 This resin composition is applied to a substrate, for example, by coating, to form a photosensitive film. Then, exposure, development, and heating are performed as needed to harden the material onto the substrate.

上述聚醯亞胺前驅物等環化樹脂的前驅物例如藉由加熱而環化,並在硬化物中成為聚醯亞胺等環化樹脂。 The aforementioned cyclized resin precursors, such as polyimide precursors, are cyclized, for example, by heating, and thus become cyclized resins such as polyimide in the cured material.

樹脂組成物能夠藉由公知的塗佈方法等而適用,因此可以說製造上的適應性優異,例如所適用之樹脂組成物在適用時的形狀、大小、適用位置等設計的自由度高等。除了聚醯亞胺等環化樹脂所具有之高性能以外,從 該種製造上的適應性優異之觀點考慮,越來越期待上述樹脂組成物在產業上的應用開發。 Resin compositions can be applied using well-known coating methods, thus offering excellent manufacturing adaptability. For example, the design freedom in terms of the shape, size, and application location of the resin composition is high. In addition to the high performance of cyclic resins such as polyimide, considering this excellent manufacturing adaptability, there is increasing anticipation for the industrial application development of these resin compositions.

例如,在專利文獻1中,記載有一種感活性能量線鹼產生劑,其特徵為,其係具有特定的胺酯結構。 For example, Patent Document 1 describes a sensitive energy line alkali generator characterized by having a specific amine ester structure.

[專利文獻1]日本特開2007-241205號公報 [Patent Document 1] Japanese Patent Application Publication No. 2007-241205

在該種樹脂組成物中,要求提高組成物的保存穩定性和提高所獲得之硬化物的斷裂伸長率這兩者。 In this type of resin composition, it is required to improve both the preservation stability of the composition and the elongation at break of the obtained cured product.

本發明的目的為,提供一種組成物的保存穩定性及所獲得之硬化物的斷裂伸長率優異之樹脂組成物、將上述樹脂組成物硬化而成之硬化物、包含上述硬化物之積層體、上述硬化物之製造方法及包含上述硬化物或上述積層體之半導體元件。 The purpose of this invention is to provide a resin composition with excellent preservation stability and elongation at break of the obtained cured product, a cured product obtained by curing the resin composition, a laminate containing the cured product, a method for manufacturing the cured product, and a semiconductor device containing the cured product or the laminate.

將本發明的代表性實施態樣的例子示於以下。 Examples of representative embodiments of the present invention are shown below.

<1>一種樹脂組成物,其係包含環化樹脂的前驅物及藉由鹼的作用而產生鹼之化合物B。 <1> A resin composition comprising a precursor of a cyclized resin and compound B, which produces a base through the action of a base.

<2>如<1>所述之樹脂組成物,其中,從化合物B產生之鹼為胺。 <2> The resin composition as described in <1>, wherein the alkali produced from compound B is an amine.

<3>如<1>或<2>所述之樹脂組成物,其中,化合物B具有胺酯鍵。 <3> A resin composition as described in <1> or <2>, wherein compound B has an amino ester bond.

<4>如<1>至<3>之任一項所述之樹脂組成物,其中,化合物B為下述式(1-1)、式(1-2)或式(1-3)所表示之化合物。 <4> A resin composition as described in any of <1> to <3>, wherein compound B is a compound represented by formula (1-1), formula (1-2), or formula (1-3).

[化學式1] [Chemical Formula 1]

式(1-1)中,R1表示氫原子或可以經取代的烴基,R2表示可以經取代的烴基,R1和R2可以鍵結而形成環結構;式(1-2)中,R1表示氫原子或可以經取代的烴基,R2表示可以經取代的烴基,R1和R2可以鍵結而形成環結構,R3分別獨立地表示氫原子或可以經取代的烴基,R4表示氰基、硝基、-C(=O)OR、-OC(=O)R、-C(=O)R、-S(=O)2R、氟化烷基或鹵素原子,R表示可以經取代的烴基;式(1-3)中,R1表示氫原子或可以經取代的烴基,R2表示可以經取代的烴基,R1和R2可以鍵結而形成環結構,R3分別獨立地表示氫原子或可以經取代的烴基,Ar表示經選自氰基、硝基、-C(=O)OR、-OC(=O)R、-C(=O)R、-S(=O)2R、氟化烷基、鹵素原子中的至少1個基團取代之芳香族基,R表示可以經取代的烴基。 In formula (1-1), R1 represents a hydrogen atom or a substituted hydrocarbon, R2 represents a substituted hydrocarbon, and R1 and R2 can bond to form a ring structure; in formula (1-2), R1 represents a hydrogen atom or a substituted hydrocarbon, R2 represents a substituted hydrocarbon, R1 and R2 can bond to form a ring structure, R3 independently represents a hydrogen atom or a substituted hydrocarbon, R4 represents a cyano, nitro, -C(=O)OR, -OC(=O)R, -C(=O)R, -S(=O) 2R , fluorinated alkyl or halogen atom, and R represents a substituted hydrocarbon; in formula (1-3), R1 represents a hydrogen atom or a substituted hydrocarbon, R 2 represents a substitutable hydrocarbon. R1 and R2 can bond to form a ring structure. R3 represents a hydrogen atom or a substitutable hydrocarbon independently. Ar represents an aromatic group substituted with at least one group selected from cyano, nitro, -C(=O)OR, -OC(=O)R, -C(=O)R, -S(=O) 2R , fluorinated alkyl, and halogen atom. R represents a substitutable hydrocarbon.

<5>如<1>至<4>之任一項所述之樹脂組成物,其係進一步包含熱鹼產生劑或光鹼產生劑。 <5> The resin composition described in any of <1> to <4> further comprises a thermo-alkali generator or a photo-alkali generator.

<6>如<1>至<5>之任一項所述之樹脂組成物,其係進一步包含熱鹼產生劑。 <6> The resin composition described in any of <1> to <5> further comprises a heat-generating agent.

<7>如<1>至<6>之任一項所述之樹脂組成物,其係進一步包含光聚合起始劑。 <7> The resin composition as described in any of <1> to <6> further comprises a photopolymerization initiator.

<8>如<1>至<7>之任一項所述之樹脂組成物,其係進一步包含聚合性化合物。 <8> The resin composition described in any of <1> to <7> further comprises a polymeric compound.

<9>一種硬化物,其係將<1>至<8>之任一項所述之樹脂組成物硬化而成。 <9> A hardener formed by hardening any of the resin compositions described in <1> to <8>.

<10>一種積層體,其係包括2層以上的由<9>所述之硬化物形成之層,並且在由上述硬化物形成之層之間的任一個之間包括金屬層。 <10> A laminate comprising two or more layers formed of the hardened material described in <9>, and including a metal layer between any of the layers formed of the hardened material.

<11>一種硬化物之製造方法,其係包括將<1>至<8>之任一項所述之樹脂組成物適用於基材上而形成膜之膜形成步驟。 <11> A method for manufacturing a hardened material, comprising a film-forming step of adapting any one of the resin compositions described in <1> to <8> onto a substrate to form a film.

<12>如<11>所述之硬化物之製造方法,其係包括選擇性地曝光上述膜之曝光步驟及使用顯影液對上述膜進行顯影而形成圖案之顯影步驟。 <12> The method for manufacturing the hardened material as described in <11> includes an exposure step of selectively exposing the film and a development step of developing the film using a developing solution to form a pattern.

<13>如<11>或<12>所述之硬化物之製造方法,其係包括在50~450℃下對上述膜進行加熱之加熱步驟。 <13> The method for manufacturing the hardened material as described in <11> or <12> includes a heating step of heating the film at 50~450°C.

<14>一種半導體元件,其係包含<9>所述之硬化物或<10>所述之積層體。 <14> A semiconductor device comprising the hardened material described in <9> or the laminate described in <10>.

依據本發明,提供一種組成物的保存穩定性及所獲得之硬化物的斷裂伸長率優異之樹脂組成物、將上述樹脂組成物硬化而成之硬化物、包含上述硬化物之積層體、上述硬化物之製造方法及包含上述硬化物或上述積層體之半導體元件。 According to the present invention, a resin composition exhibiting excellent preservation stability and elongation at break of the resulting cured product is provided; a cured product obtained by curing the resin composition; a laminate comprising the cured product; a method for manufacturing the cured product; and a semiconductor device comprising the cured product or the laminate.

以下,對本發明的主要實施形態進行說明。然而,本發明並不限於所明示之實施形態。 The main embodiments of the present invention will be described below. However, the present invention is not limited to the embodiments described.

在本說明書中,用“~”記號表示之數值範圍表示將記載於“~”的前後之 數值分別作為下限值及上限值包括之範圍。 In this specification, the range of values indicated by the "~" symbol represents the range encompassed by the values recorded before and after the "~" as the lower and upper limits, respectively.

在本說明書中,“步驟”這一用語不僅表示獨立之步驟,只要能夠實現該步驟所預期之作用,則亦表示包括無法與其他步驟明確區分之步驟。 In this instruction manual, the term "step" refers not only to an independent step, but also to steps that cannot be clearly distinguished from other steps, provided that the intended effect of the step is achieved.

關於本說明書中之基團(原子團)的標記,未標註經取代及未經取代的標記同時包括不具有取代基的基團(原子團)和具有取代基之基團(原子團)。例如,“烷基”不僅包括不具有取代基的烷基(未經取代的烷基),而且還包括具有取代基之烷基(取代烷基)。 Regarding the designation of group names in this specification, the designations for unsubstituted and unsubstituted groups include both unsubstituted and substituted group names. For example, "alkyl" includes not only unsubstituted alkyl groups (unsubstituted alkyl groups) but also substituted alkyl groups (substituted alkyl groups).

在本說明書中,除非另有說明,則“曝光”不僅包括利用光之曝光,而且還包括利用電子束、離子束等粒子束之曝光。又,作為用於曝光之光,可以舉出水銀燈的明線光譜、以準分子雷射為代表之遠紫外線、極紫外線(EUV光)、X射線、電子束等光化射線或放射線。 In this instruction manual, unless otherwise stated, "exposure" includes not only exposure using light, but also exposure using particle beams such as electron beams and ion beams. Furthermore, examples of light used for exposure include brightline light from mercury lamps, far-ultraviolet light (represented by excimer lasers), extreme ultraviolet light (EUV light), X-rays, and photochemical rays or radiation such as electron beams.

在本說明書中,“(甲基)丙烯酸酯”表示“丙烯酸酯”及“甲基丙烯酸酯”這兩者或其中任一者,“(甲基)丙烯酸”表示“丙烯酸”及“甲基丙烯酸”這兩者或其中任一者,“(甲基)丙烯醯基”表示“丙烯醯基”及“甲基丙烯醯基”這兩者或其中任一者。 In this specification, "(meth)acrylate" means either "acrylate" or "methacrylate," "(meth)acrylic acid" means either "acrylic acid" or "methacrylic acid," and "(meth)acrylyl" means either "acrylyl" or "methacrylyl."

在本說明書中,結構式中的Me表示甲基,Et表示乙基,Bu表示丁基,Ph表示苯基。 In this specification, Me represents methyl, Et represents ethyl, Bu represents butyl, and Ph represents phenyl.

在本說明書中,總固體成分是指組成物的所有成分中除了溶劑以外之成分的總質量。又,在本說明書中,固體成分濃度為除了溶劑以外之其他成分相對於組成物的總質量之質量百分率。 In this specification, total solids content refers to the total mass of all components of the composition, excluding the solvent. Furthermore, in this specification, solids concentration is the mass percentage of all components other than the solvent relative to the total mass of the composition.

在本說明書中,除非另有說明,則重量平均分子量(Mw)及數量平均分子量(Mn)為使用凝膠滲透層析(GPC)法進行測定之值,並且被定義 為聚苯乙烯換算值。在本說明書中,關於重量平均分子量(Mw)及數量平均分子量(Mn),例如能夠藉由使用HLC-8220GPC(TOSOH CORPORAT ION製),並將保護管柱HZ-L、TSKgel Super HZM-M、TSKgel Super HZ 4000、TSKgel Super HZ3000及TSKgel Super HZ2000(以上為TOSOH CORPORATION製)串聯連接而用作管柱來求出。除非另有說明,則該等分子量為使用THF(四氫呋喃)作為洗提液進行測定者。其中,在溶解性低的情況等THF不適合作為洗提液的情況下,亦能夠使用NMP(N-甲基-2-吡咯啶酮)。又,除非另有說明,則GPC測定中之檢測為使用UV線(紫外線)的波長254nm檢測器者。 In this instruction manual, unless otherwise stated, the weight-average molecular weight (Mw) and number-average molecular weight (Mn) are values determined using gel osmosis chromatography (GPC) and are defined as polystyrene equivalents. In this instruction manual, the weight-average molecular weight (Mw) and number-average molecular weight (Mn) can be determined, for example, using an HLC-8220 GPC (manufactured by TOSOH CORPORATION) with guard columns HZ-L, TSKgel Super HZM-M, TSKgel Super HZ 4000, TSKgel Super HZ3000, and TSKgel Super HZ2000 (all manufactured by TOSOH CORPORATION) connected in series. Unless otherwise stated, these molecular weights are determined using THF (tetrahydrofuran) as the eluent. In cases where THF is unsuitable as an eluent due to low solubility, NMP (N-methyl-2-pyrrolidone) can be used. Furthermore, unless otherwise specified, the detection in GPC assays uses a UV (ultraviolet) detector with a wavelength of 254 nm.

在本說明書中,關於構成積層體之各層的位置關係,記載為“上”或“下”時,只要在所關注之複數層中成為基準之層的上側或下側存在其他層即可。亦即,亦可以在成為基準之層與上述其他層之間進一步夾有第3層或要素,並且成為基準之層與上述其他層無需接觸。又,除非另有說明,則將對於基材逐漸堆疊層之方向稱為“上”,或者,在具有樹脂組成物層之情況下,將從基材朝向樹脂組成物層之方向稱為“上”,將其相反方向稱為“下”。再者,該種上下方向的設定係為了便於說明本說明書,在實際態樣中,本說明書中之“上”方向亦可以與鉛直朝上不同。 In this specification, when referring to the positional relationship of the layers constituting the laminate as "upper" or "lower," it is sufficient that there are other layers above or below the reference layer among the plurality of layers in question. That is, a third layer or element may be sandwiched between the reference layer and the other layers mentioned above, and the reference layer does not need to be in contact with the other layers. Furthermore, unless otherwise stated, the direction in which layers are gradually stacked on the substrate is referred to as "upper," or, in the case of a resin composition layer, the direction from the substrate toward the resin composition layer is referred to as "upper," and the opposite direction is referred to as "lower." Furthermore, this up-down orientation is for ease of explanation of this instruction manual. In actual practice, the "up" direction in this instruction manual may differ from "vertically upward."

在本說明書中,除非另有說明,則作為組成物中所包含之各成分,組成物亦可以包含與該成分對應之2種以上的化合物。又,除非另有說明,則組成物中之各成分的含量表示與該成分對應之所有化合物的合計含量。 In this specification, unless otherwise stated, each component included in the composition may contain two or more compounds corresponding to that component. Furthermore, unless otherwise stated, the content of each component in the composition represents the total content of all compounds corresponding to that component.

在本說明書中,除非另有說明,則溫度為23℃,氣壓為101,325Pa(1氣壓),相對濕度為50%RH。 Unless otherwise stated, the temperature in this manual is 23°C, the pressure is 101,325 Pa (1 atmosphere), and the relative humidity is 50% RH.

在本說明書中,較佳態樣的組合為更佳態樣。 In this instruction manual, the combination of preferred samples is referred to as the better sample.

(樹脂組成物) (Resin components)

本發明的樹脂組成物包含環化樹脂的前驅物(以下,亦稱為“特定樹脂,”)及藉由鹼的作用而產生鹼之化合物B(以下,亦簡稱為“化合物B”。)。 The resin composition of this invention comprises a precursor of a cyclized resin (hereinafter, also referred to as "the specific resin") and compound B (hereinafter, also referred to as "compound B"), which generates a base through the action of a base.

本發明的樹脂組成物用於形成供於曝光及顯影之感光膜為較佳,用於形成供於曝光及使用了包含有機溶劑之顯影液之顯影之膜為較佳。 The resin composition of this invention is preferably used to form a photosensitive film for exposure and development, and preferably to form a developing film for exposure and development using a developing solution containing an organic solvent.

又,本發明的樹脂組成物用於形成供於負型顯影之感光膜為較佳。 Furthermore, the resin composition of this invention is preferably used to form a photosensitive film for negative developing.

在本發明中,負型顯影是指在曝光及顯影中,藉由顯影而去除非曝光部之顯影,正型顯影是指藉由顯影而去除曝光部之顯影。 In this invention, negative development refers to the removal of unexposed areas by developing during exposure and development, while positive development refers to the removal of exposed areas by developing.

作為上述曝光的方法、上述顯影液及上述顯影的方法,例如使用在後述硬化物之製造方法的說明中之曝光步驟中所說明之曝光方法、在顯影步驟中所說明之顯影液及顯影方法。 The exposure method, the developing solution, and the developing method described above can be, for example, the exposure method described in the exposure step of the explanation of the method for manufacturing the cured material described later, and the developing solution and developing method described in the developing step.

在本發明的樹脂組成物中,組成物的保存穩定性及所獲得之硬化物的斷裂伸長率優異。 The resin composition of this invention exhibits excellent preservation stability and the resulting cured product demonstrates superior elongation at break.

可以獲得上述效果之機制雖尚不明確,但是推測為如下。 While the mechanism by which these effects are achieved is not yet clear, it is speculated to be as follows.

自先前,一直研究包含環化樹脂的前驅物和熱鹼產生劑之樹脂組成物。在聚醯亞胺前驅物等環化樹脂的前驅物中,藉由鹼的作用而進行醯亞胺化等環化反應。利用該特性,形成包含具有環化樹脂的前驅物和鹼產生劑之樹脂組成物之膜,之後進行高溫加熱處理等,從而能夠獲得包含具有高耐熱性和高機械特性之環化樹脂之硬化物。 Previously, research has focused on resin compositions containing cyclic resin precursors and alkali-generating agents. In cyclic resin precursors such as polyimide precursors, cyclization reactions such as amide formation are carried out by the action of an alkali. Utilizing this property, a film containing a resin composition containing a cyclic resin precursor and an alkali-generating agent is formed, followed by high-temperature heating treatment, thereby obtaining a cured cyclic resin containing high heat resistance and high mechanical properties.

另一方面,可知在保管該種組成物時,在組成物液中產生微量的鹼性 化合物,從而有時在組成物中進行環化樹脂的前驅物的環化反應。 On the other hand, it is known that trace amounts of alkaline compounds are generated in the liquid composition during storage, which sometimes leads to the cyclization reaction of cyclized resin precursors within the composition.

藉此,產生環化樹脂的前驅物的溶劑溶解性降低且組成物中之上述樹脂的析出等問題。該等環化樹脂的前驅物在鹼性條件下促進環化,因此有時藉由將組成物調整為酸性來抑制環化。 This leads to problems such as reduced solvent solubility of the precursors of cyclized resins and precipitation of the aforementioned resins in the composition. These cyclized resin precursors promote cyclization under alkaline conditions; therefore, cyclization is sometimes inhibited by adjusting the composition to an acidic state.

然而,在保管時產生大量鹼之情況下,即使在製備組成物時製備成酸性之情況下,在組成物中亦藉由鹼的作用而促進環化,因此有時僅將組成物調整為酸性係難以獲得保管時的穩定性(亦稱為組成物的保存穩定性)的。 However, even when the composition is prepared in an acidic environment, the presence of a large amount of alkali during storage can promote cyclization within the composition due to the alkali's effect. Therefore, simply adjusting the composition to an acidic environment is sometimes insufficient to achieve the stability required for storage (also known as the storage stability of the composition).

在本發明中,藉由使用藉由鹼的作用而產生鹼之化合物B,能夠以高級別兼顧樹脂組成物的保存穩定性和所獲得之硬化膜的機械特性(斷裂伸長率)。 In this invention, by using compound B, which generates an alkali through the action of an alkali, it is possible to achieve a high degree of balance between the preservation stability of the resin composition and the mechanical properties (elongation at break) of the obtained hardened film.

在樹脂組成物中,化合物B具有高穩定性,在保管時不易產生鹼,因此保存穩定性高。另一方面,認為在藉由加熱處理等進行硬化時,藉由化合物B自身的一部分進行熱分解而產生之鹼或從附加於樹脂組成物中之鹼產生劑產生之鹼的作用,化合物B快速分解並釋放充分量的鹼。藉此,認為充分進行環化樹脂的前驅物中之環化反應,能夠實現高機械特性(斷裂伸長率)。 In the resin composition, compound B exhibits high stability and is not prone to alkali formation during storage, thus ensuring high storage stability. Furthermore, it is believed that during hardening processes such as heat treatment, compound B rapidly decomposes and releases a sufficient amount of alkali due to the thermal decomposition of a portion of itself or from alkali-generating agents attached to the resin composition. Therefore, it is believed that sufficient cyclization reactions in the precursors of cyclized resins can achieve high mechanical properties (elongation at break).

其中,在專利文獻1中,對包含環化樹脂的前驅物及化合物B之樹脂組成物沒有記載。 Patent document 1 does not describe a resin composition comprising a precursor of a cyclized resin and compound B.

以下,對本發明的樹脂組成物中所包含之成分進行詳細說明。 The components contained in the resin composition of this invention will be described in detail below.

<特定樹脂> <Specific resin>

本發明的樹脂組成物包含環化樹脂的前驅物(特定樹脂)。 The resin composition of this invention includes a precursor of a cyclized resin (a specific resin).

環化樹脂為在主鏈結構中包含醯亞胺環結構或唑環結構之樹脂為較佳。 Cyclic resins contain amide ring structures or... Resins with an azole ring structure are preferred.

在本發明中,主鏈表示在樹脂分子中相對最長的鍵結鏈。 In this invention, the main chain refers to the relatively longest bond chain in the resin molecule.

作為環化樹脂,可以舉出聚醯亞胺、聚苯并唑、聚醯胺醯亞胺等。 Examples of cyclic resins include polyimide and polybenzo[a]pyrene. Zyrazole, polyamide, amide, etc.

環化樹脂的前驅物是指因外部刺激產生化學結構的變化而成為環化樹脂之樹脂,藉由熱產生化學結構的變化而成為環化樹脂之樹脂為較佳,藉由熱產生閉環反應而形成環結構以成為環化樹脂之樹脂為更佳。 Precursors to cyclized resins are resins that undergo chemical structural changes due to external stimuli to become cyclized resins. Resins that undergo chemical structural changes through heat to become cyclized resins are preferred, and those that form a ring structure through a heat-induced ring-closing reaction are even better.

作為環化樹脂的前驅物,可以舉出聚醯亞胺前驅物、聚苯并唑前驅物、聚醯胺醯亞胺前驅物等。 Examples of precursors for cyclic resins include polyimide precursors and polybenzo[a]pyrene precursors. Azole precursors, polyamide-imide precursors, etc.

亦即,本發明的樹脂組成物包含選自包括聚醯亞胺前驅物、聚苯并唑前驅物及聚醯胺醯亞胺前驅物之群組中的至少1種樹脂(特定樹脂)作為特定樹脂為較佳。 That is, the resin composition of the present invention comprises selected from polyimide precursors, polyphenylene oxides, etc. At least one resin (specific resin) from the group consisting of azole precursors and polyamide imide precursors is preferred as the specific resin.

本發明的樹脂組成物包含聚醯亞胺前驅物作為特定樹脂為較佳。 The resin composition of this invention preferably includes a polyimide precursor as a specific resin.

又,特定樹脂具有聚合性基為較佳,包含自由基聚合性基為更佳。 Furthermore, it is preferable for a particular resin to have polymerizable groups, and even more preferable if it contains free radical polymerizable groups.

在特定樹脂具有自由基聚合性基之情況下,本發明的樹脂組成物包含後述自由基聚合起始劑為較佳,包含後述自由基聚合起始劑且包含後述自由基交聯劑為更佳。進而,依據需要,能夠包含後述敏化劑。由該種本發明的樹脂組成物例如形成負型感光膜。 In cases where a particular resin possesses free radical polymerizable groups, it is preferable that the resin composition of the present invention includes the free radical polymerization initiator described later; more preferably, it includes both the free radical polymerization initiator and the free radical crosslinker described later. Furthermore, as needed, it can include the sensitizer described later. Such a resin composition of the present invention can, for example, be used to form a negative photosensitive film.

又,特定樹脂可以具有酸分解性基等極性轉換基。 Furthermore, certain resins can possess polar switching groups such as acid-degrading groups.

在特定樹脂具有酸分解性基之情況下,本發明的樹脂組成物包含後述光酸產生劑為較佳。由該種本發明的樹脂組成物例如形成作為化學增幅型 之正型感光膜或負型感光膜。 In cases where a particular resin possesses acid-degrading groups, it is preferable that the resin composition of the present invention includes the photoacid generator described later. Such a resin composition of the present invention can be used to form, for example, a chemically amplified positive or negative photosensitive film.

〔聚醯亞胺前驅物〕 [Polyimide precursors]

本發明中所使用之聚醯亞胺前驅物的種類等並無特別規定,但是包含下述式(2)所表示之重複單元為較佳。 The type of polyimide precursor used in this invention is not specifically specified, but it is preferable to include repeating units represented by the following formula (2).

式(2)中,A1及A2分別獨立地表示氧原子或-NH-,R111表示2價的有機基,R115表示4價的有機基,R113及R114分別獨立地表示氫原子或1價的有機基。 In formula (2), A1 and A2 represent oxygen atoms or -NH- respectively, R111 represents a divalent organic group, R115 represents a tetravalent organic group, and R113 and R114 represent hydrogen atoms or monovalent organic groups respectively.

式(2)中之A1及A2分別獨立地表示氧原子或-NH-,氧原子為較佳。 In formula (2), A1 and A2 represent oxygen atoms or -NH- respectively, with oxygen atoms being preferred.

式(2)中之R111表示2價的有機基。作為2價的有機基,可以例示包含直鏈或支鏈的脂肪族基、環狀脂肪族基及芳香族基之基團,包括碳數2~20的直鏈或支鏈的脂肪族基、碳數3~20的環狀脂肪族基、碳數3~20的芳香族基或該等組合之基團為較佳,包含碳數6~20的芳香族基之基團為更佳。上述直鏈或支鏈的脂肪族基可以經鏈中的烴基包含雜原子之基團取代,並且上述環狀的脂肪族基及芳香族基可以經環員的烴基包含雜原子之基團取代。作為本發明的較佳的實施形態,可以例示-Ar-及-Ar-L-Ar-所表示之基團,特佳為-Ar-L-Ar-所表示之基團。其中,Ar分別獨立地為芳香族基,L為包括單鍵、可以經氟原子取代的碳數1~10的脂肪族烴基、-O-、- CO-、-S-、-SO2-或-NHCO-或上述中的2個以上的組合之基團。該等較佳範圍如上所述。 In formula (2), R 111 represents a divalent organic group. Examples of divalent organic groups include aliphatic groups, cyclic aliphatic groups, and aromatic groups that are linear or branched, preferably linear or branched aliphatic groups with 2 to 20 carbon atoms, cyclic aliphatic groups with 3 to 20 carbon atoms, aromatic groups with 3 to 20 carbon atoms, or combinations thereof, and more preferably groups that include aromatic groups with 6 to 20 carbon atoms. The linear or branched aliphatic groups can be substituted by groups whose hydrocarbon groups contain heteroatoms, and the cyclic aliphatic groups and aromatic groups can be substituted by groups whose hydrocarbon groups contain heteroatoms. As a preferred embodiment of the present invention, groups represented by -Ar- and -Ar-L-Ar- can be exemplified, with the group represented by -Ar-L-Ar- being particularly preferred. Wherein, Ar is independently an aromatic group, and L is a group comprising a single bond, an aliphatic hydrocarbon group having 1 to 10 carbon atoms that can be substituted with fluorine atoms, -O-, -CO-, -S-, -SO₂- , or -NHCO-, or a combination of two or more of the above. These preferred ranges are as described above.

R111衍生自二胺為較佳。作為聚醯亞胺前驅物的製造中所使用之二胺,可以舉出直鏈或支鏈的脂肪族、環狀脂肪族或芳香族二胺等。二胺可以僅使用1種,亦可以使用2種以上。 R 111 is preferably derived from a diamine. Examples of diamines used in the manufacture of polyimide precursors include linear or branched aliphatic, cyclic aliphatic, or aromatic diamines. Only one type of diamine may be used, or two or more may be used.

具體而言,包含包括碳數2~20的直鏈或支鏈的脂肪族基、碳數3~20的環狀脂肪族基、碳數3~20的芳香族基或該等組合之基團之二胺為較佳,包含碳數6~20的芳香族基之二胺為更佳。上述直鏈或支鏈的脂肪族基可以經鏈中的烴基包含雜原子之基團取代,並且上述環狀的脂肪族基及芳香族基可以經環員的烴基包含雜原子之基團取代。作為包含芳香族基之基團的例子,可以舉出下述。 Specifically, diamines comprising aliphatic groups (2-20 carbon atoms), cyclic aliphatic groups (3-20 carbon atoms), aromatic groups (3-20 carbon atoms), or combinations thereof are preferred, and diamines comprising aromatic groups (6-20 carbon atoms) are even more preferred. The aforementioned linear or branched aliphatic groups can be substituted by groups containing heteroatoms in the hydrocarbon group of the chain, and the aforementioned cyclic aliphatic and aromatic groups can be substituted by groups containing heteroatoms in the hydrocarbon group of the ring member. Examples of groups comprising aromatic groups are as follows.

式中,A表示單鍵或2價的連接基,選自單鍵或可以經氟原子取代的碳數1~10的脂肪族烴基、-O-、-C(=O)-、-S-、-SO2-、-NHCO-或該等組合中之基團為較佳,選自單鍵、可以經氟原子取代的碳數1~3的伸烷基、 -O-、-C(=O)-、-S-或-SO2-中之基團為更佳,-CH2-、-O-、-S-、-SO2-、-C(CF3)2-或-C(CH3)2-為進一步較佳。 In the formula, A represents a single bond or a divalent linker group, preferably selected from a single bond or a group of 1 to 10 carbon atoms that can be substituted by a fluorine atom, such as an aliphatic hydrocarbon group, -O-, -C(=O)-, -S-, -SO 2- , -NHCO-, or combinations thereof. It is more preferred to select a single bond, a group of 1 to 3 carbon atoms that can be substituted by a fluorine atom, such as an alkyl group, -O-, -C(=O)-, -S-, or -SO 2- . -CH 2- , -O-, -S-, -SO 2- , -C(CF 3 ) 2- , or -C(CH 3 ) 2- are even more preferred.

式中,*表示與其他結構的鍵結部位。 In the formula, * indicates a bonding location with other structures.

作為二胺,具體而言,可以舉出選自1,2-二胺基乙烷、1,2-二胺基丙烷、1,3-二胺基丙烷、1,4-二胺基丁烷及1,6-二胺基己烷;1,2-二胺基環戊烷或1,3-二胺基環戊烷、1,2-二胺基環己烷、1,3-二胺基環己烷或1,4-二胺基環己烷、1,2-雙(胺基甲基)環己烷、1,3-雙(胺基甲基)環己烷或1,4-雙(胺基甲基)環己烷、雙-(4-胺基環己基)甲烷、雙-(3-胺基環己基)甲烷、4,4’-二胺基-3,3’-二甲基環己基甲烷及異佛爾酮二胺;間苯二胺或對苯二胺、二胺基甲苯、4,4’-二胺基聯苯或3,3’-二胺基聯苯、4,4’-二胺基二苯醚、3,3’-二胺基二苯醚、4,4’-二胺基二苯基甲烷及3,3’-二胺基二苯基甲烷、4,4’-二胺基二苯基碸及3,3-二胺基二苯基碸、4,4’-二胺基二苯醚及3,3’-二胺基二苯醚、4,4’-二胺基二苯甲酮或3,3’-二胺基二苯甲酮、3,3’-二甲基-4,4’-二胺基聯苯、2,2’-二甲基-4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、2,2-雙(4-胺基苯基)丙烷、2,2-雙(4-胺基苯基)六氟丙烷、2,2-雙(3-羥基-4-胺基苯基)丙烷、2,2-雙(3-羥基-4-胺基苯基)六氟丙烷、2,2-雙(3-胺基-4-羥基苯基)丙烷、2,2-雙(3-胺基-4-羥基苯基)六氟丙烷、雙(3-胺基-4-羥基苯基)碸、雙(4-胺基-3-羥基苯基)碸、4,4’-二胺基對聯三苯、4,4’-雙(4-胺基苯氧基)聯苯、雙[4-(4-胺基苯氧基)苯基]碸、雙[4-(3-胺基苯氧基)苯基]碸、雙[4-(2-胺基苯氧基)苯基]碸、1,4-雙(4-胺基苯氧基)苯、9,10-雙(4-胺基苯基)蒽、3,3’-二甲基-4,4’-二胺基二苯基碸、1,3-雙(4-胺基苯氧基)苯、1,3-雙(3-胺基苯氧基)苯、1,3-雙(4- 胺基苯基)苯、3,3’-二乙基-4,4’-二胺基二苯基甲烷、3,3’-二甲基-4,4’-二胺基二苯基甲烷、4,4’-二胺基八氟聯苯、2,2-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、9,9-雙(4-胺基苯基)-10-氫蒽、3,3’,4,4’-四胺基聯苯、3,3’,4,4’-四胺基二苯醚、1,4-二胺基蒽醌、1,5-二胺基蒽醌、3,3-二羥基-4,4’-二胺基聯苯、9,9’-雙(4-胺基苯基)茀、4,4’-二甲基-3,3’-二胺基二苯基碸、3,3’,5,5’-四甲基-4,4’-二胺基二苯基甲烷、2,4-二胺基枯烯及2,5-二胺基枯烯、2,5-二甲基-對苯二胺、乙醯胍胺、2,3,5,6-四甲基-對苯二胺、2,4,6-三甲基-間苯二胺、雙(3-胺基丙基)四甲基二矽氧烷、雙(對胺基苯基)八甲基五矽氧烷、2,7-二胺基茀、2,5-二胺基吡啶、1,2-雙(4-胺基苯基)乙烷、二胺基苯甲醯苯胺、二胺苯甲酸的酯、1,5-二胺基萘、二胺基三氟甲苯、1,3-雙(4-胺基苯基)六氟丙烷、1,4-雙(4-胺基苯基)八氟丁烷、1,5-雙(4-胺基苯基)十氟戊烷、1,7-雙(4-胺基苯基)十四氟庚烷、2,2-雙[4-(3-胺基苯氧基)苯基]六氟丙烷、2,2-雙[4-(2-胺基苯氧基)苯基]六氟丙烷、2,2-雙[4-(4-胺基苯氧基)-3,5-二甲基苯基]六氟丙烷、2,2-雙[4-(4-胺基苯氧基)-3,5-雙(三氟甲基)苯基]六氟丙烷、對雙(4-胺基-2-三氟甲基苯氧基)苯、4,4’-雙(4-胺基-2-三氟甲基苯氧基)聯苯、4,4’-雙(4-胺基-3-三氟甲基苯氧基)聯苯、4,4’-雙(4-胺基-2-三氟甲基苯氧基)二苯基碸、4,4’-雙(3-胺基-5-三氟甲基苯氧基)二苯基碸、2,2-雙[4-(4-胺基-3-三氟甲基苯氧基)苯基]六氟丙烷、3,3’,5,5’-四甲基-4,4’-二胺基聯苯、4,4’-二胺基-2,2’-雙(三氟甲基)聯苯、2,2’,5,5’,6,6’-六氟聯甲苯胺及4,4’-二胺基四聯苯中的至少1種二胺。 As a diamine, specifically, examples include those selected from 1,2-diaminoethane, 1,2-diaminopropane, 1,3-diaminopropane, 1,4-diaminobutane, and 1,6-diaminohexane; 1,2-diaminocyclopentane or 1,3-diaminocyclopentane, 1,2-diaminocyclohexane, 1,3-diaminocyclohexane or 1,4-diaminocyclohexane, 1,2-bis(aminomethyl)cyclohexane, 1,3-bis(aminomethyl)cyclohexane or 1,4-bis(aminomethyl)cyclohexane, bis-(4-aminocyclohexyl)methane, bis-(3-aminocyclohexyl)methane, 4,4'-diamino-3,3'- Dimethylcyclohexylmethane and isophorone diamine; m-phenylenediamine or p-phenylenediamine, diaminotoluene, 4,4'-diaminobiphenyl or 3,3'-diaminobiphenyl, 4,4'-diaminodiphenyl ether, 3,3'-diaminodiphenyl ether, 4,4'-diaminodiphenylmethane and 3,3'-diaminodiphenylmethane, 4,4'-diaminodiphenyl sulfone and 3,3'-diaminodiphenyl sulfone, 4,4'-diaminodiphenyl ether and 3,3'-diaminodiphenyl ether, 4,4'-diaminodibenzophenone or 3,3'-diaminodibenzophenone, 3,3'-dimethyl-4,4'-diaminobiphenyl, 2,2'-dimethyl -4,4'-Diaminobiphenyl, 3,3'-Dimethoxy-4,4'-Diaminobiphenyl, 2,2-bis(4-aminophenyl)propane, 2,2-bis(4-aminophenyl)hexafluoropropane, 2,2-bis(3-hydroxy-4-aminophenyl)propane, 2,2-bis(3-hydroxy-4-aminophenyl)hexafluoropropane, 2,2-bis(3-amino-4-hydroxyphenyl)propane, 2,2-bis(3-amino-4-hydroxyphenyl)hexafluoropropane, bis(3-amino-4-hydroxyphenyl) phosphate, bis(4-amino-3-hydroxyphenyl) phosphate, 4,4'-diamino-p-terphenyl, 4,4'-bis(4 1,4-bis(4-aminophenoxy)phenyl]benzene, bis[4-(3-aminophenoxy)phenyl]benzene, bis[4-(2-aminophenoxy)phenyl]benzene, 1,4-bis(4-aminophenoxy)benzene, 9,10-bis(4-aminophenoxy)anthracene, 3,3'-dimethyl-4,4'-diaminodiphenylbenzene, 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(3-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 3,3'-diethyl-4,4'-diaminodiphenylmethane, 3,3'-dimethyl-4,4'-diaminodiphenyl Methane, 4,4’-diaminooctafluorobiphenyl, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 9,9-bis(4-aminophenyl)-10-hydroanthracene, 3,3’,4,4’-tetraaminobiphenyl, 3,3’,4,4’-tetraaminodiphenyl ether, 1,4-diaminoanthraquinone, 1,5-diaminoanthraquinone, 3,3-dihydroxy-4,4’-diaminobiphenyl, 9,9’-bis(4-aminophenyl)furan, 4,4’-dimethyl-3,3’-diaminodiphenyl sulfonium, 3,3’,5,5’-tetramethyl- 4,4'-Diaminodiphenylmethane, 2,4-Diaminocumene and 2,5-Diaminocumene, 2,5-Dimethyl-p-phenylenediamine, acetoguanidine, 2,3,5,6-Tetramethyl-p-phenylenediamine, 2,4,6-Trimethyl-m-phenylenediamine, bis(3-aminopropyl)tetramethyldisiloxane, bis(p-aminophenyl)octamethylpentasiloxane, 2,7-Diaminopyridine, 2,5-Diaminopyridine, 1,2-bis(4-aminophenyl)ethane, diaminobenzoniline, esters of diaminobenzoic acid, 1,5-Diaminonaphthalene, diaminotrifluorotoluene, 1,3-bis(4-aminophenyl)hexafluoropropane, 1,4-bis... (4-aminophenyl)octafluorobutane, 1,5-bis(4-aminophenyl)decafluoropentane, 1,7-bis(4-aminophenyl)tetrafluoroheptane, 2,2-bis[4-(3-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis[4-(2-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)-3,5-dimethylphenyl]hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)-3,5-bis(trifluoromethyl)phenyl]hexafluoropropane, p-bis(4-amino-2-trifluoromethylphenoxy)benzene, 4,4'-bis(4-amino-2-trifluoromethyl)phenyl At least one diamine selected from the following: phenoxy)biphenyl, 4,4'-bis(4-amino-3-trifluoromethylphenoxy)biphenyl, 4,4'-bis(4-amino-2-trifluoromethylphenoxy)diphenyl sulfonium, 4,4'-bis(3-amino-5-trifluoromethylphenoxy)diphenyl sulfonium, 2,2-bis[4-(4-amino-3-trifluoromethylphenoxy)phenyl]hexafluoropropane, 3,3',5,5'-tetramethyl-4,4'-diaminobiphenyl, 4,4'-diamino-2,2'-bis(trifluoromethyl)biphenyl, 2,2',5,5',6,6'-hexafluorobitoluidine, and 4,4'-diaminotetraphenyl.

又,國際公開第2017/038598號的0030~0031段中所記載 的二胺(DA-1)~(DA-18)亦較佳。 Furthermore, the diamines (DA-1) to (DA-18) described in paragraphs 0030-0031 of International Patent Application Publication No. 2017/038598 are also preferred.

又,亦可以較佳地使用在主鏈上具有國際公開第2017/038598號的0032~0034段中所記載的2個以上的伸烷基二醇單元之二胺。 Alternatively, a diamine comprising two or more alkyl diol units as described in paragraphs 0032 to 0034 of International Publication No. 2017/038598 on the main chain can also be preferred.

從所獲得之有機膜的柔軟性的觀點考慮,R111由-Ar-L-Ar-表示為較佳。其中,Ar分別獨立地為芳香族基,L為包括可以經氟原子取代的碳數1~10的脂肪族烴基、-O-、-CO-、-S-、-SO2-或-NHCO-或上述中的2個以上的組合之基團。Ar為伸苯基為較佳,L為可以經氟原子取代的碳數1或2的脂肪族烴基、-O-、-CO-、-S-或-SO2-為較佳。此處的脂肪族烴基為伸烷基為較佳。 From the viewpoint of the flexibility of the obtained organic membrane, R 111 is preferably represented by -Ar-L-Ar-. Here, Ar is independently an aromatic group, and L is a group including an aliphatic hydrocarbon of 1 to 10 carbon atoms that can be substituted with a fluorine atom, -O-, -CO-, -S-, -SO₂- , or -NHCO-, or a combination of two or more of the above. Ar is preferably phenyl, and L is preferably an aliphatic hydrocarbon of 1 or 2 carbon atoms that can be substituted with a fluorine atom, -O-, -CO-, -S-, or -SO₂- . Here, the aliphatic hydrocarbon is preferably alkyl.

又,從i射線透射率的觀點考慮,R111為下述式(51)或式(61)所表示之2價的有機基為較佳。尤其,從i射線透射率、易獲得性的觀點考慮,式(61)所表示之2價的有機基為更佳。 Furthermore, from the viewpoint of i-ray transmittance, it is preferable that R 111 is a divalent organic group represented by formula (51) or formula (61) below. In particular, from the viewpoint of i-ray transmittance and availability, the divalent organic group represented by formula (61) is even more preferable.

式(51) Equation (51)

式(51)中,R50~R57分別獨立地為氫原子、氟原子或1價的有機基,R50~R57中的至少1個為氟原子、甲基或三氟甲基,*分別獨立地表示與式(2)中的氮原子的鍵結部位。 In formula (51), R 50 ~ R 57 are each independently a hydrogen atom, a fluorine atom or a monovalent organic group, and at least one of R 50 ~ R 57 is a fluorine atom, a methyl or a trifluoromethyl atom, and * independently represents the bonding site with the nitrogen atom in formula (2).

作為R50~R57的1價的有機基,可以舉出碳數1~10(較佳為碳數1~6)的未經取代的烷基、碳數1~10(較佳為碳數1~6)的氟化烷基等。 Examples of monovalent organic groups, such as R 50 to R 57 , include unsubstituted alkyl groups with 1 to 10 carbon atoms (preferably 1 to 6 carbon atoms) and fluorinated alkyl groups with 1 to 10 carbon atoms (preferably 1 to 6 carbon atoms).

式(61)中,R58及R59分別獨立地為氟原子、甲基或三氟甲基,*分別獨立地表示與式(2)中的氮原子的鍵結部位。 In formula (61), R 58 and R 59 are fluorine atoms, methyl or trifluoromethyl atoms, respectively, and * represent the bonding sites with nitrogen atoms in formula (2).

作為提供式(51)或式(61)的結構之二胺,可以舉出2,2’-二甲基聯苯胺、2,2’-雙(三氟甲基)-4,4’-二胺基聯苯、2,2’-雙(氟)-4,4’-二胺基聯苯、4,4’-二胺基八氟聯苯等。該等可以使用1種或組合使用2種以上。 Examples of diamines providing the structure of formula (51) or formula (61) include 2,2'-dimethylbenzidine, 2,2'-bis(trifluoromethyl)-4,4'-diaminobiphenyl, 2,2'-bis(fluoro)-4,4'-diaminobiphenyl, and 4,4'-diaminooctafluorobiphenyl. One or more of these may be used.

式(2)中之R115表示4價的有機基。作為4價的有機基,包含芳香環之4價的有機基為較佳,下述式(5)或式(6)所表示之基團為更佳。 In formula (2), R 115 represents a tetravalent organic group. As a tetravalent organic group, a tetravalent organic group containing an aromatic ring is preferred, and the group represented by formula (5) or formula (6) below is even more preferred.

式(5)或式(6)中,*分別獨立地表示與其他結構的鍵結部位。 In equation (5) or (6), * independently represents the bonding location with other structures.

式(5)中,R112為單鍵或2價的連接基,選自單鍵或可以經氟原子取代的碳數1~10的脂肪族烴基、-O-、-CO-、-S-、-SO2-及-NHCO-以及該等組合中之基團為較佳,選自單鍵、可以經氟原子取代的碳數1~3的伸烷基、-O-、-CO-、-S-及-SO2-中之基團為更佳,選自包括-CH2-、-C(CF3)2-、-C(CH3)2-、-O-、-CO-、-S-及-SO2-之群組中的2價的基團為進一步較佳。 In formula (5), R 112 is a single bond or a divalent linker, preferably selected from a single bond or a group of 1 to 10 carbon atoms that can be substituted by a fluorine atom, such as aliphatic hydrocarbons, -O-, -CO-, -S-, -SO 2- and -NHCO-, and combinations thereof. It is more preferably selected from a single bond, a group of 1 to 3 carbon atoms that can be substituted by a fluorine atom, such as alkyl groups, -O-, -CO-, -S- and -SO 2- . It is even more preferably selected from a divalent group including -CH 2- , -C(CF 3 ) 2- , -C(CH 3 ) 2- , -O-, -CO-, -S- and -SO 2- .

關於R115,具體而言,可以舉出從四羧酸二酐去除酐基之後所殘存之四羧酸殘基等。作為與R115對應之結構,聚醯亞胺前驅物可以僅包含1種四羧酸二酐殘基,亦可以包含2種以上。 Regarding R 115 , specifically, examples include the tetracarboxylic acid residue remaining after the anhydride group is removed from tetracarboxylic acid dianhydride. As a structure corresponding to R 115 , polyimide precursors may contain only one type of tetracarboxylic acid dianhydride residue, or they may contain two or more types.

四羧酸二酐由下述式(O)表示為較佳。 Tetracarboxylic dianhydrides are preferably represented by the following formula (O).

式(O)中,R115表示4價的有機基。R115的較佳範圍與式(2)中之R115的含義相同,較佳範圍亦相同。 In equation (O), R 115 represents a tetravalent organic group. The preferred range of R 115 is the same as that of R 115 in equation (2), and the preferred range is also the same.

作為四羧酸二酐的具體例,可以舉出均苯四甲酸二酐(PMDA)、3,3’,4,4’-聯苯四羧酸二酐、3,3’,4,4’-二苯硫醚四羧酸二酐、3,3’,4,4’-二苯基碸四羧酸二酐、3,3’,4,4’-二苯甲酮四羧酸二酐、3,3’,4,4’-二苯基甲烷四羧酸二酐、2,2’,3,3’-二苯基甲烷四羧酸二酐、2,3,3’,4’-聯苯四羧酸二酐、2,3,3’,4’-二苯甲酮四羧酸二酐、4,4’-氧二鄰苯二甲酸二酐、2,3,6,7-萘四羧酸二酐、1,4,5,7-萘四羧酸二酐、2,2-雙(3,4-二羧基苯基)丙烷二酐、2,2-雙(2,3-二羧基苯基)丙烷二酐、2,2-雙(3,4-二羧基苯基)六氟丙烷二酐、1,3-二苯基六氟丙烷-3,3,4,4-四羧酸二酐、1,4,5,6-萘四羧酸二酐、2,2’,3,3’-二苯基四羧酸二酐、3,4,9,10-並四羧酸二酐、1,2,4,5-萘四羧酸二酐、1,4,5,8-萘四羧酸二酐、1,8,9,10-菲四羧酸二酐、1,1-雙(2,3-二羧基苯基)乙烷二酐、1,1-雙(3,4-二羧基苯基)乙烷二酐、1,2,3,4-苯四羧酸二酐及該等碳數1~6 的烷基及碳數1~6的烷氧基衍生物。 Specific examples of tetracarboxylic dianhydrides include pyromellitic dianhydride (PMDA), 3,3’,4,4’-biphenyltetracarboxylic dianhydride, 3,3’,4,4’-diphenyl sulfide tetracarboxylic dianhydride, 3,3’,4,4’-diphenyl sulfide tetracarboxylic dianhydride, 3,3’,4,4’-benzophenone tetracarboxylic dianhydride, 3,3’,4,4’-diphenylmethane tetracarboxylic dianhydride, 2,2’,3,3’-diphenylmethane tetracarboxylic dianhydride, 2,3,3’,4’-biphenyltetracarboxylic dianhydride, 2,3,3’,4’-benzophenone tetracarboxylic dianhydride, 4,4’-oxophthalic dianhydride, 2,3,6,7-naphthalene tetracarboxylic dianhydride, 1,4,5,7-naphthalene tetracarboxylic dianhydride, and 2,2-bis(3,4-dicarboxyphenyl)propane. Dihydrides, 2,2-bis(2,3-dicarboxyphenyl)propane dianhydride, 2,2-bis(3,4-dicarboxyphenyl)hexafluoropropane dianhydride, 1,3-diphenylhexafluoropropane-3,3,4,4-tetracarboxylic acid dianhydride, 1,4,5,6-naphthalenetetracarboxylic acid dianhydride, 2,2',3,3'-diphenyltetracarboxylic acid dianhydride, 3,4,9,10-paracetamoltetracarboxylic acid dianhydride, 1,2,4,5-naphthalenetetracarboxylic acid dianhydride, 1,4,5,8-naphthalenetetracarboxylic acid dianhydride, 1,8,9,10-phenanthrenetetracarboxylic acid dianhydride, 1,1-bis(2,3-dicarboxyphenyl)ethane dianhydride, 1,1-bis(3,4-dicarboxyphenyl)ethane dianhydride, 1,2,3,4-benzenetetracarboxylic acid dianhydride, and such alkyl groups having 1 to 6 carbon atoms and alkoxy derivatives having 1 to 6 carbon atoms.

又,亦可以舉出國際公開第2017/038598號的0038段中所記載的四羧酸二酐(DAA-1)~(DAA-5)作為較佳例。 Alternatively, the tetracarboxylic acid dianhydrides (DAA-1) to (DAA-5) described in paragraph 0038 of International Publication No. 2017/038598 can be cited as a better example.

式(2)中,R111和R115中的至少一者亦能夠具有OH基。更具體而言,作為R111,可以舉出雙胺基苯酚衍生物的殘基。 In formula (2), at least one of R 111 and R 115 can also have an OH group. More specifically, as R 111 , the residual group of a diaminophenol derivative can be cited.

式(2)中之R113及R114分別獨立地表示氫原子或1價的有機基。作為1價的有機基,包含直鏈或支鏈的烷基、環狀烷基、芳香族基或聚伸烷氧基為較佳。又,R113及R114中的至少一者包含聚合性基為較佳,兩者包含聚合性基為更佳。R113及R114中的至少一者包含2個以上的聚合性基亦較佳。作為聚合性基為能夠藉由熱、自由基等的作用而進行交聯反應的基團,自由基聚合性基為較佳。作為聚合性基的具體例,可以舉出具有乙烯性不飽和鍵之基團、烷氧基甲基、羥甲基、醯氧基甲基、環氧基、氧環丁烷基、苯并唑基、嵌段異氰酸酯基、胺基。作為聚醯亞胺前驅物所具有之自由基聚合性基,具有乙烯性不飽和鍵之基團為較佳。 In formula (2), R 113 and R 114 independently represent a hydrogen atom or a monovalent organic group. As a monovalent organic group, it is preferable to include a straight-chain or branched alkyl group, a cyclic alkyl group, an aromatic group, or a polyalkylene group. Furthermore, it is preferable that at least one of R 113 and R 114 contains a polymerizable group, and even more preferable that both contain polymerizable groups. It is also preferable that at least one of R 113 and R 114 contains two or more polymerizable groups. As a polymerizable group, it is a group capable of cross-linking reactions through the action of heat, free radicals, etc., and a free radical polymerizable group is preferred. Specific examples of polymerizable groups include groups with ethylene-unsaturated bonds, alkoxymethyl, hydroxymethyl, acetoxymethyl, epoxy, oxobutyl, and benzo[a] group. Azolium group, block isocyanate group, amine group. As a free radical polymerizable group for polyimide precursors, groups with ethylene unsaturated bonds are preferred.

作為具有乙烯性不飽和鍵之基團,可以舉出乙烯基、烯丙基、異烯丙基、2-甲基烯丙基、具有與乙烯基直接鍵結之芳香環之基團(例如,乙烯基苯基等)、(甲基)丙烯醯胺基、(甲基)丙烯醯氧基、下述式(III)所表示之基團等,下述式(III)所表示之基團為較佳。 Examples of groups having vinyl unsaturated bonds include vinyl, allyl, isoallyl, 2-methylallyl, groups having an aromatic ring directly bonded to a vinyl group (e.g., vinylphenyl), (meth)acrylamide, (meth)acryloxy, and groups represented by formula (III) below, with groups represented by formula (III) below being preferred.

式(III)中,R200表示氫原子、甲基、乙基或羥甲基,氫原子或甲基為較佳。 In formula (III), R 200 represents a hydrogen atom, methyl, ethyl or hydroxymethyl, with hydrogen atom or methyl being preferred.

式(III)中,*表示與其他結構的鍵結部位。 In equation (III), * indicates a bonding location with other structures.

式(III)中,R201表示碳數2~12的伸烷基、-CH2CH(OH)CH2-、伸環烷基或聚伸烷氧基。 In formula (III), R 201 represents an alkyl group with 2 to 12 carbon atoms, -CH 2 CH(OH)CH 2 -, cycloalkyl group or polyalkylene group.

較佳的R201的例子可以舉出伸乙基、伸丙基、三亞甲基、四亞甲基、五亞甲基、六亞甲基、八亞甲基、十二亞甲基等伸烷基、1,2-丁二基、1,3-丁二基、-CH2CH(OH)CH2-、聚伸烷氧基,伸乙基、伸丙基等伸烷基、-CH2CH(OH)CH2-、環己基、聚伸烷氧基為更佳,伸乙基、伸丙基等伸烷基或聚伸烷氧基為進一步較佳。 Examples of preferred R 201 include alkylene, propylene, trimethylene, tetramethylene, pentamethylene, hexamethylene, octamethylene, dodecamethylene, 1,2-butadiene, 1,3-butadiene, -CH 2 CH(OH)CH 2- , polyalkylene, alkylene, propylene, -CH 2 CH(OH)CH 2- , cyclohexylene, polyalkylene, and alkylene, propylene, or polyalkylene are preferred.

在本發明中,聚伸烷氧基是指伸烷氧基直接鍵結2個以上之基團。聚伸烷氧基中所包含之複數個伸烷氧基中之伸烷基分別可以相同,亦可以不同。 In this invention, a polyalkylene group refers to an alkylene group directly bonded to two or more groups. The alkylene groups within the plurality of alkylene groups contained in a polyalkylene group may be the same or different.

在聚伸烷氧基包含伸烷基不同之複數種伸烷氧基之情況下,聚伸烷氧基中之伸烷氧基的排列可以為無規排列,亦可以為具有嵌段之排列,還可以為具有交替等圖案之排列。 When a polyalkoxy group contains multiple alkoxy groups with different alkyl groups, the arrangement of the alkoxy groups in the polyalkoxy group can be random, block-shaped, or alternating.

上述伸烷基的碳數(在伸烷基具有取代基之情況下,包含取代基的碳數)為2以上為較佳,2~10為更佳,2~6為更佳,2~5為進一步較佳,2~4為更進一步較佳,2或3為特佳,2為最佳。 The number of carbon atoms in the aforementioned alkyl group (including the number of carbon atoms containing the substituent if the alkyl group has substituents) is preferably 2 or more, 2 to 10 is more preferred, 2 to 6 is even more preferred, 2 to 5 is further preferred, 2 to 4 is even more preferred, 2 or 3 is particularly preferred, and 2 is the best.

又,上述伸烷基可以具有取代基。作為較佳的取代基,可以舉出烷基、芳基、鹵素原子等。 Furthermore, the aforementioned alkyl groups may have substituents. Preferred substituents include alkyl, aryl, and halogen atoms.

又,聚伸烷氧基中所包含之伸烷氧基的數量(聚伸烷氧基的重複數) 為2~20為較佳,2~10為更佳,2~6為進一步較佳。 Furthermore, the number of alkoxy groups contained in the polyalkoxy group (the repetition number of the polyalkoxy group) is preferably 2 to 20, more preferably 2 to 10, and even more preferably 2 to 6.

作為聚伸烷氧基,從溶劑溶解性及耐溶劑性的觀點考慮,聚乙烯氧基、聚伸丙氧基、聚三亞甲氧基、聚四亞甲氧基或複數個乙烯氧基與複數個伸丙氧基鍵結而獲得之基團為較佳,聚乙烯氧基或聚伸丙氧基為更佳,聚乙烯氧基為進一步較佳。在上述複數個乙烯氧基與複數個伸丙氧基鍵結而獲得之基團中,乙烯氧基與伸丙氧基可以無規排列,亦可以形成嵌段而排列,還可以排列成交替等圖案狀。該等基團中之乙烯氧基等重複數個較佳態樣如上所述。 From the viewpoint of solvent solubility and solvent resistance, polyvinyloxy, polypropyleneoxy, polytrimethyleneoxy, polytetramethethyleneoxy, or groups obtained by bonding a plurality of ethyleneoxy groups with a plurality of propoxy groups are preferred as polyvinyloxy groups. Polyvinyloxy or polypropyleneoxy groups are more preferred, and polyvinyloxy groups are even more preferred. In the groups obtained by bonding a plurality of ethyleneoxy groups with a plurality of propoxy groups, the ethyleneoxy and propoxy groups can be arranged randomly, can form blocks, or can be arranged in alternating patterns. The preferred states of repeated ethyleneoxy groups in these groups are as described above.

式(2)中,在R113為氫原子之情況或在R114為氫原子之情況下,聚醯亞胺前驅物可以與具有乙烯性不飽和鍵之三級胺化合物形成共軛鹼。作為該種具有乙烯性不飽和鍵之三級胺化合物的例子,可以舉出甲基丙烯酸N,N-二甲基胺基丙酯。 In formula (2), when R 113 is a hydrogen atom or when R 114 is a hydrogen atom, the polyimide precursor can form a conjugated base with a tertiary amine compound having an ethylene unsaturated bond. N,N-dimethylaminopropyl methacrylate is an example of such a tertiary amine compound having an ethylene unsaturated bond.

式(2)中,R113及R114中的至少一者可以為酸分解性基等極性轉換基。作為酸分解性基,只要為在酸的作用下分解而產生酚性羥基、羧基等鹼可溶性基者,則並無特別限定,但是縮醛基、縮酮基、甲矽烷基、甲矽烷基醚基、三級烷基酯基等為較佳,從曝光靈敏度的觀點考慮,縮醛基或縮酮基為更佳。 In formula (2), at least one of R 113 and R 114 can be a polar conversion group such as an acid-degradable group. As an acid-degradable group, there is no particular limitation as long as it is an alkaline soluble group such as a phenolic hydroxyl group or a carboxyl group that decomposes under the action of acid. However, acetal, ketal, silyl, silyl ether, and tertiary alkyl ester groups are preferred. From the perspective of exposure sensitivity, acetal or ketal groups are more preferred.

作為酸分解性基的具體例,可以舉出第三丁氧基羰基、異丙氧基羰基、四氫吡喃基、四氫呋喃基、乙氧基乙基、甲氧基乙基、乙氧基甲基、三甲基甲矽烷基、第三丁氧基羰基甲基、三甲基甲矽烷基醚基等。從曝光靈敏度的觀點考慮,乙氧基乙基或四氫呋喃基為較佳。 Specific examples of acid-degrading groups include tributoxycarbonyl, isopropoxycarbonyl, tetrahydropyranyl, tetrahydrofuranyl, ethoxyethyl, methoxyethyl, ethoxymethyl, trimethylsilyl, tributoxycarbonylmethyl, and trimethylsilyl ether. From the perspective of exposure sensitivity, ethoxyethyl or tetrahydrofuranyl is preferred.

又,聚醯亞胺前驅物在結構中具有氟原子亦較佳。聚醯亞胺 前驅物中的氟原子含量為10質量%以上為較佳,並且20質量%以下為較佳。 Furthermore, it is preferable for polyimide precursors to have fluorine atoms in their structure. The fluorine atom content in the polyimide precursor is preferably 10% by mass or more, and preferably 20% by mass or less.

又,為了提高與基板的密接性,聚醯亞胺前驅物可以與具有矽氧烷結構之脂肪族基共聚。具體而言,作為二胺,可以舉出使用雙(3-胺基丙基)四甲基二矽氧烷、雙(對胺基苯基)八甲基五矽氧烷等之態樣。 Furthermore, to improve adhesion to the substrate, the polyimide precursor can be copolymerized with aliphatic groups having a siloxane structure. Specifically, examples of diamines include bis(3-aminopropyl)tetramethyldisiloxane and bis(p-aminophenyl)octamethylpentasiloxane.

式(2)所表示之重複單元為式(2-A)所表示之重複單元為較佳。亦即,本發明中所使用之聚醯亞胺前驅物中的至少1種為具有式(2-A)所表示之重複單元之前驅物為較佳。藉由使聚醯亞胺前驅物包含式(2-A)所表示之重複單元,能夠進一步加大曝光寬容度的寬度。 The repeating unit represented by formula (2) is preferably the repeating unit represented by formula (2-A). That is, it is preferable that at least one of the polyimide precursors used in this invention is a precursor having the repeating unit represented by formula (2-A). By including the repeating unit represented by formula (2-A) in the polyimide precursor, the exposure tolerance can be further increased.

式(2-A) Equation (2-A)

式(2-A)中,A1及A2表示氧原子,R111及R112分別獨立地表示2價的有機基,R113及R114分別獨立地表示氫原子或1價的有機基,R113及R114中的至少一者為包含聚合性基之基團,兩者為包含聚合性基之基團為較佳。 In formula (2-A), A1 and A2 represent oxygen atoms, R111 and R112 independently represent divalent organic groups, R113 and R114 independently represent hydrogen atoms or monovalent organic groups, and at least one of R113 and R114 is a group containing polymerizable groups, preferably both of which are groups containing polymerizable groups.

A1、A2、R111、R113及R114分別獨立地與式(2)中之A1、A2、R111、R113及R114的含義相同,較佳範圍亦相同。 A1 , A2 , R111 , R113 and R114 are independently equivalent to A1 , A2 , R111 , R113 and R114 in formula (2), and their preferred ranges are also the same.

R112與式(5)中之R112的含義相同,較佳範圍亦相同。 R 112 has the same meaning as R 112 in equation (5), and the preferred range is also the same.

聚醯亞胺前驅物可以包含1種式(2)所表示之重複單元, 亦可以包含2種以上。又,亦可以包含式(2)所表示之重複單元的結構異構物。又,聚醯亞胺前驅物除了上述式(2)的重複單元以外,還可以包含其他種類的重複單元,這是不言而喻的。 Polyimide precursors may contain one or more repeating units represented by formula (2). They may also contain structural isomers of the repeating units represented by formula (2). Furthermore, it is self-evident that polyimide precursors may contain other types of repeating units besides the repeating units of formula (2).

作為本發明中之聚醯亞胺前驅物的一實施形態,可以舉出式(2)所表示之重複單元的含量為所有重複單元的50莫耳%以上之態樣。上述合計含量為70莫耳%以上為更佳,90莫耳%以上為進一步較佳,超過90莫耳%為特佳。上述合計含量的上限並無特別限定,除了末端以外的聚醯亞胺前驅物中之所有重複單元亦可以為式(2)所表示之重複單元。 As one embodiment of the polyimide precursor of this invention, an example is provided where the content of the repeating unit represented by formula (2) is 50 mol% or more of all repeating units. A total content of 70 mol% or more is preferred, 90 mol% or more is further preferred, and more than 90 mol% is especially preferred. There is no particular upper limit to the total content; all repeating units in the polyimide precursor, except for the terminal units, can also be the repeating units represented by formula (2).

聚醯亞胺前驅物的重量平均分子量(Mw)較佳為5,000~100,000,更佳為10,000~50,000,進一步較佳為15,000~40,000。又,數量平均分子量(Mn)較佳為2,000~40,000,更佳為3,000~30,000,進一步較佳為4,000~20,000。 The weight-average molecular weight (Mw) of the polyimide precursor is preferably 5,000 to 100,000, more preferably 10,000 to 50,000, and even more preferably 15,000 to 40,000. Furthermore, the number-average molecular weight (Mn) is preferably 2,000 to 40,000, more preferably 3,000 to 30,000, and even more preferably 4,000 to 20,000.

上述聚醯亞胺前驅物的分子量的分散度為1.5以上為較佳,1.8以上為更佳,2.0以上為進一步較佳。聚醯亞胺前驅物的分子量的分散度的上限值並無特別規定,例如為7.0以下為較佳,6.5以下為更佳,6.0以下為進一步較佳。 The molecular weight dispersion of the aforementioned polyimide precursor is preferably 1.5 or higher, more preferably 1.8 or higher, and even more preferably 2.0 or higher. There is no specific upper limit specified for the molecular weight dispersion of the polyimide precursor; for example, 7.0 or lower is preferred, 6.5 or lower is more preferred, and 6.0 or lower is even more preferred.

在本說明書中,分子量的分散度為利用重量平均分子量/數量平均分子量計算出之值。 In this specification, the molecular weight dispersion is a value calculated using the weight-average molecular weight / number-average molecular weight.

又,在樹脂組成物包含複數種聚醯亞胺前驅物作為特定樹脂之情況下,至少1種聚醯亞胺前驅物的重量平均分子量、數量平均分子量及分散度在上述範圍內為較佳。又,將上述複數種聚醯亞胺前驅物作為1個樹脂計算出之重量平均分子量、數量平均分子量及分散度分別在上述範圍內亦較 佳。 Furthermore, when the resin composition includes multiple polyimide precursors as a specific resin, it is preferable that the weight-average molecular weight, number-average molecular weight, and dispersibility of at least one polyimide precursor are within the aforementioned ranges. It is also preferable that the weight-average molecular weight, number-average molecular weight, and dispersibility calculated when considering the multiple polyimide precursors as a single resin are each within the aforementioned ranges.

〔聚苯并唑前驅物〕 Polybenzo[ [Pro-azole]

關於本發明中所使用之聚苯并唑前驅物的結構等,並無特別規定,但是較佳為包含下述式(3)所表示之重複單元。 Regarding the polybenzo[a] used in this invention There are no particular requirements regarding the structure of azole precursors, but it is preferred that they contain repeating units represented by the following formula (3).

式(3)中,R121表示2價的有機基,R122表示4價的有機基,R123及R124分別獨立地表示氫原子或1價的有機基。 In equation (3), R 121 represents a divalent organic group, R 122 represents a tetravalent organic group, and R 123 and R 124 represent hydrogen atoms or monovalent organic groups, respectively.

式(3)中,R123及R124分別與式(2)中之R113的含義相同,較佳範圍亦相同。亦即,至少一者為聚合性基為較佳。 In equation (3), R 123 and R 124 have the same meaning as R 113 in equation (2), and the preferred range is also the same. That is, it is preferred that at least one of them is a polymerizable group.

式(3)中,R121表示2價的有機基。作為2價的有機基,包含脂肪族基及芳香族基中的至少一者之基團為較佳。作為脂肪族基,直鏈脂肪族基為較佳。R121為二羧酸殘基為較佳。二羧酸殘基可以僅使用1種,亦可以使用2種以上。 In formula (3), R 121 represents a divalent organic group. Preferably, the divalent organic group comprises at least one of an aliphatic group and an aromatic group. As an aliphatic group, a linear aliphatic group is preferred. R 121 is preferably a dicarboxylic acid residue. Only one type of dicarboxylic acid residue may be used, or two or more types may be used.

作為二羧酸殘基,包含脂肪族基之二羧酸及包含芳香族基之二羧酸殘基為較佳,包含芳香族基之二羧酸殘基為更佳。 As a dicarboxylic acid residue, dicarboxylic acids containing aliphatic groups and dicarboxylic acid residues containing aromatic groups are preferred, with dicarboxylic acid residues containing aromatic groups being even more preferred.

作為包含脂肪族基之二羧酸,包含直鏈或支鏈(較佳為直鏈)脂肪族基之二羧酸為較佳,包括直鏈或支鏈(較佳為直鏈)脂肪族基和2個-COOH之二羧酸為更佳。直鏈或支鏈(較佳為直鏈)的脂肪族基的碳數為2~30為較佳,2~25為更佳,3~20為進一步較佳,4~15為更進一步較佳,5 ~10為特佳。直鏈的脂肪族基為伸烷基為較佳。 As a dicarboxylic acid containing an aliphatic group, a dicarboxylic acid containing a straight-chain or branched (preferably straight-chain) aliphatic group is preferred, and a dicarboxylic acid containing a straight-chain or branched (preferably straight-chain) aliphatic group and two -COOH groups is even more preferred. The number of carbon atoms in the straight-chain or branched (preferably straight-chain) aliphatic group is preferably 2-30, more preferably 2-25, further preferably 3-20, even more preferably 4-15, and particularly preferably 5-10. The straight-chain aliphatic group is preferably an alkyl group.

作為包含直鏈的脂肪族基之二羧酸,可以舉出丙二酸、二甲基丙二酸、乙基丙二酸、異丙基丙二酸、二正丁基丙二酸、丁二酸、四氟丁二酸、甲基丁二酸、2,2-二甲基丁二酸、2,3-二甲基丁二酸、二甲基甲基丁二酸、戊二酸、六氟戊二酸、2-甲基戊二酸、3-甲基戊二酸、2,2-二甲基戊二酸、3,3-二甲基戊二酸、3-乙基-3-甲基戊二酸、己二酸、八氟己二酸、3-甲基己二酸、庚二酸、2,2,6,6-四甲基庚二酸、辛二酸、十二氟辛二酸、壬二酸、癸二酸、十六氟癸二酸、1,9-壬二酸、十二烷二酸、十三烷二酸、十四烷二酸、十五烷二酸、十六烷二酸、十七烷二酸、十八烷二酸、十九烷二酸、二十烷二酸、二十一烷二酸、二十二烷二酸、二十三烷二酸、二十四烷二酸、二十五烷二酸、二十六烷二酸、二十七烷二酸、二十八烷二酸、二十九烷二酸、三十烷二酸、三十一烷二酸、三十二烷二酸、二乙醇酸(diglycolic acid)以及下述式所表示之二羧酸等。 Examples of dicarboxylic acids containing aliphatic groups in a linear chain include malonic acid, dimethylmalonic acid, ethylmalonic acid, isopropylmalonic acid, di-n-butylmalonic acid, succinic acid, tetrafluorosuccinic acid, methylsuccinic acid, 2,2-dimethylsuccinic acid, 2,3-dimethylsuccinic acid, dimethylmethylsuccinic acid, glutaric acid, hexafluoroglutaric acid, 2-methylglutaric acid, 3-methylglutaric acid, 2,2-dimethylglutaric acid, 3,3-dimethylglutaric acid, 3-ethyl-3-methylglutaric acid, adipic acid, octafluoroadipic acid, 3-methyladipic acid, pimelic acid, and 2,2,6,6-tetrafluorodicarboxylic acid. Methyl pimelic acid, suberic acid, dodecanedioic acid, azelaic acid, sebacic acid, hexafluorosebacic acid, 1,9-azelaic acid, dodecanedioic acid, tridecanedioic acid, tetradecanedioic acid, pentadecanedioic acid, hexadecanedioic acid, heptadecanedioic acid, octadecanedioic acid, nonadecanedioic acid, eicosanedioic acid, eicosanedioic acid Monoacanedioic acid, behenedioic acid, tricosanedioic acid, tetracosanedioic acid, pentacosanedioic acid, hexacosanedioic acid, heptacosanedioic acid, octacanedioic acid, nonacosanedioic acid, triacontanedioic acid, triacontanedioic acid, triacontanedioic acid, diglycolic acid acid) and the dicarboxylic acid represented by the following formula, etc.

(式中,Z為碳數1~6的烴基,n為1~6的整數。) (In the formula, Z represents a hydrocarbon group with 1 to 6 carbon atoms, and n is an integer from 1 to 6.)

作為包含芳香族基之二羧酸,以下具有芳香族基之二羧酸為較佳,以下僅包括具有芳香族基之基團和2個-COOH之二羧酸為更佳。 As dicarboxylic acids containing aromatic groups, the following dicarboxylic acids having aromatic groups are preferred, and the following dicarboxylic acids consisting only of aromatic groups and two -COOH groups are even more preferred.

[化學式12] [Chemical Formula 12]

式中,A表示選自包括-CH2-、-O-、-S-、-SO2-、-CO-、-NHCO-、-C(CF3)2-及-C(CH3)2-之群組中的2價的基團,*分別獨立地表示與其他結構的鍵結部位。 In the formula, A represents a divalent group selected from the group consisting of -CH 2 -, -O-, -S-, -SO 2 -, -CO-, -NHCO-, -C(CF 3 ) 2 - and -C(CH 3 ) 2 -, and * represents the bonding site with other structures independently.

作為包含芳香族基之二羧酸的具體例,可以舉出4,4’-羰基二苯甲酸及4,4’-二羧基二苯醚、鄰苯二甲酸。 Specific examples of dicarboxylic acids containing aromatic groups include 4,4'-carbonyl dibenzoic acid, 4,4'-dicarboxylic acid diphenyl ether, and phthalic acid.

式(3)中,R122表示4價的有機基。作為4價的有機基,與上述式(2)中之R115的含義相同,較佳範圍亦相同。 In equation (3), R 122 represents a tetravalent organic group. As a tetravalent organic group, it has the same meaning as R 115 in equation (2) above, and the preferred range is also the same.

R122為源自雙胺基苯酚衍生物之基團亦較佳,作為源自雙胺基苯酚衍生物之基團,例如可以舉出3,3’-二胺基-4,4’-二羥基聯苯、4,4’-二胺基-3,3’-二羥基聯苯、3,3’-二胺基-4,4’-二羥基二苯碸、4,4’-二胺基-3,3’-二羥基二苯碸、雙-(3-胺基-4-羥基苯基)甲烷、2,2-雙(3-胺基-4-羥基苯基)丙烷、2,2-雙-(3-胺基-4-羥基苯基)六氟丙烷、2,2-雙-(4-胺基-3-羥基苯基)六氟丙烷、雙-(4-胺基-3-羥基苯基)甲烷、2,2-雙-(4-胺基-3-羥基苯基)丙烷、4,4’-二胺基-3,3’-二羥基二苯甲酮、3,3’-二胺基-4,4’-二羥基二苯甲酮、4,4’-二胺基-3,3’-二羥基二苯醚、3,3’-二胺基-4,4’-二羥基二苯醚、1,4-二胺基-2, 5-二羥基苯、1,3-二胺基-2,4-二羥基苯、1,3-二胺基-4,6-二羥基苯等。該等雙胺基苯酚可以單獨使用或者混合使用。 R 122 is preferably a group derived from a diaminophenol derivative. Examples of groups derived from diaminophenol derivatives include 3,3'-diamino-4,4'-dihydroxybiphenyl, 4,4'-diamino-3,3'-dihydroxybiphenyl, 3,3'-diamino-4,4'-dihydroxydiphenyl ion, 4,4'-diamino-3,3'-dihydroxydiphenyl ion, bis-(3-amino-4-hydroxyphenyl)methane, 2,2-bis(3-amino-4-hydroxyphenyl)propane, and 2,2-bis-(3-amino-4-hydroxyphenyl)propane. Examples of bis(4-hydroxyphenyl)hexafluoropropane, 2,2-bis(4-amino-3-hydroxyphenyl)hexafluoropropane, bis(4-amino-3-hydroxyphenyl)methane, 2,2-bis(4-amino-3-hydroxyphenyl)propane, 4,4'-diamino-3,3'-dihydroxybenzophenone, 3,3'-diamino-4,4'-dihydroxybenzophenone, 4,4'-diamino-3,3'-dihydroxydiphenyl ether, 3,3'-diamino-4,4'-dihydroxydiphenyl ether, 1,4-diamino-2,5-dihydroxybenzene, 1,3-diamino-2,4-dihydroxybenzene, 1,3-diamino-4,6-dihydroxybenzene, etc. These diaminophenols can be used alone or in combination.

在雙胺基苯酚衍生物中,下述具有芳香族基之雙胺基苯酚衍生物為較佳。 Among diaminophenol derivatives, the following diaminophenol derivatives having aromatic groups are preferred.

式中,X1表示-O-、-S-、-C(CF3)2-、-CH2-、-SO2-、-NHCO-,*及#分別表示與其他結構的鍵結部位。R表示氫原子或1價的取代基,氫原子或烴基為較佳,氫原子或烷基為更佳。又,R122為上述式所表示之結構亦較佳。在R122為上述式所表示之結構之情況下,在共計4個*及#中,任意2個為與式(3)中的R122所鍵結之氮原子的鍵結部位且其他2個為與式(3)中的R122所鍵結之氧原子的鍵結部位為較佳,2個*為與式(3)中的R122所鍵結之氧原子的鍵結部位且2個#為與式(3)中的R122所鍵結之氮原子的鍵結部位,或者2個*為與式(3)中的R122所鍵結之氮原子的鍵結部位且2個#為與式(3)中的R122所鍵結之氧原子的鍵結部位為更佳,2個*為 與式(3)中的R122所鍵結之氧原子的鍵結部位且2個#為與式(3)中的R122所鍵結之氮原子的鍵結部位為進一步較佳。 In the formula, X1 represents -O-, -S-, -C( CF3 ) 2- , -CH2- , -SO2- , and -NHCO-, and * and # represent the bonding sites with other structures, respectively. R represents a hydrogen atom or a monovalent substituent, with hydrogen atom or alkyl group being preferred, and hydrogen atom or alkyl group being even more preferred. Furthermore, R122 is also preferred to represent the structure described in the above formula. When R 122 has the structure represented by the above formula, it is preferable that any two of the four * and # are bonded to nitrogen atoms bound to R 122 in formula (3) and the other two are bonded to oxygen atoms bound to R 122 in formula (3). It is even better that two * are bonded to oxygen atoms bound to R 122 in formula (3) and two # are bonded to nitrogen atoms bound to R 122 in formula (3), or two * are bonded to nitrogen atoms bound to R 122 in formula (3) and two # are bonded to oxygen atoms bound to R 122 in formula (3). The bonding sites of the oxygen atoms bonded by 122 and the two # are more preferably the bonding sites of the nitrogen atoms bonded by R in equation (3).

雙胺基苯酚衍生物為式(A-s)所表示之化合物亦較佳。 The diaminophenol derivatives represented by formula (A-s) are also preferred.

式(A-s)中,R1為選自氫原子、伸烷基、取代伸烷基、-O-、-S-、-SO2-、-CO-、-NHCO-、單鍵或下述式(A-sc)之群組中的有機基。R2為氫原子、烷基、烷氧基、醯氧基、環狀烷基中的任一個,其可以相同亦可以不同。R3為氫原子、直鏈或支鏈烷基、烷氧基、醯氧基、環狀烷基中的任一個,其可以相同亦可以不同。 In formula (As), R1 is an organic group selected from hydrogen atom, alkyl group, substituted alkyl group, -O-, -S-, -SO2- , -CO-, -NHCO-, single bond, or the group of formulas (A-sc) below. R2 is any one of hydrogen atom, alkyl group, alkoxy group, acetoxy group, or cyclic alkyl group, which may be the same or different. R3 is any one of hydrogen atom, straight or branched alkyl group, alkoxy group, acetoxy group, or cyclic alkyl group, which may be the same or different.

(式(A-sc)中,*表示與上述式(A-s)所表示之雙胺基苯酚衍生物的胺基苯酚基的芳香環鍵結。) (In formula (A-sc), * indicates an aromatic ring bond with the aminophenol group of the diaminophenol derivative represented by formula (A-s) above.)

上述式(A-s)中,認為在酚性羥基的鄰位亦即在R3上亦具有取代基會使醯胺鍵的羰基碳與羥基的距離更靠近,在進一步提高在低溫下硬化時成為高環化率之效果之方面而言為特佳。 In the above formula (As), it is considered that having a substituent at the position adjacent to the phenolic hydroxyl group, that is, at R3 , will bring the carbonyl carbon of the amide bond closer to the hydroxyl group, which is particularly good in terms of further improving the effect of achieving a high cyclization rate when hardening at low temperatures.

又,上述式(A-s)中,R2為烷基且R3為烷基時能夠維持對i射線的高透明性和在低溫下硬化時為高環化率之效果,因此為較佳。 Furthermore, in the above formula (As), when R2 is an alkyl group and R3 is an alkyl group, it can maintain high transparency to i-rays and achieve a high cyclization rate when hardened at low temperatures, which is therefore better.

又,上述式(A-s)中,R1為伸烷基或取代伸烷基為進一步較佳。作為R1之伸烷基及取代伸烷基的具體例,可以舉出碳數1~8的直鏈狀或支鏈狀烷基,其中,在一邊維持對i射線的高透明性和在低溫下硬化時為高環化率之效果一邊能夠獲得對溶劑具有充分的溶解性之平衡優異之聚苯并唑前驅物之方面而言,-CH2-、-CH(CH3)-、-C(CH3)2-為更佳。 Furthermore, in the above formula (As), it is even more preferable that R1 is an alkylene group or a substituted alkylene group. Specific examples of alkylene groups and substituted alkylene groups of R1 include linear or branched alkyl groups having 1 to 8 carbon atoms, in which polystyrene exhibits an excellent balance between maintaining high transparency to X-rays and high cyclization rate during low-temperature curing, while also achieving sufficient solubility in solvents. Regarding azole precursors, -CH2- , -CH( CH3 )-, and -C( CH3 ) 2- are preferred.

作為上述式(A-s)所表示之雙胺基苯酚衍生物之製造方法,例如能夠參閱日本特開2013-256506號公報的0085~0094段及實施例1(0189~0190段),並將該等內容編入本說明書中。 For a method of manufacturing the diaminophenol derivative represented by the above formula (A-s), please refer to paragraphs 0085 to 0094 and Example 1 (paragraphs 0189 to 0190) of Japanese Patent Application Publication No. 2013-256506, and such contents are incorporated herein by reference.

作為上述式(A-s)所表示之雙胺基苯酚衍生物的結構的具體例,可以舉出日本特開2013-256506號公報的0070~0080段中所記載者,並將該等內容編入本說明書中。當然,並不限定於該等,這是不言而喻的。 Specific examples of the structures of diaminophenol derivatives represented by the above formula (A-s) can be found in paragraphs 0070-0080 of Japanese Patent Application Publication No. 2013-256506, and such contents are incorporated herein by reference. However, it is self-evident that these are not the only possible examples.

聚苯并唑前驅物除了上述式(3)的重複單元以外,還可以包含其他種類的重複單元。 Polybenzo[ In addition to the repeated units of formula (3) above, azole precursors may also contain other types of repeated units.

在能夠抑制伴隨閉環而產生翹曲之方面而言,聚苯并唑前驅物包含下述式(SL)所表示之二胺殘基作為其他種類的重複單元為較佳。 In terms of suppressing warping caused by ring closure, polyphenylene oxide (PPO) It is preferable that the azole precursor contains a diamine residue represented by the following formula (SL) as a repeating unit of other types.

[化學式16] [Chemical Formula 16]

式(SL)中,Z具有a結構和b結構,R1s為氫原子或碳數1~10的烴基,R2s為碳數1~10的烴基,R3s、R4s、R5s、R6s中的至少1個為芳香族基,其餘為氫原子或碳數1~30的有機基,其分別可以相同亦可以不同。a結構及b結構的聚合可以為嵌段聚合,亦可以為無規聚合。關於Z部分的莫耳%,a結構為5~95莫耳%、b結構為95~5莫耳%,a+b為100莫耳%。 In formula (SL), Z has an a-structure and a b-structure. R1s is a hydrogen atom or an hydrocarbon with 1 to 10 carbon atoms, R2s is an hydrocarbon with 1 to 10 carbon atoms, at least one of R3s , R4s , R5s , and R6s is an aromatic group, and the rest are hydrogen atoms or organic groups with 1 to 30 carbon atoms. These groups can be the same or different. The polymerization of the a-structure and the b-structure can be block polymerization or random polymerization. Regarding the molar percentage of the Z part, the a-structure is 5 to 95 molars, the b-structure is 95 to 5 molars, and a+b is 100 molars.

式(SL)中,作為較佳的Z,可以舉出b結構中的R5s及R6s為苯基者。又,式(SL)所示之結構的分子量為400~4,000為較佳,500~3,000為更佳。藉由將上述分子量設在上述範圍內,能夠更有效地減小聚苯并唑前驅物在脫水閉環後的彈性模數,能夠兼顧能夠抑制翹曲之效果和提高溶劑溶解性之效果。 In formula (SL), Z can be preferably represented by R5s and R6s in the b structure being phenyl. Furthermore, the molecular weight of the structure shown in formula (SL) is preferably 400-4,000, and more preferably 500-3,000. By setting the molecular weight within the above range, the polyphenylene oxide content can be reduced more effectively. The elastic modulus of the azole precursor after dehydration and ring closure can achieve both the effect of inhibiting warpage and improving solvent solubility.

在包含式(SL)所表示之二胺殘基作為其他種類的重複單元之情況下,進一步包含從四羧酸二酐中去除酐基之後殘存之四羧酸殘基作為重複單元亦較佳。作為該種四羧酸殘基的例子,可以舉出式(2)中的R115的例子。 In cases where the diamine residue represented by formula (SL) is used as another type of repeating unit, it is preferable to further include the tetracarboxylic acid residue remaining after the removal of the anhydride group from the tetracarboxylic acid dianhydride as a repeating unit. As an example of such a tetracarboxylic acid residue, R 115 in formula (2) can be cited.

聚苯并唑前驅物的重量平均分子量(Mw)例如較佳為18,000~30,000,更佳為20,000~29,000,進一步較佳為22,000~28,000。又,數量平均分子量(Mn)較佳為7,200~14,000,更佳為8,000~12,000,進一 步較佳為9,200~11,200。 Polybenzo[ The weight-average molecular weight (Mw) of the azole precursor is preferably 18,000 to 30,000, more preferably 20,000 to 29,000, and even more preferably 22,000 to 28,000. The number-average molecular weight (Mn) is preferably 7,200 to 14,000, more preferably 8,000 to 12,000, and even more preferably 9,200 to 11,200.

上述聚苯并唑前驅物的分子量的分散度為1.4以上為較佳,1.5以上為更佳,1.6以上為進一步較佳。聚苯并唑前驅物的分子量的分散度的上限值並無特別規定,例如2.6以下為較佳,2.5以下為更佳,2.4以下為進一步較佳,2.3以下為更進一步較佳,2.2以下為又更進一步較佳。 The above polybenzo[a] A molecular weight dispersion of 1.4 or higher for the azole precursor is preferred, 1.5 or higher is even better, and 1.6 or higher is further preferred. (Polybenzoxylene) There is no specific upper limit for the molecular weight dispersity of azole precursors. For example, 2.6 or less is preferred, 2.5 or less is better, 2.4 or less is even better, 2.3 or less is even better, and 2.2 or less is even better.

又,在樹脂組成物包含複數種聚苯并唑前驅物作為特定樹脂之情況下,至少1種聚苯并唑前驅物的重量平均分子量、數量平均分子量及分散度在上述範圍內為較佳。又,將上述複數種聚苯并唑前驅物作為1個樹脂計算出之重量平均分子量、數量平均分子量及分散度分別在上述範圍內亦較佳。 Furthermore, the resin composition contains multiple types of polystyrene. In the case of azole precursors as specific resins, at least one polybenzo[a]azole precursor is present. The weight-average molecular weight, number-average molecular weight, and dispersibility of the azole precursor are preferably within the above-mentioned ranges. Furthermore, the above-mentioned plurality of polybenzo[…] The weight-average molecular weight, number-average molecular weight, and dispersibility of the azole precursor as a resin are also better if they are within the above-mentioned ranges.

〔聚醯胺醯亞胺前驅物〕 [Polyamide imide precursor]

聚醯胺醯亞胺前驅物包含下述式(PAI-2)所表示之重複單元為較佳。 Polyamide imide precursors preferably contain repeating units represented by the following formula (PAI-2).

式(PAI-2)中,R117表示3價的有機基,R111表示2價的有機基,A2表示氧原子或-NH-,R113表示氫原子或1價的有機基。 In formula (PAI-2), R 117 represents a trivalent organic group, R 111 represents a divalent organic group, A 2 represents an oxygen atom or -NH-, and R 113 represents a hydrogen atom or a monovalent organic group.

式(PAI-2)中,R117可以例示直鏈狀或支鏈狀的脂肪族基、環狀的脂肪族基及芳香族基、雜芳族基團或者單鍵或藉由連接基將該等連接2個以上而獲得之基團,碳數2~20的直鏈的脂肪族基、碳數3~20的 支鏈的脂肪族基、碳數3~20的環狀的脂肪族基、碳數6~20的芳香族基或者單鍵或藉由連接基將該等組合2個以上而獲得之基團為較佳,碳數6~20的芳香族基或者單鍵或藉由連接基將碳數6~20的芳香族基組合2個以上而獲得之基團為更佳。 In formula (PAI-2), R 117 can be exemplified as a linear or branched aliphatic group, a cyclic aliphatic group, an aromatic group, a heteroaryl group, or a group obtained by connecting two or more of these groups with a single bond or by a linking group. It is preferred to have a linear aliphatic group with 2 to 20 carbons, a branched aliphatic group with 3 to 20 carbons, a cyclic aliphatic group with 3 to 20 carbons, an aromatic group with 6 to 20 carbons, or a group obtained by combining two or more of these groups with a single bond or by a linking group. It is even more preferred to have an aromatic group with 6 to 20 carbons, or an aromatic group obtained by combining two or more of these groups with a single bond or by a linking group.

作為上述連接基,-O-、-S-、-C(=O)-、-S(=O)2-、伸烷基、鹵化伸烷基、伸芳基或該等鍵結2個以上而形成之連接基為較佳,-O-、-S-、伸烷基、鹵化伸烷基、伸芳基或該等鍵結2個以上而形成之連接基為更佳。 As the linking group mentioned above, a linking group formed by -O-, -S-, -C(=O)-, -S(=O) 2- , alkylene, halogenated alkylene, arylene, or two or more of the above bonds is preferred, and a linking group formed by -O-, -S-, alkylene, halogenated alkylene, arylene, or two or more of the above bonds is even more preferred.

作為上述伸烷基,碳數1~20的伸烷基為較佳,碳數1~10的伸烷基為更佳,碳數1~4的伸烷基為進一步較佳。 Of the aforementioned alkyl groups, those having 1 to 20 carbon atoms are preferred, those having 1 to 10 carbon atoms are more preferred, and those having 1 to 4 carbon atoms are even more preferred.

作為上述鹵化伸烷基,碳數1~20的鹵化伸烷基為較佳,碳數1~10的鹵化伸烷基為更佳,碳數1~4的鹵化伸烷基為更佳。又,作為上述鹵化伸烷基中之鹵素原子,可以舉出氟原子、氯原子、溴原子、碘原子等,氟原子為較佳。上述鹵化伸烷基可以具有氫原子,亦可以使所有氫原子經鹵素原子取代,但是所有氫原子經鹵素原子取代為較佳。作為較佳的鹵化伸烷基的例子,可以舉出(二三氟甲基)亞甲基等。 Of the aforementioned halogenated alkyl groups, those with 1 to 20 carbon atoms are preferred, those with 1 to 10 carbon atoms are more preferred, and those with 1 to 4 carbon atoms are even more preferred. Furthermore, examples of halogen atoms in the aforementioned halogenated alkyl groups include fluorine, chlorine, bromine, and iodine atoms, with fluorine atoms being preferred. The aforementioned halogenated alkyl groups may contain hydrogen atoms, or all hydrogen atoms may be substituted with halogen atoms, but substitution with halogen atoms is preferred. Examples of preferred halogenated alkyl groups include (di-trifluoromethyl)methylene.

作為上述伸芳基,伸苯基或伸萘基為較佳,伸苯基為更佳,1,3-伸苯基或1,4-伸苯基為進一步較佳。 Of the aforementioned aryl group, phenyl or naphthyl group is preferred, phenyl group is more preferred, and 1,3-phenyl or 1,4-phenyl group is even more preferred.

又,R117從至少1個羧基可以被鹵化的三羧酸化合物衍生為較佳。作為上述鹵化,氯化為較佳。 Furthermore, R 117 is preferably derived from a tricarboxylic acid compound in which at least one carboxyl group can be halogenated. Chlorination is preferred as the halogenation method described above.

在本發明中,將具有3個羧基之化合物稱為三羧酸化合物。 In this invention, compounds having three carboxyl groups are referred to as tricarboxylic acid compounds.

上述三羧酸化合物的3個羧基中的2個羧基可以被酸酐化。 Two of the three carboxyl groups in the above tricarboxylic acid compound can be anhydride-substituted.

作為用於聚醯胺醯亞胺前驅物的製造中之可以被鹵化的三羧酸化合物, 可以舉出支鏈狀的脂肪族、環狀的脂肪族或芳香族的三羧酸化合物等。 As halogenable tricarboxylic acid compounds used in the manufacture of polyamide imine precursors, examples include branched aliphatic, cyclic aliphatic, or aromatic tricarboxylic acid compounds.

該等三羧酸化合物可以僅使用1種,亦可以使用2種以上。 One or more of these tricarboxylic acid compounds may be used.

具體而言,作為三羧酸化合物,包含碳數2~20的直鏈的脂肪族基、碳數3~20的支鏈的脂肪族基、碳數3~20的環狀的脂肪族基、碳數6~20的芳香族基或者單鍵或藉由連接基將該等組合2個以上而獲得之基團之三羧酸化合物為較佳,包含碳數6~20的芳香族基或者單鍵或藉由連接基將碳數6~20的芳香族基組合2個以上而獲得之基團之三羧酸化合物為更佳。 Specifically, as a tricarboxylic acid compound, a tricarboxylic acid compound comprising a straight-chain aliphatic group having 2 to 20 carbon atoms, a branched aliphatic group having 3 to 20 carbon atoms, a cyclic aliphatic group having 3 to 20 carbon atoms, an aromatic group having 6 to 20 carbon atoms, or a single bond or a group formed by combining two or more of these groups via a linker is preferred. A tricarboxylic acid compound comprising an aromatic group having 6 to 20 carbon atoms, or a single bond or a group formed by combining two or more aromatic groups having 6 to 20 carbon atoms via a linker is even more preferred.

又,作為三羧酸化合物的具體例,可以舉出藉由單鍵、-O-、-CH2-、-C(CH3)2-、-C(CF3)2-、-SO2-或伸苯基連接1,2,3-丙烷三羧酸、1,3,5-戊烷三羧酸、檸檬酸、偏苯三甲酸、2,3,6-萘三羧酸、鄰苯二甲酸(或者,鄰苯二甲酸酐)與苯甲酸之化合物等。 Furthermore, specific examples of tricarboxylic acid compounds include compounds in which 1,2,3-propanetricarboxylic acid, 1,3,5 - pentanetricarboxylic acid, citric acid, trimellitic acid, 2,3,6-naphthalenetricarboxylic acid, phthalic acid (or phthalic anhydride) and benzoic acid are linked by single bonds, -O-, -CH2-, -C( CH3 ) 2- , -C( CF3 )2-, -SO2- , or extended phenyl groups.

該等化合物可以為2個羧基被酐化之化合物(例如,偏苯三甲酸酐),亦可以為至少1個羧基被鹵化之化合物(例如,偏苯三酸酐醯氯)。 These compounds can be compounds in which two carboxyl groups are anhydride-substituted (e.g., trimellitic anhydride), or compounds in which at least one carboxyl group is halogenated (e.g., trimellitic anhydride acetochlor).

式(PAI-2)中,R111、A2、R113分別與上述式(2)中之R111、A2、R113的含義相同,較佳態樣亦相同。 In formula (PAI-2), R111 , A2 , and R113 have the same meaning as R111 , A2 , and R113 in formula (2) above, and the better state is also the same.

聚醯胺醯亞胺前驅物可以進一步包含其他重複單元。 Polyamide imide precursors can further include other repeating units.

作為其他重複單元,可以舉出上述式(2)所表示之重複單元、下述式(PAI-1)所表示之重複單元等。 Other examples of repeating units include the repeating unit represented by equation (2) above, and the repeating unit represented by equation (PAI-1) below.

[化學式18] [Chemical Formula 18]

式(PAI-1)中,R116表示2價的有機基,R111表示2價的有機基。 In formula (PAI-1), R 116 represents a divalent organic group, and R 111 represents a divalent organic group.

式(PAI-1)中,R116可以例示直鏈狀或支鏈狀的脂肪族基、環狀的脂肪族基及芳香族基、雜芳族基團或者單鍵或藉由連接基將該等連接2個以上而獲得之基團,碳數2~20的直鏈的脂肪族基、碳數3~20的支鏈的脂肪族基、碳數3~20的環狀的脂肪族基、碳數6~20的芳香族基或者單鍵或藉由連接基將該等組合2個以上而獲得之基團為較佳,碳數6~20的芳香族基或者單鍵或藉由連接基將碳數6~20的芳香族基組合2個以上而獲得之基團為更佳。 In formula (PAI-1), R 116 can be an example of a linear or branched aliphatic group, a cyclic aliphatic group, an aromatic group, a heteroaryl group, or a group obtained by connecting two or more of these groups with a single bond or by linking groups. It is preferred to have a linear aliphatic group with 2 to 20 carbons, a branched aliphatic group with 3 to 20 carbons, a cyclic aliphatic group with 3 to 20 carbons, an aromatic group with 6 to 20 carbons, or a group obtained by combining two or more of these groups with a single bond or by linking groups. It is even more preferred to have an aromatic group with 6 to 20 carbons, or an aromatic group obtained by combining two or more of these groups with a single bond or by linking groups.

作為上述連接基,-O-、-S-、-C(=O)-、-S(=O)2-、伸烷基、鹵化伸烷基、伸芳基或該等鍵結2個以上而形成之連接基為較佳,-O-、-S-、伸烷基、鹵化伸烷基、伸芳基或該等鍵結2個以上而形成之連接基為更佳。 As the linking group mentioned above, a linking group formed by -O-, -S-, -C(=O)-, -S(=O) 2- , alkylene, halogenated alkylene, arylene, or two or more of the above bonds is preferred, and a linking group formed by -O-, -S-, alkylene, halogenated alkylene, arylene, or two or more of the above bonds is even more preferred.

作為上述伸烷基,碳數1~20的伸烷基為較佳,碳數1~10的伸烷基為更佳,碳數1~4的伸烷基為進一步較佳。 Of the aforementioned alkyl groups, those having 1 to 20 carbon atoms are preferred, those having 1 to 10 carbon atoms are more preferred, and those having 1 to 4 carbon atoms are even more preferred.

作為上述鹵化伸烷基,碳數1~20的鹵化伸烷基為較佳,碳數1~10的鹵化伸烷基為更佳,碳數1~4的鹵化伸烷基為更佳。又,作為上述鹵化伸烷基中之鹵素原子,可以舉出氟原子、氯原子、溴原子、碘原子等,氟原子為較佳。上述鹵化伸烷基可以具有氫原子,亦可以使所有氫原子經鹵素原子取代,但是所有氫原子經鹵素原子取代為較佳。作為較佳的鹵化伸 烷基的例子,可以舉出(二三氟甲基)亞甲基等。 Of the aforementioned halogenated alkyl groups, those with 1 to 20 carbon atoms are preferred, those with 1 to 10 carbon atoms are more preferred, and those with 1 to 4 carbon atoms are even more preferred. Furthermore, examples of halogen atoms in the aforementioned halogenated alkyl groups include fluorine, chlorine, bromine, and iodine atoms, with fluorine atoms being preferred. The aforementioned halogenated alkyl groups may contain hydrogen atoms, or all hydrogen atoms may be substituted with halogen atoms, but substitution with halogen atoms is preferred. Examples of preferred halogenated alkyl groups include (di-trifluoromethyl)methylene.

作為上述伸芳基,伸苯基或伸萘基為較佳,伸苯基為更佳,1,3-伸苯基或1,4-伸苯基為進一步較佳。 Of the aforementioned aryl group, phenyl or naphthyl group is preferred, phenyl group is more preferred, and 1,3-phenyl or 1,4-phenyl group is even more preferred.

又,R116從二羧酸化合物或二羧酸二鹵化物衍生為較佳。 Furthermore, it is preferable that R 116 is derived from dicarboxylic acid compounds or dicarboxylic acid dihalides.

在本發明中,將具有2個羧基之化合物稱為二羧酸化合物,且將具有2個被鹵化之羧基之化合物稱為二羧酸二鹵化物。 In this invention, compounds having two carboxyl groups are referred to as dicarboxylic acid compounds, and compounds having two halogenated carboxyl groups are referred to as dicarboxylic acid dihalides.

二羧酸二鹵化物中之羧基只要被鹵化即可,例如被氯化為較佳。亦即,二羧酸二鹵化物為二羧酸二氯化物化合物為較佳。 In dicarboxylic acid dihalides, the carboxyl group only needs to be halogenated; for example, chlorination is preferred. That is, dicarboxylic acid dihalides are preferably dicarboxylic acid dichloride compounds.

作為用於聚醯胺醯亞胺前驅物的製造中之可以被鹵化的二羧酸化合物或二羧酸二鹵化物,可以舉出直鏈狀或支鏈狀的脂肪族、環狀的脂肪族或芳香族二羧酸化合物或二羧酸二鹵化物等。 Examples of halogenable dicarboxylic acid compounds or dicarboxylic acid dihalides that can be used in the manufacture of polyamide imine precursors include linear or branched aliphatic, cyclic, or aromatic dicarboxylic acid compounds or dicarboxylic acid dihalides.

該等二羧酸化合物或二羧酸二鹵化物可以僅使用1種,亦可以使用2種以上。 One or more of these dicarboxylic acid compounds or dicarboxylic acid dihalides may be used.

具體而言,作為二羧酸化合物或二羧酸二鹵化物,包含碳數2~20的直鏈的脂肪族基、碳數3~20的支鏈的脂肪族基、碳數3~20的環狀的脂肪族基、碳數6~20的芳香族基或者單鍵或藉由連接基將該等組合2個以上而獲得之基團之二羧酸化合物或二羧酸二鹵化物為較佳,包含碳數6~20的芳香族基或者單鍵或藉由連接基將碳數6~20的芳香族基組合2個以上而獲得之基團之二羧酸化合物或二羧酸二鹵化物為更佳。 Specifically, as a dicarboxylic acid compound or dicarboxylic acid dihalogenate, it is preferable that the compound or dicarboxylic acid dihalogenate comprises a straight-chain aliphatic group having 2 to 20 carbon atoms, a branched aliphatic group having 3 to 20 carbon atoms, a cyclic aliphatic group having 3 to 20 carbon atoms, an aromatic group having 6 to 20 carbon atoms, or a single bond or a group obtained by combining two or more of these groups via a linker. It is even more preferable that the compound or dicarboxylic acid dihalogenate comprises an aromatic group having 6 to 20 carbon atoms, or a single bond or a group obtained by combining two or more aromatic groups having 6 to 20 carbon atoms via a linker.

又,作為二羧酸化合物的具體例,可以舉出丙二酸、二甲基丙二酸、乙基丙二酸、異丙基丙二酸、二正丁基丙二酸、琥珀酸、四氟琥珀酸、甲基琥珀酸、2,2-二甲基琥珀酸、2,3-二甲基琥珀酸、二甲基甲基琥 珀酸、戊二酸、六氟戊二酸、2-甲基戊二酸、3-甲基戊二酸、2,2-二甲基戊二酸、3,3-二甲基戊二酸、3-乙基-3-甲基戊二酸、己二酸、八氟己二酸、3-甲基己二酸、庚二酸、2,2,6,6-四甲基庚二酸、辛二酸、十二氟辛二酸、壬二酸、癸二酸、十六氟癸二酸、1,9-壬二酸、十二烷二酸、十三烷二酸、十四烷二酸、十五烷二酸、十六烷二酸、十七烷二酸、十八烷二酸、十九烷二酸、二十烷二酸、二十一烷二酸、二十二烷二酸、二十三烷二酸、二十四烷二酸、二十五烷二酸、二十六烷二酸、二十七烷二酸、二十八烷二酸、二十九烷二酸、三十烷二酸、三十一烷二酸、三十二烷二酸、二乙醇酸、鄰苯二甲酸、間苯二甲酸、對苯二甲酸、4,4’-聯苯羧酸、4,4’-聯苯羧酸、4,4’-二羧基二苯醚、二苯甲酮-4,4’-二羧酸等。 Furthermore, specific examples of dicarboxylic acid compounds include malonic acid, dimethylmalonic acid, ethylmalonic acid, isopropylmalonic acid, di-n-butylmalonic acid, succinic acid, tetrafluorosuccinic acid, methylsuccinic acid, 2,2-dimethylsuccinic acid, 2,3-dimethylsuccinic acid, dimethylmethylsuccinic acid, glutaric acid, hexafluoroglutaric acid, 2-methylglutaric acid, 3-methylglutaric acid, 2,2-dimethylglutaric acid, 3,3-dimethylglutaric acid, 3-ethyl-3-methylglutaric acid, adipic acid, octafluoroadipic acid, 3-methyladipic acid, pimelic acid, 2,2,6,6-tetramethylpimelic acid, octanoic acid, dodecafluorooctanoic acid, azelaic acid, sebacic acid, and hexafluoro... Sebacatedioic acid, 1,9-azeladic acid, dodecanedioic acid, tridecanedioic acid, tetradecanedioic acid, pentadecanedioic acid, hexadecanedioic acid, heptadecanedioic acid, octadecanedioic acid, nonadecanedioic acid, eicosanedioic acid, hexadecanedioic acid, dohenedioic acid, tricosanedioic acid, tetracosanedioic acid, pentacosanedioic acid, hexadecanedioic acid, Heptadecanedioic acid, octadecanedioic acid, nonacosanedioic acid, triacontanedioic acid, triacontanedioic acid, triacontanedioic acid, diglycolic acid, phthalic acid, isophthalic acid, terephthalic acid, 4,4’-biphenylcarboxylic acid, 4,4’-biphenylcarboxylic acid, 4,4’-dicarboxyl diphenyl ether, benzophenone-4,4’-dicarboxylic acid, etc.

作為二羧酸二鹵化物的具體例,可以舉出將上述二羧酸化合物的具體例中之2個羧基進行鹵化而形成之結構的化合物。 As a specific example of a dicarboxylic acid dihalide, a compound with a structure formed by halogenating two carboxyl groups in the aforementioned dicarboxylic acid compounds can be cited.

式(PAI-1)中,R111與上述式(2)中之R111的含義相同,較佳態樣亦相同。 In formula (PAI-1), R 111 has the same meaning as R 111 in formula (2) above, and the better state is also the same.

又,聚醯胺醯亞胺前驅物在結構中具有氟原子亦較佳。聚醯胺醯亞胺前驅物中的氟原子含量為10質量%以上為較佳,並且20質量%以下為較佳。 Furthermore, it is preferable that the polyamide-imide precursor contains fluorine atoms in its structure. A fluorine atom content of 10% by mass or more, and less than 20% by mass, is preferred in the polyamide-imide precursor.

又,為了提高與基板的密接性,聚醯胺醯亞胺前驅物可以與具有矽氧烷結構之脂肪族基共聚。具體而言,作為二胺成分,可以舉出使用雙(3-胺基丙基)四甲基二矽氧烷、雙(對胺基苯基)八甲基五矽氧烷等之態樣。 Furthermore, to improve adhesion to the substrate, the polyamide imine precursor can be copolymerized with aliphatic groups having a siloxane structure. Specifically, examples of diamine components include bis(3-aminopropyl)tetramethyldisiloxane and bis(p-aminophenyl)octamethylpentasiloxane.

作為本發明中之聚醯胺醯亞胺前驅物的一實施形態,可以舉 出式(PAI-2)所表示之重複單元、式(PAI-1)所表示之重複單元及式(2)所表示之重複單元的合計含量為所有重複單元的50莫耳%以上之態樣。上述合計含量為70莫耳%以上為更佳,90莫耳%以上為進一步較佳,超過90莫耳%為特佳。上述合計含量的上限並無特別限定,除了末端以外的聚醯胺醯亞胺前驅物中之所有重複單元可以為式(PAI-2)所表示之重複單元、式(PAI-1)所表示之重複單元及式(2)所表示之重複單元中的任一個。 As an embodiment of the polyamide imide precursor of the present invention, an example is provided where the total content of the repeating unit represented by formula (PAI-2), the repeating unit represented by formula (PAI-1), and the repeating unit represented by formula (2) is 50 mol% or more of all repeating units. A total content of 70 mol% or more is preferred, 90 mol% or more is further preferred, and more than 90 mol% is particularly preferred. There is no particular upper limit to the total content; all repeating units in the polyamide imide precursor, except for the terminal units, can be any one of the repeating units represented by formula (PAI-2), formula (PAI-1), and formula (2).

又,作為本發明中之聚醯胺醯亞胺前驅物的另一實施形態,可以舉出式(PAI-2)所表示之重複單元及式(PAI-1)所表示之重複單元的合計含量為所有重複單元的50莫耳%以上之態樣。上述合計含量為70莫耳%以上為更佳,90莫耳%以上為進一步較佳,超過90莫耳%為特佳。上述合計含量的上限並無特別限定,除了末端以外的聚醯胺醯亞胺前驅物中之所有重複單元可以為式(PAI-2)所表示之重複單元或式(PAI-1)所表示之重複單元中的任一個。 Furthermore, as another embodiment of the polyamide-imide precursor of this invention, an example is provided where the total content of the repeating units represented by formula (PAI-2) and formula (PAI-1) is 50 mol% or more of all repeating units. A total content of 70 mol% or more is preferred, 90 mol% or more is further preferred, and more than 90 mol% is particularly preferred. There is no particular upper limit to the total content; all repeating units in the polyamide-imide precursor, except for the terminal units, can be any one of the repeating units represented by formula (PAI-2) or formula (PAI-1).

聚醯胺醯亞胺前驅物的重量平均分子量(Mw)較佳為2,000~500,000,更佳為5,000~100,000,進一步較佳為10,000~50,000。又,數量平均分子量(Mn)較佳為800~250,000,更佳為2,000~50,000,進一步較佳為4,000~25,000。 The weight-average molecular weight (Mw) of the polyamide amide precursor is preferably 2,000 to 500,000, more preferably 5,000 to 100,000, and even more preferably 10,000 to 50,000. Furthermore, the number-average molecular weight (Mn) is preferably 800 to 250,000, more preferably 2,000 to 50,000, and even more preferably 4,000 to 25,000.

聚醯胺醯亞胺前驅物的分子量的分散度為1.5以上為較佳,1.8以上為更佳,2.0以上為進一步較佳。聚醯胺醯亞胺前驅物的分子量的分散度的上限值並無特別規定,例如為7.0以下為較佳,6.5以下為更佳,6.0以下為進一步較佳。又,在樹脂組成物包含複數種聚醯胺醯亞胺前驅物作為特定樹脂之情況下,至少1種聚醯胺醯亞胺前驅物的重量平均分子量、數量平均 分子量及分散度在上述範圍內為較佳。又,將上述複數種聚醯胺醯亞胺前驅物作為1個樹脂計算出之重量平均分子量、數量平均分子量及分散度分別在上述範圍內亦較佳。 The molecular weight dispersion of the polyamide-imide precursor is preferably 1.5 or higher, more preferably 1.8 or higher, and even more preferably 2.0 or higher. There is no particular upper limit specified for the molecular weight dispersion of the polyamide-imide precursor; for example, 7.0 or lower is preferred, 6.5 or lower is more preferred, and 6.0 or lower is even more preferred. Furthermore, when the resin composition includes multiple polyamide-imide precursors as a specific resin, it is preferable that the weight average molecular weight, number average molecular weight, and dispersion of at least one polyamide-imide precursor are within the above-mentioned ranges. Furthermore, it is also preferable that the weight-average molecular weight, number-average molecular weight, and dispersity calculated when treating the aforementioned multiple polyamide imide precursors as a single resin are all within the ranges described above.

〔聚醯亞胺前驅物等之製造方法〕 [Manufacturing methods for polyimide precursors, etc.]

聚醯亞胺前驅物等例如能夠利用如下方法而獲得:在低溫下使四羧酸二酐和二胺進行反應之方法、在低溫下使四羧酸二酐和二胺進行反應而獲得聚醯胺酸並使用縮合劑或烷化劑使其酯化之方法、藉由四羧酸二酐和醇而獲得二酯,之後在二胺和縮合劑的存在下使其進行反應之方法、藉由四羧酸二酐和醇而獲得二酯,之後使用鹵化劑使其餘的二羧酸鹵化,並使其與二胺進行反應之方法等。在上述製造方法中,藉由四羧酸二酐和醇而獲得二酯,之後使用鹵化劑使其餘的二羧酸鹵化,並使其與二胺進行反應之方法為更佳。 Polyimide precursors can be obtained, for example, by reacting tetracarboxylic dianhydride and diamine at low temperature; by reacting tetracarboxylic dianhydride and diamine at low temperature to obtain polyamide and then esterifying it using a condensing agent or alkylating agent; by obtaining a diester from tetracarboxylic dianhydride and alcohol, and then reacting it in the presence of diamine and a condensing agent; by obtaining a diester from tetracarboxylic dianhydride and alcohol, then halogenating the remaining dicarboxylic acid with a halogenating agent, and then reacting it with diamine, etc. Among the above manufacturing methods, the method of obtaining a diester from tetracarboxylic dianhydride and alcohol, then halogenating the remaining dicarboxylic acid with a halogenating agent, and then reacting it with diamine is preferred.

作為上述縮合劑,例如可以舉出二環己基碳二醯亞胺、二異丙基碳二醯亞胺、1-乙氧基羰基-2-乙氧基-1,2-二氫喹啉、1,1-羰基二氧基-二-1,2,3-苯并三唑、N,N’-二琥珀醯亞胺基碳酸酯(Disuccinimidyl carbonate)、三氟乙酸酐等。 Examples of such condensing agents include dicyclohexylcarbodiimide, diisopropylcarbodiimide, 1-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, 1,1-carbonyldioxy-di-1,2,3-benzotriazole, N,N'-disuccinimidyl carbonate, and trifluoroacetic anhydride.

作為上述烷化劑,可以舉出N,N-二甲基甲醯胺二甲基縮醛、N,N-二甲基甲醯胺二乙基縮醛、N,N-二烷基甲醯胺二烷基縮醛、原甲酸三甲酯、原甲酸三乙酯等。 Examples of the aforementioned alkylating agents include N,N-dimethylformamide dimethyl acetal, N,N-dimethylformamide diethyl acetal, N,N-dialkylformamide dialkyl acetal, trimethyl orthoformate, and triethyl orthoformate.

作為上述鹵化劑,可以舉出硫醯氯、草醯氯、氧氯化磷等。 Examples of such halogenating agents include thiocyanate, glyphosate, and phosphorus oxychloride.

在聚醯亞胺前驅物等之製造方法中,在進行反應時,使用有機溶劑為較佳。有機溶劑可以為1種,亦可以為2種以上。 In the manufacturing process of polyimide precursors, it is preferable to use an organic solvent during the reaction. One or more organic solvents may be used.

作為有機溶劑,能夠依據原料適當設定,但是可以例示吡啶、二乙二醇二甲醚(二甘二甲醚)、N-甲基吡咯啶酮、N-乙基吡咯啶酮、丙酸乙酯、二甲基乙醯胺、二甲基甲醯胺、四氫呋喃、γ-丁內酯等。 As an organic solvent, it can be appropriately set according to the raw materials, but examples include pyridine, diethylene glycol dimethyl ether (diethylene glycol dimethyl ether), N-methylpyrrolidone, N-ethylpyrrolidone, ethyl propionate, dimethylacetamide, dimethylformamide, tetrahydrofuran, γ-butyrolactone, etc.

在聚醯亞胺前驅物等之製造方法中,在進行反應時,添加鹼性化合物為較佳。鹼性化合物可以為1種,亦可以為2種以上。 In the manufacturing process of polyimide precursors, it is preferable to add an alkaline compound during the reaction. The alkaline compound can be one type or two or more types.

鹼性化合物能夠依據原料適當設定,但是可以例示三乙胺、二異丙基乙胺、吡啶、1,8-二氮雜雙環[5.4.0]十一碳-7-烯、N,N-二甲基-4-胺基吡啶等。 The alkaline compound can be appropriately set according to the raw materials, but examples include triethylamine, diisopropylethylamine, pyridine, 1,8-diazabicyclo[5.4.0]undec-7-ene, N,N-dimethyl-4-aminopyridine, etc.

-封端劑- -Pre-constriction agent-

在聚醯亞胺前驅物等之製造方法中,為了進一步提高保存穩定性,密封殘存於聚醯亞胺前驅物等樹脂末端之羧酸酐、酸酐衍生物或胺基為較佳。在密封殘存於樹脂末端之羧酸酐及酸酐衍生物時,作為封端劑,可以舉出一元醇、酚、硫醇、苯硫酚、單胺等,從反應性、膜的穩定性的觀點考慮,使用一元醇、酚類或單胺為更佳。作為一元醇的較佳化合物,可以舉出甲醇、乙醇、丙醇、丁醇、己醇、辛醇、十二醇、苯甲醇、2-苯基乙醇、2-甲氧基乙醇、2-氯甲醇、糠醇等一級醇、異丙醇、2-丁醇、環己醇、環戊醇、1-甲氧基-2-丙醇等二級醇、第三丁醇、金剛烷醇等三級醇。作為酚類的較佳化合物,可以舉出酚、甲氧基苯酚、甲基酚、萘-1-醇、萘-2-醇、羥基苯乙烯等酚類等。又,作為單胺的較佳化合物,可以舉出苯胺、2-乙炔基苯胺、3-乙炔基苯胺、4-乙炔基苯胺、5-胺基-8-羥基喹啉、1-羥基-7-胺基萘、1、羥基-6-胺基萘、1-羥基-5-胺基萘、1-羥基-4-胺基萘、2-羥基-7-胺基萘、2、羥基-6-胺基萘、2-羥基-5-胺基萘、1-羧基-7-胺基萘、1-羧基-6-胺基萘、1-羧基-5-胺基萘、2-羧基-7-胺基萘、2-羧基-6-胺基萘、2-羧基-5-胺基萘、2-胺 基苯甲酸、3-胺基苯甲酸、4-胺基苯甲酸、4-胺基水楊酸、5-胺基水楊酸、6-胺基水楊酸、2-胺基苯磺酸、3-胺基苯磺酸、4-胺基苯磺酸、3-胺基-4,6-二羥基嘧啶、2-胺基酚、3-胺基酚、4-胺基酚、2-胺基苯硫酚、3-胺基苯硫酚、4-胺基苯硫酚等。該等可以使用2種以上,藉由使複數種封端劑進行反應,可以導入複數個不同之末端基。 In the manufacturing process of polyimide precursors, etc., it is preferable to seal the carboxylic anhydride, anhydride derivative, or amine group remaining at the ends of the resin, etc., in order to further improve storage stability. When sealing the carboxylic anhydride and anhydride derivative remaining at the ends of the resin, monohydric alcohols, phenols, thiols, benzenethiophenols, monoamines, etc., can be used as end-capping agents. From the viewpoint of reactivity and film stability, monohydric alcohols, phenols, or monoamines are preferred. Preferred compounds for monohydric alcohols include methanol, ethanol, propanol, butanol, hexanol, octanol, dodecanol, benzyl alcohol, 2-phenylethanol, 2-methoxyethanol, 2-chloromethanol, furfuryl alcohol, etc.; secondary alcohols include isopropanol, 2-butanol, cyclohexanol, cyclopentanol, 1-methoxy-2-propanol, etc.; and tertiary alcohols include tert-butanol, adamantanol, etc. Preferred compounds for phenols include phenols, methoxyphenol, methylphenol, naphth-1-ol, naphth-2-ol, hydroxystyrene, etc. Furthermore, preferred compounds as monoamines include aniline, 2-ethynylaniline, 3-ethynylaniline, 4-ethynylaniline, 5-amino-8-hydroxyquinoline, 1-hydroxy-7-aminonaphthalene, 1-hydroxy-6-aminonaphthalene, 1-hydroxy-5-aminonaphthalene, 1-hydroxy-4-aminonaphthalene, 2-hydroxy-7-aminonaphthalene, 2-hydroxy-6-aminonaphthalene, 2-hydroxy-5-aminonaphthalene, 1-carboxy-7-aminonaphthalene, 1-carboxy-6-aminonaphthalene, and 1-carboxy-5-aminonaphthalene. Examples of amino acids include 2-carboxy-7-aminonaphthalene, 2-carboxy-6-aminonaphthalene, 2-carboxy-5-aminonaphthalene, 2-aminobenzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, 4-aminosalicylic acid, 5-aminosalicylic acid, 6-aminosalicylic acid, 2-aminobenzenesulfonic acid, 3-aminobenzenesulfonic acid, 4-aminobenzenesulfonic acid, 3-amino-4,6-dihydroxypyrimidine, 2-aminophenol, 3-aminophenol, 4-aminophenol, 2-aminobenzenethiophenol, 3-aminobenzenethiophenol, and 4-aminobenzenethiophenol. Two or more of these can be used, and by reacting a plurality of end-capping agents, a plurality of different terminal groups can be introduced.

又,在密封樹脂末端的胺基時,能夠用具有能夠與胺基進行反應的官能基之化合物進行密封。對胺基之較佳的密封劑為羧酸酐、羧酸氯化物、羧酸溴化物、磺酸氯化物、磺酸酐、磺酸羧酸酐等為較佳,羧酸酐、羧酸氯化物為更佳。作為羧酸酐的較佳化合物,可以舉出乙酸酐、丙酸酐、草酸酐、琥珀酸酐、順丁烯二酸酐、鄰苯二甲酸酐、苯甲酸酐、5-降莰烯-2,3-二羧酸酐等。又,作為羧酸氯化物的較佳化合物,可以舉出乙醯氯、丙烯醯氯、丙醯氯、甲基丙烯醯氯、三甲基乙醯氯、環己烷甲醯氯、2-乙基己醯氯、桂皮醯氯、1-金剛烷甲醯氯、七氟丁醯氯、硬脂酸醯氯、苯甲醯氯等。 Furthermore, when sealing the amine groups at the ends of the resin, compounds with functional groups capable of reacting with the amine groups can be used for sealing. Preferred sealants for amine groups include carboxylic anhydrides, carboxylic acid chlorides, carboxylic acid bromides, sulfonic acid chlorides, sulfonic acid anhydrides, and sulfonic acid carboxylic anhydrides, with carboxylic anhydrides and carboxylic acid chlorides being even more preferred. Examples of preferred carboxylic anhydrides include acetic anhydride, propionic anhydride, oxalic anhydride, succinic anhydride, maleic anhydride, phthalic anhydride, benzoic anhydride, and 5-norcamphene-2,3-dicarboxylic anhydride. Furthermore, preferred compounds for carboxylic acid chlorides include acetyl chloride, acrylamide chloride, propionyl chloride, methacrylamide chloride, trimethylacetyl chloride, cyclohexanemethyl chloride, 2-ethylhexyl chloride, cinnamic acid chloride, 1-draconanemethyl chloride, heptafluorobutyric acid chloride, stearic acid chloride, and benzoyl chloride.

-固體析出- -Solid precipitation-

在製造聚醯亞胺前驅物等時,可以包括使固體析出之步驟。具體而言,依據需要過濾出在反應液中共存之脫水縮合劑的吸水副產物之後,向水、脂肪族低級醇或其混合液等的不良溶劑投入所獲得之聚合物成分,使聚合物成分析出以作為固體析出並使其乾燥,從而能夠獲得聚醯亞胺前驅物等。為了提高純化度,可以重複將聚醯亞胺前驅物等再溶解、再沉澱、乾燥等的操作。進而,可以包括使用離子交換樹脂來去除離子性雜質之步驟。 In the manufacture of polyimide precursors, a solid precipitation step may be included. Specifically, after filtering out the water-absorbing byproducts of the dehydrating condensing agent coexisting in the reaction solution as needed, the obtained polymer components are added to a poor solvent such as water, aliphatic lower alcohols, or mixtures thereof, causing the polymer components to precipitate as a solid and then dried, thereby obtaining the polyimide precursor. To improve purity, the processes of re-dissolving, re-precipitating, and drying the polyimide precursor can be repeated. Furthermore, a step of using an ion exchange resin to remove ionic impurities may be included.

〔含量〕 [Content]

本發明的樹脂組成物中之特定樹脂的含量相對於樹脂組成物的總固體 成分為20質量%以上為較佳,30質量%以上為更佳,40質量%以上為進一步較佳,50質量%以上為更進一步較佳。又,本發明的樹脂組成物中之樹脂的含量相對於樹脂組成物的總固體成分為99.5質量%以下為較佳,99質量%以下為更佳,98質量%以下為進一步較佳,97質量%以下為更進一步較佳,95質量%以下為又更進一步較佳。 The content of a specific resin in the resin composition of the present invention, relative to the total solid content of the resin composition, is preferably 20% by mass or more, more preferably 30% by mass or more, further preferably 40% by mass or more, and even more preferably 50% by mass or more. Furthermore, the content of the resin in the resin composition of the present invention, relative to the total solid content of the resin composition, is preferably 99.5% by mass or less, more preferably 99% by mass or less, further preferably 98% by mass or less, even more preferably 97% by mass or less, and even more preferably 95% by mass or less.

本發明的樹脂組成物可以僅包含1種特定樹脂,亦可以包含2種以上。在包含2種以上之情況下,合計量在上述範圍內為較佳。 The resin composition of this invention may contain only one specific resin, or it may contain two or more. When two or more resins are contained, the total amount within the above-mentioned range is preferred.

又,本發明的樹脂組成物包含至少2種樹脂亦較佳。 Furthermore, it is preferable that the resin composition of this invention contains at least two resins.

具體而言,本發明的樹脂組成物可以合計包含2種以上的特定樹脂和後述其他樹脂,亦可以包含2種以上的特定樹脂,但是包含2種以上的特定樹脂為較佳。 Specifically, the resin composition of the present invention may collectively comprise two or more specific resins and other resins described below, or may comprise two or more specific resins, but comprising two or more specific resins is preferred.

在本發明的樹脂組成物包含2種以上的特定樹脂之情況下,例如包含為聚醯亞胺前驅物且源自二酐的結構(上述式(2)中所述之R115)不同之2種以上的聚醯亞胺前驅物為較佳。 In the case where the resin composition of the present invention contains two or more specific resins, it is preferable to contain two or more polyimide precursors that are polyimide precursors and are derived from dianhydrides (R 115 as described in formula (2) above) with different structures.

<其他樹脂> <Other Resins>

本發明的樹脂組成物可以包含上述特定樹脂和與特定樹脂不同之其他樹脂(以下,亦簡稱為“其他樹脂”)。 The resin composition of this invention may include the specific resin described above and other resins different from the specific resin (hereinafter also referred to as "other resins").

作為其他樹脂,可以舉出酚樹脂、聚醯胺、環氧樹脂、包含聚矽氧烷、矽氧烷結構之樹脂、(甲基)丙烯酸樹脂、(甲基)丙烯酸醯胺樹脂、胺酯樹脂、丁醛樹脂、苯乙烯樹脂、聚醚樹脂、聚酯樹脂等。 Other resins include phenolic resins, polyamides, epoxy resins, resins containing polysiloxanes or siloxane structures, (meth)acrylate resins, (meth)acrylate amide resins, amine ester resins, butyraldehyde resins, styrene resins, polyether resins, and polyester resins.

例如,藉由進一步加入(甲基)丙烯酸樹脂,可以獲得塗佈性優異之樹脂組成物,並且可以獲得耐溶劑性優異之圖案(硬化物)。 For example, by further adding (meth)acrylate resins, resin compositions with excellent paintability can be obtained, and patterns (cured products) with excellent solvent resistance can also be obtained.

例如,代替後述聚合性化合物或除了後述聚合性化合物以外,將重量平均分子量為20,000以下的聚合性基值高的(例如,樹脂1g中之聚合性基的含有莫耳量為1×10-3莫耳/g以上)(甲基)丙烯酸樹脂添加至樹脂組成物中,從而能夠提高樹脂組成物的塗佈性、圖案(硬化物)的耐溶劑性等。 For example, instead of the polymerizable compounds described later, or in addition to the polymerizable compounds described later, a (meth)acrylate resin with a high polymerizable group value (e.g., the molar content of polymerizable groups in 1g of resin is 1× 10⁻³ moles/g or more) with a weight average molecular weight of 20,000 or less can be added to the resin composition, thereby improving the paintability of the resin composition, the solvent resistance of the pattern (cured material), etc.

在本發明的樹脂組成物包含其他樹脂之情況下,其他樹脂的含量相對於樹脂組成物的總固體成分為0.01質量%以上為較佳,0.05質量%以上為更佳,1質量%以上為進一步較佳,2質量%以上為更進一步較佳,5質量%以上為又更進一步較佳,10質量%以上為再更進一步較佳。 When the resin composition of the present invention includes other resins, it is preferable that the content of the other resins relative to the total solid content of the resin composition is 0.01% by mass or more, more preferably 0.05% by mass or more, further preferably 1% by mass or more, even more preferably 2% by mass or more, still more preferably 5% by mass or more, and even more preferably 10% by mass or more.

又,本發明的樹脂組成物中之其他樹脂的含量相對於樹脂組成物的總固體成分為80質量%以下為較佳,75質量%以下為更佳,70質量%以下為進一步較佳,60質量%以下為更進一步較佳,50質量%以下為又更進一步較佳。 Furthermore, in the resin composition of the present invention, the content of other resins relative to the total solid content of the resin composition is preferably 80% by weight or less, more preferably 75% by weight or less, further preferably 70% by weight or less, even more preferably 60% by weight or less, and even more preferably 50% by weight or less.

又,作為本發明的樹脂組成物的較佳的一態樣,亦能夠設為其他樹脂的含量為低含量之態樣。在上述態樣中,其他樹脂的含量相對於樹脂組成物的總固體成分為20質量%以下為較佳,15質量%以下為更佳,10質量%以下為進一步較佳,5量%以下為更進一步較佳,1質量%以下為又更進一步較佳。上述含量的下限並無特別限定,只要為0質量%以上即可。 Furthermore, as a preferred embodiment of the resin composition of the present invention, it is also possible to design an embodiment with a low content of other resins. In the above-mentioned embodiments, it is preferable that the content of other resins relative to the total solid content of the resin composition is 20% by mass or less, more preferably 15% by mass or less, further preferably 10% by mass or less, even more preferably 5% by mass or less, and even more preferably 1% by mass or less. There is no particular limitation on the lower limit of the above content; it is acceptable as long as it is 0% by mass or more.

本發明的樹脂組成物可以僅包含1種其他樹脂,亦可以包含2種以上。在包含2種以上之情況下,合計量在上述範圍內為較佳。 The resin composition of this invention may contain only one other resin, or it may contain two or more. When two or more resins are contained, the aggregate amount is preferably within the above-mentioned range.

<化合物B> <Compound B>

本發明的樹脂組成物包含藉由鹼的作用而產生鹼之化合物B。 The resin composition of this invention includes compound B, which produces a base through the action of a base.

作為化合物B,例如可以舉出具有被鹼分解性基保護之鹼基之化合物。 Compound B can be exemplified by compounds having a base group protected by a base-decomposing group.

作為被鹼分解性基保護之鹼基,並無特別限定,例如能夠使用用鹼進行脫保護之公知的胺的保護基,例如具有胺基甲酸酯結構之基團為較佳,可以舉出9-芴基甲基胺基甲酸酯、1,1-二甲基-2-氰基甲基胺基甲酸酯、對硝基苄基胺基甲酸酯、2,4-二氯苄基胺基甲酸酯等。 The base group protected by the base-decomposing group is not particularly limited. For example, it can be a protected group of a known amine that can be deprotected using a alkali. Groups with an aminocarbamate structure are preferred, such as 9-fluorenylmethylaminocarbamate, 1,1-dimethyl-2-cyanomethylaminocarbamate, p-nitrobenzylaminocarbamate, and 2,4-dichlorobenzylaminocarbamate.

又,化合物B包含胺酯鍵為較佳。上述胺酯鍵包含於被鹼分解性基保護之鹼基中為較佳,藉由鹼的作用而上述胺酯鍵分解以產生胺為更佳。 Furthermore, it is preferable that compound B contains an amino ester bond. Preferably, the amino ester bond is contained within a base protected by a base-decomposing group, and it is even more preferable that the amino ester bond decomposes to produce an amine through the action of a base.

藉由鹼的作用而從化合物B產生之鹼為胺為較佳,二級胺或三級胺為更佳。 The alkali produced from compound B by the action of a base is preferably an amine, and secondary or tertiary amines are even better.

又,藉由鹼的作用而從化合物B產生之鹼的共軛酸的pKa為0以上之鹼為較佳,3以上之鹼為更佳,6以上之鹼為更佳。上述共軛酸的pKa的下限並無特別限定,但是30以下為較佳。 Furthermore, for the condylar acid of the base produced from compound B by the action of the base, a pKa of 0 or higher is preferred, 3 or higher is even more preferred, and 6 or higher is still preferred. There is no particular limitation on the lower limit of the pKa of the aforementioned condylar acids, but 30 or lower is preferred.

pKa為考慮到從酸中釋放氫離子之解離反應而將其平衡常數Ka用其負的常用對數pKa表示者。在本說明書中,除非另有說明,則pKa設為基於ACD/ChemSketch(註冊商標)之計算值。 pKa is the negative common logarithm of the equilibrium constant Ka, representing the dissociation reaction that releases hydrogen ions from an acid. In this specification, unless otherwise stated, pKa is assumed to be a calculation based on ACD/ChemSketch (registered trademark).

在存在複數個上述共軛酸的pKa之情況下,至少1個在上述範圍內為較佳。 In the presence of multiple pKa values of the aforementioned conjugated acids, it is preferable that at least one pKa falls within the aforementioned range.

藉由鹼的作用而從化合物B產生之鹼可以為僅具有1個鹼基之鹼,亦可以為具有2個以上之鹼。 The base produced from compound B by the action of a base can be a base with only one base group, or it can be a base with two or more base groups.

又,藉由鹼的作用而從化合物B產生之鹼可以為1分子,亦可以為2分子以上。 Furthermore, the alkali produced from compound B through the action of the alkali can be one molecule or more than two molecules.

藉由鹼的作用而從化合物B產生之鹼的分子量為50~300 為較佳,80~250為更佳。 The molecular weight of the alkali produced from compound B by the action of the alkali is preferably 50-300, and even more preferably 80-250.

作為所產生之鹼的具體例,並無特別限定,但是可以舉出哌啶、4-羥基乙基哌啶、4-(3-苯丙基哌啶)、環己胺、二異丙胺、二環己胺、二甲基哌啶、1,3-二-4-哌啶基丙烷、2,6-二甲基哌啶、甲基環己胺、4-羥基甲基哌啶、二異丁胺、異丙基環己胺、二第三異丁胺等。 There are no particular limitations on the specific examples of the alkali produced, but examples include piperidine, 4-hydroxyethylpiperidine, 4-(3-phenylpropylpiperidine), cyclohexylamine, diisopropylamine, dicyclohexylamine, dimethylpiperidine, 1,3-di-4-piperidinylpropane, 2,6-dimethylpiperidine, methylcyclohexylamine, 4-hydroxymethylpiperidine, diisobutylamine, isopropylcyclohexylamine, and ditert-isobutylamine.

化合物B為下述式(1-1)、式(1-2)或式(1-3)所表示之化合物為較佳,下述式(1-1)所表示之化合物為更佳。 Compound B is preferably represented by formula (1-1), formula (1-2), or formula (1-3), with the compound represented by formula (1-1) being more preferred.

式(1-1)中,R1表示氫原子或可以經取代的烴基,R2表示可以經取代的烴基,R1和R2可以鍵結而形成環結構; 式(1-2)中,R1表示氫原子或可以經取代的烴基,R2表示可以經取代的烴基,R1和R2可以鍵結而形成環結構,R3分別獨立地表示氫原子或可以經取代的烴基,R4表示氰基、硝基、-C(=O)OR、-OC(=O)R、-C(=O)R、-S(=O)2R、氟化烷基或鹵素原子,R表示可以經取代的烴基; 式(1-3)中,R1表示氫原子或可以經取代的烴基,R2表示可以經取代的烴基,R1和R2可以鍵結而形成環結構,R3分別獨立地表示氫原子或可以經取代的烴基,Ar表示經選自氰基、硝基、-C(=O)OR、-OC(=O)R、-C(=O)R、-S(=O)2R、氟化烷基、鹵素原子中的至少1個基團取代之芳香族基,R表示可以經取代的烴基。 In formula (1-1), R1 represents a hydrogen atom or a substituted hydrocarbon, R2 represents a substituted hydrocarbon, and R1 and R2 can bond to form a ring structure; In formula (1-2), R1 represents a hydrogen atom or a substituted hydrocarbon, R2 represents a substituted hydrocarbon, R1 and R2 can bond to form a ring structure, R3 independently represents a hydrogen atom or a substituted hydrocarbon, R4 represents a cyano, nitro, -C(=O)OR, -OC(=O)R, -C(=O)R, -S(=O) 2R , fluorinated alkyl or halogen atom, and R represents a substituted hydrocarbon; In formula (1-3), R1 represents a hydrogen atom or a substituted hydrocarbon, R 2 represents a substitutable hydrocarbon. R1 and R2 can bond to form a ring structure. R3 represents a hydrogen atom or a substitutable hydrocarbon independently. Ar represents an aromatic group substituted with at least one group selected from cyano, nitro, -C(=O)OR, -OC(=O)R, -C(=O)R, -S(=O) 2R , fluorinated alkyl, and halogen atom. R represents a substitutable hydrocarbon.

式(1-1)中,R1表示氫原子或可以經取代的烴基,可以經取代的烴基為較佳。 In equation (1-1), R1 represents a hydrogen atom or a substitutable group, with a substitutable group being preferred.

作為上述烴基,烷基、烯基、炔基或芳基為較佳,烷基或芳基為更佳。 Of the aforementioned hydrocarbon groups, alkyl, alkenyl, alkynyl, or aryl are preferred, with alkyl or aryl being even more preferred.

作為上述烷基,碳數1~10的烷基為較佳,碳數2~10的烷基為更佳。作為上述烷基,可以為直鏈狀、支鏈狀或環狀中的任一個,亦可以為由該等組合表示之基團。 Of the aforementioned alkyl groups, those having 1 to 10 carbon atoms are preferred, and those having 2 to 10 carbon atoms are even more preferred. The aforementioned alkyl groups can be any of straight-chain, branched-chain, or cyclic, or can be groups represented by combinations thereof.

作為上述烯基,碳數2~10的烯基為較佳,碳數2~6的烯基為更佳。作為上述烯基,可以為直鏈狀、支鏈狀或環狀中的任一個,亦可以為由該等組合表示之基團。 Of the alkenyl groups described above, those having 2 to 10 carbon atoms are preferred, and those having 2 to 6 carbon atoms are even more preferred. The alkenyl group can be any of linear, branched, or cyclic forms, or can be a group represented by a combination of these.

作為上述炔基,碳數2~10的炔基為較佳,碳數2~6的炔基為更佳。作為上述炔基,可以為直鏈狀、支鏈狀或環狀中的任一個,亦可以為由該等組合表示之基團。 Of the aforementioned alkynyl groups, those with 2 to 10 carbon atoms are preferred, and those with 2 to 6 carbon atoms are even more preferred. The aforementioned alkynyl group can be any of linear, branched, or cyclic, or can be a group represented by a combination of these.

作為上述芳基,碳數1~20的芳基為較佳,碳數6~10的芳基為更佳,苯基為進一步較佳。又,上述芳基為芳香族烴基為較佳。 Of the aforementioned aryl groups, those with 1 to 20 carbon atoms are preferred, those with 6 to 10 carbon atoms are more preferred, and phenyl groups are even more preferred. Furthermore, it is preferable that the aforementioned aryl group is an aromatic hydrocarbon.

作為上述烴基中之取代基,能夠在可以獲得本發明的效果之範圍內使用公知的取代基,可以舉出羥基等。 As substituents in the aforementioned hydrocarbon groups, known substituents can be used within the scope that achieves the effects of the present invention; examples include hydroxyl groups.

式(1-1)中,R2表示可以經取代的烴基。R2的較佳態樣與上述式(1-1)中的R1的較佳態樣相同。 In equation (1-1), R2 represents a substitutable hydrocarbon. The preferred state of R2 is the same as that of R1 in equation (1-1) above.

式(1-1)中,R1和R2可以鍵結而形成環結構。作為所形成之環結構,5員環或6員環為較佳,6員環為較佳。又,上述環結構可以為脂肪族環結構,亦可以為芳香族環結構,但是脂肪族環結構為較佳。 In equation (1-1), R1 and R2 can be bonded to form a ring structure. A 5-membered or 6-membered ring structure is preferred, with a 6-membered ring being more desirable. Furthermore, the aforementioned ring structure can be an aliphatic ring structure or an aromatic ring structure, but an aliphatic ring structure is preferred.

具體而言,作為R1和R2鍵結而形成之環結構,可以舉出可以具有取代 基之哌啶環。 Specifically, as a ring structure formed by the R1 and R2 bonds, piperidine rings that can have substituents can be cited as an example.

作為上述取代基,可以舉出烷基、羥基烷基、芳烷基等。 Examples of substituents mentioned above include alkyl, hydroxyalkyl, and aralkyl groups.

式(1-2)中,R1及R2的較佳態樣分別與式(1-1)中的R1及R2的較佳態樣相同。 In equation (1-2), the better states of R1 and R2 are the same as those of R1 and R2 in equation (1-1).

式(1-2)中,R3分別獨立地表示氫原子或可以經取代的烴基。作為上述烴基,烷基、烯基、炔基或芳基為較佳,烷基或芳基為更佳,烷基為更佳。 In formulas (1-2), R3 independently represents a hydrogen atom or a substituted hydrocarbon. Alkyl, alkenyl, alkynyl or aryl are preferred as the above hydrocarbons, alkyl or aryl are more preferred, and alkyl is even more preferred.

作為上述烷基,碳數1~10的烷基為較佳,碳數1~4的烷基為更佳,甲基為進一步較佳。作為上述烷基,可以為直鏈狀、支鏈狀或環狀中的任一個,亦可以為由該等組合表示之基團。 Of the aforementioned alkyl groups, those having 1 to 10 carbon atoms are preferred, those having 1 to 4 carbon atoms are more preferred, and methyl groups are even more preferred. The aforementioned alkyl groups can be any of straight-chain, branched-chain, or cyclic, or can be groups represented by combinations thereof.

作為上述烯基,碳數2~10的烯基為較佳,碳數2~6的烯基為更佳。作為上述烯基,可以為直鏈狀、支鏈狀或環狀中的任一個,亦可以為由該等組合表示之基團。 Of the alkenyl groups described above, those having 2 to 10 carbon atoms are preferred, and those having 2 to 6 carbon atoms are even more preferred. The alkenyl group can be any of linear, branched, or cyclic forms, or can be a group represented by a combination of these.

作為上述炔基,碳數2~10的炔基為較佳,碳數2~6的炔基為更佳。作為上述炔基,可以為直鏈狀、支鏈狀或環狀中的任一個,亦可以為由該等組合表示之基團。 Of the aforementioned alkynyl groups, those with 2 to 10 carbon atoms are preferred, and those with 2 to 6 carbon atoms are even more preferred. The aforementioned alkynyl group can be any of linear, branched, or cyclic, or can be a group represented by a combination of these.

作為上述芳基,碳數1~10的芳基為較佳,碳數6~10的芳基為更佳,苯基為進一步較佳。又,上述芳基為芳香族烴基為較佳。 Of the aforementioned aryl groups, those with 1 to 10 carbon atoms are preferred, those with 6 to 10 carbon atoms are more preferred, and phenyl groups are even more preferred. Furthermore, it is preferable that the aforementioned aryl group is an aromatic hydrocarbon.

作為上述烴基中之取代基,能夠在可以獲得本發明的效果之範圍內使用公知的取代基,可以舉出羥基等。 As substituents in the aforementioned hydrocarbon groups, known substituents can be used within the scope that achieves the effects of the present invention; examples include hydroxyl groups.

式(1-2)中,R4表示氰基、硝基、-C(=O)OR、-OC(=O)R、-C(=O)R、-S(=O)2R、氟化烷基或鹵素原子,從鹼的產生效率的觀點考慮, 氰基為較佳。R表示可以經取代的烴基,烷基、烯基、炔基、芳香族烴基或由該等組合表示之基團為較佳,烷基、芳香族烴基或由該等組合表示之基團為更佳,碳數1~10的烷基、苯基、萘基或由該等組合表示之基團為進一步較佳。作為R中之取代基,可以舉出鹵素原子、羥基、烷氧基等。 In formula (1-2), R4 represents a cyano, nitro, -C(=O)OR, -OC(=O)R, -C(=O)R, -S(=O) 2R , fluorinated alkyl, or halogen atom. From the viewpoint of alkali production efficiency, cyano is preferred. R represents a substitutable hydrocarbon group, preferably alkyl, alkenyl, alkynyl, aromatic hydrocarbon, or a combination thereof. Alkyl, aromatic hydrocarbon, or a combination thereof is more preferred, and alkyl, phenyl, naphthyl, or a combination thereof with 1 to 10 carbon atoms is even more preferred. Examples of substituents in R include halogen atoms, hydroxyl groups, and alkoxy groups.

式(1-3)中,R1及R2的較佳態樣分別與式(1-1)中的R1及R2的較佳態樣相同。 In equation (1-3), the better states of R1 and R2 are the same as those of R1 and R2 in equation (1-1).

式(1-3)中,R3的較佳態樣與式(1-2)中的R3的較佳態樣相同。 In equation (1-3), the best state of R3 is the same as that of R3 in equation (1-2).

式(1-3)中,Ar表示經選自氰基、硝基、-C(=O)OR、-OC(=O)R、-C(=O)R、-S(=O)2R、氟化烷基、鹵素原子中的至少1個基團取代之芳香族基。 In formula (1-3), Ar represents an aromatic group substituted with at least one group selected from cyano, nitro, -C(=O)OR, -OC(=O)R, -C(=O)R, -S(=O) 2R , fluorinated alkyl, halogen atom.

R的較佳態樣與上述式(1-2)中之R相同。 The optimal state of R is the same as that of R in equation (1-2) above.

作為上述芳香族基,碳數1~20的芳香族基為較佳,碳數6~10的芳香族基為更佳,苯基為進一步較佳。上述芳香族基可以為芳香族烴基,亦可以為芳香族雜環基,但是芳香族烴基為較佳。 Of the aforementioned aromatic groups, those with 1 to 20 carbon atoms are preferred, those with 6 to 10 carbon atoms are even more preferred, and phenyl groups are further preferred. These aromatic groups can be aromatic hydrocarbons or aromatic heterocyclic groups, but aromatic hydrocarbons are preferred.

又,使用不具有酸基的化合物作為化合物B亦較佳。依據上述態樣,認為亦容易抑制銅等金屬的遷移,所獲得之硬化膜成為密接性優異者。 Furthermore, using a compound without an acid group as compound B is also preferable. Based on the above, it is believed that the migration of metals such as copper is also easily suppressed, resulting in a hardened film with excellent adhesion.

化合物B的分子量為100~700為較佳,100~500為較佳,150~400為更佳。 The molecular weight of compound B is preferably 100-700, preferably 100-500, and even more preferably 150-400.

作為化合物B的具體例,可以舉出下述化合物。 As specific examples of compound B, the following compounds can be cited.

[化學式20] [Chemical Formula 20]

[化學式21] [Chemical Formula 21]

化合物B的含量相對於本發明的樹脂組成物的總質量為0.1~20.0質量%為較佳,0.1~10.0質量%為更佳,0.5~5.0質量%為進一步較佳。 The content of compound B relative to the total mass of the resin composition of the present invention is preferably 0.1~20.0% by mass, more preferably 0.1~10.0% by mass, and even more preferably 0.5~5.0% by mass.

<有機金屬錯合物> <Organometallic complexes>

從耐藥品性的觀點考慮,本發明的樹脂組成物包含有機金屬錯合物為較佳。 From the perspective of drug resistance, it is preferable that the resin composition of this invention contains organometallic complexes.

有機金屬錯合物只要為包含金屬原子之有機錯合物即可,但是包含金屬原子及有機基之錯合物為較佳,有機基對金屬原子進行配位之化合物為更佳,茂金屬化合物為進一步較佳。 Organometallic complexes only need to be organic complexes containing metal atoms, but complexes containing both metal atoms and organic groups are preferred. Compounds in which the organic groups coordinate to the metal atoms are even better, and metallocene compounds are even more preferred.

在本發明中,茂金屬化合物是指具有2個可以具有取代基的環戊二烯基陰離子衍生物作為η5-配位體之有機金屬錯合物。 In this invention, metallocene compounds refer to organometallic complexes having two cyclopentadienyl anionic derivatives, which can have substituents, as n5-ligands.

作為上述有機基,並無特別限定,但是烴基或由烴基與雜原子的組合形成之基團為較佳。作為雜原子,氧原子、硫原子及氮原子為較佳。 There are no particular limitations on the aforementioned organic groups, but hydrocarbon groups or groups formed by combinations of hydrocarbon groups and heteroatoms are preferred. Oxygen, sulfur, and nitrogen atoms are preferred as heteroatoms.

在本發明中,有機基中的至少1個為環狀基為較佳,至少2個為環狀基為更佳。 In this invention, it is preferred that at least one of the organic groups is a cyclic group, and even more preferred that at least two are cyclic groups.

上述環狀基選自5員環的環狀基及6員環的環狀基為較佳,5員環的環狀基為更佳。 The cyclic bases mentioned above are preferably selected from 5-membered and 6-membered cyclic bases, with 5-membered cyclic bases being even more preferred.

上述環狀基可以為烴環,亦可以為雜環,但是烴環為較佳。 The aforementioned cyclic group can be a hydrocarbon ring or a heterocyclic ring, but a hydrocarbon ring is preferred.

作為5員環的環狀基,環戊二烯基為較佳。 As a 5-membered cyclic group, cyclopentadienyl is preferred.

又,本發明中所使用之有機金屬錯合物在1分子中包含2~4個環狀基為較佳。 Furthermore, it is preferable that the organometallic complex used in this invention contains 2 to 4 cyclic groups per molecule.

作為有機金屬錯合物中所包含之金屬,並無特別限定,但是與第4族元素對應之金屬為較佳,選自包括鈦、鋯及鉿之群組中的至少1種金屬為更佳,選自包括鈦及鋯之群組中的至少1種金屬為進一步較佳,鈦為特佳。 The metals included in the organometallic complex are not particularly limited, but metals corresponding to Group 4 elements are preferred. It is even more preferred to select at least one metal from the group consisting of titanium, zirconium, and ruthenium, and it is further preferred to select at least one metal from the group consisting of titanium and zirconium. Titanium is particularly preferred.

有機金屬錯合物可以包含2個以上的金屬原子,亦可以僅包含1個金屬原子,但是僅包含1個金屬原子為較佳。在有機金屬錯合物包含2個以上的金屬原子之情況下,可以僅包含1種金屬原子,亦可以包含2種以上的金屬原子。 Organometallic complexes can contain two or more metal atoms, or they can contain only one metal atom, but containing only one metal atom is preferred. When an organometallic complex contains two or more metal atoms, it can contain only one type of metal atom, or it can contain two or more types of metal atoms.

有機金屬錯合物為二茂鐵化合物、二茂鈦化合物、二茂鋯(Zirconocene)化合物或二茂鉿(Hafnocene)化合物為較佳,二茂鈦化合物、 二茂鋯化合物或二茂鉿化合物為更佳,二茂鈦化合物或二茂鋯化合物為進一步較佳,二茂鈦化合物為特佳。 The organometallic complex is preferably a ferrocene compound, a titanium diacene compound, a zirconia diacene compound, or a hafnocene compound; more preferably a titanium diacene compound, a zirconia diacene compound, or a hafnocene compound; even more preferably a titanium diacene compound or a zirconia diacene compound; and most preferably a titanium diacene compound.

有機金屬錯合物具有光自由基聚合起始能之態樣亦為本發明的較佳態樣之一。 The organometallic complex with a photoradical polymerization initiation energy is also one of the preferred states of this invention.

在本發明中,具有光自由基聚合起始能表示能夠產生能夠藉由光的照射而開始自由基聚合之自由基(free radicals)。例如,在對包含自由基交聯劑和有機金屬錯合物之組成物照射了有機金屬錯合物吸收光且自由基交聯劑不吸收光的波長區域中的光時,能夠藉由確認自由基交聯劑有無消失來確認有無光自由基聚合起始能。在確認有無消失時,能夠依據自由基交聯劑的種類來選擇適當的方法,例如只要藉由IR測定(紅外分光測定)或HPLC測定(高效液相層析法)來確認即可。 In this invention, the concept of a photoradical polymerization initiation energy indicates the ability to generate free radicals capable of initiating free radical polymerization upon light irradiation. For example, when a composition containing a radical crosslinker and an organometallic complex is irradiated with light in a wavelength range where the organometallic complex absorbs light but the radical crosslinker does not, the presence or absence of a photoradical polymerization initiation energy can be determined by confirming whether the radical crosslinker disappears. When confirming the presence or absence of disappearance, an appropriate method can be selected based on the type of radical crosslinker; for example, confirmation can be made simply by IR determination (infrared spectroscopy) or HPLC determination (high-performance liquid chromatography).

在有機金屬錯合物具有光自由基聚合起始能之情況下,有機金屬錯合物為茂金屬化合物為較佳,二茂鈦化合物、二茂鋯化合物或二茂鉿化合物為更佳,二茂鈦化合物或二茂鋯化合物為進一步較佳,二茂鈦化合物為特佳。 When the organometallic complex possesses a photoradical polymerization initiation energy, metallocene compounds are preferred, with titanium diacene, zirconium diacene, or titanium diacene being even more preferred, titanium diacene or zirconium diacene being further preferred, and titanium diacene being particularly preferred.

在有機金屬錯合物不具有光自由基聚合起始能的情況下,有機金屬錯合物為選自包括二茂鈦化合物、四烷氧基鈦化合物、醯化鈦化合物、鈦螯合物、二茂鋯化合物及二茂鉿化合物之群組中的至少1種化合物為較佳,選自包括二茂鈦化合物、二茂鋯化合物及二茂鉿化合物之群組中的至少1種化合物為更佳,選自包括二茂鈦化合物及二茂鋯化合物之群組中的至少1種化合物為進一步較佳,二茂鈦化合物為特佳。 When the organometallic complex does not possess a photoradical polymerization initiation energy, it is preferable that the organometallic complex is selected from at least one compound chosen from the group consisting of titanium diacene compounds, tetraalkoxy titanium compounds, nitrified titanium compounds, titanium chelates, zirconium diacene compounds, and titanium diacene compounds; more preferably, it is selected from at least one compound chosen from the group consisting of titanium diacene compounds, zirconium diacene compounds, and titanium diacene compounds; even more preferably, it is selected from at least one compound chosen from the group consisting of titanium diacene compounds and zirconium diacene compounds; and titanium diacene compounds are particularly preferred.

有機金屬錯合物的分子量為50~2,000為較佳,100~1,000 為更佳。 The molecular weight of organometallic complexes is preferably 50–2,000, and even more preferably 100–1,000.

作為有機金屬錯合物,可以較佳地舉出下述式(P)所表示之化合物。 As organometallic complexes, compounds represented by the following formula (P) are preferred examples.

式(P)中,M為金屬原子,R分別獨立地為取代基。 In formula (P), M represents a metal atom, and R are each an independent substituent.

上述R分別獨立地選自芳香族基、烷基、鹵素原子及烷基磺醯氧基為較佳。 Preferably, R is selected independently from aromatic groups, alkyl groups, halogen atoms, and alkyl sulfonyloxy groups.

式(P)中,作為M所表示之金屬原子,鐵原子、鈦原子、鋯原子或鉿原子為較佳,鈦原子、鋯原子或鉿原子為更佳,鈦原子或鋯原子為進一步較佳,鈦原子為特佳。 In formula (P), iron, titanium, zirconium, or ruthenium atoms are preferred as the metal atom represented by M; titanium, zirconium, or ruthenium atoms are even more preferred; titanium or zirconium atoms are further preferred; and titanium atoms are particularly preferred.

作為式(P)的R中之芳香族基,可以舉出碳數6~20的芳香族基,碳數6~20的芳香族烴基為較佳,可以舉出苯基、1-萘基或2-萘基等。 As for the aromatic group in R of formula (P), examples of aromatic groups with 6 to 20 carbon atoms are preferred, such as phenyl, 1-naphthyl, or 2-naphthyl.

作為式(P)的R中之烷基,碳數1~20的烷基為較佳,碳數1~10的烷基為更佳,可以舉出甲基、乙基、丙基、辛基、異丙基、第三丁基、異戊基、2-乙基己基、2-甲基己基及環戊基等。 As for the alkyl group in R of formula (P), alkyl groups with 1 to 20 carbon atoms are preferred, and alkyl groups with 1 to 10 carbon atoms are even more preferred. Examples include methyl, ethyl, propyl, octyl, isopropyl, tributyl, isopentyl, 2-ethylhexyl, 2-methylhexyl, and cyclopentyl.

作為上述R中之鹵素原子,可以舉出F、Cl、Br及I。 Examples of halogen atoms in the aforementioned R group include F, Cl, Br, and I.

作為構成上述R中之烷基磺醯氧基之烷基,碳數1~20的烷基為較佳,碳數1~10的烷基為更佳,可以舉出甲基、乙基、丙基、辛基、異丙基、第三丁基、異戊基、2-乙基己基、2-甲基己基及環戊基等。 As the alkyl group constituting the alkyl sulfonyloxy group in R above, an alkyl group having 1 to 20 carbon atoms is preferred, and an alkyl group having 1 to 10 carbon atoms is even more preferred. Examples include methyl, ethyl, propyl, octyl, isopropyl, tributyl, isopentyl, 2-ethylhexyl, 2-methylhexyl, and cyclopentyl.

上述R還可以具有取代基。作為取代基的例子,可以舉出鹵素原子(F、Cl、Br、I)、羥基、羧基、胺基、氰基、芳基、烷氧基、芳氧基、醯基、烷氧羰基、芳氧羰基、醯氧基、單烷基胺基、二烷基胺基、單芳胺基及二芳基胺基等。 The R group mentioned above can also have substituents. Examples of substituents include halogen atoms (F, Cl, Br, I), hydroxyl, carboxyl, amino, cyano, aryl, alkoxy, aryloxy, acetyl, alkoxycarbonyl, aryloxycarbonyl, acetyloxy, monoalkylamine, dialkylamine, monoarylamine, and diarylamine.

作為有機金屬錯合物的具體例,並無特別限定,但是可以例示四異丙氧基鈦、四(2-乙基己氧基)鈦、二異丙氧基雙(乙醯乙酸乙酯)鈦、二異丙氧基雙(乙醯丙酮)鈦、雙(η5-2,4-環戊二烯-1-基)雙(2,6-二氟-3-(1H-吡咯-1-基)苯基)鈦、五甲基環戊二烯基三甲醇鈦、雙(η5-2,4-環戊二烯-1-基)雙(2,6-二氟苯基)鈦及下述化合物。 Specific examples of organometallic complexes are not particularly limited, but examples include tetraisopropoxytitanium, tetra(2-ethylhexyloxy)titanium, diisopropoxybis(ethyl acetate)titanium, diisopropoxybis(acetate acetone)titanium, bis(η5-2,4-cyclopentadien-1-yl)bis(2,6-difluoro-3-(1H-pyrrolo-1-yl)phenyl)titanium, pentamethylcyclopentadienyltrimethyltitanium, bis(η5-2,4-cyclopentadien-1-yl)bis(2,6-difluorophenyl)titanium, and the following compounds.

除此以外,亦能夠使用國際公開第2018/025738號的0078~0088段中所記載的化合物,但是並不限定於此。 In addition, compounds described in paragraphs 0078 to 0088 of International Publication No. 2018/025738 may be used, but are not limited thereto.

有機金屬錯合物的含量相對於本發明的樹脂組成物的總固體成分為0.1~30質量%為較佳。下限為1.0質量%以上為更佳,1.5質量%以上為進一步較佳,3.0質量%以上為特佳。上限為25質量%以下為更佳。 The content of organometallic compounds relative to the total solids content of the resin composition of the present invention is preferably 0.1 to 30% by mass. A lower limit of 1.0% by mass or more is more preferred, 1.5% by mass or more is further preferred, and 3.0% by mass or more is particularly preferred. An upper limit of 25% by mass or less is more preferred.

有機金屬錯合物能夠使用1種或2種以上。在使用2種以上之情況下,合計量在上述範圍內為較佳。 One or more organometallic complexes may be used. When using two or more, it is preferable that the total amount be within the range mentioned above.

<溶劑> Solvents

本發明的樹脂組成物包含溶劑為較佳。 The resin composition of this invention preferably includes a solvent.

溶劑能夠任意使用公知的溶劑。溶劑較佳為有機溶劑。作為有機溶劑,可以舉出酯類、醚類、酮類、環狀烴類、亞碸類、醯胺類、脲類、醇類等化合物。 Any known solvent can be used. Organic solvents are preferred. Examples of organic solvents include esters, ethers, ketones, cyclic hydrocarbons, sulfides, amides, ureas, and alcohols.

作為酯類,例如可以舉出乙酸乙酯、乙酸正丁酯、乙酸異丁酯、乙酸己酯、甲酸戊酯、乙酸異戊酯、丙酸丁酯、丁酸異丙酯、丁酸乙酯、丁酸丁酯、乳酸甲酯、乳酸乙酯、γ-丁內酯、ε-己內酯、δ-戊內酯、烷氧基乙酸烷基酯(例如,烷氧基乙酸甲酯、烷氧基乙酸乙酯、烷氧基乙酸丁酯(例如,甲氧基乙酸甲酯、甲氧基乙酸乙酯、甲氧基乙酸丁酯、乙氧基乙酸甲酯、乙氧基乙酸乙酯等))、3-烷氧基丙酸烷基酯類(例如,3-烷氧基丙酸甲酯、3-烷氧基丙酸乙酯等(例如,3-甲氧基丙酸甲酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸甲酯、3-乙氧基丙酸乙酯等))、2-烷氧基丙酸烷基酯類(例如,2-烷氧基丙酸甲酯、2-烷氧基丙酸乙酯、2-烷氧基丙酸丙酯等(例如,2-甲氧基丙酸甲酯、2-甲氧基丙酸乙酯、2-甲氧基丙酸丙酯、2-乙氧基丙酸甲酯、2-乙氧基丙酸乙酯))、2-烷氧基-2-甲基丙酸甲酯及2-烷氧基-2-甲基丙酸乙酯(例如,2-甲氧基-2-甲基丙酸甲酯、2-乙氧基-2-甲基丙酸乙酯等)、丙酮酸甲酯、丙酮酸乙酯、丙酮酸丙酯、乙醯乙酸甲酯、乙醯乙酸乙酯、2-氧代丁酸甲酯、2-氧代丁酸乙酯、己酸乙酯、庚酸乙酯、丙二酸二甲酯、丙二酸二乙酯等作為較佳者。 Examples of esters include ethyl acetate, n-butyl acetate, isobutyl acetate, hexyl acetate, amyl formate, isoamyl acetate, butyl propionate, isopropyl butyrate, ethyl butyrate, butyl butyrate, methyl lactate, ethyl lactate, γ-butyrolactone, ε-caprolactone, δ-valerolactone, alkyl alkoxyacetic acid esters (e.g., methyl alkoxyacetic acid, ethyl alkoxyacetic acid, butyl alkoxyacetic acid (e.g., methyl methoxyacetic acid, ethyl methoxyacetic acid, butyl methoxyacetic acid, methyl ethoxyacetic acid, ethyl ethoxyacetic acid, etc.)), and alkyl 3-alkoxypropionic acid esters (e.g., methyl 3-alkoxypropionic acid, ethyl 3-alkoxypropionic acid, etc. (e.g., methyl 3-methoxypropionic acid, ethyl 3-methoxypropionic acid, methyl 3-ethoxypropionic acid, methyl 3-ethoxypropionic acid)). Ethyl esters, etc.), alkyl esters of 2-alkoxypropionates (e.g., methyl 2-alkoxypropionate, ethyl 2-alkoxypropionate, propyl 2-alkoxypropionate, etc. (e.g., methyl 2-methoxypropionate, ethyl 2-methoxypropionate, propyl 2-methoxypropionate, methyl 2-ethoxypropionate, ethyl 2-ethoxypropionate), methyl 2-alkoxy-2-methylpropionate and ethyl 2-alkoxy-2-methylpropionate (e.g., methyl 2-methoxy-2-methylpropionate, ethyl 2-ethoxy-2-methylpropionate, etc.), methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, methyl 2-oxobutyrate, ethyl 2-oxobutyrate, ethyl hexanoate, ethyl heptanoate, dimethyl malonate, diethyl malonate, etc. are preferred.

作為醚類,例如可以舉出乙二醇二甲醚、二乙二醇二甲醚、二乙二醇二乙醚、二乙二醇乙基甲基醚、二乙二醇丁基甲基醚、三乙二醇二甲醚、四乙二醇二甲醚、四氫呋喃、乙二醇單甲醚、乙二醇單乙醚、甲基溶纖劑乙酸酯、乙基溶纖劑乙酸酯、二乙二醇單甲醚、二乙二醇單乙醚、二乙二醇單丁醚、丙二醇單甲醚、丙二醇二甲醚、丙二醇單甲醚乙酸酯、丙二醇單乙醚乙酸酯、乙二醇單丁醚、乙二醇單丁醚乙酸酯、二乙二醇乙基甲基醚、丙二醇單丙醚乙酸酯、二丙二醇二甲醚等作為較佳者。 Examples of preferred ethers include ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol ethyl methyl ether, diethylene glycol butyl methyl ether, triethylene glycol dimethyl ether, tetraethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl solvent acetate, ethyl solvent acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol dimethyl ether acetate, propylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether, ethylene glycol monobutyl ether acetate, diethylene glycol ethyl methyl ether, propylene glycol monopropyl ether acetate, and dipropylene glycol dimethyl ether.

作為酮類,例如可以舉出甲基乙基酮、環己酮、環戊酮、2-庚酮、3-庚酮、3-甲基環己酮、左旋葡聚糖酮、二氫葡聚糖酮等作為較佳者。 Among ketones, methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, 3-methylcyclohexanone, L-glucanone, and dihydroglucanone are considered superior examples.

作為環狀烴類,例如可以舉出甲苯、二甲苯、苯甲醚等芳香族烴類、檸檬烯等環式萜烯類作為較佳者。 As cyclic hydrocarbons, aromatic hydrocarbons such as toluene, xylene, and anisole, and cyclic terpenes such as limonene are preferred examples.

作為亞碸類,例如可以舉出二甲基亞碸作為較佳者。 As an ion, dimethyl ion is a preferred example.

作為醯胺類,可以舉出N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮、N-環己酯-2-吡咯啶酮、N,N-二甲基乙醯胺、N,N-二甲基甲醯胺、N,N-二甲基異丁醯胺、3-甲氧基-N,N-二甲基丙醯胺、3-丁氧基-N,N-二甲基丙醯胺、N-甲醯基嗎啉、N-乙醯基嗎啉等作為較佳者。 Among the amides, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N-cyclohexyl-2-pyrrolidone, N,N-dimethylacetamide, N,N-dimethylformamide, N,N-dimethylisobutylamide, 3-methoxy-N,N-dimethylpropionic acid, 3-butoxy-N,N-dimethylpropionic acid, N-methoxymorpholine, and N-acetylmorpholine are considered preferred.

作為脲類,可以舉出N,N,N’,N’-四甲基脲、1,3-二甲基-2-咪唑啶酮等作為較佳者。 Among ureas, N,N,N',N'-tetramethylurea and 1,3-dimethyl-2-imidazolidinedione are considered superior options.

作為醇類,可以舉出甲醇、乙醇、1-丙醇、2-丙醇、1-丁醇、1-戊醇、1-己醇、苯甲醇、乙二醇單甲基醚、1-甲氧基-2-丙醇、2-乙氧基乙醇、二乙二醇單乙醚、二乙二醇單二乙二醇單己醚、三乙二醇單甲基醚、 丙二醇單丙二醇單乙醚、丙二醇單甲醚、聚乙二醇單甲基醚、聚丙二醇、四乙二醇、乙二醇單丁醚、乙二醇單乙二醇單芐醚、乙二醇單乙二醇單苯基醚、甲基苯基甲醇、正戊醇、甲基戊醇及雙丙酮醇等。 Examples of alcohols include methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 1-pentanol, 1-hexanol, benzyl alcohol, ethylene glycol monomethyl ether, 1-methoxy-2-propanol, 2-ethoxyethanol, diethylene glycol monoethyl ether, diethylene glycol monohexyl ether, triethylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monomethyl ether, polyethylene glycol monomethyl ether, polypropylene glycol, tetraethylene glycol, ethylene glycol monobutyl ether, ethylene glycol monobenzyl ether, ethylene glycol monophenyl ether, methylphenylmethanol, n-pentanol, methylpentanol, and diacetone alcohol.

關於溶劑,從塗佈面性狀的改善等觀點考慮,混合2種以上之形態亦較佳。 Regarding solvents, from the perspective of improving coating properties, mixing two or more forms is preferable.

在本發明中,選自3-乙氧基丙酸甲酯、3-乙氧基丙酸乙酯、乙基溶纖劑乙酸酯、乳酸乙酯、二乙二醇二甲醚、乙酸丁酯、3-甲氧基丙酸甲酯、2-庚酮、環己酮、環戊酮、γ-丁內酯、二甲基亞碸、乙基卡必醇乙酸酯、丁基卡必醇乙酸酯、N-甲基-2-吡咯啶酮、丙二醇甲醚及丙二醇甲醚乙酸酯、左旋葡聚糖酮、二氫葡聚糖酮中之1種溶劑或由2種以上構成之混合溶劑為較佳。同時使用二甲基亞碸和γ-丁內酯或同時使用N-甲基-2-吡咯啶酮和乳酸乙酯為特佳。 In this invention, a solvent selected from methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, ethyl solvent acetate, ethyl lactate, diethylene glycol dimethyl ether, butyl acetate, methyl 3-methoxypropionate, 2-heptanone, cyclohexanone, cyclopentanone, γ-butyrolactone, dimethyl sulfoxide, ethyl carbitol acetate, butyl carbitol acetate, N-methyl-2-pyrrolidone, propylene glycol methyl ether and propylene glycol methyl ether acetate, L-glucanone, and dihydroglucanone, or a mixture of two or more solvents, is preferred. The simultaneous use of dimethyl sulfoxide and γ-butyrolactone, or the simultaneous use of N-methyl-2-pyrrolidone and ethyl lactate, is particularly preferred.

從塗佈性的觀點考慮,將溶劑的含量設為本發明的樹脂組成物的總固體成分濃度成為5~80質量%之量為較佳,設為成為5~75質量%之量為更佳,設為成為10~70質量%之量為進一步較佳,設為成為20~70質量%為更進一步較佳。關於溶劑含量,只要依據塗膜的所期望厚度和塗佈方法進行調節即可。 From a coatability perspective, it is preferable to set the solvent content to 5-80% by mass of the total solids concentration of the resin composition of this invention, more preferably 5-75% by mass, further preferably 10-70% by mass, and even more preferably 20-70% by mass. The solvent content can be adjusted according to the desired coating thickness and coating method.

本發明的樹脂組成物可以僅含有1種溶劑,亦可以含有2種以上。在含有2種以上的溶劑之情況下,其合計在上述範圍內為較佳。 The resin composition of this invention may contain only one solvent or two or more solvents. When containing two or more solvents, it is preferable that the total amount falls within the above-mentioned range.

〔聚合起始劑〕 [Aggregation Initiator]

本發明的樹脂組成物包含能夠藉由光和/或熱而開始聚合之聚合起始劑為較佳。尤其,包含光聚合起始劑為較佳。 The resin composition of the present invention preferably contains a polymerization initiator capable of initiating polymerization by light and/or heat. In particular, it is preferable to include a photopolymerization initiator.

光聚合起始劑為光自由基聚合起始劑為較佳。作為光自由基聚合起始劑,並無特別限制,能夠從公知的光自由基聚合起始劑中適當選擇。例如,對紫外線區域至可見區域的光線具有感光性之光自由基聚合起始劑為較佳。又,亦可以為與光激勵之敏化劑產生某些作用而生成活性自由基之活性劑。 Photopolymerization initiators are preferably photoradical polymerization initiators. There are no particular limitations on the photoradical polymerization initiator; it can be appropriately selected from known photoradical polymerization initiators. For example, photoradical polymerization initiators that are photosensitizing to light in the ultraviolet to visible regions are preferred. Alternatively, an active agent that interacts with a photosensitive agent to generate active free radicals can also be used.

光自由基聚合起始劑至少含有1種在波長約240~800nm(較佳為330~500nm)的範圍內至少具有約50L/mol-1/cm-1莫耳吸光係數之化合物為較佳。關於化合物的莫耳吸光係數,能夠使用公知的方法來測定。例如,藉由紫外可見分光光度計(Varian Medical Systems,Inc.製Cary-5 spectrophotometer),並使用乙酸乙酯溶劑在0.01g/L的濃度下進行測定為較佳。 The photoradical polymerization initiator preferably contains at least one compound having a molar absorptivity of at least about 50 L/ mol⁻¹ / cm⁻¹ in the wavelength range of about 240–800 nm (preferably 330–500 nm). The molar absorptivity of the compound can be determined using known methods. For example, it is preferable to determine it using a UV-Vis spectrophotometer (Varian Medical Systems, Inc., Cary-5 spectrophotometer) with ethyl acetate solvent at a concentration of 0.01 g/L.

作為光自由基聚合起始劑,能夠任意使用公知的化合物。例如,可以舉出鹵化烴衍生物(例如具有三骨架之化合物、具有二唑骨架之化合物、具有三鹵甲基之化合物等)、醯基氧化膦等醯基膦化合物、六芳基雙咪唑、肟衍生物等肟化合物、有機過氧化物、硫化合物、酮化合物、芳香族鎓鹽、酮肟醚、胺基苯乙酮等α-胺基酮化合物、羥基苯乙酮等α-羥基酮化合物、偶氮系化合物、疊氮化合物、茂金屬化合物、有機硼化合物、鐵芳烴錯合物等。關於該等詳細內容,能夠參閱日本特開2016-027357號公報的0165~0182段、國際公開第2015/199219號的0138~0151段的記載,並將該內容編入本說明書中。又,可以舉出日本特開2014-130173號公報的0065~0111段、日本專利第6301489號公報中所記載之化合物、MATERIAL STAGE 37~60p,vol.19,No.3,2019中所記載之過氧化物系光聚合起 始劑、國際公開第2018/221177號中所記載的光聚合起始劑、國際公開第2018/110179號中所記載的光聚合起始劑、日本特開2019-043864號公報中所記載的光聚合起始劑、日本特開2019-044030號公報中所記載的光聚合起始劑、日本特開2019-167313號公報中所記載的過酸化物系起始劑,並將該等內容亦編入本說明書中。 As a photoradical polymerization initiator, any known compound can be used. For example, halogenated hydrocarbon derivatives (e.g., those with trihalomethanes) can be cited. Compounds with skeletons, possessing Compounds with a diazole skeleton, compounds containing trihalomyl groups, etc., acetyphosphine compounds such as acetyphosphine oxide, hexaaryl diimidazole, oxime compounds such as oxime derivatives, organic peroxides, sulfur compounds, ketone compounds, aromatic onium salts, ketoxime ethers, α-amino ketone compounds such as aminoacetophenone, α-hydroxy ketone compounds such as hydroxyacetophenone, azo compounds, azide compounds, metallocene compounds, organoboron compounds, iron-aromatic complexes, etc. For details regarding these, please refer to paragraphs 0165 to 0182 of Japanese Patent Application Publication No. 2016-027357 and paragraphs 0138 to 0151 of International Publication No. 2015/199219, and these contents are incorporated herein by reference. Furthermore, examples include paragraphs 0065 to 0111 of Japanese Patent Application Publication No. 2014-130173, the compound described in Japanese Patent No. 6301489, and the MATERIAL STAGE. The peroxide-based photopolymerization initiators described in 37~60p, vol.19, No.3, 2019, the photopolymerization initiators described in International Publication No. 2018/221177, the photopolymerization initiators described in International Publication No. 2018/110179, the photopolymerization initiators described in Japanese Patent Application Publication No. 2019-043864, the photopolymerization initiators described in Japanese Patent Application Publication No. 2019-044030, and the peracid-based initiators described in Japanese Patent Application Publication No. 2019-167313 are also incorporated herein by reference.

作為酮化合物,例如可以例示日本特開2015-087611號公報的0087段中所記載的化合物,並將該內容編入本說明書中。在市售品中,亦可以較佳地使用KAYACURE DETX-S(Nippon Kayaku Co.,Ltd.製)。 As a ketone compound, examples include those described in paragraph 0087 of Japanese Patent Application Publication No. 2015-087611, and this content is incorporated herein by reference. KAYACURE DETX-S (manufactured by Nippon Kayaku Co., Ltd.) is also preferably used in commercially available products.

在本發明的一實施態樣中,作為光自由基聚合起始劑,能夠較佳地使用羥基苯乙酮化合物、胺基苯乙酮化合物及醯基膦化合物。更具體而言,例如能夠使用日本特開平10-291969號公報中所記載的胺基苯乙酮系起始劑、日本專利第4225898號中所記載的醯基氧化膦系起始劑,並將該內容編入本說明書中。 In one embodiment of the present invention, hydroxyacetophenone compounds, aminoacetophenone compounds, and amide phosphine compounds are preferably used as photoradical polymerization initiators. More specifically, for example, aminoacetophenone-based initiators as described in Japanese Patent Application Publication No. 10-291969 and amide phosphine oxide-based initiators as described in Japanese Patent No. 4225898 can be used, and this content is incorporated herein by reference.

作為α-羥基酮系起始劑,能夠使用Omnirad 184、Omnirad 1173、Omnirad 2959、Omnirad 127(以上為IGM Resins B.V.公司製)、IRGACURE 184(IRGACURE為註冊商標)、DAROCUR 1173、IRGACURE 500、IRGACURE-2959、IRGACURE 127(產品名稱:均為BASF公司製)。 As α-hydroxyketone initiators, the following can be used: Omnirad 184, Omnirad 1173, Omnirad 2959, Omnirad 127 (all manufactured by IGM Resins B.V.), IRGACURE 184 (IRGACURE is a registered trademark), DAROCUR 1173, IRGACURE 500, IRGACURE-2959, and IRGACURE 127 (all manufactured by BASF).

作為α-胺基酮系起始劑,能夠使用Omnirad 907、Omnirad 369、Omnirad 369E、Omnirad 379EG(以上為IGM Resins B.V.公司製)、IRGACURE 907、IRGACURE 369及IRGACURE 379(產品名稱:均為BASF公司製)。 As α-aminoketone initiators, Omnirad 907, Omnirad 369, Omnirad 369E, Omnirad 379EG (all manufactured by IGM Resins B.V.), IRGACURE 907, IRGACURE 369, and IRGACURE 379 (all manufactured by BASF) can be used.

作為胺基苯乙酮系起始劑,亦能夠使用極大吸收波長與365nm或405nm等波長光源匹配之日本特開2009-191179號公報中所記載的化合物,並將該內容編入本說明書中。 As an aminoacetophenone-based initiator, compounds described in Japanese Patent Application Publication No. 2009-191179, which have extremely high absorption wavelengths and are matched with light sources of wavelengths such as 365 nm or 405 nm, can also be used, and this content is incorporated into this specification.

作為醯基氧化膦系起始劑,可以舉出2,4,6-三甲基苯甲醯基-二苯基-氧化膦等。又,能夠使用Omnirad 819、Omnirad TPO(以上為IGM Resins B.V.公司製)、IRGACURE-819或IRGACURE-TPO(產品名稱:均為BASF公司製)。 Examples of amide-based phosphine oxide initiators include 2,4,6-trimethylbenzoyl-diphenylphosphine oxide. Additionally, Omnirad 819, Omnirad TPO (both manufactured by IGM Resins B.V.), IRGACURE-819, or IRGACURE-TPO (all manufactured by BASF) can be used.

作為茂金屬化合物,可以例示IRGACURE-784、IRGACURE-784EG(均為BASF公司製)、Keycure VIS 813(King Brother Chem公司製)等。 Examples of metallocene compounds include IRGACURE-784, IRGACURE-784EG (both manufactured by BASF), and Keycure VIS 813 (manufactured by King Brother Chem).

作為光自由基聚合起始劑,可以更佳地舉出肟化合物。藉由使用肟化合物,能夠更有效地提高曝光寬容度。肟化合物的曝光寬容度(曝光餘量)較廣,並且亦作為光硬化促進劑而起作用,因此為特佳。 Oxime compounds are a better example of photoradical polymerization initiators. Using oxime compounds allows for a more effective increase in exposure tolerance. Oxime compounds are particularly advantageous because they offer a wider exposure tolerance (residue) and also act as photocuring accelerators.

作為肟化合物的具體例,可以舉出日本特開2001-233842號公報中所記載的化合物、日本特開2000-080068號公報中所記載的化合物、日本特開2006-342166號公報中所記載的化合物、J.C.S.Perkin II(1979年,pp.1653-1660)中所記載的化合物、J.C.S.Perkin II(1979年,pp.156-162)中所記載的化合物、Journal of Photopolymer Science and Technology(1995年,pp.202-232)中所記載的化合物、日本特開2000-066385號公報中所記載的化合物、日本特表2004-534797號公報中所記載的化合物、日本特開2017-019766號公報中所記載的化合物、日本專利第6065596號公報中所記載的化合物、國際公開第2015/152153號中所記載的化合物、國際公開第2 017/051680號中所記載的化合物、日本特開2017-198865號公報中所記載的化合物、國際公開第2017/164127號的0025~0038段中所記載的化合物、國際公開第2013/167515號中所記載的化合物等,並將該內容編入本說明書中。 Specific examples of oxime compounds include compounds described in Japanese Patent Application Publication No. 2001-233842, Japanese Patent Application Publication No. 2000-080068, Japanese Patent Application Publication No. 2006-342166, compounds described in J.C.S. Perkin II (1979, pp. 1653-1660), compounds described in J.C.S. Perkin II (1979, pp. 156-162), and compounds described in the Journal of Photopolymer Science and... Compounds described in Technology (1995, pp. 202-232), compounds described in Japanese Patent Application Publication No. 2000-066385, compounds described in Japanese Patent Application Publication No. 2004-534797, compounds described in Japanese Patent Application Publication No. 2017-019766, compounds described in Japanese Patent Application Publication No. 6065596, and compounds described in International Publication No. 20 The compounds described in Japanese Patent Application Publication No. 15/152153, Japanese Patent Application Publication No. 2017/051680, Japanese Unexamined Patent Application No. 2017-198865, compounds described in paragraphs 0025 to 0038 of Japanese Patent Application Publication No. 2017/164127, and compounds described in Japanese Patent Application Publication No. 2013/167515, etc., are included in this specification.

作為較佳的肟化合物,例如可以舉出下述結構的化合物、3-苯甲醯氧基亞胺基丁烷-2-酮、3-乙醯氧基亞胺基丁烷-2-酮、3-丙醯氧基亞胺基丁烷-2-酮、2-乙醯氧基亞胺基戊烷-3-酮、2-乙醯氧基亞胺基-1-苯基丙烷-1-酮、2-苯甲醯氧基亞胺基-1-苯基丙烷-1-酮、3-(4-甲苯磺醯氧基)亞胺基丁烷-2-酮及2-乙氧基羰氧基亞胺基-1-苯基丙烷-1-酮等。在本發明的樹脂組成物中,尤其使用肟化合物(肟系的光自由基聚合起始劑)作為光自由基聚合起始劑為較佳。肟系光自由基聚合起始劑在分子內具有>C=N-O-C(=O)-的連接基。 Preferred oxime compounds include, for example, compounds with the following structures: 3-benzoxylidene-iminobutane-2-one, 3-acetoxylidene-iminobutane-2-one, 3-propoxylidene-iminobutane-2-one, 2-acetoxylidene-iminopentane-3-one, 2-acetoxylidene-1-phenylpropane-1-one, 2-benzoxylidene-1-phenylpropane-1-one, 3-(4-toluenesulfonoxy)iminobutane-2-one, and 2-ethoxycarbonyloxylidene-1-phenylpropane-1-one. In the resin composition of the present invention, the use of oxime compounds (oxime-based photoradical polymerization initiators) as photoradical polymerization initiators is particularly preferred. Oxime-based photoradical polymerization initiators possess an intramolecular linker with a >C=N-O-C(=O)- group.

在市售品中,亦可以較佳地使用IRGACURE OXE 01、IR GACURE OXE 02、IRGACURE OXE 03、IRGACURE OXE 04(以上為BASF公司製)、ADEKA OPTOMER N-1919(ADEKA CORPORATION製、日本特開2012-014052號公報中所記載的光自由基聚合起始劑2)。又,亦能夠使用TR-PBG-304、TR-PBG-305(Changzhou Tronly New Electronic Materials CO.,LTD.製)、ADEKA ARKLS NCI-730、NCI-831及ADEKA ARKLS NCI-930(ADEKA CORPORATION製)。又,能夠使用DFI-091(DAITO CHEMIX Co.,Ltd.製)、SpeedCure PDO(SARTOMER ARKEMA製)。又,亦能夠使用下述結構的肟化合物。 Among commercially available products, IRGACURE OXE 01, IR GACURE OXE 02, IRGACURE OXE 03, and IRGACURE OXE 04 (all manufactured by BASF), and ADEKA OPTOMER N-1919 (manufactured by ADEKA CORPORATION, the photoradical polymerization initiator 2 disclosed in Japanese Patent Application Publication No. 2012-014052) are also suitable. Furthermore, TR-PBG-304, TR-PBG-305 (manufactured by Changzhou Tronly New Electronic Materials CO.,LTD.), ADEKA ARKLS NCI-730, NCI-831, and ADEKA ARKLS NCI-930 (manufactured by ADEKA CORPORATION) are also suitable. Furthermore, DFI-091 (manufactured by DAITO CHEMIX Co., Ltd.) and SpeedCure PDO (manufactured by SARTOMER ARKEMA) can be used. Also, oxime compounds with the following structures can be used.

作為光自由基聚合起始劑,亦能夠使用具有茀環之肟化合物。作為具有茀環之肟化合物的具體例,可以舉出日本特開2014-137466號公報中所記載的化合物、日本專利06636081號中所記載的化合物,並將該內容編入本說明書中。 Oxime compounds with dicyclic rings can also be used as photoradical polymerization initiators. Specific examples of dicyclic oxime compounds include the compounds described in Japanese Patent Application Publication No. 2014-137466 and Japanese Patent No. 06636081, the contents of which are incorporated herein by reference.

作為光自由基聚合起始劑,亦能夠使用具有咔唑環中的至少1個苯環成為萘環之骨架之肟化合物。作為該種肟化合物的具體例,可以舉 出國際公開第2013/083505號中所記載的化合物,並將該內容編入本說明書中。 As a photoradical polymerization initiator, oxime compounds having at least one benzene ring in a carbazole ring forming a naphthalene ring skeleton can also be used. Specific examples of such oxime compounds include those described in International Publication No. 2013/083505, the contents of which are incorporated herein by reference.

又,亦能夠使用具有氟原子之肟化合物。作為該種肟化合物的具體例,可以舉出日本特開2010-262028號公報中所記載之化合物、日本特表2014-500852號公報的0345段中所記載之化合物24、36~40、日本特開2013-164471號公報的0101段中所記載之化合物(C-3)等,並將該內容編入本說明書中。 Furthermore, oxime compounds containing fluorine atoms can also be used. Specific examples of such oxime compounds include compounds described in Japanese Patent Application Publication No. 2010-262028, compounds 24, 36-40 described in paragraph 0345 of Japanese Patent Application Publication No. 2014-500852, and compound (C-3) described in paragraph 0101 of Japanese Patent Application Publication No. 2013-164471, and these contents are incorporated herein by reference.

作為光聚合起始劑,能夠使用具有硝基之肟化合物。具有硝基之肟化合物設為二聚體亦較佳。作為具有硝基之肟化合物的具體例,可以舉出日本特開2013-114249號公報的0031~0047段、日本特開2014-137466號公報的0008~0012段、0070~0079段中所記載之化合物、日本專利4223071號公報的0007~0025段中所記載之化合物,並將該內容編入本說明書中。又,作為具有硝基之肟化合物,亦可以舉出ADEKA ARKLS NCI-831(ADEKA CORPORATION製)。 As a photopolymerization initiator, an oxime compound containing a nitro group can be used. It is preferable that the oxime compound containing a nitro group is a dimer. Specific examples of oxime compounds containing a nitro group include the compounds described in paragraphs 0031-0047 of Japanese Patent Application Publication No. 2013-114249, paragraphs 0008-0012 and 0070-0079 of Japanese Patent Application Publication No. 2014-137466, and paragraphs 0007-0025 of Japanese Patent Application Publication No. 4223071, the contents of which are incorporated herein by reference. Furthermore, ADEKA ARKLS NCI-831 (manufactured by ADEKA CORPORATION) is also an example of an oxime compound containing a nitro group.

作為光自由基聚合起始劑,亦能夠使用具有苯并呋喃骨架之肟化合物。作為具體例,可以舉出國際公開第2015/036910號中所記載之OE-01~OE-75。 Oxime compounds with a benzofuran skeleton can also be used as photoradical polymerization initiators. Specific examples include OE-01 to OE-75 as described in International Publication No. 2015/036910.

作為光自由基聚合起始劑,亦能夠使用在咔唑骨架上鍵結有具有羥基之取代基之肟化合物。作為該種光聚合起始劑,可以舉出國際公開第2019/088055號中所記載之化合物等,並將該內容編入本說明書中。 As a photoradical polymerization initiator, oxime compounds with hydroxyl substituents bonded to the carbazole skeleton can also be used. Compounds described in International Publication No. 2019/088055 can be cited as such photopolymerization initiators, and this information is incorporated herein by reference.

作為光聚合起始劑,亦能夠使用具有在芳香族環上導入有拉電子基團之芳香族環基ArOX1之肟化合物(以下,亦稱為肟化合物OX)。 作為上述芳香族環基ArOX1所具有之拉電子基團,可以舉出醯基、硝基、三氟甲基、烷基亞磺醯基、芳基亞磺醯基、烷基磺醯基、芳基磺醯基、氰基,醯基及硝基為較佳,從容易形成耐光性優異之膜等理由考慮,醯基為更佳,苯甲醯基為進一步較佳。苯甲醯基可以具有取代基。作為取代基,鹵素原子、氰基、硝基、羥基、烷基、烷氧基、芳基、芳氧基、雜環基、雜環氧基、烯基、烷基硫基、芳基硫基、醯基或胺基為較佳,烷基、烷氧基、芳基、芳氧基、雜環氧基、烷基硫基、芳基硫基或胺基為更佳,烷氧基、烷基硫基或胺基為進一步較佳。 As a photopolymerization initiator, an oxime compound (hereinafter also referred to as an oxime compound OX) having an electron-withdrawing group on the aromatic ring Ar OX1 can also be used. Examples of electron-withdrawing groups in the aforementioned aromatic cycloalgyl Ar OX1 include vinyl, nitro, trifluoromethyl, alkylsulfinyl, arylsulfinyl, alkylsulfinyl, arylsulfinyl, and cyano. Vinyl and nitro are preferred, but vinyl is more preferred due to its ease of forming films with excellent lightfastness, and benzoyl is even more preferred. Benzyl may have substituents. As substituents, halogen atoms, cyano, nitro, hydroxyl, alkyl, alkoxy, aryl, aryloxy, heterocyclic, heterocyclic, alkenyl, alkylthio, arylthio, acetyl, or amino are preferred, alkyl, alkoxy, aryl, aryloxy, heterocyclic, alkylthio, arylthio, or amino are even more preferred, and alkoxy, alkylthio, or amino are even more preferred.

肟化合物OX為選自式(OX1)所表示之化合物及式(OX2)所表示之化合物中的至少1種為較佳,式(OX2)所表示之化合物為更佳。 The oxime compound OX is preferably selected from at least one compound represented by formula (OX1) and formula (OX2), with the compound represented by formula (OX2) being more preferred.

式中,RX1表示烷基、烯基、烷氧基、芳基、芳氧基、雜環基、雜環氧基、烷基硫基、芳基硫基、烷基亞磺醯基、芳基亞磺醯基、烷基磺醯基、芳基磺醯基、醯基、醯氧基、胺基、亞膦醯基、胺甲醯基或胺磺醯基,RX2表示烷基、烯基、烷氧基、芳基、芳氧基、雜環基、雜環氧基、烷 基硫基、芳基硫基、烷基亞磺醯基、芳基亞磺醯基、烷基磺醯基、芳基磺醯基、醯氧基或胺基,RX3~RX14分別獨立地表示氫原子或取代基。 In the formula, RX1 represents alkyl, alkenyl, alkoxy, aryl, aryloxy, heterocyclic, heterocyclic, alkylthio, arylthio, alkylsulfinyl, arylsulfinyl, alkylsulfonyl, arylsulfonyl, acetyl, acetoxy, amino, phosphine, aminomethyl, or aminosulfonyl; RX2 represents alkyl, alkenyl, alkoxy, aryl, aryloxy, heterocyclic, heterocyclic, alkylthio, arylthio, alkylsulfinyl, arylsulfinyl, alkylsulfonyl, arylsulfonyl, acetoxy, or amino; and RX3 to RX14 each independently represent a hydrogen atom or a substituent.

其中,RX10~RX14中的至少1個為拉電子基團。 Among them, at least one of RX10 to RX14 is an electron-withdrawing group.

在上述式中,RX12為拉電子基團,RX10、RX11、RX13、RX14為氫原子為較佳。 In the above formula, RX12 is an electron-withdrawing group, and RX10 , RX11 , RX13 , and RX14 are preferably hydrogen atoms.

作為肟化合物OX的具體例,可以舉出日本專利第4600600號公報的0083~0105段中所記載的化合物,並將該內容編入本說明書中。 As specific examples of oxime compounds (OX), the compounds described in paragraphs 0083 to 0105 of Japanese Patent No. 4600600 are cited, and this content is incorporated into this specification.

作為最佳的肟化合物,可以舉出日本特開2007-269779號公報中所示之具有特定取代基之肟化合物或日本特開2009-191061號公報中所示之具有硫芳基之肟化合物等,並將該內容編入本說明書中。 Examples of optimal oxime compounds include those with specific substituents as described in Japanese Patent Application Publication No. 2007-269779 and those with thioaryl groups as described in Japanese Patent Application Publication No. 2009-191061, and these are incorporated herein by reference.

從曝光靈敏度的觀點考慮,光自由基聚合起始劑為選自包括三鹵甲基三化合物、苄基二甲基縮酮化合物、α-羥基酮化合物、α-胺基酮化合物、醯基膦化合物、氧化膦化合物、茂金屬化合物、肟化合物、三芳基咪唑二聚體、鎓鹽化合物、苯并噻唑化合物、二苯甲酮化合物、苯乙酮化合物及其衍生物、環戊二烯基-苯-鐵錯合物及其鹽、鹵甲基二唑化合物、3-芳基取代香豆素化合物之群組中的化合物為較佳。 From the perspective of exposure sensitivity, photoradical polymerization initiators are selected from sources including trihalomethanes. Compounds, benzyl dimethyl ketone compounds, α-hydroxy ketone compounds, α-amino ketone compounds, acetophosphine compounds, phosphine oxide compounds, metallocene compounds, oxime compounds, triarylimidazolium dimers, onium salt compounds, benzothiazole compounds, benzophenone compounds, acetophenone compounds and their derivatives, cyclopentadienyl-benzene-iron complexes and their salts, halogenated compounds Compounds from the group consisting of diazole compounds and 3-aryl-substituted coumarin compounds are preferred.

進一步較佳的光自由基聚合起始劑為三鹵甲基三化合物、α-胺基酮化合物、醯基膦化合物、氧化膦化合物、茂金屬化合物、肟化合物、三芳基咪唑二聚體、鎓鹽化合物、二苯甲酮化合物、苯乙酮化合物,選自包括三鹵甲基三化合物、α-胺基酮化合物、茂金屬化合物、肟化合物、三芳基咪唑二聚體、二苯甲酮化合物之群組中的至少1種化合物為更進一步 較佳,使用茂金屬化合物或肟化合物為又更進一步較佳。 A further preferred photoradical polymerization initiator is trihalomethane trihalomethane. Compounds, α-aminoketone compounds, acetylsphine compounds, phosphine oxide compounds, metallocene compounds, oxime compounds, triarylimidazolium dimers, onium salt compounds, benzophenone compounds, acetophenone compounds, selected from compounds including trihalomethanes. It is further preferred to use at least one compound from the group consisting of compounds, α-aminoketone compounds, metallocene compounds, oxime compounds, triarylimidazolium dimers, and benzophenone compounds, and it is even more preferred to use metallocene compounds or oxime compounds.

又,光自由基聚合起始劑亦能夠使用二苯甲酮、N,N’-四甲基-4,4’-二胺基二苯甲酮(米其勒酮(Michler’s ketone))等N,N’-四烷基-4,4’-二胺基二苯甲酮,2-苄基-2-二甲基胺基-1-(4-嗎啉基苯基)-丁酮-1,2-甲基-1-[4-(甲硫基)苯基]-2-嗎啉基-丙酮-1等芳香族酮、烷基蒽醌等與芳香環縮環而形成之醌類、安息香烷基醚等安息香醚化合物、安息香、烷基安息香等安息香化合物、苄基二甲基縮酮等苄基衍生物等。又,亦能夠使用下述式(I)所表示之化合物。 Furthermore, photoradical polymerization initiators can also include benzophenone, N,N'-tetraalkyl-4,4'-diaminobenzophenone (Michler's ketone), and other N,N'-tetraalkyl-4,4'-diaminobenzophenones; aromatic ketones such as 2-benzyl-2-dimethylamino-1-(4-morpholinylphenyl)-butanone-1,2-methyl-1-[4-(methylthio)phenyl]-2-morpholinyl-acetone-1; quinones formed by condensation of aromatic rings with alkyl anthraquinones; benzoin ether compounds such as benzoin alkyl ethers; benzoin compounds such as benzoin and alkyl benzoin; and benzyl derivatives such as benzyl dimethyl ketone. Compounds represented by formula (I) below can also be used.

式(I)中,RI00為碳數1~20的烷基、藉由1個以上的氧原子而中斷之碳數2~20的烷基、碳數1~12的烷氧基或苯基或碳數1~20的烷基、碳數1~12的烷氧基、鹵素原子、環戊基、環己基、碳數2~12的烯基、經藉由1個以上的氧原子而中斷之碳數2~18的烷基及碳數1~4的烷基中的至少1個取代的苯基或聯苯基,RI01為式(II)所表示之基團或為與RI00相同的基團,RI02~RI04分別獨立地為碳數1~12的烷基、碳數1~12的烷氧基或鹵素原子。 In formula (I), RI00 is an alkyl group having 1 to 20 carbon atoms, an alkyl group having 2 to 20 carbon atoms interrupted by one or more oxygen atoms, an alkoxy group having 1 to 12 carbon atoms or a phenyl group, or an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, a halogen atom, a cyclopentyl group, a cyclohexyl group, an alkenyl group having 2 to 12 carbon atoms, an alkyl group having 2 to 18 carbon atoms interrupted by one or more oxygen atoms, and an alkyl group having 1 to 4 carbon atoms, at least one of which is a substituted phenyl or biphenyl group. RI01 is a group represented by formula (II) or a group identical to RI00 . RI02 to RI04 are each independently an alkyl group having 1 to 12 carbon atoms, an alkoxy group having 1 to 12 carbon atoms or a halogen atom.

[化學式28] [Chemical Formula 28]

式中,RI05~RI07與上述式(I)的RI02~RI04相同。 In the formula, R I05 ~ R I07 are the same as R I02 ~ R I04 in the above formula (I).

又,光自由基聚合起始劑亦能夠使用國際公開第2015/125469號的0048~0055段中所記載的化合物,並將該內容編入本說明書中。 Furthermore, the photoradical polymerization initiators may also include compounds described in paragraphs 0048 to 0055 of International Publication No. 2015/125469, and this content is incorporated into this specification.

作為光自由基聚合起始劑,可以使用2官能或3官能以上的光自由基聚合起始劑。藉由使用該種光自由基聚合起始劑,從光自由基聚合起始劑的1分子產生2個以上的自由基,因此可以獲得良好的靈敏度。又,在使用非對稱結構的化合物之情況下,結晶性降低而在溶劑等中的溶解性提高,變得難以經時析出,從而能夠提高樹脂組成物的經時穩定性。作為2官能或3官能以上的光自由基聚合起始劑的具體例,可以舉出日本特表2010-527339號公報、日本特表2011-524436號公報、國際公開第2015/004565號、日本特表2016-532675號公報的0407~0412段、國際公開第2017/033680號的0039~0055段中所記載之肟化合物的二聚體、日本特表2013-522445號公報中所記載之化合物(E)及化合物(G)、國際公開第2016/034963號中所記載之Cmpd1~7、日本特表2017-523465號公報的0007段中所記載之肟酯類光起始劑、日本特開2017-167399號公報的0020~0033段中所記載之光起始劑、日本特開2017-151342號公報的0017~0026段中所記載之光聚合起始劑(A)、日本專利第6469669號公報中所記載之肟酯光起始劑等,並將該內容編入本說明書中。 As a photoradical polymerization initiator, a photoradical polymerization initiator with two or more functionalities can be used. By using such a photoradical polymerization initiator, two or more free radicals are generated from one molecule of the initiator, thus achieving good sensitivity. Furthermore, when using compounds with asymmetrical structures, the crystallinity decreases while the solubility in solvents increases, making it difficult to precipitate over time, thereby improving the long-term stability of the resin composition. Specific examples of photoradical polymerization initiators with two or more functions include dimers of oxime compounds described in Japanese Patent Application Publication No. 2010-527339, Japanese Patent Application Publication No. 2011-524436, International Publication No. 2015/004565, paragraphs 0407-0412 of Japanese Patent Application Publication No. 2016-532675, and paragraphs 0039-0055 of International Publication No. 2017/033680; and compounds (E) and (G) described in Japanese Patent Application Publication No. 2013-522445. The photoinitiators described in this specification include Cmpd1-7 as disclosed in International Publication No. 2016/034963, oxime ester photoinitiators described in paragraph 0007 of Japanese Patent Application Publication No. 2017-523465, photoinitiators described in paragraphs 0020-0033 of Japanese Patent Application Publication No. 2017-167399, photopolymerization initiator (A) described in paragraphs 0017-0026 of Japanese Patent Application Publication No. 2017-151342, and oxime ester photoinitiators described in Japanese Patent No. 6469669.

在包含光聚合起始劑之情況下,其含量相對於本發明的樹脂 組成物的總固體成分為0.1~30質量%為較佳,更佳為0.1~20質量%,進一步較佳為0.5~15質量%,更進一步較佳為1.0~10質量%。光聚合起始劑可以僅含有1種,亦可以含有2種以上。在含有2種以上的光聚合起始劑之情況下,合計量在上述範圍內為較佳。 When a photopolymerization initiator is included, its content relative to the total solid content of the resin composition of the present invention is preferably 0.1-30% by mass, more preferably 0.1-20% by mass, further preferably 0.5-15% by mass, and even more preferably 1.0-10% by mass. The photopolymerization initiator may be contained in only one type or in two or more types. When two or more photopolymerization initiators are contained, the total amount is preferably within the above range.

再者,光聚合起始劑有時亦作為熱聚合起始劑而發揮功能,因此有時藉由烘箱或加熱板等的加熱而進一步進行基於光聚合起始劑之交聯。 Furthermore, photopolymerization initiators sometimes also function as thermal polymerization initiators; therefore, heating with an oven or heating plate can sometimes further facilitate crosslinking based on the photopolymerization initiator.

〔敏化劑〕 [Sensitizer]

樹脂組成物可以包括敏化劑。敏化劑吸收特定的活性放射線而成為電子激勵狀態。成為電子激勵狀態之敏化劑與熱自由基聚合起始劑、光自由基聚合起始劑等接觸,從而產生電子轉移、能量轉移、發熱等作用。藉此,熱自由基聚合起始劑、光自由基聚合起始劑引起化學變化而分解,並生成自由基、酸或鹼。 Resin components may include sensitizers. Sensitizers absorb specific active radiation to become electronically excited. These electronically excited sensitizers then come into contact with thermal free radical polymerization initiators, photofree radical polymerization initiators, etc., thereby generating electron transfer, energy transfer, and heating. As a result, the thermal free radical polymerization initiators and photofree radical polymerization initiators undergo chemical changes and decompose, generating free radicals, acids, or bases.

作為能夠使用的敏化劑,能夠使用二苯甲酮系、米其勒酮系、香豆素系、吡唑偶氮系、苯胺基偶氮系、三苯基甲烷系、蒽醌系、蒽系、蒽吡啶酮系、亞苄基系、氧雜菁系、吡唑并三唑偶氮系、吡啶酮偶氮系、花青系、啡噻系、吡咯并吡唑偶氮次甲基系、系、酞菁系、苯并吡喃系、靛藍系等化合物。 As usable sensitizers, benzophenone-based, milchnerone-based, coumarin-based, pyrazole azo, aniline azo, triphenylmethane-based, anthraquinone-based, anthracene-based, anthraquinone-based, benzylene-based, oxocyanine-based, pyrazolotriazole azo, pyridone azo, anthocyanin-based, and phenanthrene-based sensitizers are all suitable. Series, pyrrolopyrazole azomethine series, Compounds such as phthalocyanine, benzopyran, and indigo series.

作為敏化劑,例如可以舉出米其勒酮、4,4’-雙(二乙胺基)二苯甲酮、2,5-雙(4’-二乙胺基亞苄基)環戊烷、2,6-雙(4’-二乙胺基亞苄基)環己酮、2,6-雙(4’-二乙胺基亞苄基)-4-甲基環己酮、4,4’-雙(二甲基胺基)查耳酮、4,4’-雙(二乙胺基)查耳酮、對二甲基胺基苯亞烯丙基二氫茚酮、對二甲基胺基亞苄基二氫茚酮、2-(對二甲基胺基苯基亞聯苯基)-苯并噻唑、2- (對二甲基胺基苯基亞乙烯基)苯并噻唑、2-(對二甲基胺基苯基亞乙烯基)異萘并噻唑、1,3-雙(4’-二甲基胺基亞苄基)丙酮、1,3-雙(4’-二乙胺基亞苄基)丙酮、3,3’-羰基-雙(7-二乙胺基香豆素)、3-乙醯基-7-二甲基胺基香豆素、3-乙氧基羰基-7-二甲基胺基香豆素、3-苄氧基羰基-7-二甲基胺基香豆素、3-甲氧基羰基-7-二乙胺基香豆素、3-乙氧基羰基-7-二乙胺基香豆素(7-(二乙胺基)香豆素-3-羧酸乙酯)、N-苯基-N’-乙基乙醇胺、N-苯基二乙醇胺、N-對甲苯基二乙醇胺、N-苯基乙醇胺、4-嗎啉基二苯甲酮、二甲基胺基苯甲酸異戊酯、二乙胺基苯甲酸異戊酯、2-巰基苯并咪唑、1-苯基-5-巰基四唑、2-巰基苯并噻唑、2-(對二甲基胺基苯乙烯基)苯并唑、2-(對二甲基胺基苯乙烯基)苯并噻唑、2-(對二甲基胺基苯乙烯基)萘并(1,2-d)噻唑、2-(對二甲基胺基苯甲醯基)苯乙烯、二苯基乙醯胺、苯甲醯苯胺、N-甲基乙醯苯胺、3’,4’-二甲基乙醯苯胺等。 Examples of sensitizers include milchnerone, 4,4'-bis(diethylamino)benzophenone, 2,5-bis(4'-diethylaminobenzyl)cyclopentane, 2,6-bis(4'-diethylaminobenzyl)cyclohexanone, 2,6-bis(4'-diethylaminobenzyl)-4-methylcyclohexanone, 4,4'-bis(dimethylamino)chalcone, 4,4'-bis(diethylamino)chalcone, p-dimethylaminophenylenepropyl dihydroindone, p-dimethylaminobenzyl dihydroindone, 2-(p-dimethylaminophenylbiphenylene)-benzothiazole, 2- (p-Dimethylaminophenylethylene)benzothiazole, 2-(p-Dimethylaminophenylethylene)isonaphthothiazole, 1,3-bis(4'-dimethylaminobenzyl)acetone, 1,3-bis(4'-diethylaminobenzyl)acetone, 3,3'-carbonyl-bis(7-diethylaminocoumarin), 3-acetylated-7-dimethylaminocoumarin, 3-ethoxycarbonyl-7-dimethylaminocoumarin, 3-benzyloxycarbonyl-7-dimethylaminocoumarin, 3-methoxycarbonyl-7 -Diethylaminocoumarin, 3-ethoxycarbonyl-7-diethylaminocoumarin (7-(diethylamino)coumarin-3-carboxylic acid ethyl ester), N-phenyl-N'-ethylethanolamine, N-phenyldiethanolamine, N-p-tolyldiethanolamine, N-phenylethanolamine, 4-morpholinobenzophenone, isoamyl dimethylaminobenzoate, isoamyl diethylaminobenzoate, 2-phenylbenzimidazole, 1-phenyl-5-phenyltetrazole, 2-phenylbenzothiazole, 2-(p-dimethylaminostyryl)benzo[[...]] Zyrazole, 2-(p-dimethylaminostyryl)benzothiazole, 2-(p-dimethylaminostyryl)naphtho(1,2-d)thiazole, 2-(p-dimethylaminobenzoyl)styrene, diphenylacetamide, benzoaniline, N-methylacetamide, 3',4'-dimethylacetamide, etc.

又,可以使用其他敏化色素。 Alternatively, other sensitizing pigments can be used.

關於敏化色素的詳細內容,能夠參閱日本特開2016-027357號公報的0161~0163段的記載,並將該內容編入本說明書中。 For detailed information regarding the sensitized pigments, please refer to paragraphs 0161 to 0163 of Japanese Patent Application Publication No. 2016-027357, and this information is incorporated into this specification.

在樹脂組成物包含敏化劑之情況下,敏化劑的含量相對於樹脂組成物的總固體成分為0.01~20質量%為較佳,0.1~15質量%為更佳,0.5~10質量%為進一步較佳。敏化劑可以單獨使用1種,亦可以同時使用2種以上。 When the resin composition contains a sensitizer, the sensitizer content relative to the total solids content of the resin composition is preferably 0.01~20% by weight, more preferably 0.1~15% by weight, and even more preferably 0.5~10% by weight. A single sensitizer can be used, or two or more sensitizers can be used simultaneously.

〔鏈轉移劑〕 [Chain transfer agent]

本發明的樹脂組成物可以含有鏈轉移劑。關於鏈轉移劑,例如在高分子詞典第三版(高分子學會(The Society of Polymer Science,Japan)編, 2005年)683-684頁中被定義。作為鏈轉移劑,例如可以使用在分子內具有-S-S-、-SO2-S-、-N-O-、SH、PH、SiH及GeH之化合物群組、具有用於RAFT(Reversible Addition Fragmentation chain Transfer:可逆加成鏈轉移聚合)聚合之硫羰硫基之二硫代苯甲酸酯、三硫代碳酸酯、二硫代胺基甲酸酯、黃原酸酯(Xanthate)化合物等。該等對低活性自由基供給氫而生成自由基或者在被氧化之後可以藉由去質子來生成自由基。尤其,能夠較佳地使用硫醇化合物。 The resin composition of this invention may contain a chain transfer agent. Chain transfer agents are defined, for example, in the 3rd edition of the Polymer Dictionary (edited by the Society of Polymer Science, Japan, 2005), pages 683-684. Examples of chain transfer agents include compounds containing -SS-, -SO₂ , -S-, -NO-, SH, PH, SiH, and GeH within the molecule, as well as dithiobenzoate, trithiocarbonate, dithiocarbamate, and xanthate compounds having a thiocarbonyl sulfide group for RAFT (Reversible Addition Fragmentation Chain Transfer) polymerization. These compounds can generate free radicals by donating hydrogen to low-activity free radicals or by deprotonation after oxidation. In particular, it allows for better use of thiol compounds.

又,鏈轉移劑亦能夠使用國際公開第2015/199219號的0152~0153段中所記載的化合物,並將該內容編入本說明書中。 Furthermore, the chain transfer agent may also use the compounds described in paragraphs 0152-0153 of International Publication No. 2015/199219, and that content is incorporated into this specification.

在本發明的樹脂組成物具有鏈轉移劑之情況下,鏈轉移劑的含量相對於本發明的樹脂組成物的總固體成分100質量份為0.01~20質量份為較佳,0.1~10質量份為更佳,0.5~5質量份為進一步較佳。鏈轉移劑可以為僅1種,亦可以為2種以上。在鏈轉移劑為2種以上之情況下,其合計在上述範圍內為較佳。 When the resin composition of the present invention contains a chain transfer agent, the content of the chain transfer agent relative to 100 parts by weight of the total solid content of the resin composition of the present invention is preferably 0.01 to 20 parts by weight, more preferably 0.1 to 10 parts by weight, and further preferably 0.5 to 5 parts by weight. The chain transfer agent may be only one type or may be two or more types. When there are two or more chain transfer agents, it is preferable that their total content is within the above-mentioned range.

〔光酸產生劑〕 [Photosensitive acid generator]

本發明的樹脂組成物包含光酸產生劑為較佳。 The resin composition of this invention preferably contains a photosensitive acid generator.

光酸產生劑表示藉由200nm~900nm的光照射而產生布忍斯特酸及路易斯酸中的至少一者之化合物。所照射之光較佳為波長300nm~450nm的光,更佳為330nm~420nm的光。在單獨使用光酸產生劑或與敏化劑的同時使用時,能夠藉由感光而產生酸的光酸產生劑為較佳。 A photoacid generator is a compound that produces at least one of Brinzyl acid and Lewis acid upon irradiation with light in the range of 200 nm to 900 nm. Preferably, the irradiated light has a wavelength of 300 nm to 450 nm, and more preferably 330 nm to 420 nm. When used alone or in conjunction with a sensitizer, a photoacid generator capable of producing acid through photosensitivity is preferred.

作為所產生之酸的例子,可以較佳地舉出鹵化氫、羧酸、磺酸、亞磺酸、硫代亞磺酸、磷酸、磷酸單酯、磷酸二酯、硼衍生物、磷衍生物、銻 衍生物、過氧化鹵素、磺酸醯胺等。 Examples of acids produced include hydrogen halides, carboxylic acids, sulfonic acids, sulfinic acids, thiosulfinic acids, phosphoric acid, monophosphate esters, diesters, boron derivatives, phosphorus derivatives, antimony derivatives, halogen peroxides, and sulfonamides.

作為本發明的樹脂組成物中所使用之光酸產生劑,例如可以舉出醌二疊氮化合物、肟磺酸鹽化合物、有機鹵化化合物、有機硼酸鹽化合物、二磺酸化合物、鎓鹽化合物等。 Examples of photoacid generators used in the resin composition of this invention include, for instance, quinone diazide compounds, oxime sulfonate compounds, organic halogenated compounds, organic borate compounds, disulfonic acid compounds, and onmium salt compounds.

從靈敏度、保存穩定性的觀點考慮,有機鹵素化合物、肟磺酸鹽化合物、鎓鹽化合物為較佳,從所形成之膜的機械特性等之觀點考慮,肟酯為較佳。 From the perspectives of sensitivity and preservation stability, organohalogen compounds, oxime sulfonate compounds, and onium salt compounds are preferred; from the perspective of the mechanical properties of the formed film, oxime esters are preferred.

作為醌二疊氮化合物,可以舉出醌二疊氮的磺酸酯鍵於1價或多元的羥基化合物而獲得者,醌二疊氮的磺酸磺醯胺鍵於1價或多元的胺化合物而獲得者,醌二疊氮的磺酸酯鍵和/或磺醯胺鍵於聚羥基聚胺化合物而獲得者等。該等聚羥基化合物、聚胺基化合物、聚羥基聚胺基化合物的所有官能基可以未經醌二疊氮取代,但是進行平均而官能基整體的40莫耳%以上經醌二疊氮取代為較佳。藉由含有該種醌二疊氮化合物,能夠獲得對作為通常的紫外線之水銀燈的i射線(波長365nm)、h射線(波長405nm)、g射線(波長436nm)進行感光之樹脂組成物。 Examples of quinone diazonium compounds include those obtained by attaching a quinone diazonium sulfonate bond to a monovalent or polyvalent hydroxyl group, those obtained by attaching a quinone diazonium sulfonate sulfonamide bond to a monovalent or polyvalent amine group, and those obtained by attaching a quinone diazonium sulfonate bond and/or a sulfonamide bond to a polyhydroxy polyamine compound. All functional groups of these polyhydroxy compounds, polyamine compounds, and polyhydroxy polyamine compounds may not be substituted with quinone diazonium, but it is preferable that at least 40 mol% of the total functional groups are substituted with quinone diazonium on average. By using this quinone diazonium compound, it is possible to obtain a resin composition that is photosensitive to the i-rays (wavelength 365 nm), h-rays (wavelength 405 nm), and g-rays (wavelength 436 nm) of a conventional ultraviolet mercury lamp.

作為羥基化合物,具體而言,可以舉出酚、三羥基二苯甲酮、4甲氧基苯酚、異丙醇、辛醇、第三丁醇、環己醇、萘酚、Bis-Z、BisP-EZ、TekP-4HBPA、TrisP-HAP、TrisP-PA、TrisP-SA、TrisOCR-PA、BisOCHP-Z、BisP-MZ、BisP-PZ、BisP-IPZ、BisOCP-IPZ、BisP-CP、BisRS-2P、BisRS-3P、BisP-OCHP、亞甲基三-FR-CR、BisRS-26X、DML-MBPC、DML-MBOC、DML-OCHP、DML-PCHP、DML-PC、DML-PTBP、DML-34X、DML-EP、DML-POP、二羥甲基-BisOC-P、DML-PFP、DML-PSBP、DML-MT risPC、TriML-P、TriML-35XL、TML-BP、TML-HQ、TML-pp-BPF、TML-BPA、TMOM-BP、HML-TPPHBA、HML-TPHAP(以上為產品名稱,Honshu Chemical Industry Co.,Ltd.製)、BIR-OC、BIP-PC、BIR-PC、BIR-PTBP、BIR-PCHP、BIP-BIOC-F、4PC、BIR-BIPC-F、TEP-BIP-A、46DMOC、46DMOEP、TM-BIP-A(以上為產品名稱,ASAHI YUKIZAI CORPORATION製)、2,6-二甲氧基甲基-4-第三丁基酚、2,6-二甲氧基甲基-對甲酚、2,6-二乙醯氧基甲基-對甲酚、萘酚、四羥基二苯甲酮、沒食子酸甲基酯、雙酚A、雙酚E、亞甲基雙酚、BisP-AP(產品名稱,Honshu Chemical Industry Co.,Ltd.製)、酚醛清漆樹脂等,但是並不限定於該等。 As hydroxyl compounds, specific examples include phenol, trihydroxybenzophenone, 4-methoxyphenol, isopropanol, octanol, tributanol, cyclohexanol, naphthol, Bis-Z, BisP-EZ, TekP-4HBPA, TrisP-HAP, TrisP-PA, TrisP-SA, TrisOCR-PA, BisOCHP-Z, BisP-MZ, BisP-PZ, BisP-IPZ, BisOCP-IPZ, BisP-CP, BisRS-2P, BisRS-3P, BisP-OCHP, methylene tri-FR-CR, BisRS- 26X, DML-MBPC, DML-MBOC, DML-OCHP, DML-PCHP, DML-PC, DML-PTBP, DML-34X, DML-EP, DML-POP, Dihydroxymethyl-BisOC-P, DML-PFP, DML-PSBP, DML-MTrisPC, TriML-P, TriML-35XL, TML-BP, TML-HQ, TML-pp-BPF, TML-BPA, TMOM-BP, HML-TPPHBA, HML-TPHAP (These are product names, Honshu) The products manufactured by ASAHI YUKIZAI CORPORATION include, but are not limited to, BIR-OC, BIP-PC, BIR-PTBP, BIR-PCHP, BIP-BIOC-F, 4PC, BIR-BIPC-F, TEP-BIP-A, 46DMOC, 46DMOEP, TM-BIP-A (the above are product names, manufactured by ASAHI YUKIZAI CORPORATION), 2,6-dimethoxymethyl-4-tert-butylphenol, 2,6-dimethoxymethyl-p-cresol, 2,6-diacetoxymethyl-p-cresol, naphthol, tetrahydroxybenzophenone, methyl gallate, bisphenol A, bisphenol E, methylene bisphenol, BisP-AP (product name, manufactured by Honshu Chemical Industry Co., Ltd.), phenolic varnish resins, etc. (The following are product names: BIR-OC, BIP-PC, BIR-PTBP, BIR-PCHP, BIP-BIOC-F, 4PC, BIR-BIPC-F, TEP-BIP-A, 46DMOC, 46DMOEP, TM-BIP-A (the above are product names, manufactured by ASAHI YUKIZAI CORPORATION), 2,6-dimethoxymethyl-4-tert-butylphenol, 2,6-dimethoxymethyl-p-cresol, 2,6-diacetoxymethyl-p-cresol, naphthol, tetrahydroxybenzophenone, methyl gallate, bisphenol A, bisphenol E, methylene bisphenol, BisP-AP (product name, manufactured by Honshu Chemical Industry Co., Ltd.), phenolic varnish resins, etc.

作為胺基化合物,具體而言,可以舉出苯胺、甲基苯胺、二乙胺、丁胺、1,4-伸苯基二胺、1,3-伸苯基二胺、4,4’-二胺基二苯醚、4,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基碸、4,4’-二胺基二苯醚等,但是並不限定於該等。 As an amino compound, examples include aniline, methylaniline, diethylamine, butylamine, 1,4-phenylenediamine, 1,3-phenylenediamine, 4,4'-diaminodiphenyl ether, 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenyl sulfone, and 4,4'-diaminodiphenyl ether, but it is not limited to these.

又,作為聚羥基聚胺基化合物,具體而言,可以舉出2,2-雙(3-胺基-4-羥基苯基)六氟丙烷、3,3’-二羥基聯苯胺等,但是並不限定於該等。 Furthermore, examples of polyhydroxy polyamine compounds include 2,2-bis(3-amino-4-hydroxyphenyl)hexafluoropropane and 3,3'-dihydroxybenzidine, but these are not limited to these.

在該等之中,包含酚化合物及與4-萘醌二疊氮磺醯基的酯作為醌二疊氮化合物為較佳。藉此,能夠獲得對i射線曝光之更高的靈敏度和更高的解析度。 Among these, compounds containing phenolic compounds and esters with a 4-naphthoquinone diazidesulfonate group are preferred as quinone diazide compounds. This allows for higher sensitivity and higher resolution to i-ray exposure.

本發明的樹脂組成物中所使用之醌二疊氮化合物的含量相對於樹脂100質量份為1~50質量份為較佳,10~40質量份為更佳。藉由將醌二疊氮化合物的含量設在該範圍內,可以獲得曝光部和未曝光部的對 比度,從而能夠實現更高靈敏度化,因此為較佳。進而,可以依據需要添加敏化劑等。 The content of the quinone diazonium compound used in the resin composition of this invention is preferably 1 to 50 parts by weight, and more preferably 10 to 40 parts by weight, relative to 100 parts by weight of the resin. By setting the content of the quinone diazonium compound within this range, the contrast between the exposed and unexposed areas can be obtained, thereby achieving higher sensitivity, which is therefore preferable. Furthermore, sensitizers, etc., can be added as needed.

光酸產生劑為包含肟磺酸鹽基之化合物(以下,亦簡稱為“肟磺酸鹽化合物”)為較佳。 The photoacid generator is preferably a compound containing an oxime sulfonate group (hereinafter also referred to as "oxime sulfonate compound").

肟磺酸鹽化合物只要具有肟磺酸鹽基,則並無特別限制,但是下述式(OS-1)、後述式(OS-103)、式(OS-104)或式(OS-105)所表示之肟磺酸鹽化合物為較佳。 There are no particular restrictions on the presence of an oxime sulfonate group in the oxime sulfonate compound; however, oxime sulfonate compounds represented by the following formula (OS-1), formula (OS-103), formula (OS-104), or formula (OS-105) are preferred.

式(OS-1)中,X3表示烷基、烷氧基或鹵素原子。在存在複數個X3之情況下,分別可以相同,亦可以不同。上述X3中之烷基及烷氧基可以具有取代基。作為上述X3中之烷基,碳數1~4的直鏈狀或支鏈狀烷基為較佳。作為上述X3中之烷氧基,碳數1~4的直鏈狀或支鏈狀烷氧基為較佳。作為上述X3中之鹵素原子,氯原子或氟原子為較佳。 In formula (OS-1), X3 represents an alkyl, alkoxy, or halogen atom. When there are multiple X3 atoms, they may be the same or different. The alkyl and alkoxy atoms in X3 may have substituents. Preferably, the alkyl group in X3 is a straight-chain or branched alkyl group having 1 to 4 carbon atoms. Preferably, the alkoxy group in X3 is a straight-chain or branched alkoxy group having 1 to 4 carbon atoms. Preferably, the halogen atom in X3 is a chlorine or fluorine atom.

式(OS-1)中,m3表示0~3的整數,0或1為較佳。在m3為2或3時,複數個X3可以相同亦可以不同。 In equation (OS-1), m3 represents an integer from 0 to 3, with 0 or 1 being preferred. When m3 is 2 or 3, the complex numbers X3 can be the same or different.

式(OS-1)中,R34表示烷基或芳基,碳數1~10的烷基、碳數1~10的烷氧基、碳數1~5的鹵化烷基、碳數1~5的鹵化烷氧基、可以經W取代的苯基、可以經W取代的萘基或可以經W取代的蒽基為較佳。W表示鹵素原子、氰基、硝基、碳數1~10的烷基、碳數1~10的烷氧基、碳數1 ~5的鹵化烷基或碳數1~5的鹵化烷氧基、碳數6~20的芳基、碳數6~20的鹵化芳基。 In formula (OS-1), R 34 represents an alkyl or aryl group, preferably an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a halogenated alkyl group having 1 to 5 carbon atoms, a halogenated alkoxy group having 1 to 5 carbon atoms, a phenyl group that can be substituted with W, a naphthyl group that can be substituted with W, or an anthracene group that can be substituted with W. W represents a halogen atom, a cyano group, a nitro group, an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a halogenated alkyl group having 1 to 5 carbon atoms, or a halogenated alkoxy group having 1 to 5 carbon atoms, an aryl group having 6 to 20 carbon atoms, or a halogenated aryl group having 6 to 20 carbon atoms.

式(OS-1)中,m3為3,X3為甲基,X3的取代位置為鄰位,R34為碳數1~10的直鏈狀烷基、7,7-二甲基-2-氧代降崁基甲基或對甲苯基的化合物為特佳。 In formula (OS-1), m3 is 3, X3 is methyl, X3 is substituted at an ortho position, and R34 is preferably a straight-chain alkyl group with 1 to 10 carbon atoms, 7,7-dimethyl-2-oxonorcanylmethyl or p-tolyl.

作為式(OS-1)所表示之肟磺酸鹽化合物的具體例,可以例示日本特開2011-209692號公報的0064~0068段、日本特開2015-194674號公報的0158~0167段中所記載之以下化合物,並將該等內容編入本說明書中。 Specific examples of oxime sulfonate compounds represented by formula (OS-1) include the following compounds described in paragraphs 0064 to 0068 of Japanese Patent Application Publication No. 2011-209692 and paragraphs 0158 to 0167 of Japanese Patent Application Publication No. 2015-194674, and these contents are incorporated herein by reference.

式(OS-103)~式(OS-105)中,Rs1表示烷基、芳基或雜芳基,有時存在複數個之Rs2分別獨立地表示氫原子、烷基、芳基或鹵素原子,有時存在複數個之Rs6分別獨立地表示鹵素原子、烷基、烷氧基、磺酸基、胺基磺醯基或烷氧基磺醯基,Xs表示O或S,ns表示1或2,ms表示 0~6的整數。 In formulas (OS-103) to (OS-105), Rs1 represents alkyl, aryl, or heteroaryl; sometimes there are multiple Rs2 that independently represent hydrogen, alkyl, aryl, or halogen atoms; sometimes there are multiple Rs6 that independently represent halogen, alkyl, alkoxy, sulfonic acid, aminosulfonyl, or alkoxysulfonyl; Xs represents O or S; ns represents 1 or 2; and ms represents an integer from 0 to 6.

式(OS-103)~式(OS-105)中,Rs1所表示之烷基(碳數1~30為較佳)、芳基(碳數6~30為較佳)或雜芳基(碳數4~30為較佳)在可以獲得本發明的效果之範圍內可以具有公知的取代基。 In formulas (OS-103) to (OS-105), the alkyl group (preferably with 1 to 30 carbons), aryl group (preferably with 6 to 30 carbons), or heteroaryl group (preferably with 4 to 30 carbons) represented by R s1 may have known substituents within the range that can achieve the effects of the present invention.

式(OS-103)~式(OS-105)中,Rs2為氫原子、烷基(碳數1~12為較佳)或芳基(碳數6~30為較佳)為較佳,氫原子或烷基為更佳。在化合物中有時存在2個以上之Rs2中,1個或2個為烷基、芳基或鹵素原子為較佳,1個為烷基、芳基或鹵素原子為更佳,1個為烷基且其餘為氫原子為特佳。Rs2所表示之烷基或芳基在可以獲得本發明的效果之範圍內可以具有公知的取代基。 In formulas (OS-103) to (OS-105), Rs2 is preferably a hydrogen atom, an alkyl group (preferably with 1 to 12 carbon atoms), or an aryl group (preferably with 6 to 30 carbon atoms), with a hydrogen atom or alkyl group being more preferred. In compounds where two or more Rs2 groups are present, it is preferred that one or two are alkyl, aryl, or halogen atoms, more preferred that one is an alkyl, aryl, or halogen atom, and especially preferred that one is an alkyl group and the remainder are hydrogen atoms. The alkyl or aryl group represented by Rs2 may have known substituents within the range that allows the effects of the present invention to be obtained.

式(OS-103)、式(OS-104)或式(OS-105)中,Xs表示O或S,O為較佳。上述式(OS-103)~(OS-105)中,包含Xs作為環員之環為5員環或6員環。 In formulas (OS-103), (OS-104), or (OS-105), Xs represents O or S, with O being preferred. In formulas (OS-103) to (OS-105), a ring containing Xs as a member is a 5-member ring or a 6-member ring.

式(OS-103)~式(OS-105)中,ns表示1或2,在Xs為O之情況下,ns為1為較佳,並且在Xs為S之情況下,ns為2為較佳。 In equations (OS-103) to (OS-105), ns represents 1 or 2. When Xs is 0, ns being 1 is preferred, and when Xs is S, ns being 2 is preferred.

式(OS-103)~式(OS-105)中,Rs6所表示之烷基(碳數1~30為較佳)及烷氧基(碳數1~30為較佳)可以具有取代基。 In formulas (OS-103) to (OS-105), the alkyl group (preferably with 1 to 30 carbon atoms) and alkoxy group (preferably with 1 to 30 carbon atoms) represented by R s6 may have substituents.

式(OS-103)~式(OS-105)中,ms表示0~6的整數,0~2的整數為較佳,0或1為更佳,0為特佳。 In equations (OS-103) to (OS-105), ms represents an integer from 0 to 6, with integers from 0 to 2 being preferred, 0 or 1 being even better, and 0 being exceptionally good.

又,上述式(OS-103)所表示之化合物為下述式(OS-106)、式(OS-110)或式(OS-111)所表示之化合物為特佳,上述式(OS-104)所表示之化合物為下述式(OS-107)所表示之化合物為特佳,上述式(OS -105)所表示之化合物為下述式(OS-108)或式(OS-109)所表示之化合物為特佳。 Furthermore, the compound represented by formula (OS-103) is preferably represented by formula (OS-106), formula (OS-110), or formula (OS-111); the compound represented by formula (OS-104) is preferably represented by formula (OS-107); and the compound represented by formula (OS-105) is preferably represented by formula (OS-108) or formula (OS-109).

式(OS-106)~式(OS-111)中,Rt1表示烷基、芳基或雜芳基,Rt7表示氫原子或溴原子,Rt8表示氫原子、碳數1~8的烷基、鹵素原子、氯甲基、溴甲基、溴乙基、甲氧基甲基、苯基或氯苯基,Rt9表示氫原子、鹵素原子、甲基或甲氧基,Rt2表示氫原子或甲基。 In formulas (OS-106) to (OS-111), Rt1 represents alkyl, aryl, or heteroaryl; Rt7 represents a hydrogen atom or a bromine atom; Rt8 represents a hydrogen atom, an alkyl atom with 1 to 8 carbon atoms, a halogen atom, chloromethyl, bromomethyl, bromoethyl, methoxymethyl, phenyl, or chlorophenyl; Rt9 represents a hydrogen atom, a halogen atom, a methyl or methoxy; and Rt2 represents a hydrogen atom or a methyl.

式(OS-106)~式(OS-111)中,Rt7表示氫原子或溴原子,氫原子為較佳。 In formulas (OS-106) to (OS-111), R t7 represents a hydrogen atom or a bromine atom, with hydrogen atom being preferred.

式(OS-106)~式(OS-111)中,Rt8表示氫原子、碳數1~8的烷基、鹵素原子、氯甲基、溴甲基、溴乙基、甲氧基甲基、苯基或氯苯基,碳數1~8的烷基、鹵素原子或苯基為較佳,碳數1~8的烷基為更佳,碳數1~6的烷基為進一步較佳,甲基為特佳。 In formulas (OS-106) to (OS-111), R t8 represents a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, a halogen atom, a chloromethyl group, a bromomethyl group, a bromoethyl group, a methoxymethyl group, a phenyl group, or a chlorophenyl group. It is preferred that the alkyl group having 1 to 8 carbon atoms or a halogen atom or a phenyl group has 1 to 8 carbon atoms, even more preferred, and alkyl group having 1 to 6 carbon atoms is even more preferred. Methyl is particularly preferred.

式(OS-106)~式(OS-111)中,Rt9表示氫原子、鹵素原子、甲基或甲氧基,氫原子為較佳。 In formulas (OS-106) to (OS-111), R t9 represents a hydrogen atom, a halogen atom, a methyl group, or a methoxy group, with a hydrogen atom being preferred.

Rt2表示氫原子或甲基,氫原子為較佳。 R t2 represents a hydrogen atom or a methyl group, with a hydrogen atom being preferred.

又,在上述肟磺酸鹽化合物中,關於肟的立體結構(E,Z),可以為其中任一者,亦可以為混合物。 Furthermore, in the above-mentioned oxime sulfonate compounds, the stereostructure (E, Z) of the oxime can be either one of them or a mixture thereof.

作為上述式(OS-103)~式(OS-105)所表示之肟磺酸鹽化合物的具體例,可以例示日本特開2011-209692號公報的0088~0095段、日本特開2015-194674號公報的0168~0194段中所記載的化合物,並將該等內容編入本說明書中。 Specific examples of oxime sulfonate compounds represented by formulas (OS-103) to (OS-105) are the compounds described in paragraphs 0088 to 0095 of Japanese Patent Application Publication No. 2011-209692 and paragraphs 0168 to 0194 of Japanese Patent Application Publication No. 2015-194674, and these contents are incorporated herein by reference.

作為包含至少1個肟磺酸鹽基之肟磺酸鹽化合物的較佳的其他態樣,可以舉出下述式(OS-101)、式(OS-102)所表示之化合物。 Other preferred embodiments of oxime sulfonate compounds containing at least one oxime sulfonate group include compounds represented by the following formulas (OS-101) and (OS-102).

式(OS-101)或式(OS-102)中,Ru9表示氫原子、烷基、烯基、烷氧基、烷氧羰基、醯基、胺甲醯基、胺磺醯基、磺基、氰基、芳基或雜芳基。Ru9為氰基或芳基之態樣為更佳,Ru9為氰基、苯基或萘基之態樣為進一步較佳。 In formula (OS-101) or formula (OS-102), Ru9 represents a hydrogen atom, alkyl, alkenyl, alkoxy, alkoxycarbonyl, acetyl, aminomethyl, aminosulfonyl, sulfonyl, cyano, aryl, or heteroaryl. It is preferred that Ru9 is cyano or aryl, and it is further preferred that Ru9 is cyano, phenyl, or naphthyl.

式(OS-101)或式(OS-102)中,Ru2a表示烷基或芳基。 In formula (OS-101) or formula (OS-102), Ru2a represents alkyl or aryl.

式(OS-101)或式(OS-102)中,Xu表示-O-、-S-、-NH-、-NRu5-、-CH2-、-CRu6H-或CRu6Ru7-,Ru5~Ru7分別獨立地表示烷基或芳基。 In formula (OS-101) or formula (OS-102), Xu represents -O-, -S-, -NH-, -NR u5- , -CH 2- , -CR u6 H- or CR u6 R u7- , and R u5 ~ R u7 represent alkyl or aryl groups independently.

式(OS-101)或式(OS-102)中,Ru1~Ru4分別獨立地表示氫原子、鹵素原子、烷基、烯基、烷氧基、胺基、烷氧羰基、烷基羰基、芳基羰基、醯胺基、磺基、氰基或芳基。Ru1~Ru4中的2個分別可以相互鍵結而形成環。此時,環可以進行縮環而與苯環一同形成縮合環。作為Ru1~Ru4,氫原子、鹵素原子或烷基為較佳,並且Ru1~Ru4中的至少2個相互鍵結而形成芳基之態樣亦較佳。其中,Ru1~Ru4均為氫原子之態樣為較佳。上述取代基均還可以具有取代基。 In formula (OS-101) or formula (OS-102), Ru1 to Ru4 independently represent a hydrogen atom, a halogen atom, an alkyl group, an alkenyl group, an alkoxy group, an amino group, an alkoxycarbonyl group, an alkylcarbonyl group, an arylcarbonyl group, a amide group, a sulfonyl group, a cyano group, or an aryl group. Two of Ru1 to Ru4 can be bonded together to form a ring. In this case, the ring can undergo ring condensation to form a condensed ring together with the benzene ring. Preferably, Ru1 to Ru4 are hydrogen atoms, halogen atoms, or alkyl groups, and it is also preferred that at least two of Ru1 to Ru4 are bonded together to form an aryl group. Preferably, all of Ru1 to Ru4 are hydrogen atoms. The above-mentioned substituents may also have substituents.

上述式(OS-101)所表示之化合物為式(OS-102)所表示之化合物為更佳。 The compound represented by formula (OS-101) is preferably represented by formula (OS-102).

又,在上述肟磺酸鹽化合物中,關於肟或苯并噻唑環的立體結構(E,Z等),分別可以為其中任一者,亦可以為混合物。 Furthermore, in the aforementioned oxime sulfonate compounds, the stereostructure (E, Z, etc.) of the oxime or benzothiazole ring can be either one of them or a mixture thereof.

作為式(OS-101)所表示之化合物的具體例,可以例示日本特開2011-209692號公報的0102~0106段、日本特開2015-194674號公報的0195~0207段中所記載的化合物,並將該等內容編入本說明書中。 Specific examples of compounds represented by formula (OS-101) include those described in paragraphs 0102 to 0106 of Japanese Patent Application Publication No. 2011-209692 and paragraphs 0195 to 0207 of Japanese Patent Application Publication No. 2015-194674, and these contents are incorporated herein by reference.

在上述化合物之中,下述b-9、b-16、b-31、b-33為較佳。 Of the compounds mentioned above, b-9, b-16, b-31, and b-33 are preferred.

[化學式33] [Chemical Formula 33]

作為市售品,可以舉出WPAG-336(FUJIFILM Wako Pure Chemical Corporation製)、WPAG-443(FUJIFILM Wako Pure Chemical Corporation製)、MBZ-101(Midori Kagaku Co.,Ltd.製)等。 Commercially available examples include WPAG-336 (manufactured by FUJIFILM Wako Pure Chemical Corporation), WPAG-443 (manufactured by FUJIFILM Wako Pure Chemical Corporation), and MBZ-101 (manufactured by Midori Kagaku Co., Ltd.).

又,亦可以舉出下述結構式所表示之化合物作為較佳例。 Furthermore, compounds represented by the following structural formulas can be cited as better examples.

作為有機鹵化化合物,具體而言,可以舉出若林等“Bull Chem.Soc Japan”42、2924(1969)、美國專利第3,905,815號說明書、日本特公昭46-4605號、日本特開昭48-36281號公報、日本特開昭55-32070號公報、日本特開昭60-239736號公報、日本特開昭61-169835號公報、日本特開昭61-169837號公報、日本特開昭62-58241號公報、日本特開昭62-212401號公報、日本特開昭63-70243號公報、日本特開昭63-298339號公報、M.P.Hutt“Jurnal of Heterocyclic Chemistry”1(No3),(1970)等中所記 載的化合物,並將該等內容編入本說明書中。尤其,可以舉出經三鹵甲基取代之唑化合物:S-三化合物作為較佳例。 As for organic halogenated compounds, specific examples include Wakabayashi et al.'s "Bull Chem. Soc Japan" 42,2924 (1969), U.S. Patent No. 3,905,815, Japanese Patent Publication Nos. 46-4605, 48-36281, 55-32070, 60-239736, 61-169835, 61-169837, 62-58241, 62-212401, 63-70243, 63-298339, and MP Hutt's "Jurnal of Heterocyclic Compounds described in Chemistry, No. 1 (1970), etc., are included in this specification. In particular, compounds substituted with trihalomethanes can be cited. Azole compounds: S-triazole Compounds are a better example.

更佳地,可以舉出至少1個單、二或三鹵素取代甲基與s-三環鍵結而成之s-三衍生物,具體而言,例如可以舉出2,4,6-三(單氯甲基)-s-三、2,4,6-三(二氯甲基)-s-三、2,4,6-三(三氯甲基)-s-三、2-甲基-4,6-雙(三氯甲基)-s-三、2-正丙基-4,6-雙(三氯甲基)-s-三、2-(α,α,β-三氯乙基)-4,6-雙(三氯甲基)-s-三、2-苯基-4,6-雙(三氯甲基)-s-三、2-(對甲氧基苯基)-4,6-雙(三氯甲基)-s-三、2-(3,4-環氧苯基)-4,6-雙(三氯甲基)-s-三、2-(對氯苯基)-4,6-雙(三氯甲基)-s-三、2-〔1-(對甲氧基苯基)-2,4-丁二烯基〕-4,6-雙(三氯甲基)-s-三、2-苯乙烯基-4,6-雙(三氯甲基)-s-三、2-(對甲氧基苯乙烯基)-4,6-雙(三氯甲基)-s-三、2-(對異丙氧基苯乙烯基)-4,6-雙(三氯甲基)-s-三、2-(對甲苯基)-4,6-雙(三氯甲基)-s-三、2-(4-萘氧基萘基)-4,6-雙(三氯甲基)-s-三、2-苯硫基-4,6-雙(三氯甲基)-s-三、2-苄硫基-4,6-雙(三氯甲基)-s-三、2,4,6-三(二溴甲基)-s-三、2,4,6-三(三溴甲基)-s-三、2-甲基-4,6-雙(三溴甲基)-s-三、2-甲氧基-4,6-雙(三溴甲基)-s-三等。 More preferably, at least one mono-, di-, or trihalomethane-substituted methyl group and s-trihalomethane can be cited as examples. S-three formed by ring bonding Derivatives, specifically, for example, 2,4,6-tris(monochloromethyl)-s-tris 2,4,6-Tris(dichloromethyl)-s-tris 2,4,6-Tris(trichloromethyl)-s-tris 2-Methyl-4,6-bis(trichloromethyl)-s-tri 2-n-propyl-4,6-bis(trichloromethyl)-s-tri 2-(α,α,β-trichloroethyl)-4,6-bis(trichloromethyl)-s-tri 2-Phenyl-4,6-bis(trichloromethyl)-s-tri 2-(p-methoxyphenyl)-4,6-bis(trichloromethyl)-s-tri 2-(3,4-epoxyphenyl)-4,6-bis(trichloromethyl)-s-tri 2-(p-chlorophenyl)-4,6-bis(trichloromethyl)-s-tri 2-[1-(p-methoxyphenyl)-2,4-butadienyl]-4,6-bis(trichloromethyl)-s-tri 2-Styryl-4,6-bis(trichloromethyl)-s-tri 2-(p-methoxystyryl)-4,6-bis(trichloromethyl)-s-tri 2-(p-isopropoxystyryl)-4,6-bis(trichloromethyl)-s-tri 2-(p-Tolyl)-4,6-bis(trichloromethyl)-s-tri 2-(4-naphthoxynaphthyl)-4,6-bis(trichloromethyl)-s-tri 2-Phenylenyl-4,6-bis(trichloromethyl)-s-tri 2-Benzylthio-4,6-bis(trichloromethyl)-s-tri 2,4,6-Tris(dibromomethyl)-s-tris 2,4,6-Tris(tribromomethyl)-s-tris 2-Methyl-4,6-bis(tribromomethyl)-s-tri 2-Methoxy-4,6-bis(tribromomethyl)-s-tri wait.

作為有機硼酸鹽化合物,例如可以舉出日本特開昭62-143044號公報、日本特開昭62-150242號公報、日本特開平9-188685號公報、日本特開平9-188686號公報、日本特開平9-188710號公報、日本特開2000-131837號公報、日本特開2002-107916號公報、日本專利第2764769號公報、日本特開2002-116539號公報等及Kunz,Martin“Rad Tech'98.Procee ding April 19-22,1998,Chicago”等中所記載之有機硼酸鹽、日本特開平6-157623號公報、日本特開平6-175564號公報、日本特開平6-175561號公報中所記載的有機硼鋶錯合物或有機硼氧代鋶錯合物、日本特開平6-175554號公報、日本特開平6-175553號公報中所記載的有機硼錪錯合物、日本特開平9-188710號公報中所記載的有機硼鏻錯合物、日本特開平6-348011號公報、日本特開平7-128785號公報、日本特開平7-140589號公報、日本特開平7-306527號公報、日本特開平7-292014號公報等有機硼過渡金屬配位錯合物等作為具體例,並將該等內容編入本說明書中。 Examples of organoborate compounds include, for instance, Japanese Patent Application Publication Nos. 62-143044, 62-150242, 9-188685, 9-188686, 9-188710, 2000-131837, 2002-107916, Japanese Patent No. 2764769, 2002-116539, and Kunz, Martin, “Rad Tech’98. Proceedings”. The organoborates described in "Chicago" etc., Japanese Patent Application Publication Nos. 6-157623, 6-175564, and 6-175561, and the organoboronium complexes or organoboronoxystrontium complexes described in Japanese Patent Application Publication Nos. 6-175554 and 6-175553, etc. Specific examples include organoboronium ilmenides disclosed in Japanese Patent Application Publication No. 9-188710, and organoboronium transition metal coordination ilmenides such as those in Japanese Patent Application Publication Nos. 6-348011, 7-128785, 7-140589, 7-306527, and 7-292014, the contents of which are incorporated herein by reference.

作為二碸化合物,可以舉出日本特開昭61-166544號公報、日本專利申請2001-132318公報等中所記載之化合物及重氮二碸化合物。 Examples of disulfide compounds include those described in Japanese Patent Application Publication No. 61-166544 and Japanese Patent Application No. 2001-132318, as well as diazonium compounds.

作為上述鎓鹽化合物,例如可以舉出S.I.Schlesinger,Photogr.Sci.Eng.,18,387(1974)、T.S.Bal et al,Polymer,21,423(1980)中所記載的重氮鹽、美國專利第4,069,055號說明書、日本特開平4-365049號公報等中所記載的銨鹽、美國專利第4,069,055號、美國專利第4,069,056號的各說明書中所記載的鏻鹽、歐洲專利第104,143號、美國專利第339,049號、美國專利第410,201號的各說明書、日本特開平2-150848號、日本特開平2-296514號公報中所記載的錪鹽、歐洲專利第370,693號、歐洲專利第390,214號、歐洲專利第233,567號、歐洲專利第297,443號、歐洲專利第297,442號、美國專利第4,933,377號、美國專利第161,811號、美國專利第410,201號、美國專利第339,049號、美國專利第4,760,013號、美國專利第4,734,444號、美國專利第2,833,827號、德國專利第2,904,626號、德國專利第3,604,580號、德國專利第3,604,581號的各說明書中所記載的 鋶鹽、J.V.Crivello et al,Macromolecules,10(6),1307(1977)、J.V.Crivello et al,J.Polymer Sci.,Polymer Chem.Ed.,17,1047(1979)中所記載的硒鹽、C.S.Wen et al,Teh,Proc.Conf.Rad.Curing ASIA,p478 Tokyo,Oct(1988)中所記載的砷鹽、吡啶鎓鹽等鎓鹽等,並將該等內容編入本說明書中。 Examples of such onium salt compounds include S.I. Schlesinger, Photogr. Sci. Eng., 18, 387 (1974), and T.S. Bal et al. Diazo salts as described in al, Polymer, 21,423 (1980), ammonium salts as described in U.S. Patent No. 4,069,055, Japanese Patent Application Publication No. 4-365049, phosphonium salts as described in the specifications of U.S. Patent Nos. 4,069,055 and 4,069,056, European Patent Nos. 104,143, 339,049 and 410,201, tin salts as described in Japanese Patent Application Publication Nos. 2-150848 and 2-296514, European Patent Nos. 370,693 and 39 The strontium salts described in the specifications of J.V. Crivello's patents 0,214, 233,567, 297,443, 297,442, 4,933,377, 161,811, 410,201, 339,049, 4,760,013, 4,734,444, 2,833,827, 2,904,626, 3,604,580, and 3,604,581, are described in the specifications of these patents. Selenium salts described in J.V. Crivello et al., Macromolecules, 10(6), 1307 (1977), and arsenic salts, pyridinium salts, etc., described in C.S. Wen et al., Teh, Proc. Conf. Rad. Curing ASIA, p478 Tokyo, Oct (1988), are included in this specification.

作為鎓鹽,可以舉出下述通式(RI-I)~(RI-III)所表示之鎓鹽。 As onium salts, examples can be given by the general formulas (RI-I) to (RI-III).

式(RI-I)中,Ar11表示可以具有1~6個取代基之碳數20以下的芳基,作為較佳的取代基,可以舉出碳數1~12的烷基、碳數2~12的烯基、碳數2~12的炔基、碳數6~12的芳基、碳數1~12的烷氧基、碳數1~12的芳氧基、鹵素原子、碳數1~12的烷基胺基、碳數2~12的二烷基胺基、烷基的碳數為1~12的烷基醯胺基或芳基的碳數為6~20的芳基醯胺基、羰基、羧基、氰基、磺醯基、碳數1~12的硫代烷基、碳數1~12的硫代芳基。Z11 -表示1價的陰離子,其為鹵素離子、過氯酸離子、六氟磷酸鹽離子、四氟硼酸鹽離子、磺酸離子、亞磺酸離子、硫代磺酸離子、硫酸離子,從穩定性的方面考慮,過氯酸離子、六氟磷酸鹽離子、四氟硼酸鹽離子、 磺酸離子、亞磺酸離子為較佳。式(RI-II)中,Ar21、Ar22各自獨立地表示可以具有1~6個取代基的碳數1~20的芳基,作為較佳的取代基,可以舉出碳數1~12的烷基、碳數2~12的烯基、碳數2~12的炔基、碳數1~12的芳基、碳數1~12的烷氧基、碳數1~12的芳氧基、鹵素原子、碳數1~12的單烷基胺基、烷基的碳數分別獨立地為1~12的二烷基胺基、烷基的碳數為1~12的烷基醯胺基或芳基醯胺基、羰基、羧基、氰基、磺醯基、碳數1~12的硫代烷基、碳數1~12的硫代芳基。Z21-表示1價的陰離子,其為鹵素離子、過氯酸離子、六氟磷酸鹽離子、四氟硼酸鹽離子、磺酸離子、亞磺酸離子、硫代磺酸離子、硫酸離子,從穩定性、反應性的方面考慮,過氯酸離子、六氟磷酸鹽離子、四氟硼酸鹽離子、磺酸離子、亞磺酸離子、羧酸離子為較佳。式(RI-III)中,R31、R32、R33各自獨立地表示可以具有1~6個取代基之碳數6~20的芳基或烷基、烯基、炔基,較佳地,從反應性、穩定性的方面考慮,芳基為較佳。作為較佳的取代基,可以舉出碳數1~12的烷基、碳數2~12的烯基、碳數2~12的炔基、碳數1~12的芳基、碳數1~12的烷氧基、碳數1~12的芳氧基、鹵素原子、碳數1~12的單烷基胺基、烷基的碳數為1~12的二烷基胺基、烷基的碳數為1~12的烷基醯胺基或芳基醯胺基、羰基、羧基、氰基、磺醯基、碳數1~12的硫代烷基、碳數1~12的硫代芳基。Z31 -表示1價的陰離子,其為鹵素離子、過氯酸離子、六氟磷酸鹽離子、四氟硼酸鹽離子、磺酸離子、亞磺酸離子、硫代磺酸離子、硫酸離子,從穩定性、反應性的方面考慮,過氯酸離子、六氟磷酸鹽離子、四氟硼酸鹽離子、磺酸離子、亞磺酸離子、羧酸離子為較佳。 In formula (RI-I), Ar 11 represents an aryl group having 1 to 6 substituents with 20 or fewer carbon atoms. Examples of preferred substituents include alkyl groups with 1 to 12 carbon atoms, alkenyl groups with 2 to 12 carbon atoms, alkynyl groups with 2 to 12 carbon atoms, aryl groups with 6 to 12 carbon atoms, alkoxy groups with 1 to 12 carbon atoms, aryloxy groups with 1 to 12 carbon atoms, halogen atoms, alkylamino groups with 1 to 12 carbon atoms, dialkylamino groups with 2 to 12 carbon atoms, alkylamide groups of alkyl groups with 1 to 12 carbon atoms, or arylamide groups of aryl groups with 6 to 20 carbon atoms, carbonyl groups, carboxyl groups, cyano groups, sulfonyl groups, thioalkyl groups with 1 to 12 carbon atoms, and thioaryl groups with 1 to 12 carbon atoms. Z 11 - indicates a monovalent anion, which can be a halogen ion, perchlorate ion, hexafluorophosphate ion, tetrafluoroborate ion, sulfonic acid ion, sulfinic acid ion, thiosulfonic acid ion, or sulfate ion. From a stability perspective, perchlorate ion, hexafluorophosphate ion, tetrafluoroborate ion, sulfonic acid ion, and sulfinic acid ion are preferred. In formula (RI-II), Ar 21 and Ar 22 each independently represent aryl groups with 1 to 20 carbon atoms that may have 1 to 6 substituents. Examples of preferred substituents include alkyl groups with 1 to 12 carbon atoms, alkenyl groups with 2 to 12 carbon atoms, alkynyl groups with 2 to 12 carbon atoms, aryl groups with 1 to 12 carbon atoms, alkoxy groups with 1 to 12 carbon atoms, aryloxy groups with 1 to 12 carbon atoms, halogen atoms, monoalkylamino groups with 1 to 12 carbon atoms, dialkylamino groups with 1 to 12 carbon atoms of each alkyl group, alkylamide or arylamide groups with 1 to 12 carbon atoms of the alkyl group, carbonyl groups, carboxyl groups, cyano groups, sulfonyl groups, thioalkyl groups with 1 to 12 carbon atoms, and thioaryl groups with 1 to 12 carbon atoms. Z 21 - indicates a monovalent anion, which can be a halogen ion, perchlorate ion, hexafluorophosphate ion, tetrafluoroborate ion, sulfonic acid ion, sulfinic acid ion, thiosulfonic acid ion, or sulfate ion. Considering stability and reactivity, perchlorate ion, hexafluorophosphate ion, tetrafluoroborate ion, sulfonic acid ion, sulfinic acid ion, or carboxylic acid ion are preferred. In formula (RI-III), R 31 , R 32 , and R 33 each independently represent an aryl or alkyl, alkenyl, or alkynyl group with 6 to 20 carbon atoms that can have 1 to 6 substituents. Preferably, aryl is preferred in terms of reactivity and stability. Preferred substituents include alkyl groups having 1 to 12 carbon atoms, alkenyl groups having 2 to 12 carbon atoms, alkynyl groups having 2 to 12 carbon atoms, aryl groups having 1 to 12 carbon atoms, alkoxy groups having 1 to 12 carbon atoms, aryloxy groups having 1 to 12 carbon atoms, halogen atoms, monoalkylamino groups having 1 to 12 carbon atoms, dialkylamino groups of alkyl groups having 1 to 12 carbon atoms, alkylamide or arylamide groups of alkyl groups having 1 to 12 carbon atoms, carbonyl groups, carboxyl groups, cyano groups, sulfonyl groups, thioalkyl groups having 1 to 12 carbon atoms, and thioaryl groups having 1 to 12 carbon atoms. Z 31 - indicates a monovalent anion, which can be a halogen ion, perchlorate ion, hexafluorophosphate ion, tetrafluoroborate ion, sulfonic acid ion, sulfinic acid ion, thiosulfonic acid ion, or sulfate ion. Considering stability and reactivity, perchlorate ion, hexafluorophosphate ion, tetrafluoroborate ion, sulfonic acid ion, sulfinic acid ion, or carboxylic acid ion are preferred.

作為較佳的光酸產生劑的具體例,可以舉出以下者。 Specific examples of better photosensitive acid generators include the following.

[化學式37] [Chemical Formula 37]

[化學式38] [Chemical Formula 38]

[化學式39] [Chemical Formula 39]

光酸產生劑相對於樹脂組成物的總固體成分使用0.1~20質量%為較佳,使用0.5~18質量%為更佳,使用0.5~10質量%為進一步較佳,使用0.5~3質量%為更進一步較佳,使用0.5~1.2質量%為又更進一步較佳。 The photosensitive acid generator is preferably used at 0.1-20% by weight relative to the total solids content of the resin composition, more preferably at 0.5-18% by weight, further preferably at 0.5-10% by weight, even more preferably at 0.5-3% by weight, and still more preferably at 0.5-1.2% by weight.

光酸產生劑可以單獨使用1種,亦可以組合使用複數種。在組合使用 複數種的情況下,該等合計量在上述範圍內為較佳。 Photosensitive acid generators can be used alone or in combination of multiple types. When using multiple types in combination, the total amount is preferably within the range described above.

又,為了對所期望的光源賦予感光性,與敏化劑同時使用亦較佳。 Furthermore, it is preferable to use it simultaneously with a sensitizer in order to impart photosensitivity to the desired light source.

<鹼產生劑> Alkali-producing agents

本發明的樹脂組成物可以包含鹼產生劑。其中,鹼產生劑為能夠藉由物理或化學作用而產生鹼之化合物。作為對本發明的樹脂組成物來說較佳的鹼產生劑,可以舉出熱鹼產生劑及光鹼產生劑。 The resin composition of the present invention may include a alkali-generating agent. The alkali-generating agent is a compound capable of generating alkali through physical or chemical action. Preferred alkali-generating agents for the resin composition of the present invention include thermal alkali-generating agents and photoalkali-generating agents.

設為鹼產生劑不包含上述化合物B。 Assume that the alkali-generating agent does not contain compound B.

本發明的樹脂組成物包含鹼產生劑為較佳,包含熱鹼產生劑或光鹼產生劑為更佳,包含熱鹼產生劑為進一步較佳。藉由使樹脂組成物含有熱鹼產生劑,例如藉由加熱而能夠促進前驅物的環化反應,成為硬化物的機械特性或耐藥品性良好者,例如作為半導體封裝中所包含之再配線層用層間絕緣膜的性能變得良好。 The resin composition of this invention preferably contains an alkali-generating agent, more preferably a thermal alkali-generating agent or a light alkali-generating agent, and even more preferably a thermal alkali-generating agent. By including a thermal alkali-generating agent in the resin composition, such as one that can promote the cyclization reaction of the precursor by heating, the cured material exhibits good mechanical properties or chemical resistance, for example, its performance as an interlayer insulating film for rewiring layers included in semiconductor packaging becomes better.

作為鹼產生劑,可以為離子型鹼產生劑,亦可以為非離子型鹼產生劑。作為從鹼產生劑產生之鹼,例如可以舉出二級胺、三級胺。 As a base-producing agent, it can be either an ionic or nonionic base-producing agent. Examples of bases produced from a base-producing agent include, for example, secondary and tertiary amines.

對本發明之鹼產生劑並無特別限制,能夠使用公知的鹼產生劑。作為公知的鹼產生劑,例如能夠使用胺甲醯基肟化合物、胺甲醯基羥胺化合物、胺甲酸化合物、甲醯胺化合物、乙醯胺化合物、胺基甲酸酯化合物、苄胺基甲酸酯化合物、硝基苄胺基甲酸酯化合物、磺酸醯胺化合物、咪唑衍生物化合物、胺醯亞胺化合物、吡啶衍生物化合物、α-胺基苯乙酮衍生物化合物、四級銨鹽衍生物化合物、吡啶鎓鹽、α-內酯環衍生物化合物、胺醯亞胺化合物、鄰苯二甲醯亞胺衍生物化合物、醯氧基亞胺基化合物等。 There are no particular limitations on the alkali-generating agent of this invention, and known alkali-generating agents can be used. Examples of known alkali-generating agents include, for instance, aminomethyloxime compounds, aminomethylhydroxylamine compounds, carbamic acid compounds, methylamine compounds, acetylamine compounds, carbamate compounds, benzyl carbamate compounds, nitrobenzyl carbamate compounds, sulfonic acid amide compounds, imidazole derivative compounds, aminoimidide compounds, pyridine derivative compounds, α-aminoacetophenone derivative compounds, quaternary ammonium salt derivative compounds, pyridinium salts, α-lactone ring derivative compounds, aminoimidide compounds, phthalimide derivative compounds, and acetoimide compounds.

作為非離子型鹼產生劑的具體的化合物,可以舉出式(B1)、式(B2) 或式(B3)所表示之化合物。 Specific compounds that can be cited as nonionic alkali generators include those represented by formulas (B1), (B2), or (B3).

式(B1)及式(B2)中,Rb1、Rb2及Rb3分別獨立地為不具有三級胺結構的有機基、鹵素原子或氫原子。其中,Rb1及Rb2不會同時成為氫原子。又,Rb1、Rb2及Rb3均不具有羧基。再者,在本說明書中,三級胺結構是指3價的氮原子的3個鍵結鍵均與烴系碳原子進行共價鍵之結構。因此,在所鍵結之碳原子為形成羰基之碳原子之情況亦即在與氮原子一同形成醯胺基之情況下,並不限於此。 In formulas (B1) and (B2), Rb1 , Rb2 , and Rb3 are independently organic groups, halogen atoms, or hydrogen atoms that do not possess a tertiary amine structure. Rb1 and Rb2 do not simultaneously constitute hydrogen atoms. Furthermore, Rb1 , Rb2 , and Rb3 do not possess a carboxyl group. Moreover, in this specification, a tertiary amine structure refers to a structure where all three bonds of a trivalent nitrogen atom are covalently bonded to hydrocarbon carbon atoms. Therefore, it is not limited to the case where the bonded carbon atoms are carbon atoms forming a carbonyl group, i.e., when they form a amide group together with the nitrogen atom.

式(B1)、式(B2)中,Rb1、Rb2及Rb3中的至少1個包含環狀結構為較佳,至少2個包含環狀結構為更佳。作為環狀結構,可以為單環及縮合環中的任一個,單環或2個單環縮合而成之縮合環為較佳。單環為5員環或6員環為較佳,6員環為更佳。單環為環己烷環及苯環為較佳,環己烷環為更佳。 In formulas (B1) and (B2), it is preferable that at least one of Rb1 , Rb2 , and Rb3 contains a cyclic structure, and it is even more preferable that at least two contain a cyclic structure. The cyclic structure can be either a monocyclic ring or a condensed ring, preferably a monocyclic ring or a condensed ring formed by the condensation of two monocyclic rings. It is preferable that the monocyclic ring is a 5-membered or 6-membered ring, with a 6-membered ring being more preferred. It is preferable that the monocyclic ring is a cyclohexane ring or a benzene ring, with a cyclohexane ring being more preferred.

更具體而言,Rb1及Rb2為氫原子、烷基(碳數1~24為較佳,2~18為更佳,3~12為進一步較佳)、烯基(碳數2~24為較佳,2~18為更佳,3~12為進一步較佳)、芳基(碳數6~22為較佳,6~18為更佳,6~10為進一步較佳)或芳烷基(碳數7~25為較佳,7~19為更佳,7~12為進一步較佳)為較佳。該等基團可以在發揮本發明的效果之範圍內具有取代基。Rb1與Rb2可以相互鍵結而形成環。作為所形成之環,4~7員的含氮雜環為較佳。尤其,Rb1及Rb2為可以具有取代基之直鏈、支鏈或 環狀的烷基(碳數1~24為較佳,2~18為更佳,3~12為進一步較佳)為較佳,可以具有取代基之環烷基(碳數3~24為較佳,3~18為更佳,3~12為進一步較佳)為更佳,可以具有取代基之環己基為進一步較佳。 More specifically, Rb1 and Rb2 are preferably hydrogen atoms, alkyl groups (preferably with 1-24 carbon atoms, more preferably with 2-18 carbon atoms, and even more preferably with 3-12 carbon atoms), alkenyl groups (preferably with 2-24 carbon atoms, more preferably with 2-18 carbon atoms, and even more preferably with 3-12 carbon atoms), aryl groups (preferably with 6-22 carbon atoms, more preferably with 6-18 carbon atoms, and even more preferably with 6-10 carbon atoms), or aralkyl groups (preferably with 7-25 carbon atoms, more preferably with 7-19 carbon atoms, and even more preferably with 7-12 carbon atoms). These groups may have substituents within the scope of achieving the effects of the present invention. Rb1 and Rb2 may bond to each other to form a ring. A nitrogen-containing heterocycle with 4-7 members is preferred as the formed ring. In particular, Rb 1 and Rb 2 are preferably straight-chain, branched or cyclic alkyl groups (preferably with 1 to 24 carbons, more preferably with 2 to 18 carbons, and even more preferably with 3 to 12 carbons) that may have substituents, and are preferably cycloalkyl groups (preferably with 3 to 24 carbons, more preferably with 3 to 18 carbons, and even more preferably with 3 to 12 carbons) that may have substituents, and are even more preferably cyclohexyl groups that may have substituents.

作為Rb3,可以舉出烷基(碳數1~24為較佳,2~18為更佳,3~12為進一步較佳)、芳基(碳數6~22為較佳,6~18為更佳,6~10為進一步較佳)、烯基(碳數2~24為較佳,2~12為更佳,2~6為進一步較佳)、芳烷基(碳數7~23為較佳,7~19為更佳,7~12為進一步較佳)、芳烯基(碳數8~24為較佳,8~20為更佳,8~16為進一步較佳)、烷氧基(碳數1~24為較佳,2~18為更佳,3~12為進一步較佳)、芳氧基(碳數6~22為較佳,6~18為更佳,6~12為進一步較佳)或芳烷氧基(碳數7~23為較佳,7~19為更佳,7~12為進一步較佳)。其中,環烷基(碳數3~24為較佳,3~18為更佳,3~12為進一步較佳)、芳烯基、芳烷氧基為較佳。Rb3在發揮本發明的效果之範圍內還可以具有取代基。 As for Rb 3 , examples include alkyl groups (preferably with 1-24 carbons, more preferably with 2-18 carbons, and even more preferably with 3-12 carbons), aryl groups (preferably with 6-22 carbons, more preferably with 6-18 carbons, and even more preferably with 6-10 carbons), alkenyl groups (preferably with 2-24 carbons, more preferably with 2-12 carbons, and even more preferably with 2-6 carbons), and aralkyl groups (preferably with 7-23 carbons, more preferably with 7-19 carbons, and even more preferably with 7-12 carbons). The preferred groups are aryl (preferably 8-24 carbons, more preferably 8-20, and even more preferably 8-16 carbons), alkoxy (preferably 1-24 carbons, more preferably 2-18, and even more preferably 3-12 carbons), aryloxy (preferably 6-22 carbons, more preferably 6-18, and even more preferably 6-12 carbons), or arylalkoxy (preferably 7-23 carbons, more preferably 7-19, and even more preferably 7-12 carbons). Cycloalkyl (preferably 3-24 carbons, more preferably 3-18, and even more preferably 3-12 carbons), aryl, and arylalkoxy groups. Rb3 may also have substituents within the scope of the invention's effects.

式(B1)所表示之化合物為下述式(B1-1)或下述式(B1-2)所表示之化合物為較佳。 The compound represented by formula (B1) is preferably a compound represented by formula (B1-1) or formula (B1-2) below.

式中,Rb11及Rb12和Rb31及Rb32分別與式(B1)中之Rb1及Rb2的含義相同。 In the formula, Rb 11 and Rb 12 and Rb 31 and Rb 32 have the same meaning as Rb 1 and Rb 2 in formula (B1), respectively.

Rb13為烷基(碳數1~24為較佳,2~18為更佳,3~12為進一步較佳)、烯基(碳數2~24為較佳,2~18為更佳,3~12為進一步較佳)、芳基(碳 數6~22為較佳,6~18為更佳,6~12為進一步較佳)、芳烷基(碳數7~23為較佳,7~19為更佳,7~12為進一步較佳),在發揮本發明的效果之範圍內可以具有取代基。其中,Rb13為芳烷基為較佳。 Rb 13 can be an alkyl group (preferably with 1-24 carbons, more preferably with 2-18 carbons, and even more preferably with 3-12 carbons), an alkenyl group (preferably with 2-24 carbons, more preferably with 2-18 carbons, and even more preferably with 3-12 carbons), an aryl group (preferably with 6-22 carbons, more preferably with 6-18 carbons, and even more preferably with 6-12 carbons), or an aralkyl group (preferably with 7-23 carbons, more preferably with 7-19 carbons, and even more preferably with 7-12 carbons). Substituents may be present within the scope of achieving the effects of the present invention. Among these, it is preferred that Rb 13 be an aralkyl group.

Rb33及Rb34分別獨立地為氫原子、烷基(碳數1~12為較佳,1~8為更佳,1~3為進一步較佳)、烯基(碳數2~12為較佳,2~8為更佳,2~3為進一步較佳)、芳基(碳數6~22為較佳,6~18為更佳,6~10為進一步較佳)、芳烷基(碳數7~23為較佳,7~19為更佳,7~11為進一步較佳),氫原子為較佳。 Rb 33 and Rb 34 are respectively independently hydrogen atoms, alkyl (preferably 1-12 carbons, more preferably 1-8 carbons, and even more preferably 1-3 carbons), alkenyl (preferably 2-12 carbons, more preferably 2-8 carbons, and even more preferably 2-3 carbons), aryl (preferably 6-22 carbons, more preferably 6-18 carbons, and even more preferably 6-10 carbons), aralkyl (preferably 7-23 carbons, more preferably 7-19 carbons, and even more preferably 7-11 carbons), with hydrogen atoms being preferred.

Rb35為烷基(碳數1~24為較佳,1~12為更佳,3~8為進一步較佳)、烯基(碳數2~12為較佳,2~10為更佳,3~8為進一步較佳)、芳基(碳數6~22為較佳,6~18為更佳,6~12為進一步較佳)、芳烷基(碳數7~23為較佳,7~19為更佳,7~12為進一步較佳),芳基為較佳。 Rb 35 is an alkyl group (preferably with 1-24 carbons, more preferably with 1-12 carbons, and even more preferably with 3-8 carbons), an alkenyl group (preferably with 2-12 carbons, more preferably with 2-10 carbons, and even more preferably with 3-8 carbons), an aryl group (preferably with 6-22 carbons, more preferably with 6-18 carbons, and even more preferably with 6-12 carbons), an aralkyl group (preferably with 7-23 carbons, more preferably with 7-19 carbons, and even more preferably with 7-12 carbons), with aryl being preferred.

又,式(B1-1)所表示之化合物為式(B1-1a)所表示之化合物亦較佳。 Furthermore, the compound represented by formula (B1-1) is preferably the same as the compound represented by formula (B1-1a).

Rb11及Rb12與式(B1-1)中之Rb11及Rb12的含義相同。 Rb 11 and Rb 12 have the same meaning as Rb 11 and Rb 12 in formula (B1-1).

Rb15及Rb16為氫原子、烷基(碳數1~12為較佳,1~6為更佳,1~3為進一步較佳)、烯基(碳數2~12為較佳,2~6為更佳,2~3為進一步較佳)、芳基(碳數6~22為較佳,6~18為更佳,6~10為進一步較佳)、芳烷基(碳數7~23為較佳,7~19為更佳,7~11為進一步較佳),氫原 子或甲基為較佳。 Rb 15 and Rb 16 are preferably hydrogen atoms, alkyl groups (1-12 carbons are preferred, 1-6 are more preferred, and 1-3 are even more preferred), alkenyl groups (2-12 carbons are preferred, 2-6 are more preferred, and 2-3 are even more preferred), aryl groups (6-22 carbons are preferred, 6-18 are more preferred, and 6-10 are even more preferred), aralkyl groups (7-23 carbons are preferred, 7-19 are more preferred, and 7-11 are even more preferred), or preferably hydrogen atoms or methyl groups.

Rb17為烷基(碳數1~24為較佳,1~12為更佳,3~8為進一步較佳)、烯基(碳數2~12為較佳,2~10為更佳,3~8為進一步較佳)、芳基(碳數6~22為較佳,6~18為更佳,6~12為進一步較佳)、芳烷基(碳數7~23為較佳,7~19為更佳,7~12為進一步較佳),其中,芳基為較佳。 Rb 17 is an alkyl group (preferably with 1-24 carbons, more preferably with 1-12 carbons, and even more preferably with 3-8 carbons), an alkenyl group (preferably with 2-12 carbons, more preferably with 2-10 carbons, and even more preferably with 3-8 carbons), an aryl group (preferably with 6-22 carbons, more preferably with 6-18 carbons, and even more preferably with 6-12 carbons), or an aralkyl group (preferably with 7-23 carbons, more preferably with 7-19 carbons, and even more preferably with 7-12 carbons), wherein an aryl group is preferred.

在式(B3)中,L表示烴基,該烴基為在連接相鄰之氧原子和碳原子之連接鏈的路徑上具有飽和烴基之2價的烴基,並且連接鏈的路徑上的原子數為3個以上。又,RN1及RN2分別獨立地表示1價的有機基。 In formula (B3), L represents an hydrocarbon group, which is a divalent hydrocarbon group with saturated hydrocarbons in the path of the linking chain connecting adjacent oxygen and carbon atoms, and the number of atoms in the linking chain is three or more. Furthermore, RN1 and RN2 each independently represent a monovalent organic group.

在本說明書中,“連接鏈”是指在連接連接對象的2個原子或連接原子群組之間之路徑上的原子鏈中以最短(最小原子數)的方式連接該等連接對象者。例如,在下述式所表示之化合物中,L由伸苯基伸乙基構成,並且具有伸乙基作為飽和烴基,連接鏈由4個碳原子構成,連接鏈的路徑上的原子數(亦即,為構成連接鏈之原子的數量,以下,亦稱為“連接鏈長度”或“連接鏈的長度”。)為4個。 In this specification, a "linker chain" refers to an atomic chain that connects two atoms or groups of atoms in the shortest possible (minimum number of atoms) path. For example, in a compound represented by the following formula, L is composed of phenyl-ethyl groups and has ethyl groups as saturated hydrocarbons; the linker chain consists of 4 carbon atoms; and the number of atoms in the linker chain path (i.e., the number of atoms constituting the linker chain, hereinafter also referred to as the "linker chain length") is 4.

式(B3)之L中的碳數(亦包含除了連接鏈中的碳原子以 外的碳原子)為3~24為較佳。上限為12以下為更佳,10以下為進一步較佳,8以下為特佳。下限為4以上為更佳。從快速進行上述分子內環化反應之觀點考慮,L的連接鏈長度的上限為12以下為較佳,8以下為更佳,6以下為進一步較佳,5以下為特佳。尤其,L的連接鏈長度為4或5為較佳,4為最佳。作為鹼產生劑的具體的較佳化合物,例如亦可以舉出國際公開第2020/066416號的0102~0168段中所記載的化合物、國際公開第2018/038002號的0143~0177段中所記載的化合物。 The number of carbon atoms in L in formula (B3) (including carbon atoms other than those in the linker chain) is preferably 3 to 24. An upper limit of 12 or less is more preferred, 10 or less is even more preferred, and 8 or less is particularly preferred. A lower limit of 4 or more is more preferred. Considering the need for rapid intramolecular cyclization, the upper limit of the linker chain length of L is preferably 12 or less, more preferably 8 or less, even more preferably 6 or less, and particularly preferred 5 or less. In particular, a linker chain length of 4 or 5 is preferred, with 4 being optimal. Preferred compounds as alkali-generating agents include, for example, those described in paragraphs 0102-0168 of International Publication No. 2020/066416 and those described in paragraphs 0143-0177 of International Publication No. 2018/038002.

又,鹼產生劑包含下述式(N1)所表示之化合物亦較佳。 Furthermore, it is preferable that the alkali-generating agent contains a compound represented by the following formula (N1).

式(N1)中,RN1及RN2分別獨立地表示1價的有機基,RC1表示氫原子或保護基,L表示2價的連接基。 In formula (N1), RN1 and RN2 independently represent monovalent organic groups, RC1 represents a hydrogen atom or a protecting group, and L represents a divalent linking group.

L為2價的連接基,2價的有機基為較佳。連接基的連接鏈長度為1以上為較佳,2以上為更佳。作為上限,12以下為較佳,8以下為更佳,5以下為進一步較佳。連接鏈長度為在式中的2個羰基之間成為最短路程之原子排列中存在之原子的數量。 L is a divalent linker, preferably a divalent organic group. A linker chain length of 1 or more is preferred, and 2 or more is even better. As an upper limit, 12 or less is preferred, 8 or less is even better, and 5 or less is further preferred. The linker chain length is the number of atoms present in the atomic arrangement that forms the shortest path between the two carbonyl groups in the formula.

式(N1)中,RN1及RN2分別獨立地表示1價的有機基(碳數1~24為較佳,2~18為更佳,3~12為進一步較佳),烴基(碳數1~24為較佳,1~12為更佳,1~10為進一步較佳)為較佳,具體而言,可以舉出脂肪族烴基(碳數1~24為較佳,1~12為更佳,1~10為進一步較佳) 或芳香族烴基(碳數6~22為較佳,6~18為更佳,6~10為進一步較佳),脂肪族烴基為較佳。若作為RN1及RN2使用脂肪族烴基,則所產生之鹼的鹼性高,因此為較佳。再者,脂肪族烴基及芳香族烴基可以具有取代基,並且脂肪族烴基及芳香族烴基可以在脂肪族烴鏈中或芳香環中,取代基中具有氧原子。尤其,可以例示脂肪族烴基在烴鏈中具有氧原子之態樣。 In formula (N1), RN1 and RN2 independently represent monovalent organic groups (preferably 1-24 carbons, more preferably 2-18, and even more preferably 3-12 carbons) and hydrocarbon groups (preferably 1-24 carbons, more preferably 1-12, and even more preferably 1-10 carbons), respectively. Specifically, aliphatic hydrocarbons (preferably 1-24 carbons, more preferably 1-12, and even more preferably 1-10 carbons) or aromatic hydrocarbons (preferably 6-22 carbons, more preferably 6-18, and even more preferably 6-10 carbons) are examples, with aliphatic hydrocarbons being preferred. If aliphatic hydrocarbons are used as RN1 and RN2 , the resulting base will be highly basic, and therefore preferred. Furthermore, aliphatic and aromatic hydrocarbons can have substituents, and these substituents can be located within an aliphatic hydrocarbon chain or an aromatic ring, with oxygen atoms present in the substituents. In particular, examples of aliphatic hydrocarbons having oxygen atoms within a hydrocarbon chain can be illustrated.

作為構成RN1及RN2之脂肪族烴基,可以舉出直鏈或支鏈的鏈狀烷基、環狀烷基、與鏈狀烷基和環狀烷基的組合有關之基團、在鏈中具有氧原子之烷基。直鏈或支鏈的鏈狀烷基為碳數1~24者為較佳,2~18為更佳,3~12為進一步較佳。關於直鏈或支鏈的鏈狀烷基,例如可以舉出甲基、乙基、丙基、丁基、戊基、己基、庚基、辛基、壬基、癸基、十一基、十二烷基、異丙基、異丁基、第二丁基、第三丁基、異戊基、新戊基、第三戊基、異己基等。 Examples of aliphatic hydrocarbons constituting RN1 and RN2 include linear or branched chain alkyl groups, cyclic alkyl groups, groups related to combinations of linear and cyclic alkyl groups, and alkyl groups having oxygen atoms in the chain. Linear or branched chain alkyl groups with 1 to 24 carbon atoms are preferred, 2 to 18 are more preferred, and 3 to 12 are even more preferred. Examples of linear or branched chain alkyl groups include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, isopropyl, isobutyl, dibutyl, tributyl, isopentyl, neopentyl, tripentyl, and isohexyl.

環狀烷基為碳數3~12者為較佳,3~6為更佳。關於環狀烷基,例如可以舉出環丙基、環丁基、環戊基、環己基、環辛基等。 Cyclic alkyl groups with 3 to 12 carbon atoms are preferred, with 3 to 6 being even more preferred. Examples of cyclic alkyl groups include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, and cyclooctyl.

與鏈狀烷基和環狀烷基的組合有關之基團為碳數4~24者為較佳,4~18為更佳,4~12為進一步較佳。關於與鏈狀烷基和環狀烷基的組合有關之基團,例如可以舉出環己基甲基、環己基乙基、環己基丙基、甲基環己基甲基、乙基環己基乙基等。 Groups relating to combinations of alkyl and cycloalkyl groups preferably have 4 to 24 carbon atoms, more preferably 4 to 18, and even more preferably 4 to 12. Examples of groups relating to combinations of alkyl and cycloalkyl groups include cyclohexylmethyl, cyclohexylethyl, cyclohexylpropyl, methylcyclohexylmethyl, and ethylcyclohexylethyl.

在鏈中具有氧原子之烷基為碳數2~12者為較佳,2~6為更佳,2~4為進一步較佳。在鏈中具有氧原子之烷基可以為鏈狀,亦可以為環狀,並且可以為直鏈,亦可以為支鏈。 The alkyl group containing oxygen atoms in the chain is preferably composed of 2 to 12 carbon atoms, more preferably 2 to 6, and even more preferably 2 to 4. The alkyl group containing oxygen atoms in the chain can be chain-like or cyclic, and can be straight or branched.

其中,從提高後述分解生成鹼的沸點之觀點考慮,RN1及RN2為碳數5 ~12的烷基為較佳。其中,在重視與金屬(例如銅)的層積層時的密接性之配方中,具有環狀的烷基之基團或碳數1~8的烷基為較佳。 From the perspective of increasing the boiling point of the alkali produced by decomposition (described later), it is preferable that RN1 and RN2 are alkyl groups with 5 to 12 carbon atoms. In formulations where close adhesion with metals (e.g., copper) is important, it is preferable to have cyclic alkyl groups or alkyl groups with 1 to 8 carbon atoms.

RN1及RN2可以相互連接而形成環狀結構。在形成環狀結構時,可以在鏈中具有氧原子等。又,RN1及RN2所形成之環狀結構可以為單環,亦可以為縮合環,但是單環為較佳。作為所形成之環狀結構,式(N1)中的含有氮原子之5員環或6員環為較佳,例如可以舉出吡咯環、咪唑環、吡唑環、吡咯啉環、吡咯啶環、咪唑啶環、吡唑啶環、哌啶環、哌環、嗎啉環等,可以較佳地舉出吡咯啉環、吡咯啶環、哌啶環、哌環、嗎啉環。 RN1 and RN2 can be linked together to form a ring structure. When forming a ring structure, oxygen atoms, etc., can be present in the chain. Furthermore, the ring structure formed by RN1 and RN2 can be a monocyclic ring or a condensed ring, but a monocyclic ring is preferred. As the formed ring structure, a 5-membered or 6-membered ring containing a nitrogen atom in formula (N1) is preferred; examples include pyrrole rings, imidazole rings, pyrazole rings, pyrrolidine rings, imidazoleidine rings, pyrazoleidine rings, piperidine rings, and piperidine rings. Cyclic rings, morpholinic rings, etc., can be best exemplified by pyrrolidine rings, pyrrolidine rings, piperidine rings, and piperidine rings. Cyclic, morpholine cyclic.

RC1表示氫原子或保護基,氫原子為較佳。 R C1 represents a hydrogen atom or a protecting group, with a hydrogen atom being preferred.

作為保護基,藉由酸或鹼的作用進行分解之保護基為較佳,可以較佳地舉出用酸進行分解之保護基。 As a protecting group, a protecting group that decomposes under the action of an acid or alkali is preferred; examples of protecting groups that decompose under the action of an acid are readily available.

作為保護基的具體例,可以舉出鏈狀或環狀的烷基或在鏈中具有氧原子之鏈狀或環狀的烷基。作為鏈狀或環狀的烷基,可以舉出甲基、乙基、異丙基、第三丁基、環己基等。作為在鏈中具有氧原子之鏈狀的烷基,具體而言,可以舉出烷基氧基烷基,更具體而言,可以舉出甲氧基甲(MOM)基、乙氧基乙(EE)基等。作為在鏈中具有氧原子之環狀的烷基,可以舉出環氧基、環氧丙基、氧環丁烷基、四氫呋喃基、四氫吡喃(THP)基等。 Specific examples of protecting groups include chain-like or cyclic alkyl groups, or chain-like or cyclic alkyl groups having an oxygen atom in the chain. Examples of chain-like or cyclic alkyl groups include methyl, ethyl, isopropyl, tributyl, and cyclohexyl. Examples of chain-like alkyl groups having an oxygen atom in the chain include alkyloxyalkyl groups, and more specifically, methoxymethyl (MOM) and ethoxyethyl (EE). Examples of cyclic alkyl groups having an oxygen atom in the chain include epoxy, epioxypropyl, oxocyclobutane, tetrahydrofuranyl, and tetrahydropyranyl (THP).

作為構成L之2價的連接基,並無特別規定,但是烴基為較佳,脂肪族烴基為更佳。烴基可以具有取代基,並且亦可以在烴鏈中具有除了碳原子以外的種類的原子。更具體而言,可以在鏈中具有氧原子的2 價的烴連接基為較佳,可以在鏈中具有氧原子的2價的脂肪族烴基、2價的芳香族烴基或與可以在鏈中具有氧原子的2價的脂肪族烴基和2價的芳香族烴基的組合有關之基團為更佳,可以在鏈中具有氧原子的2價的脂肪族烴基為進一步較佳。該等基團不具有氧原子為較佳。 There are no particular restrictions on the type of linker constituting the divalent L, but an hydrocarbon group is preferred, and an aliphatic hydrocarbon group is even more preferred. The hydrocarbon group may have substituents and may contain atoms other than carbon atoms in the hydrocarbon chain. More specifically, a divalent hydrocarbon linker group that can contain an oxygen atom in the chain is preferred; groups relating to divalent aliphatic hydrocarbons, divalent aromatic hydrocarbons, or combinations thereof that can contain an oxygen atom in the chain are even more preferred; and divalent aliphatic hydrocarbons that can contain an oxygen atom in the chain are even more preferred. It is preferable that these groups do not contain an oxygen atom.

2價的烴連接基為碳數1~24者為較佳,2~12為更佳,2~6為進一步較佳。2價的脂肪族烴基為碳數1~12者為較佳,2~6為更佳,2~4為進一步較佳。2價的芳香族烴基為碳數6~22者為較佳,6~18為更佳,6~10為進一步較佳。與2價的脂肪族烴基和2價的芳香族烴基的組合有關之基團(例如,伸芳基烷基)為碳數7~22者為較佳,7~18為更佳,7~10為進一步較佳。 The divalent hydrocarbon linking group preferably has 1 to 24 carbon atoms, more preferably 2 to 12, and even more preferably 2 to 6. The divalent aliphatic hydrocarbon preferably has 1 to 12 carbon atoms, more preferably 2 to 6, and even more preferably 2 to 4. The divalent aromatic hydrocarbon preferably has 6 to 22 carbon atoms, more preferably 6 to 18, and even more preferably 6 to 10. Groups related to the combination of divalent aliphatic and divalent aromatic hydrocarbons (e.g., arylalkyl groups) preferably have 7 to 22 carbon atoms, more preferably 7 to 18, and even more preferably 7 to 10.

作為連接基L,具體而言,直鏈或支鏈的鏈狀伸烷基、環狀伸烷基、與鏈狀伸烷基和環狀伸烷基的組合有關之基團、在鏈中具有氧原子之伸烷基、直鏈或支鏈的鏈狀的伸烯基、環狀的伸烯基、伸芳基、伸芳基伸烷基為較佳。 As a linking group L, specifically, linear or branched chain-like alkylene groups, cyclic alkylene groups, groups relating to combinations of linear and cyclic alkylene groups, alkylene groups having an oxygen atom in the chain, linear or branched chain-like alkenyl groups, cyclic alkenyl groups, aryl groups, and arylalkylene groups are preferred.

直鏈或支鏈的鏈狀伸烷基為碳數1~12者為較佳,2~6為更佳,2~4為進一步較佳。 For linear or branched chain alkyl groups, those with 1 to 12 carbon atoms are preferred, 2 to 6 are more preferred, and 2 to 4 are even more preferred.

環狀伸烷基為碳數3~12者為較佳,3~6為更佳。 Cyclic alkyl groups with 3 to 12 carbon atoms are preferred, and those with 3 to 6 carbon atoms are even better.

與鏈狀伸烷基和環狀伸烷基的組合有關之基團為碳數4~24者為較佳,4~12為更佳,4~6為進一步較佳。 Groups related to combinations of cyclic and cycloalkyl groups with 4 to 24 carbon atoms are preferred, 4 to 12 are more preferred, and 4 to 6 are even more preferred.

在鏈中具有氧原子之伸烷基可以為鏈狀,亦可以為環狀,並且可以為直鏈,亦可以為支鏈。在鏈中具有氧原子之伸烷基為碳數1~12者為較佳,1~6為更佳,1~3為進一步較佳。 Alkyl groups containing oxygen atoms in the chain can be chain-like or cyclic, and can be straight or branched. Alkyl groups with 1 to 12 carbon atoms are preferred, 1 to 6 are more preferred, and 1 to 3 are even more preferred.

直鏈或支鏈的鏈狀的伸烯基為碳數2~12者為較佳,2~6為更佳,2~3為進一步較佳。直鏈或支鏈的鏈狀的伸烯基的C=C鍵的數量為1~10者為較佳,1~6為更佳,1~3為進一步較佳。 The linear or branched alkenyl group preferably has 2 to 12 carbon atoms, more preferably 2 to 6, and even more preferably 2 to 3. The linear or branched alkenyl group preferably has 1 to 10 C=C bonds, more preferably 1 to 6, and even more preferably 1 to 3.

環狀的伸烯基為碳數3~12者為較佳,3~6為更佳。環狀的伸烯基的C=C鍵的數量為1~6為較佳,1~4為更佳,1~2為進一步較佳。 Cyclic alkenyl groups with 3 to 12 carbon atoms are preferred, and 3 to 6 are even better. The number of C=C bonds in the cyclic alkenyl groups is preferably 1 to 6, even better with 1 to 4, and further preferably 1 to 2.

伸芳基為碳數6~22者為較佳,6~18為更佳,6~10為進一步較佳。 Aryl groups with 6-22 carbon atoms are preferred, 6-18 are even better, and 6-10 are still preferred.

伸芳基伸烷基為碳數7~23者為較佳,7~19為更佳,7~11為進一步較佳。 The arylalkyl group having 7-23 carbon atoms is preferred, 7-19 is even better, and 7-11 is further preferred.

其中,鏈狀伸烷基、環狀伸烷基、在鏈中具有氧原子之伸烷基、鏈狀的伸烯基、伸芳基、伸芳基、伸烷基為較佳,1,2-伸乙基、丙烷二基(尤其1,3-丙烷二基)、環己烷二基(尤其1,2-環己烷二基)、伸乙烯基(尤其順式伸乙烯基)、伸苯基(1,2-伸苯基)、伸苯基亞甲基(尤其1,2-伸苯基亞甲基)、氧伸乙基(尤其1,2-乙烯氧基-1,2-伸乙基)為更佳。 Among them, chain-like alkylene, cyclic alkylene, alkylene having an oxygen atom in the chain, chain-like alkenyl, aryl, aryl, and alkylene are preferred, with 1,2-ethylene, propanediyl (especially 1,3-propanediyl), cyclohexanediyl (especially 1,2-cyclohexanediyl), vinylene (especially cis-vinylene), phenylene (1,2-phenylene), phenylenemethylene (especially 1,2-phenylenemethylene), and oxyethylene (especially 1,2-ethyleneoxy-1,2-ethylene) being even more preferred.

作為鹼產生劑,可以舉出下述例,但是本發明並不僅由此做限定性解釋。 Examples of alkali-producing agents include the following, but this invention is not intended to be limited thereto.

[化學式46] [Chemical Formula 46]

非離子型熱鹼產生劑的分子量為800以下為較佳,600以下為更佳,500以下為進一步較佳。作為下限,100以上為較佳,200以上為更佳,300以上為進一步較佳。 For nonionic thermal alkali generators, a molecular weight of 800 or less is preferred, 600 or less is even better, and 500 or less is still preferred. As a lower limit, a molecular weight of 100 or more is preferred, 200 or more is even better, and 300 or more is still even better.

作為離子型鹼產生劑的具體的較佳化合物,例如亦可以舉出國際公開第2018/038002號的0148~0163段中所記載的化合物。 Preferred compounds as ionic base generators include, for example, those described in paragraphs 0148 to 0163 of International Publication No. 2018/038002.

作為銨鹽的具體例,可以舉出以下化合物,但是本發明並不限定於該等。 Specific examples of ammonium salts include the following compounds, but the invention is not limited to these.

[化學式47] [Chemical Formula 47]

作為亞胺鹽的具體例,可以舉出以下化合物,但是本發明並不限定於該等。 Specific examples of imine salts include the following compounds, but the invention is not limited to these.

在本發明的樹脂組成物包含鹼產生劑之情況下,鹼產生劑的 含量相對於本發明的樹脂組成物中的樹脂100質量份為0.1~50質量份為較佳。下限為0.3質量份以上為更佳,0.5質量份以上為進一步較佳。上限為30質量份以下為更佳,20質量份以下為進一步較佳,10質量份以下為更進一步較佳,可以為5質量份以下,亦可以為4質量份以下。 When the resin composition of the present invention contains an alkali-generating agent, the content of the alkali-generating agent is preferably 0.1 to 50 parts by weight relative to 100 parts by weight of the resin in the resin composition of the present invention. A lower limit of 0.3 parts by weight or more is preferred, and 0.5 parts by weight or more is further preferred. An upper limit of 30 parts by weight or less is preferred, 20 parts by weight or less is further preferred, 10 parts by weight or less is even more preferred, and it can be 5 parts by weight or less, or even 4 parts by weight or less.

鹼產生劑能夠使用1種或2種以上。在使用2種以上之情況下,合計量在上述範圍內為較佳。 One or more alkali-generating agents can be used. When using two or more, it is preferable that the total amount be within the above-mentioned range.

<聚合性化合物> <Polymerizing compounds>

本發明的樹脂組成物包含聚合性化合物為較佳。 The resin composition of this invention preferably contains polymeric compounds.

作為聚合性化合物,可以舉出自由基交聯劑或其他交聯劑。 As polymerizable compounds, examples include free radical crosslinkers or other crosslinking agents.

〔自由基交聯劑〕 [Free radical crosslinking agent]

本發明的樹脂組成物包含自由基交聯劑為較佳。 The resin composition of this invention preferably contains a free radical crosslinker.

自由基交聯劑為具有自由基聚合性基之化合物。作為自由基聚合性基,包含乙烯性不飽和鍵之基團為較佳。作為上述包含乙烯性不飽和鍵之基團,可以舉出乙烯基、烯丙基、乙烯基苯基、(甲基)丙烯醯基、順丁烯二醯亞胺基、(甲基)丙烯醯胺基等具有乙烯性不飽和鍵之基團。 Free radical crosslinkers are compounds possessing free radical polymerizable groups. Preferably, the free radical polymerizable group contains an ethylene-unsaturated bond. Examples of such ethylene-unsaturated groups include vinyl, allyl, vinylphenyl, (meth)acrylyl, cis-butenidimino, and (meth)acrylamide groups.

在該等之中,作為上述包含乙烯性不飽和鍵之基團,(甲基)丙烯醯基、(甲基)丙烯醯胺基、乙烯基苯基為較佳,從反應性的觀點考慮,(甲基)丙烯醯基為更佳。 Among these, (meth)acrylonitrile, (meth)acrylamide, and vinylphenyl are preferred as groups containing vinyl unsaturated bonds, and (meth)acrylonitrile is more preferred from a reactivity point of view.

自由基交聯劑為具有1個以上的乙烯性不飽和鍵之化合物為較佳,但是具有2個以上之化合物為更佳。自由基交聯劑可以具有3個以上的乙烯性不飽和鍵。 Free radical crosslinkers are preferably compounds with one or more ethylene unsaturated bonds, but compounds with two or more are even better. Free radical crosslinkers can have three or more ethylene unsaturated bonds.

作為上述具有2個以上的乙烯性不飽和鍵之化合物,具有2~15個乙 烯性不飽和鍵之化合物為較佳,具有2~10個乙烯性不飽和鍵之化合物為更佳,具有2~6個之化合物為進一步較佳。 Of the compounds having two or more ethylene unsaturated bonds, compounds having 2 to 15 ethylene unsaturated bonds are preferred, compounds having 2 to 10 ethylene unsaturated bonds are even more preferred, and compounds having 2 to 6 ethylene unsaturated bonds are further preferred.

又,從所獲得之圖案(硬化物)的膜強度的觀點考慮,本發明的樹脂組成物包含具有2個乙烯性不飽和鍵之化合物和上述具有3個以上的乙烯性不飽和鍵之化合物亦較佳。 Furthermore, from the viewpoint of the film strength of the obtained pattern (hardened material), the resin composition of the present invention comprising compounds having two ethylene unsaturated bonds and the aforementioned compounds having three or more ethylene unsaturated bonds is also preferred.

自由基交聯劑的分子量為2,000以下為較佳,1,500以下為更佳,900以下為進一步較佳。自由基交聯劑的分子量的下限為100以上為較佳。 The molecular weight of the free radical crosslinker is preferably below 2,000, more preferably below 1,500, and even more preferably below 900. A lower limit for the molecular weight of the free radical crosslinker is preferably above 100.

作為自由基交聯劑的具體例,可以舉出不飽和羧酸(例如,丙烯酸、甲基丙烯酸、衣康酸、巴豆酸、異巴豆酸、順丁烯二酸等)或其酯類、醯胺類,較佳為不飽和羧酸與多元醇化合物的酯及不飽和羧酸與多元胺化合物的醯胺類。又,亦可以較佳地使用具有羥基或胺基、氫硫基等親和性取代基之不飽和羧酸酯或醯胺類與單官能或多官能異氰酸酯類或環氧類的加成反應物、與單官能或多官能羧酸的脫水縮合反應物等。又,具有異氰酸酯基或環氧基等親電子性取代基之不飽和羧酸酯或醯胺類與單官能或多官能醇類、胺類、硫醇類的加成反應物以及具有鹵素基或甲苯磺醯氧基等脫離性取代基之不飽和羧酸酯或醯胺類與單官能或多官能醇類、胺類、硫醇類的取代反應物亦較佳。又,作為另一例,亦能夠使用替換成不飽和膦酸、苯乙烯等乙烯基苯衍生物、乙烯醚、烯丙醚等之化合物群組來代替上述不飽和羧酸。作為具體例,能夠參閱日本特開2016-027357號公報的0113~0122段的記載,並將該等內容編入本說明書中。 Specific examples of free radical crosslinkers include unsaturated carboxylic acids (e.g., acrylic acid, methacrylic acid, itaconic acid, crotonic acid, isocrotonic acid, maleic acid, etc.) or their esters and amides, preferably esters of unsaturated carboxylic acids and polyol compounds, and amides of unsaturated carboxylic acids and polyamine compounds. Furthermore, addition reactions of unsaturated carboxylic acid esters or amides with affinity substituents such as hydroxyl, amino, or hydrogen thio groups with monofunctional or polyfunctional isocyanates or epoxides, and dehydration condensation reactions with monofunctional or polyfunctional carboxylic acids, are also preferred. Furthermore, addition reactions of unsaturated carboxylic acid esters or amides having electrophilic substituents such as isocyanate groups or epoxy groups with monofunctional or polyfunctional alcohols, amines, or thiols, and substitution reactions of unsaturated carboxylic acid esters or amides having deionizing substituents such as halogen groups or toluenesulfonoxy groups with monofunctional or polyfunctional alcohols, amines, or thiols, are also preferred. As another example, compounds that replace the aforementioned unsaturated carboxylic acids can also be used, such as unsaturated phosphonic acids, vinylbenzene derivatives such as styrene, vinyl ethers, or allyl ethers. For specific examples, please refer to paragraphs 0113 to 0122 of Japanese Patent Application Publication No. 2016-027357, and such contents are incorporated herein by reference.

又,自由基交聯劑為在常壓下具有100℃以上的沸點之化合 物亦較佳。作為其例,可以舉出聚乙二醇二(甲基)丙烯酸酯、三羥甲基乙烷三(甲基)丙烯酸酯、新戊二醇二(甲基)丙烯酸酯、新戊四醇三(甲基)丙烯酸酯、新戊四醇四(甲基)丙烯酸酯、二新戊四醇五(甲基)丙烯酸酯、二新戊四醇六(甲基)丙烯酸酯、己二醇二(甲基)丙烯酸酯、三羥甲基丙烷三(丙烯醯氧基丙基)醚、三(丙烯醯氧基乙基)異三聚氰酸酯、丙三醇或三羥甲基乙烷等在多官能醇中加成環氧乙烷或環氧丙烷之後進行(甲基)丙烯酸酯化而獲得之化合物、如日本特公昭48-041708號公報、日本特公昭50-006034號公報、日本特開昭51-037193號各公報中所記載之(甲基)丙烯酸胺酯類、日本特開昭48-064183號、日本特公昭49-043191號、日本特公昭52-030490號各公報中所記載之聚酯丙烯酸酯類,作為環氧樹脂與(甲基)丙烯酸的反應產物之環氧丙烯酸酯類等多官能丙烯酸酯或甲基丙烯酸酯及該等混合物。又,日本特開2008-292970號公報的0254~0257段中所記載的化合物亦較佳。又,亦可以舉出使(甲基)丙烯酸環氧丙酯等具有環狀醚基及乙烯性不飽和鍵之化合物與多官能羧酸進行反應而獲得之多官能(甲基)丙烯酸酯等。 Furthermore, it is preferable that the free radical crosslinker is a compound with a boiling point above 100°C at normal pressure. Examples include polyethylene glycol di(meth)acrylate, trihydroxymethyl ethane tri(meth)acrylate, neopentyl glycol di(meth)acrylate, neopentyl tetramethyl acrylate, neopentyl tetramethyl acrylate, dinepentyl tetramethyl acrylate, dinepentyl tetramethyl acrylate, dinepentyl tetramethyl acrylate, hexaethylene glycol di(meth)acrylate, trihydroxymethyl propane tri(acryloyloxypropyl) ether, tri(acryloyloxyethyl) isocyanate, glycerol, or trihydroxymethyl ethane, which are added to polyfunctional alcohols to form ethylene oxide or propylene oxide, followed by (methyl) addition. Compounds obtained by esterification of acrylate, such as (meth)acrylate amino esters described in Japanese Patent Publication Nos. 48-041708, 50-006034, and 51-037193, and polyester acrylates described in Japanese Patent Publication Nos. 48-064183, 49-043191, and 52-030490, as well as epoxy acrylates and other multifunctional acrylates or methacrylates as products of the reaction of epoxy resins with (meth)acrylate, and mixtures thereof. Furthermore, compounds described in paragraphs 0254 to 0257 of Japanese Patent Publication No. 2008-292970 are also preferred. Furthermore, examples include polyfunctional (meth)acrylates obtained by reacting compounds such as glycidyl (meth)acrylate, which possess cyclic ether groups and vinyl unsaturated bonds, with polyfunctional carboxylic acids.

又,作為除了上述以外的較佳的自由基交聯劑物,亦能夠使用日本特開2010-160418號公報、日本特開2010-129825號公報、日本專利第4364216號公報等中所記載之具有茀環且具有2個以上的含有乙烯性不飽和鍵之基團之化合物或卡多(cardo)樹脂。 Furthermore, as a preferred free radical crosslinking agent besides those mentioned above, compounds having a cycloaliform ring and having two or more ethylene-containing unsaturated groups, or cardo resins, as described in Japanese Patent Application Publication No. 2010-160418, Japanese Patent Application Publication No. 2010-129825, and Japanese Patent No. 4364216, can also be used.

進而,作為其他例,亦可以舉出日本特公昭46-043946號公報、日本特公平01-040337號公報、日本特公平01-040336號公報中所記載的特定的不飽和化合物或日本特開平02-025493號公報中所記載的乙烯基 膦酸系化合物等。又,亦能夠使用日本特開昭61-022048號公報中所記載的包含全氟烷基之化合物。進而,亦能夠使用在“Journal of the Adhesion Society of Japan”vol.20、No.7、300~308頁(1984年)中作為光聚合性單體及寡聚物所介紹者。 Furthermore, as other examples, specific unsaturated compounds described in Japanese Patent Publication Nos. 46-043946, 01-040337, and 01-040336, or vinyl phosphonic acid compounds described in Japanese Patent Application Publication No. 02-025493, can also be used. Additionally, compounds containing perfluoroalkyl groups described in Japanese Patent Application Publication No. 61-022048 can also be used. Furthermore, those described as photopolymerizable monomers and oligomers in the "Journal of the Adhesion Society of Japan," vol. 20, No. 7, pp. 300-308 (1984), can also be used.

除了上述以外,亦能夠較佳地使用日本特開2015-034964號公報的0048~0051段中所記載的化合物、國際公開第2015/199219號的0087~0131段中所記載的化合物,並將該等內容編入本說明書中。 In addition to the above, compounds described in paragraphs 0048-0051 of Japanese Patent Application Publication No. 2015-034964 and compounds described in paragraphs 0087-0131 of International Publication No. 2015/199219 are also preferred, and their contents are incorporated into this specification.

又,在日本特開平10-062986號公報中,作為式(1)及式(2)而與其具體例一同記載的如下化合物亦能夠用作自由基交聯劑,該化合物為在多官能醇中加成環氧乙烷或環氧丙烷之後進行(甲基)丙烯酸酯化而獲得之化合物。 Furthermore, the following compounds, described together with specific examples of formulas (1) and (2) in Japanese Patent Application Publication No. 10-062986, can also be used as free radical crosslinking agents. These compounds are obtained by esterification of (meth)acrylate following the addition of ethylene oxide or propylene oxide to a polyfunctional alcohol.

進而,亦能夠使用日本特開2015-187211號公報的0104~0131段中所記載的化合物作為自由基交聯劑,並將該等內容編入本說明書中。 Furthermore, compounds described in paragraphs 0104 to 0131 of Japanese Patent Application Publication No. 2015-187211 can also be used as free radical crosslinking agents, and such contents are incorporated into this specification.

作為自由基交聯劑,二新戊四醇三丙烯酸酯(作為市售品為KAYARAD D-330;Nippon Kayaku Co.,Ltd.製)、二新戊四醇四丙烯酸酯(作為市售品為KAYARAD D-320;Nippon Kayaku Co.,Ltd.製、A-TMMT:Shin-Nakamura Chemical Co.,Ltd.製)、二新戊四醇五(甲基)丙烯酸酯(作為市售品為KAYARAD D-310;Nippon Kayaku Co.,Ltd.製)、二新戊四醇六(甲基)丙烯酸酯(作為市售品為KAYARAD DPHA;Nippon Kayaku Co.,Ltd.製、A-DPH;Shin-Nakamura Chemical Co.,Ltd.製)及該等(甲基)丙烯醯基經由乙二醇殘基或丙二醇殘基鍵結之結構為較佳。亦能夠使用該 等寡聚物類型。 As free radical crosslinking agents, dinepentylenetetroxide triacrylate (commercially available as KAYARAD D-330; manufactured by Nippon Kayaku Co., Ltd.), dinepentylenetetroxide tetraacrylate (commercially available as KAYARAD D-320; manufactured by Nippon Kayaku Co., Ltd., A-TMMT: manufactured by Shin-Nakamura Chemical Co., Ltd.), dinepentylenetetroxide penta(meth)acrylate (commercially available as KAYARAD D-310; manufactured by Nippon Kayaku Co., Ltd.), and dinepentylenetetroxide hexa(meth)acrylate (commercially available as KAYARAD DPHA; manufactured by Nippon Kayaku Co., Ltd., A-DPH: manufactured by Shin-Nakamura Chemical Co., Ltd.) (Made by Co., Ltd.) and the structure in which the (meth)acrylic acid groups are bonded by ethylene glycol residues or propylene glycol residues are preferred. These oligomer types can also be used.

作為自由基交聯劑的市售品,例如可以舉出Sartomer Company,Inc製的作為具有4個伸乙氧基鏈之4官能丙烯酸酯之SR-494、作為具有4個乙烯氧基鏈之2官能丙烯酸甲酯之Sartomer Company,Inc製SR-209、231、239、Nippon Kayaku Co.,Ltd.製的作為具有6個伸戊氧基鏈之6官能丙烯酸酯之DPCA-60、作為具有3個異伸丁氧基鏈之3官能丙烯酸酯之TPA-330、胺酯寡聚物UAS-10、UAB-140(NIPPON PAPER INDUSTRIES CO.,LTD.製)、NK酯M-40G、NK酯4G、NK酯M-9300、NK酯A-9300、UA-7200(Shin-Nakamura Chemical Co.,Ltd製)、DPHA-40H(Nippon Kayaku Co.,Ltd.製)、UA-306H、UA-306T、UA-306I、AH-600、T-600、AI-600(Kyoeisha chemical Co.,Ltd.製)、BLEMMER PME400(NOF CORPORATION製)等。 Commercially available free radical crosslinking agents include, for example, SR-494 (a tetrafunctional acrylate with four ethynooxy groups) manufactured by Sartomer Company, Inc.; SR-209, 231, and 239 (a difunctional methyl acrylate with four ethoxy groups) manufactured by Sartomer Company, Inc.; DPCA-60 (a hexafunctional acrylate with six pentylooxy groups) manufactured by Nippon Kayaku Co., Ltd.; TPA-330 (a trifunctional acrylate with three isobutylooxy groups); amine ester oligomers UAS-10 and UAB-140 (manufactured by NIPPON PAPER INDUSTRIES CO.,LTD.); NK ester M-40G, NK ester 4G, NK ester M-9300, NK ester A-9300; and UA-7200 (Shin-Nakamura Chemical). (Manufactured by Nippon Kayaku Co., Ltd.), DPHA-40H (manufactured by Nippon Kayaku Co., Ltd.), UA-306H, UA-306T, UA-306I, AH-600, T-600, AI-600 (manufactured by Kyoeisha Chemical Co., Ltd.), BLEMMER PME400 (manufactured by NOF CORPORATION), etc.

作為自由基交聯劑,如日本特公昭48-041708號公報、日本特開昭51-037193號公報、日本特公平02-032293號公報、日本特公平02-016765號公報中所記載之胺酯丙烯酸酯類、日本特公昭58-049860號公報、日本特公昭56-017654號公報、日本特公昭62-039417號公報、日本特公昭62-039418號公報中所記載的具有環氧乙烷系骨架之胺酯化合物類亦較佳。進而,作為自由基交聯劑,亦能夠使用日本特開昭63-277653號公報、日本特開昭63-260909號公報、日本特開平01-105238號公報中所記載之在分子內具有胺基結構或硫化物結構之化合物。 As free radical crosslinking agents, amine ester acrylates as described in Japanese Patent Publication No. 48-041708, Japanese Patent Application Publication No. 51-037193, Japanese Patent Publication No. 02-032293, Japanese Patent Publication No. 02-016765, and amine ester compounds with an ethylene oxide skeleton as described in Japanese Patent Publication No. 58-049860, Japanese Patent Publication No. 56-017654, Japanese Patent Publication No. 62-039417, and Japanese Patent Publication No. 62-039418 are also preferred. Furthermore, as a free radical crosslinking agent, compounds having an amino group structure or a sulfide structure within the molecule, as described in Japanese Patent Application Publication Nos. 63-277653, 63-260909, and 01-105238, can also be used.

自由基交聯劑可以為具有羧基、磷酸基等酸基之自由基交聯劑。具有酸基之自由基交聯劑為脂肪族多羥基化合物與不飽和羧酸的酯為 較佳,使非芳香族羧酸酐與脂肪族多羥基化合物的未反應的羥基進行反應而具有酸基之自由基交聯劑為更佳。特佳為在使非芳香族羧酸酐與脂肪族多羥基化合物的未反應的羥基進行反應而具有酸基之自由基交聯劑中,脂肪族多羥基化合物為新戊四醇或二新戊四醇之化合物。作為市售品,例如作為TOAGOSEI CO.,Ltd.製的多元酸改質丙烯酸類寡聚物,可以舉出M-510、M-520等。 Free radical crosslinkers can be free radical crosslinkers containing acid groups such as carboxyl or phosphate groups. It is preferable that the free radical crosslinker containing acid groups is an ester of an aliphatic polyhydroxyl compound and an unsaturated carboxylic acid. It is even more preferable that the free radical crosslinker contains acid groups by reacting a non-aromatic carboxylic anhydride with the unreacted hydroxyl group of an aliphatic polyhydroxyl compound. Particularly preferred is that, in the free radical crosslinker containing acid groups by reacting a non-aromatic carboxylic anhydride with the unreacted hydroxyl group of an aliphatic polyhydroxyl compound, the aliphatic polyhydroxyl compound is a neopentyl tetrol or dinepentyl tetrol. Commercially available examples include, for instance, polybasic acid-modified acrylic oligomers manufactured by TOAGOSEI CO., Ltd., such as M-510 and M-520.

具有酸基之自由基交聯劑的較佳酸值為0.1~300mgKOH/g,特佳為1~100mgKOH/g。只要自由基交聯劑的酸值在上述範圍內,則製造上的操作性優異,進而顯影性優異。又,聚合性良好。關於上述酸值,依據JIS K 0070:1992的記載來測定。 The preferred acid value for free radical crosslinkers containing acid groups is 0.1~300 mgKOH/g, with a particularly preferred value of 1~100 mgKOH/g. As long as the acid value of the free radical crosslinker is within the above range, the manufacturing process is excellent, resulting in excellent developing properties. Furthermore, it exhibits good polymerizability. The above acid values are determined according to JIS K 0070:1992.

從圖案的解析性和膜的伸縮性的觀點考慮,樹脂組成物使用2官能的甲基丙烯酸酯或丙烯酸酯為較佳。 From the perspectives of pattern resolution and membrane stretchability, it is preferable to use difunctional methacrylates or acrylates in the resin composition.

作為具體的化合物,能夠使用三乙二醇二丙烯酸酯、三乙二醇二甲基丙烯酸酯、四乙二醇二甲基丙烯酸酯、四乙二醇二丙烯酸酯、PEG(聚乙二醇)200二丙烯酸酯、PEG200二甲基丙烯酸酯、PEG600二丙烯酸酯、PEG600二甲基丙烯酸酯、聚四乙二醇二丙烯酸酯、聚四乙二醇二甲基丙烯酸酯、新戊二醇二丙烯酸酯、新戊二醇二甲基丙烯酸酯、3-甲基-1,5-戊二醇二丙烯酸酯、1,6-己二醇二丙烯酸酯、1,6己二醇二甲基丙烯酸酯、二羥甲基三環癸烷二丙烯酸酯、二羥甲基三環癸烷二甲基丙烯酸酯、雙酚A的EO(環氧乙烷)加成物二丙烯酸酯、雙酚A的EO加成物二甲基丙烯酸酯、雙酚A的PO(環氧丙烷)加成物二丙烯酸酯、雙酚A的PO加成物二甲基丙烯酸酯、2羥基-3-丙烯醯氧基丙基甲基丙烯酸酯、異三聚氰酸EO改質二丙 烯酸酯、異三聚氰酸改質二甲基丙烯酸酯、具有其他胺酯鍵之2官能丙烯酸酯、具有胺酯鍵之2官能甲基丙烯酸酯。該等依據需要能夠混合使用2種以上。 As specific compounds, the following can be used: triethylene glycol diacrylate, triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, tetraethylene glycol diacrylate, PEG (polyethylene glycol) 200 diacrylate, PEG200 dimethacrylate, PEG600 diacrylate, PEG600 dimethacrylate, polytetraethylene glycol diacrylate, polytetraethylene glycol dimethacrylate, neopentyl glycol diacrylate, neopentyl glycol dimethacrylate, 3-methyl-1,5-pentanediol diacrylate, 1,6-hexanediol diacrylate, 1,6-hexanediol diacrylate, etc. Dimethacrylates, dihydroxymethyltricyclodecane dimethacrylates, dihydroxymethyltricyclodecane dimethacrylates, ethylene oxide (EO) adduct dimethacrylates of bisphenol A, EO adduct dimethacrylates of bisphenol A, propylene oxide (PO) adduct dimethacrylates of bisphenol A, PO adduct dimethacrylates of bisphenol A, 2-hydroxy-3-acryloyloxypropyl methacrylates, cyanuric acid (EO) modified diacrylates, cyanuric acid (EO) modified dimethacrylates, difunctional acrylates having other amine ester bonds, and difunctional methacrylates having amine ester bonds. Two or more of these can be mixed as needed.

再者,例如PEG200二丙烯酸酯是指為聚乙二醇二丙烯酸酯且聚乙二醇鏈的式量為200左右者。 Furthermore, for example, PEG200 diacrylate refers to polyethylene glycol diacrylate with a polyethylene glycol chain molecular weight of approximately 200.

關於本發明的樹脂組成物,從伴隨圖案(硬化物)的彈性模數控制而抑制翹曲的觀點考慮,能夠較佳地使用單官能自由基交聯劑作為自由基交聯劑。作為單官能自由基交聯劑,可以較佳地使用正丁基(甲基)丙烯酸酯、2-乙基己基(甲基)丙烯酸酯、2-羥乙基(甲基)丙烯酸酯、丁氧基乙基(甲基)丙烯酸酯、卡必醇(甲基)丙烯酸酯、環己基(甲基)丙烯酸酯、芐基(甲基)丙烯酸酯、苯氧基乙基(甲基)丙烯酸酯、N-羥甲基(甲基)丙烯醯胺、環氧丙基(甲基)丙烯酸酯、聚乙二醇單(甲基)丙烯酸酯、聚丙二醇單(甲基)丙烯酸酯等(甲基)丙烯酸衍生物、N-乙烯基吡咯啶酮、N-乙烯基己內醯胺等N-乙烯基化合物類、烯基環氧丙醚等。作為單官能自由基交聯劑,為了抑制曝光前的揮發,在常壓下具有100℃以上的沸點之化合物亦較佳。 Regarding the resin composition of this invention, from the viewpoint of suppressing warping by controlling the elastic modulus accompanying the pattern (hardener), a monofunctional free radical crosslinker can be used better as the free radical crosslinker. As a monofunctional free radical crosslinking agent, the following are preferred: n-butyl(meth)acrylate, 2-ethylhexyl(meth)acrylate, 2-hydroxyethyl(meth)acrylate, butoxyethyl(meth)acrylate, carbitol(meth)acrylate, cyclohexyl(meth)acrylate, benzyl(meth)acrylate, phenoxyethyl(meth)acrylate, N-hydroxymethyl(meth)acrylamide, glycidyl(meth)acrylate, polyethylene glycol mono(meth)acrylate, polypropylene glycol mono(meth)acrylate, and other (meth)acrylate derivatives; N-vinyl compounds such as N-vinylpyrrolidone and N-vinylcaprolactone; and alkenyl epoxypropyl ethers. As a monofunctional free radical crosslinking agent, compounds with a boiling point above 100°C at ambient pressure are also preferred to suppress pre-exposure volatilization.

除此以外,作為2官能以上的自由基交聯劑,可以舉出鄰苯二甲酸二烯丙酯、偏苯三酸三烯丙酯等烯丙基化合物類。 Besides these, examples of allyl compounds, such as diallyl phthalate and triallyl trimellitate, can be considered as free radical crosslinking agents with two or more functions.

在含有自由基交聯劑之情況下,其含量相對於本發明的樹脂組成物的總固體成分超過0質量%且60質量%以下為較佳。下限為5質量%以上為更佳。上限為50質量%以下為更佳,30質量%以下為進一步較佳。 In the presence of a free radical crosslinker, it is preferable that its content relative to the total solid content of the resin composition of the present invention is greater than 0% by mass and less than 60% by mass. A lower limit of 5% by mass or more is more preferred. An upper limit of 50% by mass or less is more preferred, and 30% by mass or less is even more preferred.

自由基交聯劑可以單獨使用1種,亦可以混合使用2種以上。 在同時使用2種以上之情況下,其合計量在上述範圍內為較佳。 Free radical crosslinking agents can be used alone or in combination of two or more. When using two or more simultaneously, the total amount within the above-mentioned range is preferable.

〔其他交聯劑〕 [Other cross-linking agents]

本發明的樹脂組成物包含與上述自由基交聯劑不同之其他交聯劑亦較佳。 The resin composition of this invention preferably includes other crosslinking agents that are different from the aforementioned free radical crosslinking agents.

在本發明中,其他交聯劑是指除了上述自由基交聯劑以外的交聯劑,在分子內具有複數個藉由上述光酸產生劑或光鹼產生劑的感光而促進在與組成物中的其他化合物或其反應產物之間形成共價鍵之反應之基團之化合物為較佳,在分子內具有複數個藉由酸或鹼的作用而促進在與組成物中的其他化合物或其反應產物之間形成共價鍵之反應之基團之化合物為較佳。 In this invention, "other crosslinking agents" refers to crosslinking agents other than the aforementioned free radical crosslinking agents. Preferably, the compound has a plurality of groups within its molecule that, upon photosensitization by the aforementioned photoacid or photoalkali generator, promote the formation of covalent bonds between it and other compounds in the composition or their reaction products. More preferably, the compound has a plurality of groups within its molecule that, upon the action of an acid or alkali, promote the formation of covalent bonds between it and other compounds in the composition or their reaction products.

上述酸或鹼為在曝光步驟中從光酸產生劑或光鹼產生劑產生之酸或鹼為較佳。 Preferably, the acid or alkali mentioned above is generated from the photoacid generator or photoalkali generator during the exposure step.

作為其他交聯劑,具有選自包括醯氧基甲基、羥甲基及烷氧基甲基之群組中的至少1種基團之化合物為較佳,具有選自包括醯氧基甲基、羥甲基及烷氧基甲基之群組中的至少1種基團與氮原子直接鍵結之結構之化合物為更佳。 As other crosslinking agents, compounds having at least one group selected from the group consisting of acetoxymethyl, hydroxymethyl, and alkoxymethyl are preferred, and compounds having a structure in which at least one group selected from the group consisting of acetoxymethyl, hydroxymethyl, and alkoxymethyl is directly bonded to a nitrogen atom are even more preferred.

作為其他交聯劑,例如可以舉出具有使甲醛或甲醛和醇與三聚氰胺、甘脲、脲、伸烷基脲、苯并胍胺等含有胺基之化合物進行反應而經醯氧基甲基、羥甲基或烷氧基甲基取代上述胺基的氫原子之結構之化合物。該等化合物之製造方法並無特別限定,只要為具有與藉由上述方法製造的化合物相同之結構之化合物即可。又,亦可以為該等化合物的羥甲基彼此自縮合而成之寡聚物。 Other crosslinking agents include, for example, compounds that have the structure of replacing the hydrogen atom of the aforementioned amino groups with acetaldehyde, or formaldehyde and an alcohol, in a reaction involving melamine, glycourea, urea, alkyl urea, benzoguanamine, or similar amino-containing compounds, via acetoxymethyl, hydroxymethyl, or alkoxymethyl groups. The method of manufacturing these compounds is not particularly limited, as long as the compound has the same structure as the compound manufactured by the above method. Furthermore, oligomers formed by the self-condensation of the hydroxymethyl groups of these compounds can also be used.

將作為上述含有胺基之化合物而使用了三聚氰胺之交聯劑稱為三聚氰 胺系交聯劑,將使用了甘脲、脲或伸烷基脲之交聯劑稱為脲系交聯劑,將使用了伸烷基脲之交聯劑稱為伸烷基脲系交聯劑,將使用了苯并胍胺之交聯劑稱為苯并胍胺系交聯劑。 Crosslinking agents that use melamine as a component of the aforementioned amine-containing compounds are called melamine-based crosslinking agents; crosslinking agents that use urea, urea, or alkylurea are called urea-based crosslinking agents; crosslinking agents that use alkylurea are called alkylurea-based crosslinking agents; and crosslinking agents that use benzoguanidine are called benzoguanidine-based crosslinking agents.

在該等之中,本發明的樹脂組成物包含選自包括脲系交聯劑及三聚氰胺系交聯劑之群組中的至少1種化合物為較佳,包含選自包括後述甘脲系交聯劑及三聚氰胺系交聯劑之群組中的至少1種化合物為更佳。 Of these, it is preferable that the resin composition of the present invention comprises at least one compound selected from the group consisting of urea-based crosslinkers and melamine-based crosslinkers, and even more preferably, it comprises at least one compound selected from the group consisting of glycourea-based crosslinkers and melamine-based crosslinkers (described below).

作為含有本發明中之烷氧基甲基及醯氧基甲基中的至少1個之化合物,可以舉出烷氧基甲基或醯氧基甲基直接在芳香族基或下述脲結構的氮原子上或三上取代之化合物作為結構例。 As a compound containing at least one of the alkoxymethyl and acetoxymethyl groups of the present invention, examples include alkoxymethyl or acetoxymethyl groups directly on the nitrogen atom of an aromatic group or a urea structure described below, or on a tri-atom. Compounds with top substitution are used as structural examples.

上述化合物所具有之烷氧基甲基或醯氧基甲基為碳數2~5為較佳,碳數2或3為較佳,碳數2為更佳。 The alkoxymethyl or acetomethyl group in the above compounds preferably has 2 to 5 carbon atoms, with 2 or 3 carbon atoms being more preferred, and 2 carbon atoms being even more preferred.

上述化合物所具有之烷氧基甲基及醯氧基甲基的總數為1~10為較佳,更佳為2~8,特佳為3~6。 The total number of alkoxymethyl and aceoxymethyl groups in the above compounds is preferably 1 to 10, more preferably 2 to 8, and particularly preferably 3 to 6.

上述化合物的分子量較佳為1500以下,180~1200為較佳。 The molecular weight of the above-mentioned compounds is preferably below 1500, with 180-1200 being more preferred.

R100表示烷基或醯基。 R 100 indicates alkyl or acetylated.

R101及R102分別獨立地表示1價的有機基,並且可以相互鍵結而形成環。 R101 and R102 represent monovalent organic groups independently and can bond with each other to form a ring.

作為烷氧基甲基或醯氧基甲基直接在芳香族基上取代之化 合物,例如可以舉出下述通式的各種化合物。 Compounds in which alkoxymethyl or acetomethyl groups are directly substituted onto an aromatic group include, for example, various compounds of the following general formula.

式中,X表示單鍵或2價的有機基,每個R104分別獨立地表示烷基或醯基,R103表示氫原子、烷基、烯基、芳基、芳烷基或藉由酸的作用進行分解而產生鹼可溶性基之基團(例如,藉由酸的作用進行脫離之基團、-C(R4)2COOR5所表示之基團(R4分別獨立地表示氫原子或碳數1~4的烷基,R5表示藉由酸的作用進行脫離之基團。))。 In the formula, X represents a single bond or a divalent organic group, each R 104 independently represents an alkyl or acetyl group, and R 103 represents a hydrogen atom, alkyl, alkenyl, aryl, aralkyl, or a group that decomposes under the action of an acid to produce an alkaline soluble group (e.g., a group that is desorbed under the action of an acid, or a group represented by -C(R 4 ) 2 COOR 5 (R 4 independently represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, and R 5 represents a group that is desorbed under the action of an acid.)).

R105各自獨立地表示烷基或烯基,a、b及c各自獨立地為1~3,d為0~4,e為0~3,f為0~3,a+d為5以下,b+e為4以下,c+f為4以下。 R 105 independently represents alkyl or alkenyl groups, a, b and c are 1 to 3, d is 0 to 4, e is 0 to 3, f is 0 to 3, a+d is 5 or less, b+e is 4 or less, and c+f is 4 or less.

關於藉由酸的作用進行分解而產生鹼可溶性基之基團、藉由酸的作用進行脫離之基團、-C(R4)2COOR5所表示之基團中之R5,例如可以舉出-C(R36)(R37)(R3s)、-C(R36)(R37)(OR39)、-C(R01)(R02)(OR39)等。 Regarding groups that decompose under the action of acid to produce alkali-soluble groups, groups that are desorbed under the action of acid, and R5 in the group represented by -C( R4 ) 2COOR5 , examples include -C( R36 )( R37 )( R3s ), -C( R36 )( R37 )( OR39 ), and -C( R01 )( R02 )( OR39 ).

式中,R36~R39分別獨立地表示烷基、環烷基、芳基、芳烷基或烯基。R36與R37可以相互鍵結而形成環。 In the formula, R 36 to R 39 independently represent alkyl, cycloalkyl, aryl, aralkyl, or alkenyl groups. R 36 and R 37 can bond together to form a ring.

作為上述烷基,碳數1~10的烷基為較佳,碳數1~5的烷基為更佳。 Of the aforementioned alkyl groups, those having 1 to 10 carbon atoms are preferred, and those having 1 to 5 carbon atoms are even more preferred.

上述烷基可以為直鏈狀、支鏈狀中的任一個。 The alkyl group mentioned above can be either linear or branched.

作為上述環烷基,碳數3~12的環烷基為較佳,碳數3~8的環烷基為更佳。 Of the aforementioned cycloalkyl groups, those with 3 to 12 carbon atoms are preferred, and those with 3 to 8 carbon atoms are even more preferred.

上述環烷基可以為單環結構,亦可以為縮合環等多環結構。 The aforementioned cycloalkyl groups can be monocyclic or polycyclic structures, such as condensed rings.

上述芳基為碳數6~30的芳香族烴基為較佳,苯基為更佳。 The aryl group is preferably an aromatic hydrocarbon with 6 to 30 carbon atoms, and phenyl is even more preferred.

作為上述芳烷基,碳數7~20的芳烷基為較佳,碳數7~16的芳烷基為更佳。 Of the aforementioned aralkyl groups, those with 7 to 20 carbon atoms are preferred, and those with 7 to 16 carbon atoms are even more preferred.

上述芳烷基是指經烷基取代之芳基,該等烷基及芳基的較佳態樣與上述烷基及芳基的較佳態樣相同。 The aforementioned aralkyl group refers to an aryl group substituted with an alkyl group, and the preferred states of these alkyl and aryl groups are the same as those of the aforementioned alkyl and aryl groups.

上述烯基為碳數3~20的烯基為較佳,碳數3~16的烯基為更佳。 The alkenyl group described above is preferably an alkenyl group with 3 to 20 carbon atoms, and even more preferably an alkenyl group with 3 to 16 carbon atoms.

又,該等基團在可以獲得本發明的效果之範圍內還可以具有公知的取代基。 Furthermore, these groups may also have known substituents to the extent that the effects of this invention can be achieved.

R01及R02分別獨立地表示氫原子、烷基、環烷基、芳基、芳烷基或烯基。 R 01 and R 02 represent hydrogen atoms, alkyl, cycloalkyl, aryl, aralkyl or alkenyl groups, respectively.

作為藉由酸的作用進行分解而產生鹼可溶性基之基團或藉由酸的作用進行脫離之基團,較佳為三級烷基酯基、縮醛基、枯基酯基、烯醇酯基等。進一步較佳為三級烷基酯基、縮醛基。 The group that decomposes to produce an alkaline-soluble group by the action of acid, or that is desorbed by the action of acid, is preferably a trialkyl ester group, an acetal group, a cumyl ester group, or an enol ester group. More preferably, it is a trialkyl ester group or an acetal group.

作為具有烷氧基甲基之化合物,具體而言,可以舉出以下結構。關於具有醯氧基甲基之化合物,可以舉出將下述化合物的烷氧基甲基變更為醯氧基甲基之化合物。作為在分子內具有烷氧基甲基或醯氧基甲基之化合物,可以舉出以下各種化合物,但是並不限定於該等。 Specifically, the following structures can be cited as examples of compounds containing alkoxymethyl groups. Regarding compounds containing acetoxymethyl groups, compounds in which the alkoxymethyl group of the following compounds is replaced with an acetoxymethyl group can be cited. Various compounds can be cited as examples of compounds containing alkoxymethyl or acetoxymethyl groups within the molecule, but are not limited to these.

[化學式51] [Chemical Formula 51]

[化學式52] [Chemical Formula 52]

關於含有烷氧基甲基及醯氧基甲基中的至少1個之化合物,可以使用市售者,亦可以使用藉由公知的方法合成者。 For compounds containing at least one of alkoxymethyl and aceoxymethyl groups, commercially available compounds or those synthesized by known methods may be used.

從耐熱性的觀點考慮,烷氧基甲基或醯氧基甲基直接在芳香環或三環上取代之化合物為較佳。 From a heat resistance perspective, alkoxymethyl or acetomethyl groups are directly bonded to the aromatic ring or tricyclic ring. Compounds with ring substitution are preferred.

作為三聚氰胺系交聯劑的具體例,可以舉出六甲氧基甲基三聚氰胺、六乙氧基甲基三聚氰胺、六丙氧基甲基三聚氰胺、六丁氧基丁基三聚氰胺等。 Specific examples of melamine-based crosslinking agents include hexamethoxymethyl melamine, hexaethoxymethyl melamine, hexapropoxymethyl melamine, and hexabutoxybutyl melamine.

作為脲系交聯劑的具體例,例如可以舉出單羥甲基化甘脲、二羥甲基化甘脲、三羥甲基化甘脲、四羥甲基化甘脲、單甲氧基甲基化甘脲,二甲氧基甲基化甘脲、三甲氧基甲基化甘脲、四甲氧基甲基化甘脲、單乙氧基甲基化甘脲、二乙氧基甲基化甘脲、三乙氧基甲基化甘脲、四乙 氧基甲基化甘脲、單丙氧基甲基化甘脲、二丙氧基甲基化甘脲、三丙氧基甲基化甘脲、四丙氧基甲基化甘脲、單丁氧基甲基化甘脲、二丁氧基甲基化甘脲、三丁氧基甲基化甘脲或四丁氧基甲基化甘脲等甘脲系交聯劑; 雙甲氧基甲基脲、雙乙氧基甲基脲、雙丙氧基甲基脲、雙丁氧基甲基脲等脲系交聯劑、 單羥甲基化伸乙脲或二羥甲基化伸乙脲、單甲氧基甲基化伸乙脲、二甲氧基甲基化伸乙脲、單乙氧基甲基化伸乙脲、二乙氧基甲基化伸乙脲、單丙氧基甲基化伸乙脲、二丙氧基甲基化伸乙脲、單丁氧基甲基化伸乙脲或二丁氧基甲基化伸乙脲等伸乙脲系交聯劑、 單羥甲基化伸丙脲、二羥甲基化伸丙脲、單甲氧基甲基化伸丙脲、二甲氧基甲基化伸丙脲、單乙氧基甲基化伸丙脲、二乙氧基甲基化伸丙脲、單丙氧基甲基化伸丙脲、二丙氧基甲基化伸丙脲、單丁氧基甲基化伸丙脲或二丁氧基甲基化伸丙脲等伸丙脲系交聯劑、 1,3-二(甲氧基甲基)4,5-二羥基-2-咪唑啶酮、1,3-二(甲氧基甲基)-4,5-二甲氧基-2-咪唑啶酮等。 Specific examples of urea crosslinkers include monohydroxymethylated glycourea, dihydroxymethylated glycourea, trihydroxymethylated glycourea, tetrahydroxymethylated glycourea, monomethoxymethylated glycourea, dimethoxymethylated glycourea, trimethoxymethylated glycourea, tetramethoxymethylated glycourea, monoethoxymethylated glycourea, diethoxymethylated glycourea, triethoxymethylated glycourea, tetraethoxymethylated glycourea, and monopropoxymethylated glycourea. Glycourea crosslinking agents including hydroxylated glycourea, dipropoxymethylated glycourea, tripropoxymethylated glycourea, tetrapropoxymethylated glycourea, monobutoxymethylated glycourea, dibutoxymethylated glycourea, tributoxymethylated glycourea, or tetrabutoxymethylated glycourea; Urea crosslinking agents including dimethoxymethylurea, diethoxymethylurea, dipropoxymethylurea, and dibutoxymethylurea; Monohydroxymethylated ethoxyurea or dihydroxymethylated ethoxyurea. Ethylene urea, monomethoxymethylated ethylene urea, dimethoxymethylated ethylene urea, monoethoxymethylated ethylene urea, diethoxymethylated ethylene urea, monopropoxymethylated ethylene urea, dipropoxymethylated ethylene urea, monobutoxymethylated ethylene urea, or dibutoxymethylated ethylene urea, etc., are ethylene urea-based crosslinking agents; monohexyl methylated ethoxypropionate urea, dihydroxymethylated ethoxypropionate urea, monomethoxymethylated ethoxypropionate urea, dimethoxymethylated ethoxypropionate urea, monoethoxymethylated ethoxypropionate urea, dipropoxymethylated ethoxypropionate urea, monobutoxymethylated ethoxypropionate urea, or dibutoxymethylated ethoxypropionate urea, etc., are ethoxypropionate urea-based crosslinking agents; 1,3-di(methoxymethyl)4,5-dihydroxy-2-imidazolidinone, 1,3-di(methoxymethyl)-4,5-dimethoxy-2-imidazolidinone, etc.

作為苯并胍胺系交聯劑的具體例,例如可以舉出單羥甲基化苯并胍胺、二羥甲基化苯并胍胺、三羥甲基化苯并胍胺、四羥甲基化苯并胍胺、單甲氧基甲基化苯并胍胺、二甲氧基甲基化苯并胍胺、三甲氧基甲基化苯并胍胺、四甲氧基甲基化苯并胍胺、單乙氧基甲基化苯并胍胺、二乙氧基甲基化苯并胍胺、三乙氧基甲基化苯并胍胺、四乙氧基甲基化苯并胍胺、單丙氧基甲基化苯并胍胺、二丙氧基甲基化苯并胍胺、三丙氧基甲基化苯并胍胺、四丙氧基甲基化苯并胍胺、單丁氧基甲基化苯并胍胺、二 丁氧基甲基化苯并胍胺、三丁氧基甲基化苯并胍胺、四丁氧基甲基化苯并胍胺等。 Specific examples of benzoguanidine crosslinking agents include monohydroxymethylated benzoguanidine, dihydroxymethylated benzoguanidine, trihydroxymethylated benzoguanidine, tetrahydroxymethylated benzoguanidine, monomethoxymethylated benzoguanidine, dimethoxymethylated benzoguanidine, trimethoxymethylated benzoguanidine, tetramethoxymethylated benzoguanidine, monoethoxymethylated benzoguanidine, diethoxymethylated benzoguanidine, triethoxymethylated benzoguanidine, tetraethoxymethylated benzoguanidine, monopropoxymethylated benzoguanidine, dipropoxymethylated benzoguanidine, tripropoxymethylated benzoguanidine, tetrapropoxymethylated benzoguanidine, monobutoxymethylated benzoguanidine, dibutoxymethylated benzoguanidine, tributoxymethylated benzoguanidine, and tetrabutoxymethylated benzoguanidine.

除此以外,作為具有選自包括羥甲基及烷氧基甲基之群組中的至少1種基團之化合物,亦可以較佳地使用在芳香環(較佳為苯環)上直接鍵結有選自包括羥甲基及烷氧基甲基之群組中的至少1種基團之化合物。 In addition, as a compound having at least one group selected from the group consisting of hydroxymethyl and alkoxymethyl groups, it is also preferable to use a compound having at least one group selected from the group consisting of hydroxymethyl and alkoxymethyl groups directly bonded to an aromatic ring (preferably a benzene ring).

作為該種化合物的具體例,可以舉出苯二甲醇、雙(羥甲基)甲酚、雙(羥甲基)二甲氧基苯、雙(羥甲基)二苯醚、雙(羥甲基)二苯甲酮、羥甲基苯甲酸羥甲基苯酯、雙(羥甲基)聯苯、二甲基雙(羥甲基)聯苯、雙(甲氧基甲基)苯、雙(甲氧基甲基)甲酚、雙(甲氧基甲基)二甲氧基苯、雙(甲氧基甲基)二苯醚、雙(甲氧基甲基)二苯甲酮、甲氧基甲基苯甲酸甲氧基甲基苯酯、雙(甲氧基甲基)聯苯、二甲基雙(甲氧基甲基)聯苯、4,4’,4”-亞乙基三[2,6-雙(甲氧基甲基)苯酚]、5,5’-[2,2,2-三氟-1-(三氟甲基)亞乙基]雙[2-羥基-1,3-苯二甲醇]、3,3’,5,5’-四(甲氧基甲基)-1,1’-聯苯-4,4’-二醇等。 Specific examples of such compounds include benzyl glycol, bis(hydroxymethyl)cresol, bis(hydroxymethyl)dimethoxybenzene, bis(hydroxymethyl)diphenyl ether, bis(hydroxymethyl)benzophenone, hydroxymethylphenyl hydroxybenzoate, bis(hydroxymethyl)biphenyl, dimethylbis(hydroxymethyl)biphenyl, bis(methoxymethyl)benzene, bis(methoxymethyl)cresol, bis(methoxymethyl)dimethoxybenzene, bis(methoxymethyl)diphenyl ether, and bis(methoxymethyl)diphenylbenzene. Methyl ketone, methoxymethylbenzoate, bis(methoxymethyl)biphenyl, dimethylbis(methoxymethyl)biphenyl, 4,4',4”-ethylenetri[2,6-bis(methoxymethyl)phenol], 5,5’-[2,2,2-trifluoro-1-(trifluoromethyl)ethylene]bis[2-hydroxy-1,3-benzenedimethanol], 3,3’,5,5’-tetra(methoxymethyl)-1,1’-biphenyl-4,4’-diol, etc.

作為其他交聯劑,亦可以使用市售品,作為較佳的市售品,可以舉出46DMOC、46DMOEP(以上為ASAHI YUKIZAI CORPORATION製)、DML-PC、DML-PEP、DML-OC、DML-OEP、DML-34X、DML-PTBP、DML-PCHP、DML-OCHP、DML-PFP、DML-PSBP、DML-POP、DML-MBOC、DML-MBPC、DML-MTrisPC、DML-BisOC-Z、DML-BisOCHP-Z、DML-BPC、DMLBisOC-P、DMOM-PC、DMOM-PTBP、DMOM-MBPC、TriML-P、TriML-35XL、TML-HQ、TML-BP、TML-pp-BPF、TML-B PE、TML-BPA、TML-BPAF、TML-BPAP、TMOM-BP、TMOM-BPE、TMOM-BPA、TMOM-BPAF、TMOM-BPAP、HML-TPPHBA、HML-TPHAP、HMOM-TPPHBA、HMOM-TPHAP(以上為Honshu Chemical Industry Co.,Ltd.製)、NIKARAC(註冊商標,以下相同)MX-290、NIKARAC MX-280、NIKARAC MX-270、NIKARAC MX-279、NIKARAC MW-100LM、NIKARAC MX-750LM(以上為Sanwa Chemical Co.,Ltd.製)等。 Other crosslinking agents can also be used, and some preferred commercially available products include 46DMOC, 46DMOEP (all manufactured by ASAHI YUKIZAI CORPORATION), DML-PC, DML-PEP, DML-OC, DML-OEP, DML-34X, DML-PTBP, DML-PCHP, DML-OCHP, DML-PFP, DML-PSBP, DML-POP, DML-MBOC, DML-MBPC, DML-MTrisPC, DML-BisOC-Z, DML-BisOCHP-Z, DML-BPC, DMLBisOC-P, DMOM-PC, and DMOM- PTBP, DMOM-MBPC, TriML-P, TriML-35XL, TML-HQ, TML-BP, TML-pp-BPF, TML-BPE, TML-BPA, TML-BPAF, TML-BPAP, TMOM-BP, TMOM-BPE, TMOM-BPA, TMOM-BPAF, TMOM-BPAP, HML-TPPHBA, HML-TPHAP, HMOM-TPPHBA, HMOM-TPHAP (all manufactured by Honshu Chemical Industry Co., Ltd.), NIKARAC (registered trademark, same below) MX-290, NIKARAC MX-280, NIKARAC MX-270, NIKARAC MX-279, NIKARAC MW-100LM, NIKARAC MX-750LM (all manufactured by Sanwa Chemical Co., Ltd.), etc.

又,本發明的樹脂組成物包含選自包括環氧化合物、氧環丁烷化合物及苯并化合物之群組中的至少1種化合物作為其他交聯劑亦較佳。 Furthermore, the resin composition of this invention comprises compounds selected from epoxides, cyclobutane compounds, and benzo[a]benzene. At least one compound from the group of compounds is preferred as an alternative crosslinking agent.

-環氧化合物(具有環氧基之化合物)- -Epoxy compounds (compounds containing epoxy groups)-

作為環氧化合物,在一分子中具有2個以上的環氧基之化合物為較佳。環氧基在200℃以下進行交聯反應,並且不會產生由交聯引起之脫水反應,因此不易引起膜收縮。因此,含有環氧化合物對抑制本發明的樹脂組成物的低溫硬化及翹曲係有效的。 As an epoxy compound, a compound having two or more epoxy groups per molecule is preferred. Epoxy groups undergo cross-linking reactions below 200°C and do not produce dehydration reactions caused by cross-linking, thus minimizing the likelihood of film shrinkage. Therefore, the presence of epoxy compounds is effective in inhibiting low-temperature curing and warping of the resin composition of this invention.

環氧化合物含有聚環氧乙烷基為較佳。藉此,彈性模數進一步下降,並且能夠抑制翹曲。聚環氧乙烷基表示環氧乙烷的重複單元數為2以上者,重複單元數為2~15為較佳。 Epoxy compounds containing polyethylene oxide are preferred. This further reduces the elastic modulus and suppresses warping. Polyethylene oxide indicates that the number of repeating units of ethylene oxide is 2 or more, with 2 to 15 repeating units being preferred.

作為環氧化合物的例子,可以舉出雙酚A型環氧樹脂;雙酚F型環氧樹脂;丙二醇二縮水甘油醚、新戊二醇二縮水甘油醚、乙二醇二縮水甘油醚、丁二醇二縮水甘油醚、六亞甲基二醇二縮水甘油醚、三羥甲基丙烷三縮水甘油醚等伸烷基二醇型環氧樹脂或多元醇烴型環氧樹脂;聚丙二醇二縮水甘油醚等聚伸烷基二醇型環氧樹脂;聚甲基(縮水甘油氧 基丙基)矽氧烷等環氧環氧基之矽酮等,但是並不限定於該等。具體而言,可以舉出EPICLON(註冊商標)850-S、EPICLON(註冊商標)HP-4032、EPICLON(註冊商標)HP-7200、EPICLON(註冊商標)HP-820、EPICLON(註冊商標)HP-4700、EPICLON(註冊商標)HP-4770、EPICLON(註冊商標)EXA-830LVP、EPICLON(註冊商標)EXA-8183、EPICLON(註冊商標)EXA-8169、EPICLON(註冊商標)N-660、EPICLON(註冊商標)N-665-EXP-S、EPICLON(註冊商標)N-740(以上為產品名稱,DIC CORPORATION製)、Rika Resin(註冊商標)BEO-20E、Rika Resin(註冊商標)BEO-60E、Rika Resin(註冊商標)HBE-100、Rika Resin(註冊商標)DME-100、Rika Resin(註冊商標)L-200(產品名稱,New Japan Chemical Co.,Ltd.製)、EP-4003S、EP-4000S、EP-4088S、EP-3950S(以上為產品名稱,ADEKA CORPORATION製)、CELLOXIDE(註冊商標)2021P、CELLOXIDE(註冊商標)2081、CELLOXIDE(註冊商標)2000、EHPE3150、EPOLEAD(註冊商標)GT401、EPOLEAD(註冊商標)PB4700、EPOLEAD(註冊商標)PB3600(以上為產品名稱,Daicel Corporation製)、NC-3000、NC-3000-L、NC-3000-H、NC-3000-FH-75M、NC-3100、CER-3000-L、NC-2000-L、XD-1000、NC-7000L、NC-7300L、EPPN-501H、EPPN-501HY、EPPN-502H、EOCN-1020、EOCN-102S、EOCN-103S、EOCN-104S、CER-1020、EPPN-201、BREN-S、BREN-10S(以上為產品名稱,Nippon Kayaku Co.,Ltd.製)等。又,亦可以較佳地使用以下化合物。 Examples of epoxy compounds include bisphenol A type epoxy resins; bisphenol F type epoxy resins; alkyl glycol diglycidyl ether, neopentyl glycol diglycidyl ether, ethylene glycol diglycidyl ether, butylene glycol diglycidyl ether, hexamethylene glycol diglycidyl ether, trimethylolpropane triglycidyl ether, and other alkyl glycol type epoxy resins or polyol hydrocarbon type epoxy resins; polyalkylene glycol diglycidyl ether and other polyalkylene glycol type epoxy resins; and epoxy-epoxy silicones such as polymethyl(glycidyloxypropyl)siloxane, but are not limited to these. Specifically, examples include EPICLON (registered trademark) 850-S, EPICLON (registered trademark) HP-4032, EPICLON (registered trademark) HP-7200, EPICLON (registered trademark) HP-820, EPICLON (registered trademark) HP-4700, EPICLON (registered trademark) HP-4770, and EPICL. ON (registered trademark) EXA-830LVP, EPICLON (registered trademark) EXA-8183, EPICLON (registered trademark) EXA-8169, EPICLON (registered trademark) N-660, EPICLON (registered trademark) N-665-EXP-S, EPICLON (registered trademark) N-740 (the above are product names, DIC) (Manufactured by CORPORATION), Rika Resin (registered trademark) BEO-20E, Rika Resin (registered trademark) BEO-60E, Rika Resin (registered trademark) HBE-100, Rika Resin (registered trademark) DME-100, Rika Resin (registered trademark) L-200 (product name, manufactured by New Japan Chemical Co., Ltd.), EP-4003S, EP-4000S, EP-4088S, EP-3950S (the above are product names, manufactured by ADEKA) (manufactured by CORPORATION), CELLOXIDE (registered trademark) 2021P, CELLOXIDE (registered trademark) 2081, CELLOXIDE (registered trademark) 2000, EHPE3150, EPOLEAD (registered trademark) GT401, EPOLEAD (registered trademark) PB4700, EPOLEAD (registered trademark) PB3600 (the above are product names, Daicel) (Manufactured by Nippon Kayaku Co., Ltd.), NC-3000, NC-3000-L, NC-3000-H, NC-3000-FH-75M, NC-3100, CER-3000-L, NC-2000-L, XD-1000, NC-7000L, NC-7300L, EPPN-501H, EPPN-501HY, EPPN-502H, EOCN-1020, EOCN-102S, EOCN-103S, EOCN-104S, CER-1020, EPPN-201, BREN-S, BREN-10S (the above are product names, manufactured by Nippon Kayaku Co., Ltd.), etc. Furthermore, the following compounds can also be used more effectively.

[化學式53] [Chemical Formula 53]

式中,n為1~5的整數、m為1~20的整數。 In the formula, n is an integer from 1 to 5, and m is an integer from 1 to 20.

在上述結構之中,從兼顧耐熱性和伸長率的提高之觀點考慮,n為1~2、m為3~7為較佳。 Among the above structures, considering both heat resistance and improved elongation, a value of n = 1-2 and m = 3-7 is preferable.

-氧雜環丁烷化合物(具有氧環丁烷基之化合物)- -Oxycyclobutane compounds (compounds containing oxycyclobutane groups)-

作為氧雜環丁烷化合物,可以舉出在一分子中具有2個以上的氧雜環丁烷環之化合物、3-乙基-3-羥甲氧雜環丁烷、1,4-雙{[(3-乙基-3-氧環丁烷基)甲氧基]甲基}苯、3-乙基-3-(2-乙基己基甲基)氧雜環丁烷、1,4-苯二羧酸-雙[(3-乙基-3-氧環丁烷基)甲基]酯等。作為具體的例子,能夠較佳地使用TOAGOSEI CO.,ITD.製的ARON OXETANE系列(例如,OXT- 121、OXT-221),該等可以單獨使用或混合使用2種以上。 Examples of oxocyclobutane compounds include compounds having two or more oxocyclobutane rings in one molecule, 3-ethyl-3-hydroxymethoxycyclobutane, 1,4-bis{[(3-ethyl-3-oxocyclobutyl)methoxy]methyl}benzene, 3-ethyl-3-(2-ethylhexylmethyl)oxocyclobutane, and 1,4-benzenediacarboxylic acid-bis[(3-ethyl-3-oxocyclobutyl)methyl] ester. As specific examples, the ARON OXETANE series (e.g., OXT-121, OXT-221) manufactured by TOAGOSEI CO., ITD. is preferred; two or more of these can be used alone or in combination.

-苯并化合物(具有苯并唑基之化合物)- -Benzo Compounds (compounds containing benzoxazole groups) -

由於由開環加成反應引起交聯反應,苯并化合物在硬化時不產生脫氣,從而進一步減少熱收縮以抑制產生翹曲,因此為較佳。 Due to the crosslinking reaction caused by the ring-opening addition reaction, benzo[a] The compound does not produce degassing during hardening, thereby further reducing thermal shrinkage and inhibiting warping, which is therefore preferable.

作為苯并化合物的較佳例,可以舉出P-d型苯并、F-a型苯并、(以上為產品名稱,Shikoku Chemicals Corporation製)、聚羥基苯乙烯樹脂的苯并加成物、酚醛清漆型二氫苯并化合物。該等可以單獨使用或者混合使用2種以上。 As benzo[a] A better example of a compound could be a Pd-type benzo[a] , Fa type benzo (The above are product names, manufactured by Shikoku Chemicals Corporation), benzo[a]benzene of polyhydroxystyrene resin Addition compounds, phenolic varnish type dihydrobenzo[2] Compounds. These can be used alone or in combination of two or more.

其他交聯劑的含量相對於本發明的樹脂組成物的總固體成分為0.1~30質量%為較佳,0.1~20質量%為更佳,0.5~15質量%為進一步較佳,1.0~10質量%為特佳。其他交聯劑可以僅含有1種,亦可以含有2種以上。在含有2種以上的其他交聯劑之情況下,其合計在上述範圍內為較佳。 The content of other crosslinking agents relative to the total solid content of the resin composition of the present invention is preferably 0.1-30% by weight, more preferably 0.1-20% by weight, further preferably 0.5-15% by weight, and particularly preferably 1.0-10% by weight. The other crosslinking agents may be present in only one type or in two or more types. When two or more other crosslinking agents are present, it is preferable that their total content falls within the above range.

<金屬接著性改良劑> Metal adhesion modifiers

本發明的樹脂組成物包含用於提高與電極或配線等中所使用之金屬材料的接著性之金屬接著性改良劑為較佳。作為金屬接著性改良劑,可以舉出具有烷氧基甲矽烷基之矽烷偶合劑、鋁系接著助劑、鈦系接著助劑、具有磺醯胺結構之化合物及具有硫脲之化合物、磷酸衍生物化合物、β酮酸酯化合物、胺基化合物等。 The resin composition of this invention preferably includes a metal adhesion modifier for improving adhesion to metal materials used in electrodes or wiring. Examples of metal adhesion modifiers include silane coupling agents having alkoxysilyl groups, aluminum-based adhesives, titanium-based adhesives, compounds having sulfonamide structures and compounds having thiourea structures, phosphoric acid derivative compounds, β-ketoester compounds, and amino compounds.

〔矽烷偶合劑〕 [Silane coupling agent]

作為矽烷偶合劑,例如可以舉出國際公開第2015/199219號的0167段中所記載的化合物、日本特開2014-191002號公報的0062~0073段中所記 載的化合物、國際公開第2011/080992號的0063~0071段中所記載的化合物、日本特開2014-191252號公報的0060~0061段中所記載的化合物、日本特開2014-041264號公報的0045~0052段中所記載的化合物、國際公開第2014/097594號的0055段中所記載的化合物、日本特開2018-173573的0067~0078段中所記載的化合物,並將該等內容編入本說明書中。又,如日本特開2011-128358號公報的0050~0058段中所記載,使用不同的2種以上的矽烷偶合劑亦較佳。又,矽烷偶合劑使用下述化合物亦較佳。以下式中,Me表示甲基,Et表示乙基。 Examples of silane coupling agents include, for instance, the compounds described in paragraph 0167 of International Publication No. 2015/199219, the compounds described in paragraphs 0062-0073 of Japanese Patent Application Publication No. 2014-191002, the compounds described in paragraphs 0063-0071 of International Publication No. 2011/080992, and the compounds described in Japanese Patent Application Publication No. 2014-191252. The compounds described in paragraphs 0060-0061 of Japanese Patent Application Publication No. 2014-041264, paragraphs 0045-0052 of Japanese Patent Application Publication No. 2014/097594, and paragraphs 0067-0078 of Japanese Patent Application Publication No. 2018-173573 are included in this specification. Furthermore, as described in paragraphs 0050-0058 of Japanese Patent Application Publication No. 2011-128358, it is preferable to use two or more different silane coupling agents. Also, it is preferable to use the following compounds as silane coupling agents. In the following formulas, Me represents methyl and Et represents ethyl.

[化學式54] [Chemical Formula 54]

作為其他矽烷偶合劑,例如可以舉出乙烯基三甲氧基矽烷、乙烯基三乙氧基矽烷、2-(3,4-環氧環己基)乙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二甲氧基矽烷、3-環氧丙氧基丙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二乙氧基矽烷、3-環氧丙氧基丙基三乙氧基矽烷、對苯乙烯基三甲氧基矽烷、3-甲基丙烯醯氧基丙基甲基二甲氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、3-甲基丙烯醯氧基丙基甲基二乙氧基矽烷、3-甲基丙烯醯氧基丙基三乙氧基矽烷、3-丙烯醯氧基丙基三甲氧基矽烷、N-2-(胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、N-2-(胺基乙基)-3-胺基丙基三甲氧 基矽烷、3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、3-三乙氧基甲矽烷基-N-(1,3-二甲基-亞丁基)丙胺、N-苯基-3-胺基丙基三甲氧基矽烷、三-(三甲氧基甲矽烷基丙基)異氰脲酸酯、3-脲基丙基三烷氧基矽烷、3-巰基丙基甲基二甲氧基矽烷、3-巰基丙基三甲氧基矽烷、3-異氰酸酯丙基三乙氧基矽烷、3-三甲氧基甲矽烷基丙基琥珀酸酐。該等能夠單獨使用1種或組合使用2種以上。 Other silane coupling agents include, for example, vinyltrimethoxysilane, vinyltriethoxysilane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane, 3-epoxypropoxypropylmethyldimethoxysilane, 3-epoxypropoxypropyltrimethoxysilane, 3-epoxypropoxypropylmethyldiethoxysilane, 3-epoxypropoxypropyltriethoxysilane, p-styryltrimethoxysilane, 3-methacryloxypropylmethyldimethoxysilane, 3-methacryloxypropyltrimethoxysilane, 3-methacryloxypropylmethyldiethoxysilane, 3-methacryloxypropyltriethoxysilane, 3-methacryloxypropyltriethoxysilane, 3-acryloxypropyl Trimethoxysilane, N-2-(aminoethyl)-3-aminopropylmethyldimethoxysilane, N-2-(aminoethyl)-3-aminopropyltrimethoxysilane, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-triethoxysilyl-N-(1,3-dimethyl-butylene)propylamine, N-phenyl-3-aminopropyltrimethoxysilane, tris-(trimethoxysilylpropyl)isocyanurate, 3-ureopropyltrialkoxysilane, 3-piperylpropylmethyldimethoxysilane, 3-piperylpropyltrimethoxysilane, 3-isocyanate propyltriethoxysilane, 3-trimethoxysilylpropylpropylsuccinic anhydride. These can be used alone or in combination with two or more.

〔鋁系接著助劑〕 [Aluminum-based adjuvants]

作為鋁系接著助劑,例如可以舉出鋁三(乙醯乙酸乙酯)鋁、三(乙醯丙酮)鋁、乙醯乙酸乙酯二異丙醇鋁等。 Examples of aluminum-based additives include aluminum tri(ethyl acetate)aluminum, aluminum tri(acetoacetone)aluminum, and aluminum diisopropanol of ethyl acetate.

又,作為其他金屬接著性改良劑,亦能夠使用日本特開2014-186186號公報的0046~0049段中所記載的化合物、日本特開2013-072935號公報的0032~0043段中所記載的硫化物系化合物,並將該等內容編入本說明書中。 Furthermore, as other metal adhesion modifiers, compounds described in paragraphs 0046 to 0049 of Japanese Patent Application Publication No. 2014-186186 and sulfide compounds described in paragraphs 0032 to 0043 of Japanese Patent Application Publication No. 2013-072935 can also be used, and such contents are incorporated into this specification.

金屬接著性改良劑的含量相對於特定樹脂100質量份,較佳為0.01~30質量份,更佳為在0.1~10質量份的範圍內,進一步較佳為在0.5~5質量份的範圍內。藉由設為上述下限值以上,圖案與金屬層的接著性變得良好,藉由設為上述上限值以下,圖案的耐熱性、機械特性變得良好。金屬接著性改良劑可以為僅1種,亦可以為2種以上。在使用2種以上之情況下,其合計在上述範圍內為較佳。 The content of the metal adhesion modifier relative to 100 parts by weight of a specific resin is preferably 0.01 to 30 parts by weight, more preferably in the range of 0.1 to 10 parts by weight, and even more preferably in the range of 0.5 to 5 parts by weight. By setting the content above the lower limit above, the adhesion between the pattern and the metal layer becomes good; by setting the content below the upper limit above, the heat resistance and mechanical properties of the pattern become good. The metal adhesion modifier can be a single type or two or more types. When using two or more types, it is preferable that their total content is within the above range.

<遷移抑制劑> Migration inhibitors

本發明的樹脂組成物進一步包含遷移抑制劑為較佳。藉由包含遷移抑制劑,能夠有效地抑制源自金屬層(金屬配線)的金屬離子轉移至膜內。 It is preferable that the resin composition of this invention further includes a migration inhibitor. By including the migration inhibitor, the transfer of metal ions originating from the metal layer (metal wiring) into the membrane can be effectively inhibited.

作為遷移抑制劑,並無特別限制,但是可以舉出具有雜環(吡咯環、呋喃環、噻吩環、咪唑環、唑環、噻唑環、吡唑環、異唑環、異噻唑環、四唑環、吡啶環、嗒環、嘧啶環、吡環、哌啶環、哌環、嗎啉環、2H-吡喃環及6H-吡喃環、三環)之化合物、具有硫脲類及氫硫基之化合物、受阻酚系化合物、水楊酸衍生物系化合物、醯肼衍生物系化合物。尤其,能夠較佳地使用1,2,4-三唑、苯并三唑、3-胺基-1,2,4-三唑、3,5-二胺基-1,2,4-三唑等三唑系化合物、1H-四唑、5-苯基四唑、5-胺基-1H-四唑等四唑系化合物。 There are no particular limitations as a migration inhibitor, but examples can be given of those with heterocyclic rings (pyrrole ring, furan ring, thiophene ring, imidazole ring, etc.). Azole ring, thiazolyl ring, pyrazole ring, isocyanate Azole ring, isothiazol ring, tetrazol ring, pyridine ring, tadalafil Cyclic rings, pyrimidine rings, pyridine rings Cyclic, piperidine cyclohexane, piperidine cyclohexane Cyclic rings, morpholinic rings, 2H-pyranic rings and 6H-pyranic rings, tricyclic rings Compounds containing cyclohexane, compounds with thiourea and hydrogen sulfide groups, hindered phenolic compounds, salicylic acid derivatives, and acehydrazine derivatives are preferred. In particular, triazole compounds such as 1,2,4-triazole, benzotriazole, 3-amino-1,2,4-triazole, and 3,5-diamino-1,2,4-triazole, as well as tetraazole compounds such as 1H-tetrazole, 5-phenyltetrazole, and 5-amino-1H-tetrazole are preferred.

或者,亦能夠使用捕捉鹵素離子等陰離子之離子捕捉劑。 Alternatively, ion-capturing agents that capture anions such as halogen ions can be used.

作為其他遷移抑制劑,能夠使用日本特開2013-015701號公報的0094段中所記載的防鏽劑、日本特開2009-283711號公報的0073~0076段中所記載的化合物、日本特開2011-059656號公報的0052段中所記載的化合物、日本特開2012-194520號公報的0114段、0116段及0118段中所記載的化合物、國際公開第2015/199219號的0166段中所記載的化合物等,並將該等內容編入本說明書中。 As other migration inhibitors, the rust inhibitor described in paragraph 0094 of Japanese Patent Application Publication No. 2013-015701, the compounds described in paragraphs 0073-0076 of Japanese Patent Application Publication No. 2009-283711, the compounds described in paragraph 0052 of Japanese Patent Application Publication No. 2011-059656, the compounds described in paragraphs 0114, 0116 and 0118 of Japanese Patent Application Publication No. 2012-194520, and the compounds described in paragraph 0166 of International Publication No. 2015/199219, etc., can be used, and these contents are incorporated into this specification.

作為遷移抑制劑的具體例,可以舉出下述化合物。 Specific examples of migration inhibitors include the following compounds.

在本發明的樹脂組成物具有遷移抑制劑之情況下,遷移抑制劑的含量相對於本發明的樹脂組成物的總固體成分為0.01~5.0質量%為較佳,0.05~2.0質量%為更佳,0.1~1.0質量%為進一步較佳。 When the resin composition of the present invention contains a migration inhibitor, the content of the migration inhibitor relative to the total solid content of the resin composition of the present invention is preferably 0.01~5.0% by mass, more preferably 0.05~2.0% by mass, and even more preferably 0.1~1.0% by mass.

遷移抑制劑可以為僅1種,亦可以為2種以上。在遷移抑制劑為2種以上之情況下,其合計在上述範圍內為較佳。 The migration inhibitor may be a single agent or two or more. When there are two or more migration inhibitors, it is preferable that their total number falls within the range described above.

<聚合抑制劑> <Polymerization Inhibitors>

本發明的樹脂組成物包含聚合抑制劑為較佳。作為聚合抑制劑,可以舉出酚系化合物、醌系化合物、胺基系化合物、N-氧自由基化合物系化合物、硝基系化合物、亞硝基系化合物、雜芳香環系化合物、金屬化合物等。 The resin composition of this invention preferably contains a polymerization inhibitor. Examples of polymerization inhibitors include phenolic compounds, quinone compounds, amino compounds, N-oxygen radical compounds, nitro compounds, nitroso compounds, heteroaromatic ring compounds, and metallic compounds.

作為聚合抑制劑的具體的化合物,例如較佳地使用對氫醌、鄰氫醌、鄰甲氧基苯酚、對甲氧基苯酚、二-第三丁基-對甲酚、五倍子酚、對-第三丁基兒茶酚、1,4-苯醌、二苯基-對苯醌、4,4’-硫代雙(3-甲基-6-第三丁基酚)、2,2’-亞甲基雙(4-甲基-6-第三丁基酚)、N-亞硝基苯基羥基胺第一鈰鹽、N-亞硝基-N-苯基羥基胺鋁鹽、N-亞硝基二苯胺、N-苯基萘胺、伸乙基二胺四乙酸、1,2-環己二胺四乙酸、乙二醇醚二胺四乙酸、2,6-二-第三丁基-4-甲基酚、5-亞硝基-8-羥基喹啉、1-亞硝基-2-萘酚、2-亞硝基-1-萘酚、2-亞硝基-5-(N-乙基-N-磺基丙基胺)酚、N-亞硝基-N-(1-萘基)羥胺銨鹽、雙(4-羥基-3,5-第三丁基)苯基甲烷、1,3,5-三(4-第三丁基-3-羥基)-2,6-二甲基芐基)-1,3,5-三-2,4,6-(1H,3H,5H)-三酮、4-羥基-2,2,6,6-四甲基哌啶1-氧自由基、2,2,6,6-四甲基哌啶1-氧自由基、吩噻、啡、1,1-二苯基-2-吡咯肼、二丁基二硫代碳酸銅(II)、硝基苯、N-亞硝基-N-苯基羥胺鋁鹽、N-亞硝基-N-苯基羥基胺銨鹽等。又,亦能夠使用日本特開2 015-127817號公報的0060段中所記載的聚合抑制劑及國際公開第2015/125469號的0031~0046段中所記載的化合物,並將該內容編入本說明書中。 Specific compounds used as polymerization inhibitors include, preferably, p-hydroquinone, ortho-hydroquinone, ortho-methoxyphenol, p-methoxyphenol, di-tert-butyl-p-cresol, gallnutol, p-tert-butylcatechol, 1,4-benzoquinone, diphenyl-p-benzoquinone, 4,4'-thiobis(3-methyl-6-tert-butylphenol), 2,2'-methylenebis(4-methyl-6-tert-butylphenol), N-nitrosophenylhydroxylamine monocyanate, N-nitroso-N-phenylhydroxylamine aluminum salt, N-nitrosodiphenylamine, N-phenylnaphthylamine, and ethylenylene. Diaminetetraacetic acid, 1,2-cyclohexanediaminetetraacetic acid, ethylene glycol ether diaminetetraacetic acid, 2,6-di-tert-butyl-4-methylphenol, 5-nitroso-8-hydroxyquinoline, 1-nitroso-2-naphthol, 2-nitroso-1-naphthol, 2-nitroso-5-(N-ethyl-N-sulfopropylamine)phenol, N-nitroso-N-(1-naphthyl)hydroxyamine ammonium salt, bis(4-hydroxy-3,5-tert-butyl)phenylmethane, 1,3,5-tris(4-tert-butyl-3-hydroxy)-2,6-dimethylbenzyl)- ...2,6-dimethylbenzyl)-2,6-dimethylbenzyl)-2,6-dimethylbenzyl)-2,6-dimethylbenzyl)-2,6-dimethylbenzyl)-2,6- -2,4,6-(1H,3H,5H)-trione, 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxo radical, 2,2,6,6-tetramethylpiperidine 1-oxo radical, phenthia ,coffee 1,1-Diphenyl-2-pyrrolidinehydrazine, dibutyldithiocopper(II) carbonate, nitrobenzene, N-nitroso-N-phenylhydroxyamine aluminum salt, N-nitroso-N-phenylhydroxyamine ammonium salt, etc. Furthermore, polymerization inhibitors described in paragraph 0060 of Japanese Patent Application Publication No. 2015-127817 and compounds described in paragraphs 0031 to 0046 of International Publication No. 2015/125469 may also be used, and such contents are incorporated into this specification.

在本發明的樹脂組成物包含聚合抑制劑之情況下,聚合抑制劑的含量相對於本發明的樹脂組成物的總固體成分為0.01~20質量%為較佳0.02~15質量%為更佳,0.05~10質量%為進一步較佳。 When the resin composition of the present invention contains a polymerization inhibitor, the content of the polymerization inhibitor relative to the total solid content of the resin composition of the present invention is preferably 0.01~20% by weight, more preferably 0.02~15% by weight, and even more preferably 0.05~10% by weight.

聚合抑制劑可以為僅1種,亦可以為2種以上。在聚合抑制劑為2種以上之情況下,其合計在上述範圍內為較佳。 The polymerization inhibitor may be a single agent or two or more. When there are two or more polymerization inhibitors, it is preferable that their total amount falls within the range described above.

<酸捕捉劑> <Acid trap>

為了減少因從曝光至加熱為止的經時而引起之性能變化,本發明的樹脂組成物含有酸捕捉劑為較佳。其中,酸捕捉劑是指藉由存在於系統中而能夠捕捉產生酸之化合物,酸度低且pKa高的化合物為較佳。作為酸捕捉劑,具有胺基之化合物為較佳,一級胺、二級胺、三級胺、銨鹽、三級醯胺等為較佳,一級胺、二級胺、三級胺、銨鹽為較佳,二級胺、三級胺、銨鹽為更佳。 To minimize performance changes caused by the time elapsed between exposure and heating, the resin composition of this invention preferably contains an acid scavenger. The acid scavenger is a compound that can capture acid-producing compounds by being present in the system; compounds with low acidity and high pKa are preferred. As an acid scavenger, compounds with an amino group are preferred, including primary amines, secondary amines, tertiary amines, ammonium salts, and tertiary amides; primary amines, secondary amines, tertiary amines, and ammonium salts are preferred, with secondary amines, tertiary amines, and ammonium salts being even more preferred.

作為酸捕捉劑,可以較佳地舉出具有咪唑結構、二氮雜雙環結構、鎓結構、三烷基胺結構、苯胺結構或吡啶結構之化合物、具有羥基和/或醚鍵之烷基胺衍生物、具有羥基和/或醚鍵之苯胺衍生物等。在具有鎓結構之情況下,酸捕捉劑為具有選自銨、重氮、錪、鋶、鏻、吡啶鎓等中之陽離子和酸度比由酸產生劑所產生之酸更低的酸的陰離子之鹽為較佳。 As acid scavengers, preferably include compounds having imidazole, diazabicyclic, onium, trialkylamine, aniline, or pyridine structures; alkylamine derivatives having hydroxyl and/or ether bonds; and aniline derivatives having hydroxyl and/or ether bonds. In the case of an onium structure, the acid scavenger is preferably a salt having a cation selected from ammonium, diazo, monazine, strontium, phosphonium, or pyridinium, and an anion of an acid with a lower acidity than that produced by the acid generator.

作為具有咪唑結構之酸捕捉劑,可以舉出咪唑、2.4.5-三苯基咪唑、苯并咪唑、2-苯基苯并咪唑等。作為具有二氮雜雙環結構之酸捕捉劑,可以舉出1,4-二氮雜雙環[2,2,2]辛烷、1,5-二氮雜雙環[4,3,0]壬-5-烯、1, 8-二氮雜雙環[5,4,0]十一碳-7-烯等。作為具有鎓結構之酸捕捉劑,可以舉出氫氧化四丁基銨、氫氧化三芳基鋶、氫氧化苯甲醯甲基鋶、具有2-氧代烷基之鋶氫氧化物、具體而言氫氧化三苯基鋶、氫氧化三(第三丁基苯基)鋶、氫氧化雙(第三丁基苯基)錪、氫氧化苯甲醯甲基噻吩鎓、氫氧化2-氧代丙基噻吩鎓等。作為具有三烷基胺結構之酸捕捉劑,可以舉出三(正丁基)胺、三(正辛基)胺等。作為具有苯胺結構之酸捕捉劑,可以舉出2,6-二異丙基苯胺、N,N-二甲基苯胺、N,N-二丁基苯胺、N,N-二己基苯胺等。作為具有吡啶結構之酸捕捉劑,可以舉出吡啶、4-甲基吡啶等。作為具有羥基和/或醚鍵之烷基胺衍生物,可以舉出乙醇胺、二乙醇胺、三乙醇胺、N-苯基二乙醇胺、三(甲氧基乙氧基乙基)胺等。作為具有羥基和/或醚鍵之苯胺衍生物,可以舉出N,N-雙(羥乙基)苯胺等。 Examples of acid scavengers with an imidazole structure include imidazole, 2,4,5-triphenylimidazolium, benzimidazole, and 2-phenylbenzimidazole. Examples of acid scavengers with a diazabicyclic structure include 1,4-diazabicyclic[2,2,2]octane, 1,5-diazabicyclic[4,3,0]non-5-ene, and 1,8-diazabicyclic[5,4,0]undec-7-ene. Examples of acid scavengers with a bellium structure include tetrabutylammonium hydroxide, triarylstromium hydroxide, benzylmethylstromium hydroxide, strom hydroxides with a 2-oxoalkyl group, specifically triphenylstromium hydroxide, tri(tert-butylphenyl)stromium hydroxide, bis(tert-butylphenyl)monium hydroxide, benzylmethylthiophenonium hydroxide, and 2-oxopropylthiophenonium hydroxide. Examples of acid scavengers with a trialkylamine structure include tri(n-butyl)amine and tri(n-octyl)amine. Examples of acid scavengers with an aniline structure include 2,6-diisopropylaniline, N,N-dimethylaniline, N,N-dibutylaniline, and N,N-dihexylaniline. Examples of acid scavengers with a pyridine structure include pyridine and 4-methylpyridine. Examples of alkylamine derivatives with hydroxyl and/or ether bonds include ethanolamine, diethanolamine, triethanolamine, N-phenyldiethanolamine, and tris(methoxyethoxyethyl)amine. Examples of aniline derivatives with hydroxyl and/or ether bonds include N,N-bis(hydroxyethyl)aniline.

作為較佳的酸捕捉劑的具體例,可以舉出乙醇胺、二乙醇胺、三乙醇胺、乙胺、二乙胺、三乙胺、己胺、十二胺、環己胺、環己基甲基胺、環己基二甲基胺、苯胺、N-甲基苯胺、N,N-二甲基苯胺、二苯基胺、吡啶、丁胺、異丁胺、二丁胺、三丁胺、二環己胺、DBU(二氮雜雙環十一碳)、DABCO(1,4-二氮雜雙環[2.2.2]辛烷)、N,N-二異丙基乙胺、氫氧化四甲銨、乙二胺、1,5-二胺基戊烷、N-甲基己胺、N-甲基二環己胺、三辛基胺、N-乙基乙二胺、N,N-二乙基乙二胺、N,N,N’,N’-四丁基-1,6-己烷二胺、精三胺、二胺基環己烷、雙(2-甲氧基乙基)胺、哌啶、甲基哌啶、哌、托烷、N-苯基苄胺、1,2-二苯胺基乙烷(dianilinoethane)、2-胺基乙醇、甲苯胺、胺基酚、己基苯胺、伸苯基二胺、苯基乙基胺、二苄胺、吡咯、N-甲基吡咯、胍、胺基吡咯啶、吡唑、吡唑啉、胺基嗎啉、胺基烷基啉等。 Specific examples of preferred acid scavengers include ethanolamine, diethanolamine, triethanolamine, ethylamine, diethylamine, triethylamine, hexylamine, dodecylamine, cyclohexylamine, cyclohexylmethylamine, cyclohexyldimethylamine, aniline, N-methylaniline, N,N-dimethylaniline, diphenylamine, pyridine, butylamine, isobutylamine, dibutylamine, tributylamine, dicyclohexylamine, DBU (diazabicycloundecyl), and DABCO (1,4-di... Nitrogen-containing bicyclic [2.2.2]octane), N,N-diisopropylethylamine, tetramethylammonium hydroxide, ethylenediamine, 1,5-diaminopentane, N-methylhexylamine, N-methyldicyclohexylamine, trioctylamine, N-ethylethylenediamine, N,N-diethylethylenediamine, N,N,N',N'-tetrabutyl-1,6-hexanediamine, succinyltriamine, diaminocyclohexane, bis(2-methoxyethyl)amine, piperidine, methylpiperidine, piperidine , tropane, N-phenylbenzylamine, 1,2-diphenylaminoethane, 2-aminoethanol, toluidine, aminophenol, hexylaniline, phenylenediamine, phenylethylamine, dibenzylamine, pyrrole, N-methylpyrrole, guanidine, aminopyrrolidine, pyrazole, pyrazoline, aminomorphine, aminoalkyl Phosphorus, etc.

該等酸捕捉劑可以單獨使用1種,可以組合使用2種以上。 These acid-capturing agents can be used alone or in combination of two or more.

本發明之組成物可以含有酸捕捉劑,亦可以不含有酸捕捉劑,但是在含有之情況下,酸捕捉劑的含量以組成物的總固體成分為基準,通常為0.001~10質量%,較佳為0.01~5質量%。 The composition of this invention may or may not contain an acid scavenging agent. However, if it does contain an acid scavenging agent, the content of the acid scavenging agent is based on the total solid content of the composition, typically 0.001 to 10% by mass, preferably 0.01 to 5% by mass.

酸產生劑與酸捕捉劑的使用比例為酸產生劑/酸捕捉劑(莫耳比)=2.5~300為較佳。亦即,從靈敏度、解析度的觀點考慮,莫耳比為2.5以上為較佳,從抑制由浮雕圖案隨著曝光後至加熱處理為止的經時變厚而引起之解析度的降低的觀點考慮,300以下為較佳。酸產生劑/酸捕捉劑(莫耳比)更佳為5.0~200,進一步較佳為7.0~150。 The optimal ratio of acid generator to acid scavenger is 2.5 to 300 (molar ratio). That is, from the perspective of sensitivity and resolution, a molar ratio of 2.5 or higher is preferable; from the perspective of suppressing the decrease in resolution caused by the thickening of the relief pattern over time from exposure to heat treatment, a ratio below 300 is preferable. A molar ratio of 5.0 to 200 is more preferred, and 7.0 to 150 is even more desirable.

<其他添加劑> <Other Additives>

本發明的樹脂組成物在可以獲得本發明的效果之範圍內依據需要能夠配合各種的添加物、例如界面活性劑、高級脂肪酸衍生物、熱聚合起始劑、無機粒子、紫外線吸收劑、有機鈦化合物、抗氧化劑、抗凝聚劑、酚系化合物、其他高分子化合物、可塑劑及其他助劑類(例如,消泡劑、阻燃劑等)等。藉由適當含有該等成分,能夠調整膜物理性質等性質。關於該等成分,例如能夠參閱日本特開2012-003225號公報的0183段以後(所對應之美國專利申請公開第2013/0034812號說明書的0237段)的記載及日本特開2008-250074號公報的0101~0104段、0107~0109段等的記載,並將該等內容編入本說明書中。在配合該等添加劑之情況下,將其合計配合量設為本發明的樹脂組成物的固體成分的3質量%以下為較佳。 The resin composition of this invention can be combined with various additives as needed, within the scope of achieving the effects of this invention, such as surfactants, higher fatty acid derivatives, thermal polymerization initiators, inorganic particles, ultraviolet absorbers, organic titanium compounds, antioxidants, anti-coagulants, phenolic compounds, other polymers, plasticizers, and other auxiliaries (e.g., defoamers, flame retardants, etc.). By appropriately containing these components, the physical properties of the membrane can be adjusted. Regarding these components, please refer to paragraphs 0183 onwards in Japanese Patent Application Publication No. 2012-003225 (corresponding to paragraph 0237 of the specification in U.S. Patent Application Publication No. 2013/0034812) and paragraphs 0101-0104, 0107-0109, etc., in Japanese Patent Application Publication No. 2008-250074, and such contents are incorporated herein. When incorporating these additives, it is preferable that their total amount be 3% by weight or less of the solid content of the resin composition of the present invention.

〔界面活性劑〕 [Surfactants]

作為界面活性劑,能夠使用氟系界面活性劑、矽酮系界面活性劑、烴 系界面活性劑等各種界面活性劑。界面活性劑可以為非離子型界面活性劑,亦可以為陽離子型界面活性劑,亦可以為陰離子型界面活性劑。 As surfactants, various types of surfactants can be used, including fluorinated surfactants, silicone surfactants, and hydrocarbon surfactants. These surfactants can be nonionic, cationic, or anionic.

藉由在本發明的感光性樹脂組成物中含有界面活性劑,進一步提高作為塗佈液進行製備時的液體特性(尤其,流動性),從而能夠進一步改善塗佈厚的均勻性或省液性。亦即,在使用適用了含有界面活性劑之組成物之塗佈液而形成膜之情況下,被塗佈面與塗佈液的界面張力降低而改善對被塗佈面的潤濕性,從而提高對被塗佈面的塗佈性。因此,能夠更佳地進行厚度不均勻小的均勻厚度的膜形成。 By including a surfactant in the photosensitive resin composition of this invention, the liquid properties (especially flowability) during preparation as a coating liquid are further improved, thereby further improving the uniformity or liquid-saving properties of the coating thickness. That is, when forming a film using a coating liquid containing a surfactant composition, the interfacial tension between the coated surface and the coating liquid is reduced, improving the wetting of the coated surface and thus enhancing the coating properties. Therefore, it is possible to form a film with a uniform thickness and minimal thickness unevenness.

作為氟系界面活性劑,例如可以舉出MEGAFACE F171、MEGAFACE F172、MEGAFACE F173、MEGAFACE F176、MEGAFACE F177、MEGAFACE F141、MEGAFACE F142、MEGAFACE F143、MEGAFACE F144、MEGAFACE R30、MEGAFACE F437、MEGAFACE F475、MEGAFACE F479、MEGAFACE F482、MEGAFACE F554、MEGAFACE F780、RS-72-K(以上為DIC CORPORATION製)、Fluorad FC430、Fluorad FC431、Fluorad FC171、Novell FC4430、Novell FC4432(以上為3M Japan Limited製)、Surflon S-382、Surflon SC-101、Surflon SC-103、Surflon SC-104、Surflon SC-105、Surflon SC1-068、Surflon SC-381、Surflon SC-383、Surflon S-393、Surflon KH-40(以上為ASAHI GLASS CO.,LTD.製)、PF636、PF656、PF6320、PF6520、PF7002(OMNOVA Solutions Inc.製)等。氟系界面活性劑亦能夠使用日本特開2015-117327號公報的0015~0158段中所記載的化合物、日本特開2011-132503號公報的0117~0132段中所記載的化合物,並將該等內容編入本說明書中。亦能夠使用嵌段聚 合物作為氟系界面活性劑,作為具體例,例如可以舉出日本特開2011-89090號公報中所記載之化合物,並將該等內容編入本說明書中。 Examples of fluorinated surfactants include MEGAFACE F171, MEGAFACE F172, MEGAFACE F173, MEGAFACE F176, MEGAFACE F177, MEGAFACE F141, MEGAFACE F142, MEGAFACE F143, MEGAFACE F144, MEGAFACE R30, MEGAFACE F437, MEGAFACE F475, MEGAFACE F479, MEGAFACE F482, MEGAFACE F554, MEGAFACE F780, RS-72-K (manufactured by DIC CORPORATION), Fluorad FC430, Fluorad FC431, Fluorad FC171, Novell FC4430, Novell FC4432 (manufactured by 3M Japan Limited), and Surflon. S-382, Surflon SC-101, Surflon SC-103, Surflon SC-104, Surflon SC-105, Surflon SC1-068, Surflon SC-381, Surflon SC-383, Surflon S-393, Surflon KH-40 (the above is ASAHI GLASS CO., LTD.), PF636, PF656, PF6320, PF6520, PF7002 (manufactured by OMNOVA Solutions Inc.), etc. Fluorinated surfactants may also use compounds described in paragraphs 0015 to 0158 of Japanese Patent Application Publication No. 2015-117327 and paragraphs 0117 to 0132 of Japanese Patent Application Publication No. 2011-132503, and these contents are incorporated into this specification. Block polymers may also be used as fluorinated surfactants; for example, compounds described in Japanese Patent Application Publication No. 2011-89090 may be cited, and these contents are incorporated into this specification.

氟系界面活性劑亦能夠較佳地使用含氟高分子化合物,該含氟高分子化合物包含源自具有氟原子之(甲基)丙烯酸酯化合物之重複單元和源自具有2個以上(較佳為5個以上)的伸烷氧基(較佳為乙烯氧基、丙烯氧基)之(甲基)丙烯酸酯化合物之重複單元,亦可以例示下述化合物作為本發明中所使用之氟系界面活性劑。 Fluorinated surfactants can also preferably use fluorinated polymers comprising repeating units derived from (meth)acrylate compounds having fluorine atoms and repeating units derived from (meth)acrylate compounds having two or more (preferably five or more) alkoxy groups (preferably ethoxy or propyleneoxy groups). Examples of fluorinated surfactants used in this invention include the following compounds.

上述化合物的重量平均分子量較佳為3,000~50,000,5,000~30,000為更佳。 The weight-average molecular weight of the above compounds is preferably 3,000 to 50,000, and more preferably 5,000 to 30,000.

氟系界面活性劑亦能夠將在側鏈上具有乙烯性不飽和基之含氟聚合物用作氟系界面活性劑。作為具體例,可以舉出日本特開2010-164965號公報的0050~0090段及0289~0295段中所記載之化合物,並將該內容編入本說明書中。又,作為市售品,例如可以舉出DIC CORPORATION製的MEGAFACE RS-101、RS-102、RS-718K等。 Fluorinated surfactants can also utilize fluoropolymers with vinyl unsaturated groups on their side chains. Specific examples include compounds described in paragraphs 0050-0090 and 0289-0295 of Japanese Patent Application Publication No. 2010-164965, the contents of which are incorporated herein by reference. Commercially available examples include MEGAFACE RS-101, RS-102, and RS-718K manufactured by DIC CORPORATION.

氟系界面活性劑中的氟含有率為3~40質量%為較佳,更佳為5~30質量%,特佳為7~25質量%。在塗佈膜的厚度的均勻性或省液性的方面而言,氟含有率在該範圍內的氟系界面活性劑係有效的,在組成物中之溶解性亦良好。 Fluorinated surfactants preferably contain 3-40% by mass, more preferably 5-30% by mass, and most preferably 7-25% by mass. Fluorinated surfactants within this fluorine content range are effective in terms of coating thickness uniformity and liquid-saving properties, and also exhibit good solubility in the composition.

作為矽酮系界面活性劑,例如可以舉出Toray Silicone DC3PA、Toray Silicone SH7PA、Toray Silicone DC11PA、Toray Silicone SH21PA、Toray Silicone SH28PA、Toray Silicone SH29PA、Toray Silicone SH30PA、Toray Silicone SH8400(以上為Dow Coming Toray Co.,Ltd.製)、TSF-4440、TSF-4300、TSF-4445、TSF-4460、TSF-4452(以上為Momentive performance Materials Inc.製)、KP-341、KF6001、KF6002(以上為Shin-Etsu Chemical Co.,Ltd.製)、BYK307、BYK323、BYK330(以上為BYK Chemie GmbH製)等。 Examples of silicone-based surfactants include Toray Silicone DC3PA, Toray Silicone SH7PA, Toray Silicone DC11PA, Toray Silicone SH21PA, Toray Silicone SH28PA, Toray Silicone SH29PA, Toray Silicone SH30PA, Toray Silicone SH8400 (manufactured by Dow Coming Toray Co., Ltd.), TSF-4440, TSF-4300, TSF-4445, TSF-4460, TSF-4452 (manufactured by Momentive Performance Materials Inc.), KP-341, KF6001, KF6002 (manufactured by Shin-Etsu Chemical Co., Ltd.), BYK307, BYK323, and BYK330 (manufactured by BYK Chemie GmbH).

作為烴系界面活性劑,例如可以舉出PIONIN A-76、Newkalgen FS-3PG、PIONIN B-709、PIONIN B-811-N、PIONIN D-1004、PIONIN D-3104、PIONIN D-3605、PIONIN D-6112、PIONIN D-2104-D、PIONIN D-212、PIONIN D-931、PIONIN D-941、PIONIN D-951、PIONIN E-5310、PIONIN P-1050-B、PIONIN P-1028-P、PIONIN P-4050-T等(以上為TAKEMOTO OIL&FAT CO.,LTD.製)等。 Examples of hydrocarbon surfactants include PIONIN A-76, Newkalgen FS-3PG, PIONIN B-709, PIONIN B-811-N, PIONIN D-1004, PIONIN D-3104, PIONIN D-3605, PIONIN D-6112, PIONIN D-2104-D, PIONIN D-212, PIONIN D-931, PIONIN D-941, PIONIN D-951, PIONIN E-5310, PIONIN P-1050-B, PIONIN P-1028-P, and PIONIN P-4050-T (all manufactured by TAKEMOTO OIL & FAT CO.,LTD.).

作為非離子型界面活性劑,可以例示甘油、三羥甲基丙烷、三羥甲基乙烷以及該等乙氧基化物及丙氧基化物(例如,甘油丙氧基化物、甘油乙氧基化物等)、聚氧乙烯月桂基醚、聚氧乙烯硬脂基醚、聚氧乙烯油基醚、聚氧乙烯辛基苯基醚、聚氧乙烯壬基苯基醚、聚乙二醇二月桂酸酯、聚乙二醇二硬脂酸酯、山梨糖醇酐脂肪酸酯等。作為市售品,可以舉出Pluronic(註冊商標)L10、L31、L61、L62、10R5、17R2、25R2(BASF公司製)、Tetronic 304、701、704、901、904、150R1(BASF公司製)、Solsperse 20000(Lubrizol Japan Ltd.製)、NCW-101、NCW-1001、NCW-1002 (FUJIFILM Wako Pure Chemical Corporation製)、PIONIN D-6112、D-6112-W、D-6315(TAKEMOTO OIL&FAT CO.,LTD製)、OLFIN E1010、Surfynol 104、400、440(Nissin Chemical co.,ltd.製)等。 Examples of nonionic surfactants include glycerol, trihydroxymethylpropane, trihydroxymethylethane and their ethoxylated and propoxylated derivatives (e.g., glycerol propoxylated, glycerol ethoxylated, etc.), polyoxyethylene lauryl ether, polyoxyethylene stearyl ether, polyoxyethylene oil-based ether, polyoxyethylene octylphenyl ether, polyoxyethylene nonylphenyl ether, polyethylene glycol dilaurate, polyethylene glycol distearate, sorbitan fatty acid esters, etc. Commercially available products include Pluronic (registered trademark) L10, L31, L61, L62, 10R5, 17R2, 25R2 (manufactured by BASF), Tetronic 304, 701, 704, 901, 904, 150R1 (manufactured by BASF), Solsperse 20000 (manufactured by Lubrizol Japan Ltd.), NCW-101, NCW-1001, NCW-1002 (manufactured by FUJIFILM Wako Pure Chemical Corporation), PIONIN D-6112, D-6112-W, D-6315 (manufactured by TAKEMOTO OIL&FAT CO.,LTD), OLFIN E1010, Surfynol 104, 400, 440 (manufactured by Nissin Chemical Co., Ltd.), etc.

作為陽離子系界面活性劑,具體而言,可以舉出有機矽氧烷聚合物KP-341(Shih-Etsu Chemical Co.,Ltd.製)、(甲基)丙烯酸系(共)聚合物Polyflow No.75、No.77、No.90、No.95(KYOEISHA CHEMICAL Co.,LTD.製)、W001(Yusho Co.,Ltd.製)等。 As cationic surfactants, examples include organosiloxane polymer KP-341 (manufactured by Shih-Etsu Chemical Co., Ltd.), (meth)acrylic acid (co)polymers Polyflow No. 75, No. 77, No. 90, No. 95 (manufactured by KYOEISHA CHEMICAL Co.,LTD.), and W001 (manufactured by Yusho Co.,Ltd.).

作為陰離子系界面活性劑,具體而言,可以舉出W004、W005、W017(Yusho Co.,Ltd.製)、SANDET BL(SANYO KASEI Co.Ltd.製)等。 As anionic surfactants, examples include WO04, WO05, WO17 (manufactured by Yusho Co., Ltd.), and SANDET BL (manufactured by SANYO KASEI Co., Ltd.).

界面活性劑可以僅使用1種,亦可以組合使用2種以上。 Surfactants can be used alone or in combination of two or more.

界面活性劑的含量相對於組成物的總固體成分為0.001~2.0質量%為較佳,0.005~1.0質量%為更佳。 The surfactant content relative to the total solids content of the composition is preferably 0.001~2.0% by mass, and more preferably 0.005~1.0% by mass.

〔高級脂肪酸衍生物〕 [Higher fatty acid derivatives]

為了防止因氧引起的聚合阻礙,可以在本發明的樹脂組成物中添加如二十二酸或二十二酸醯胺的高級脂肪酸衍生物,從而使其在塗佈後的乾燥過程中不均勻地存在於本發明的樹脂組成物的表面上。 To prevent polymerization inhibition caused by oxygen, higher fatty acid derivatives such as docosanoic acid or docosanoylamine can be added to the resin composition of this invention, thereby causing it to exist unevenly on the surface of the resin composition of this invention during the drying process after coating.

又,高級脂肪酸衍生物亦能夠使用國際公開第2015/199219號的0155段中所記載的化合物,並將該內容編入本說明書中。 Furthermore, higher fatty acid derivatives may also use compounds described in paragraph 0155 of International Publication No. 2015/199219, and that content is incorporated into this specification.

在本發明的樹脂組成物具有高級脂肪酸衍生物之情況下,高級脂肪酸衍生物的含量相對於本發明的樹脂組成物的總固體成分為0.1~10質量%為較佳。高級脂肪酸衍生物可以為僅1種,亦可以為2種以上。在高 級脂肪酸衍生物為2種以上之情況下,其合計在上述範圍內為較佳。 When the resin composition of the present invention contains higher fatty acid derivatives, the content of the higher fatty acid derivatives relative to the total solid content of the resin composition of the present invention is preferably 0.1 to 10% by mass. There may be only one type of higher fatty acid derivative, or there may be two or more types. When there are two or more higher fatty acid derivatives, it is preferable that their total content is within the above range.

〔熱聚合起始劑〕 [Thermal polymerization initiator]

本發明的樹脂組成物可以包含熱聚合起始劑,尤其可以包含熱自由基聚合起始劑。熱自由基聚合起始劑為藉由熱的能量而產生自由基並開始或促進具有聚合性之化合物的聚合反應之化合物。藉由添加熱自由基聚合起始劑,亦能夠進行樹脂及聚合性化合物的聚合反應,因此能夠進一步提高耐溶劑性。又,有時上述光聚合起始劑亦具有藉由熱而開始聚合之功能,有時能夠作為熱聚合起始劑而添加。 The resin composition of this invention may include a thermal polymerization initiator, and more particularly, a thermal free radical polymerization initiator. A thermal free radical polymerization initiator is a compound that generates free radicals through thermal energy and initiates or promotes the polymerization reaction of a polymerizable compound. By adding a thermal free radical polymerization initiator, polymerization reactions of resins and polymerizable compounds can also occur, thus further improving solvent resistance. Furthermore, sometimes the aforementioned photopolymerization initiators also have the function of initiating polymerization through heat, and can sometimes be added as thermal polymerization initiators.

作為熱自由基聚合起始劑,具體而言,可以舉出日本特開2008-063554號公報的0074~0118段中所記載之化合物,並將該內容編入本說明書中。 Specifically, compounds described in paragraphs 0074 to 0118 of Japanese Patent Application Publication No. 2008-063554, which serve as initiators for thermal free radical polymerization, are included in this specification.

在包含熱聚合起始劑之情況下,其含量相對於本發明的樹脂組成物的總固體成分為0.1~30質量%為較佳,更佳為0.1~20質量%,進一步較佳為0.5~15質量%。熱聚合起始劑可以僅含有1種,亦可以含有2種以上。在含有2種以上的熱聚合起始劑之情況下,合計量在上述範圍內為較佳。 When a thermal polymerization initiator is included, its content relative to the total solid content of the resin composition of the present invention is preferably 0.1 to 30% by mass, more preferably 0.1 to 20% by mass, and even more preferably 0.5 to 15% by mass. The thermal polymerization initiator may be one type or may contain two or more types. When two or more thermal polymerization initiators are contained, the total amount within the above range is preferred.

〔無機粒子〕 [Inorganic particles]

本發明的樹脂組成物可以包含無機粒子。作為無機粒子,具體而言,能夠包含碳酸鈣、磷酸鈣、二氧化矽、高嶺土、滑石、二氧化鈦、氧化鋁、硫酸鋇、氟化鈣、氟化鋰、沸石、硫化鉬、玻璃等。 The resin composition of this invention can contain inorganic particles. Specifically, these inorganic particles can include calcium carbonate, calcium phosphate, silicon dioxide, kaolin, talc, titanium dioxide, aluminum oxide, barium sulfate, calcium fluoride, lithium fluoride, zeolite, molybdenum sulfide, glass, etc.

作為上述無機粒子的平均粒徑,0.01~2.0μm為較佳,0.02~1.5μm為更佳,0.03~1.0μm為進一步較佳,0.04~0.5μm為特佳。 For the average particle size of the aforementioned inorganic particles, 0.01–2.0 μm is preferred, 0.02–1.5 μm is more preferred, 0.03–1.0 μm is further preferred, and 0.04–0.5 μm is especially preferred.

無機粒子的上述平均粒徑為一次粒徑,並且為體積平均粒徑。關於體積平均粒徑,能夠藉由基於Nanotrac WAVE II EX-150(Nikkiso Co.,Ltd.製)之動態光散射法進行測定。 The aforementioned average particle size of the inorganic particles is the primary particle size and the volume average particle size. The volume average particle size can be determined using dynamic light scattering based on the Nanotrac WAVE II EX-150 (manufactured by Nikkiso Co., Ltd.).

在難以進行上述測定之情況下,亦能夠藉由離心沉降透光法、X射線透射法、雷射繞射/散射法進行測定。 In cases where the above measurements are difficult to perform, measurements can also be made using centrifugal sedimentation transmission, X-ray transmission, and laser diffraction/scattering methods.

〔紫外線吸收劑〕 [Ultraviolet absorber]

本發明的組成物可以包含紫外線吸收劑。作為紫外線吸收劑,能夠使用水楊酸酯系、二苯甲酮系、苯并三唑系、取代丙烯腈系、三系等紫外線吸收劑。 The composition of this invention may include a UV absorber. As a UV absorber, salicylate-based, benzophenone-based, benzotriazole-based, substituted acrylonitrile-based, and triglyceride-based UV absorbers can be used. It is a UV absorber.

作為水楊酸酯系紫外線吸收劑的例子,可以舉出水楊酸苯酯、水楊酸對辛基苯酯、水楊酸對第三丁基苯酯等,作為二苯甲酮系紫外線吸收劑的例子,可以舉出2,2’-二羥基-4-甲氧基二苯甲酮、2,2’-二羥基-4,4’-二甲氧基二苯甲酮、2,2’,4,4’-四羥基二苯甲酮、2-羥基-4-甲氧基二苯甲酮、2,4-二羥基二苯甲酮、2-羥基-4-辛氧基二苯甲酮等。又,作為苯并三唑系紫外線吸收劑的例子,可以舉出2-(2’-羥基-3’,5’-二-第三丁基苯基)-5-氯苯并三唑、2-(2’-羥基-3’-第三丁基-5’-甲基苯基)-5-氯苯并三唑、2-(2’-羥基-3’-第三戊基-5’-異丁基苯基)-5-氯苯并三唑、2-(2’-羥基-3’-異丁基-5’-甲基苯基)-5-氯苯并三唑、2-(2’-羥基-3’-異丁基-5’-丙基苯基)-5-氯苯并三唑、2-(2’-羥基-3’,5’-二-第三丁基苯基)苯并三唑、2-(2’-羥基-5’-甲基苯基)苯并三唑、2-[2’-羥基-5’-(1,1,3,3-四甲基)苯基]苯并三唑等。 Examples of salicylate-based UV absorbers include phenyl salicylate, p-octylphenyl salicylate, and p-tert-butylphenyl salicylate. Examples of benzophenone-based UV absorbers include 2,2'-dihydroxy-4-methoxybenzophenone, 2,2'-dihydroxy-4,4'-dimethoxybenzophenone, 2,2',4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2,4-dihydroxybenzophenone, and 2-hydroxy-4-octyloxybenzophenone. Furthermore, examples of benzotriazole-based ultraviolet absorbers include 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3'-tert-butyl-5'-methylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3'-tert-pentyl-5'-isobutylphenyl)-5-chlorobenzotriazole, and 2-(2'-hydroxy-3'-isobutylphenyl)-5-chlorobenzotriazole. Butyl-5'-methylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3'-isobutyl-5'-propylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole, 2-(2'-hydroxy-5'-methylphenyl)benzotriazole, 2-[2'-hydroxy-5'-(1,1,3,3-tetramethyl)phenyl]benzotriazole, etc.

作為取代丙烯腈系紫外線吸收劑的例子,可以舉出2-氰基-3,3-二苯基丙烯酸乙酯、2-氰基-3,3-二苯基丙烯酸2-乙基己酯等。進而,作 為三系紫外線吸收劑的例子,可以舉出2-[4-[(2-羥基-3-十二烷氧基丙基)氧基]-2-羥基苯基]-4,6-雙(2,4-二甲基苯基)-1,3,5-三、2-[4-[(2-羥基-3-十三烷氧基丙基)氧基]-2-羥基苯基]-4,6-雙(2,4-二甲基苯基)-1,3,5-三、2-(2,4-二羥基苯基)-4,6-雙(2,4-二甲基苯基)-1,3,5-三等單(羥基苯基)三化合物;2,4-雙(2-羥基-4-丙氧基苯基)-6-(2,4-二甲基苯基)-1,3,5-三、2,4-雙(2-羥基-3-甲基-4-丙氧基苯基)-6-(4-甲基苯基)-1,3,5-三、2,4-雙(2-羥基-3-甲基-4-己氧基苯基)-6-(2,4-二甲基苯基)-1,3,5-三等雙(羥基苯基)三化合物;2,4-雙(2-羥基-4-丁氧基苯基)-6-(2,4-二丁氧基苯基)-1,3,5-三、2,4,6-三(2-羥基-4-辛氧基苯基)-1,3,5-三、2,4,6-三[2-羥基-4-(3-丁氧基-2-羥基丙氧基)苯基]-1,3,5-三等三(羥基苯基)三化合物等。 Examples of acrylonitrile-based UV absorbers that can replace ethyl 2-cyano-3,3-diphenylacrylate and 2-ethylhexyl 2-cyano-3,3-diphenylacrylate are cited. Furthermore, as a tri- Examples of ultraviolet absorbers include 2-[4-[(2-hydroxy-3-dodecyloxypropyl)oxy]-2-hydroxyphenyl]-4,6-bis(2,4-dimethylphenyl)-1,3,5-trimethylolpropane. 2-[4-[(2-hydroxy-3-tetrazoxypropyl)oxy]-2-hydroxyphenyl]-4,6-bis(2,4-dimethylphenyl)-1,3,5-trimethylphenyl 2-(2,4-dihydroxyphenyl)-4,6-bis(2,4-dimethylphenyl)-1,3,5-trimethylphenyl Mono(hydroxyphenyl)tri Compound; 2,4-bis(2-hydroxy-4-propoxyphenyl)-6-(2,4-dimethylphenyl)-1,3,5-trimethylphenyl 2,4-Bis(2-hydroxy-3-methyl-4-propoxyphenyl)-6-(4-methylphenyl)-1,3,5-trimethylphenyl 2,4-Bis(2-hydroxy-3-methyl-4-hexyloxyphenyl)-6-(2,4-dimethylphenyl)-1,3,5-trimethylphenyl Isobis(hydroxyphenyl)tri Compound; 2,4-bis(2-hydroxy-4-butoxyphenyl)-6-(2,4-dibutoxyphenyl)-1,3,5-tris(hydroxyphenyl) 2,4,6-Tris(2-hydroxy-4-octyloxyphenyl)-1,3,5-tris(hydroxyphenyl) 2,4,6-Tris[2-Hydroxy-4-(3-Butoxy-2-Hydroxypropoxy)phenyl]-1,3,5 ... Tris(hydroxyphenyl)tri Compounds, etc.

在本發明中,上述各種紫外線吸收劑可以單獨使用1種,亦可以組合使用2種以上。 In this invention, the aforementioned ultraviolet absorbers can be used individually or in combination of two or more.

本發明的組成物可以包含紫外線吸收劑,亦可以不包含紫外線吸收劑,但是在包含之情況下,紫外線吸收劑的含量相對於本發明的組成物的總固體成分質量為0.001質量%以上且1質量%以下為較佳,0.01質量%以上且0.1質量%以下為更佳。 The composition of the present invention may or may not contain an ultraviolet absorber, but when it does contain an ultraviolet absorber, the content of the ultraviolet absorber relative to the total solid content of the composition of the present invention is preferably 0.001% by mass or more and 1% by mass or less, and more preferably 0.01% by mass or more and 0.1% by mass or less.

〔有機鈦化合物〕 [Organic titanium compounds]

本實施形態的樹脂組成物可以含有有機鈦化合物。由於樹脂組成物含有有機鈦化合物,因此即使在低溫下進行硬化之情況下亦能夠形成耐藥品性優異之樹脂層。 The resin composition of this embodiment may contain organic titanium compounds. Because the resin composition contains organic titanium compounds, it is possible to form a resin layer with excellent chemical resistance even when cured at low temperatures.

作為能夠使用的有機鈦化合物,可以舉出有機基經由共價鍵 或離子鍵與鈦原子鍵結者。 As usable organic titanium compounds, examples include those in which the organic groups are bonded to titanium atoms via covalent or ionic bonds.

將有機鈦化合物的具體例示於以下I)~VII)中: Specific examples of organic titanium compounds are shown in I) to VII) below:

I)鈦螯合化合物:其中,樹脂組成物的保存穩定性優異,並且可以獲得良好的硬化圖案,從而具有2個以上的烷氧基之鈦螯合化合物為更佳。具體的例子為二異丙醇雙(三乙醇胺)鈦、二(正丁醇)雙(2,4-戊二酮)鈦、二異丙醇雙(2,4-戊二酮)鈦、二異丙醇雙(四甲基庚二酮)鈦、二異丙醇雙(乙醯乙酸乙酯)鈦等。 I) Titanium chelates: Among these, titanium chelates with two or more alkoxy groups are preferred due to their excellent resin stability and ability to produce good curing patterns. Specific examples include diisopropoxide bis(triethanolamine)titanium, di(n-butanol)bis(2,4-pentanedione)titanium, diisopropoxide bis(2,4-pentanedione)titanium, diisopropoxide bis(tetramethylheptanedione)titanium, and diisopropoxide bis(ethyl acetoacetate)titanium.

II)四烷氧基鈦化合物:例如為四(正丁醇)鈦、四乙醇鈦、四(2-乙基己醇)鈦、四異丁醇鈦、四異丙醇鈦、四甲醇鈦、四甲氧基丙醇鈦、四甲基苯氧化鈦、四(正壬醇)鈦、四(正丙醇)鈦、四硬脂醇鈦、四[雙{2,2-(烯丙氧基甲基)丁醇}]鈦等。 II) Tetraalkoxytitanium compounds: Examples include tetra(n-butanol)titanium, tetraethanoltitanium, tetra(2-ethylhexanol)titanium, tetraisobutanoltitanium, tetraisopropanoltitanium, tetramethanoltitanium, tetramethoxypropanoltitanium, tetramethylphenyloxytitanium, tetra(n-nonanol)titanium, tetra(n-propanol)titanium, tetrastearyltitanium, tetra[bis{2,2-(allyloxymethyl)butanol}]titanium, etc.

III)二茂鈦化合物:例如為五甲基環戊二烯基三甲醇鈦、雙(η5-2,4-環戊二烯-1-基)雙(2,6-二氟苯基)鈦、雙(η5-2,4-環戊二烯-1-基)雙(2,6-二氟-3-(1H-吡咯-1-基)苯基)鈦等。 III) Titanium-ceramsite compounds: Examples include pentamethylcyclopentadienyltrimethyltitanium, bis(η5-2,4-cyclopentadien-1-yl)bis(2,6-difluorophenyl)titanium, and bis(η5-2,4-cyclopentadien-1-yl)bis(2,6-difluoro-3-(1H-pyrrolo-1-yl)phenyl)titanium, etc.

IV)單烷氧基鈦化合物:例如為三(二辛基磷酸酯)異丙醇鈦、三(十二烷苯基磺酸酯)異丙醇鈦等。 IV) Monoalkoxy titanium compounds: for example, titanium tris(dioctyl phosphate) isopropoxide, titanium tris(dodecanephenyl sulfonate) isopropoxide, etc.

V)氧化鈦化合物:例如為氧化鈦雙(戊二酮)、氧化鈦雙(四甲基庚二酮)、酞菁氧化鈦等。 V) Titanium oxide compounds: Examples include titanium bis(pentanedione), titanium bis(tetramethylheptanedione), and titanium phthalocyanine oxide.

VI)四乙醯丙酮鈦化合物:例如為四乙醯丙酮鈦等。 VI) Tetraacetone titanium compounds: such as tetraacetone titanium, etc.

VII)鈦酸酯偶合劑:例如為異丙基三十二烷基苯磺醯鈦酸鹽等。 VII) Titanium ester coupling agents: for example, isopropyltris(2-dodecylbenzenesulfonate) titanium salt, etc.

其中,作為有機鈦化合物,從發揮更良好的耐藥品性之觀點考慮,選自包括上述I)鈦螯合化合物、II)四烷氧基鈦化合物及III)二茂 鈦化合物之群組中的至少1種化合物為較佳。尤其,二異丙醇雙(乙醯乙酸乙酯)鈦、四(正丁醇)鈦及雙(η5-2,4-環戊二烯-1-基)雙(2,6-二氟-3-(1H-吡咯-1-基)苯基)鈦為較佳。 Among these, from the viewpoint of exhibiting better drug resistance, at least one compound selected from the group consisting of I) titanium chelates, II) tetraalkoxytitanium compounds and III) dicrocene titanium compounds is preferred as an organic titanium compound. In particular, diisopropanol bis(ethyl acetoacetate)titanium, tetra(n-butanol)titanium, and bis(n5-2,4-cyclopentadien-1-yl)bis(2,6-difluoro-3-(1H-pyrrolo-1-yl)phenyl)titanium are preferred.

在配合有機鈦化合物之情況下,其配合量相對於特定樹脂100質量份為0.05~10質量份為較佳,更較佳為0.1~2質量份。在配合量為0.05質量份以上之情況下,所獲得之硬化圖案更有效地顯現出良好的耐熱性及耐藥品性,另一方面,在配合量為10質量份以下之情況下,組成物的保存穩定性更優異。 When incorporating organotitanium compounds, the amount of these compounds relative to 100 parts by weight of a specific resin is preferably 0.05 to 10 parts by weight, more preferably 0.1 to 2 parts by weight. When the amount is 0.05 parts by weight or more, the resulting curing pattern exhibits better heat resistance and chemical resistance; conversely, when the amount is 10 parts by weight or less, the composition exhibits superior storage stability.

〔抗氧化劑〕 [Antioxidants]

本發明的組成物可以包含抗氧化劑。藉由含有抗氧化劑作為添加劑,能夠提高硬化後的膜的伸長特性和與金屬材料的密接性。作為抗氧化劑,可以舉出酚化合物、亞磷酸酯化合物及硫醚化合物等。作為酚化合物,能夠使用作為酚系抗氧化劑已知之任意的酚化合物。作為較佳的酚化合物,可以舉出受阻酚化合物。在與酚性羥基相鄰之部位(鄰位)上具有取代基之化合物為較佳。作為上述取代基,碳數1~22的經取代或未經取代的烷基為較佳。又,抗氧化劑為在相同分子內具有酚基及亞磷酸酯基之化合物亦較佳。又,抗氧化劑亦能夠較佳地使用磷系抗氧化劑。作為磷系抗氧化劑,可以舉出三[2-[[2,4,8,10-四(1,1-二甲基乙基)二苯并[d,f][1,3,2]二氧雜膦雜環庚二烯-6-基]氧基]乙基]胺、三[2-[(4,6,9,11-四-第三丁基二苯并[d,f][1,3,2]二氧雜膦雜環庚二烯-2-基)氧基]乙基]胺及亞磷酸乙基雙(2,4-二-第三丁基-6-甲基苯基)等。作為抗氧化劑的市售品,例如可以舉出Adekastab AO-20、Adekastab AO-30、Adekastab AO-40、Adekastab AO-50、Adek astab AO-50F、Adekastab AO-60、Adekastab AO-60G、Adekastab AO-80及Adekastab AO-330(以上為ADEKA CORPORATION製)等。又,抗氧化劑亦能夠使用日本專利第6268967號公報的0023~0048段中所記載之化合物,並將該內容編入本說明書中。又,本發明的組成物依據需要可以含有潛在的抗氧化劑。作為潛在的抗氧化劑,可以舉出發揮抗氧化劑作用之部位被保護基保護之化合物,且為藉由在100~250℃下進行加熱或在酸/鹼觸媒存在下在80~200℃下進行加熱以使保護基脫離而發揮抗氧化劑作用之化合物。作為潛在的抗氧化劑,可以舉出國際公開第2014/021023號、國際公開第2017/030005號及日本特開2017-008219號公報中所記載之化合物,並將該內容編入本說明書中。作為潛在的抗氧化劑的市售品,可以舉出ADEKA ARKLS GPA-5001(ADEKA CORPORATION製)等。 The composition of this invention may include an antioxidant. By including an antioxidant as an additive, the elongation properties and adhesion to metal materials of the cured film can be improved. Examples of antioxidants include phenolic compounds, phosphite compounds, and thioether compounds. As a phenolic compound, any phenolic compound known as a phenolic antioxidant can be used. As a preferred phenolic compound, hindered phenolic compounds can be used. Compounds having a substituent at the site (orthoside) adjacent to the phenolic hydroxyl group are preferred. As the above-mentioned substituent, substituted or unsubstituted alkyl groups having 1 to 22 carbon atoms are preferred. Furthermore, compounds having both phenolic and phosphite groups within the same molecule are also preferred as antioxidants. Furthermore, phosphorus-based antioxidants are also preferred. Examples of phosphorus-based antioxidants include tris[2-[[2,4,8,10-tetra(1,1-dimethylethyl)dibenzo[d,f][1,3,2]dioxane-phosphine-heptacyclohepta-6-yl]oxy]ethyl]amine, tris[2-[(4,6,9,11-tetra-tert-butyldibenzo[d,f][1,3,2]dioxane-phosphine-heptacyclohepta-2-yl)oxy]ethyl]amine, and ethyl bis(2,4-di-tert-butyl-6-methylphenyl) phosphite. Commercially available antioxidants include, for example, Adekastab AO-20, Adekastab AO-30, Adekastab AO-40, Adekastab AO-50, Adekastab AO-50F, Adekastab AO-60, Adekastab AO-60G, Adekastab AO-80, and Adekastab AO-330 (all manufactured by ADEKA CORPORATION). Furthermore, the antioxidants may also use compounds described in paragraphs 0023 to 0048 of Japanese Patent No. 6268967, and this content is incorporated into this specification. Additionally, the composition of this invention may contain potential antioxidants as needed. As potential antioxidants, compounds whose antioxidant activity is achieved by the removal of the protective group at the site of antioxidant action can be cited, and which exert their antioxidant activity by heating at 100-250°C or at 80-200°C in the presence of an acid/base catalyst to remove the protective group. Compounds described in International Publication No. 2014/021023, International Publication No. 2017/030005, and Japanese Patent Application Publication No. 2017-008219 are examples of potential antioxidants, and their contents are incorporated herein by reference. Commercially available products that are potential antioxidants include ADEKA ARKLS GPA-5001 (manufactured by ADEKA CORPORATION).

作為較佳的抗氧化劑的例子,可以舉出2,2-硫代雙(4-甲基-6-第三丁基酚)、2,6-二-第三丁基酚及式(3)所表示之化合物。 Examples of better antioxidants include 2,2-thiobis(4-methyl-6-tert-butylphenol), 2,6-di-tert-butylphenol, and compounds represented by formula (3).

通式(3)中,R5表示氫原子或碳數2以上(較佳為碳數2~10)的烷基,R6表示碳數2以上(較佳為碳數2~10)的伸烷基。R7表示碳數2以上(較佳為碳數2~10)的伸烷基、包含氧原子及氮原子中的至少任一個之1~4價的有機基。k表示1~4的整數。 In general formula (3), R5 represents a hydrogen atom or an alkyl group having 2 or more carbon atoms (preferably 2 to 10 carbon atoms), and R6 represents an alkyl group having 2 or more carbon atoms (preferably 2 to 10 carbon atoms). R7 represents an alkyl group having 2 or more carbon atoms (preferably 2 to 10 carbon atoms), or an organic group containing at least one of oxygen and nitrogen atoms in a 1 to 4 valence. k represents an integer from 1 to 4.

式(3)所表示之化合物抑制樹脂所具有之脂肪族基和酚性 羥基的氧化劣化。又,能夠藉由對金屬材料的防鏽作用來抑制金屬氧化。 The compound represented by formula (3) inhibits the oxidative degradation of the aliphatic and phenolic hydroxyl groups present in the resin. Furthermore, it can inhibit metal oxidation by preventing rust formation in metallic materials.

能夠同時作用於樹脂和金屬材料,因此k為2~4的整數為更佳。作為R7,可以舉出烷基、環烷基、烷氧基、烷基醚基、烷基甲矽烷基、烷氧基甲矽烷基、芳基、芳基醚基、羧基、羰基、烯丙基、乙烯基、雜環基、-O-、-NH-、-NHNH-、組合了該等者等,還可以具有取代基。其中,從在顯影液中的溶解性和金屬密接性的觀點考慮,具有烷基醚基、-NH-為較佳,從與樹脂的相互作用和金屬錯合物形成時之金屬密接性的觀點考慮,-NH-為更佳。 It can act on both resins and metal materials simultaneously, therefore, k being an integer from 2 to 4 is preferred. Examples of R7 include alkyl, cycloalkyl, alkoxy, alkyl ether, alkylsilyl, alkoxysilyl, aryl, aryl ether, carboxyl, carbonyl, allyl, vinyl, heterocyclic, -O-, -NH-, -NHNH-, and combinations thereof, and it may also have substituents. Among these, alkyl ethers and -NH- are preferred from the viewpoint of solubility in the developing solution and metal adhesion; -NH- is preferred from the viewpoint of interaction with resins and metal adhesion during metal complex formation.

關於通式(3)所表示之化合物,作為例子,可以舉出以下者,但是並不限於下述結構。 Examples of compounds represented by general formula (3) are given below, but are not limited to the following structures.

[化學式58] [Chemical Formula 58]

[化學式59] [Chemical Formula 59]

[化學式60] [Chemical Formula 60]

[化學式61] [Chemical Formula 61]

抗氧化劑的添加量相對於樹脂為0.1~10質量份為較佳,0.5~5質量份為更佳。藉由將添加量設為0.1質量份以上,即使在高溫高濕環境下,亦容易獲得提高伸長特性或對金屬材料之密接性的效果,並且藉由將添加量設為10質量份以下,例如藉由與光敏劑的相互作用來提高樹脂組成物的靈敏度。抗氧化劑可以僅使用1種,亦可以使用2種以上。在使用2種以上之情況下,該等合計量在上述範圍內為較佳。 The optimal amount of antioxidant added relative to the resin is 0.1 to 10 parts by weight, with 0.5 to 5 parts by weight being more preferred. By adding an amount of 0.1 parts by weight or more, it is easier to obtain improved elongation properties or adhesion to metal materials, even under high temperature and humidity environments. Conversely, by adding an amount of 10 parts by weight or less, the sensitivity of the resin composition can be improved, for example, through interaction with photosensitizers. Only one type of antioxidant may be used, or two or more may be used. When using two or more antioxidants, the total amount within the above-mentioned range is preferred.

〔抗凝聚劑〕 [Anticoagulant]

本實施形態的樹脂組成物依據需要可以含有抗凝聚劑。作為抗凝聚劑,可以舉出聚丙烯酸鈉等。 The resin composition of this embodiment may contain an anti-coagulant as needed. Examples of anti-coagulants include sodium polyacrylate.

在本發明中,抗凝聚劑可以單獨使用1種,亦可以組合使用2種以上。 In this invention, the anti-coagulant can be used alone or in combination with two or more others.

本發明的組成物可以包含抗凝聚劑,亦可以不包含抗凝聚劑,但是在包含之情況下,抗凝聚劑的含量相對於本發明的組成物的總固體成分質量為0.01質量%以上且10質量%以下為較佳,0.02質量%以上且5質量%以下為更佳。 The composition of the present invention may or may not contain an anti-coagulant, but when it does contain an anti-coagulant, the content of the anti-coagulant relative to the total solid content of the composition of the present invention is preferably 0.01% by mass or more and 10% by mass or less, and more preferably 0.02% by mass or more and 5% by mass or less.

〔酚系化合物〕 [Phenolic compounds]

本實施形態的樹脂組成物依據需要可以含有酚系化合物。作為酚系化合物,可以舉出Bis-Z、BisP-EZ、TekP-4HBPA、TrisP-HAP、TrisP-PA、BisOCHP-Z、BisP-MZ、BisP-PZ、BisP-IPZ、BisOCP-IPZ、BisP-CP、BisRS-2P、BisRS-3P、BisP-OCHP、亞甲基三-FR-CR、BisRS-26X(以上為產品名稱,Honshu Chemical Industry Co.,Ltd.製)、BIP-PC、BIR-PC、BIR-PTBP、BIR-BIPC-F(以上為產品名稱,ASAHI YUKIZAI CORPORATION製)等。 The resin composition of this embodiment may contain phenolic compounds as needed. Examples of phenolic compounds include Bis-Z, BisP-EZ, TekP-4HBPA, TrisP-HAP, TrisP-PA, BisOCHP-Z, BisP-MZ, BisP-PZ, BisP-IPZ, BisOCP-IPZ, BisP-CP, BisRS-2P, BisRS-3P, BisP-OCHP, methylene tri-FR-CR, BisRS-26X (the above are product names, manufactured by Honshu Chemical Industry Co., Ltd.), BIP-PC, BIR-PC, BIR-PTBP, and BIR-BIPC-F (the above are product names, manufactured by ASAHI YUKIZAI CORPORATION).

在本發明中,酚系化合物可以單獨使用1種,亦可以組合使用2種以上。 In this invention, a single phenolic compound may be used alone, or two or more may be used in combination.

本發明的組成物可以包含酚系化合物,亦可以不包含酚系化合物,但是在包含之情況下,酚系化合物的含量相對於本發明的組成物的總固體成分質量為0.01質量%以上且30質量%以下為較佳,0.02質量%以上且20質量%以下為更佳。 The composition of this invention may or may not contain phenolic compounds. However, when phenolic compounds are included, the content of phenolic compounds relative to the total solid content of the composition of this invention is preferably 0.01% by mass or more and 30% by mass or less, and more preferably 0.02% by mass or more and 20% by mass or less.

〔其他高分子化合物〕 [Other polymers]

作為其他高分子化合物,可以舉出矽氧烷樹脂、將(甲基)丙烯酸進行共聚而獲得之(甲基)丙烯酸聚合物、酚醛清漆樹脂、甲酚樹脂、聚羥基苯乙烯樹脂及該等共聚物等。其他高分子化合物可以為導入有羥甲基、烷氧基甲基、環氧基等交聯基之改質體。 Other examples of polymers include silicone resins, (meth)acrylic acid polymers obtained by copolymerizing (meth)acrylic acid, phenolic varnish resins, cresol resins, polyhydroxystyrene resins, and copolymers thereof. Other polymers may be modifiers incorporating cross-linking groups such as hydroxymethyl, alkoxymethyl, and epoxy groups.

在本發明中,其他高分子化合物可以單獨使用1種,亦可以組合使用2種以上。 In this invention, other polymeric compounds can be used alone or in combination of two or more.

本發明的組成物可以包含其他高分子化合物,亦可以不包含其他高分子化合物,但是在包含之情況下,其他高分子化合物的含量相對於本發明的組成物的總固體成分質量為0.01質量%以上且30質量%以下為較佳,0.02質量%以上且20質量%以下為更佳。 The composition of this invention may or may not contain other polymeric compounds. However, when other polymeric compounds are included, it is preferable that the content of these other polymeric compounds is 0.01% by mass or more and 30% by mass or less, and more preferably 0.02% by mass or more and 20% by mass or less, relative to the total solid content of the composition of this invention.

<樹脂組成物的特性> <Properties of Resin Composition>

關於本發明的樹脂組成物的黏度,能夠藉由樹脂組成物的固體成分濃度來調整。從塗佈膜厚的觀點考慮,1,000mm2/s~12,000mm2/s為較佳,2,000mm2/s~10,000mm2/s為更佳,3,000mm2/s~8,000mm2/s為進一步較佳。只要在上述範圍內,則容易獲得均勻性高的塗佈膜。在為1,000mm2/s以下時,例如難以以作為再配線用絕緣膜所需要之膜厚進行塗佈,在為12,000mm2/s以上時,塗佈表面形態有可能變差。 The viscosity of the resin composition of this invention can be adjusted by the concentration of the solid component of the resin composition. From the viewpoint of coating film thickness, 1,000 mm² /s to 12,000 mm² /s is preferred, 2,000 mm² /s to 10,000 mm² /s is more preferred, and 3,000 mm² /s to 8,000 mm² /s is even more preferred. As long as it is within the above range, it is easy to obtain a coating film with high uniformity. When it is below 1,000 mm² /s, it is difficult to coat with the film thickness required for a reinforcing insulation film, for example, and when it is above 12,000 mm² /s, the coating surface morphology may deteriorate.

組成物中所包含之酸基的量(亦稱為“抗蝕劑酸值”)相對於本發明的樹脂組成物1g為6.0mgKOH/g以下為較佳,5.0mgKOH/g以下為更佳。 The amount of acid groups contained in the composition (also known as the "anti-corrosion acid value") is preferably below 6.0 mg KOH/g per 1g of the resin composition of the present invention, and even more preferably below 5.0 mg KOH/g.

上述酸基的量的下限並無特別限定,可以為0mgKOH/g。 There is no particular limit to the amount of the aforementioned acid groups; it can be 0 mg KOH/g.

作為上述酸基,可以舉出pKa為15以下的酸基,可以舉出羧基、酚性羥基等。 Examples of acid groups mentioned above include those with a pKa of 15 or less, such as carboxyl groups and phenolic hydroxyl groups.

關於上述抗蝕劑酸值,例如藉由使用了氫氧化鉀之滴定法進行測定。 The acid value of the aforementioned corrosion inhibitor was determined, for example, by titration using potassium hydroxide.

本發明的樹脂組成物包含穩定性優異之化合物B,因此即使減少酸基的量,保存穩定性亦優異。亦即,為了提高組成物的保存穩定性,不一定需要將組成物調整為酸性。 The resin composition of this invention contains compound B, which exhibits excellent stability; therefore, even with a reduction in the amount of acid groups, excellent storage stability is maintained. In other words, it is not necessary to adjust the composition to an acidic state to improve its storage stability.

<關於樹脂組成物的含有物質的限制> <Restrictions on the substances contained in resin components>

本發明的樹脂組成物的含水率小於2.0質量%為較佳,小於1.5質量%為更佳,小於1.0質量%為進一步較佳。在為2.0%以上時,有可能損害樹脂組成物的保存穩定性。 The resin composition of this invention preferably has a moisture content of less than 2.0% by mass, more preferably less than 1.5% by mass, and even more preferably less than 1.0% by mass. A moisture content exceeding 2.0% may impair the storage stability of the resin composition.

作為維持水分的含量之方法,可以舉出調整保管條件中之濕度及降低保管時的收容容器的孔隙率等。 Methods for maintaining moisture content include adjusting the humidity of the storage conditions and reducing the porosity of the storage container.

從絕緣性的觀點考慮,本發明的樹脂組成物的金屬含量小於5質量ppm(parts per million(百萬分率))為較佳,小於1質量ppm為更佳,小於0.5質量ppm為進一步較佳。作為金屬,可以舉出鈉、鉀、鎂、鈣、鐵、銅、鉻、鎳等,但是作為有機化合物與金屬的錯合物而包含之金屬除外。在包含複數個金屬之情況下,該等金屬的合計在上述範圍內為較佳。 From an insulation perspective, it is preferable that the metal content of the resin composition of the present invention is less than 5 parts per million (ppm), more preferably less than 1 ppm, and even more preferably less than 0.5 ppm. Examples of metals include sodium, potassium, magnesium, calcium, iron, copper, chromium, and nickel, but excluding metals contained as complexes of organic compounds and metals. When multiple metals are included, it is preferable that the total amount of these metals is within the above-mentioned range.

又,作為減少意外包含於本發明的樹脂組成物中之金屬雜質之方法,可以舉出如下方法:選擇金屬含量少的原料作為構成本發明的樹脂組成物之原料;對構成本發明的樹脂組成物之原料進行過濾器過濾;將聚四氟乙烯等內襯於裝置內以在盡可能抑制污染之條件下進行蒸餾。 Furthermore, as a method to reduce unintended metallic impurities in the resin composition of the present invention, the following methods can be employed: selecting raw materials with low metal content as the raw materials for constituting the resin composition of the present invention; filtering the raw materials constituting the resin composition of the present invention using a filter; and lining the apparatus with polytetrafluoroethylene or the like to perform distillation under conditions that suppress contamination as much as possible.

若考慮本發明的樹脂組成物作為半導體材料的用途,則從配線腐蝕性的觀點考慮,鹵素原子的含量小於500質量ppm為較佳,小於300質量ppm為更佳,小於200質量ppm為進一步較佳。其中,以鹵素離子的狀態存在者小於5質量ppm為較佳,小於1質量ppm為更佳,小於0.5質量ppm為進一步較佳。作為鹵素原子,可以舉出氯原子及溴原子。氯原子及溴原子或氯離子及溴離子的合計分別在上述範圍內為較佳。 Considering the use of the resin composition of this invention as a semiconductor material, from the viewpoint of wiring corrosion, a halogen atom content of less than 500 ppm by mass is preferred, less than 300 ppm by mass is more preferred, and less than 200 ppm by mass is even more preferred. Of these, a halogen ion content of less than 5 ppm by mass is preferred, less than 1 ppm by mass is more preferred, and less than 0.5 ppm by mass is even more preferred. Chlorine and bromine atoms can be cited as examples of halogen atoms. It is preferred that the total number of chlorine and bromine atoms, or the total number of chloride and bromine ions, falls within the above-mentioned ranges.

作為調節鹵素原子的含量之方法,可以較佳地舉出離子交換處理等。 One good example of a method for regulating the content of halogen atoms is ion exchange treatment.

作為本發明的樹脂組成物的收容容器,能夠使用以往公知的收容容器。又,作為收容容器,為了抑制雜質混入原材料或本發明的樹脂組成物中,使用由6種6層樹脂構成容器內壁之多層瓶、將6種樹脂形成為7層結構之瓶亦較佳。作為該種容器,例如可以舉出日本特開2015-123351號公報中所記載的容器。 As a container for the resin composition of the present invention, conventionally known containers can be used. Furthermore, as a container, to prevent impurities from contaminating the raw materials or the resin composition of the present invention, it is preferable to use a multi-layered bottle with an inner wall composed of six layers of six different resins, or a bottle with a seven-layered structure formed from the six resins. For example, the container described in Japanese Patent Application Publication No. 2015-123351 can be cited as such a container.

<樹脂組成物的硬化物> <Curing of resin components>

藉由將本發明的樹脂組成物進行硬化,能夠獲得該樹脂組成物的硬化物。 By curing the resin composition of the present invention, a cured product of the resin composition can be obtained.

本發明的硬化物為將本發明的樹脂組成物硬化而成之硬化物。 The cured material of this invention is a cured material formed by curing the resin composition of this invention.

樹脂組成物的硬化藉由加熱進行為較佳,加熱溫度在120℃~400℃的範圍內為更佳,在140℃~380℃的範圍內為進一步較佳,在170℃~350℃的範圍內為特佳。樹脂組成物的硬化物的形態並無特別限定,能夠依據用途選擇薄膜狀、棒狀、球狀、顆粒狀等。在本發明中,該硬化物為薄膜狀為較佳。又,藉由樹脂組成物的圖案加工,亦能夠依據在壁面上形成保護膜,形成用於導通的穴(Beer hall)、調整阻抗或靜電容量或者內部應力、 賦予放熱功能等用途選擇該硬化物的形狀。該硬化物(由硬化物形成之膜)的膜厚為0.5μm以上且150μm以下為較佳。 Curing of the resin composition is preferably carried out by heating, with a heating temperature in the range of 120°C to 400°C being more preferred, in the range of 140°C to 380°C being even more preferred, and in the range of 170°C to 350°C being particularly preferred. The morphology of the cured resin composition is not particularly limited, and it can be in the form of a film, rod, sphere, or granules, depending on the application. In this invention, a film-like form of the cured composition is preferred. Furthermore, by pattern processing of the resin composition, the shape of the cured composition can be selected according to applications such as forming a protective film on the wall surface, forming beer halls for conduction, adjusting impedance or electrostatic capacitance or internal stress, and imparting heat dissipation. The thickness of the cured material (the film formed by the cured material) is preferably 0.5 μm or more and 150 μm or less.

將本發明的樹脂組成物進行硬化時的收縮率為50%以下為較佳,45%以下為更佳,40%以下為進一步較佳。其中,收縮率是指樹脂組成物的硬化前後的體積變化的百分率,並且能夠藉由下述的式來進行計算。 The shrinkage rate during curing of the resin composition of the present invention is preferably 50% or less, more preferably 45% or less, and even more preferably 40% or less. Here, shrinkage rate refers to the percentage change in volume of the resin composition before and after curing, and can be calculated using the following formula.

收縮率[%]=100-(硬化後的體積÷硬化前的體積)×100 Shrinkage rate [%] = 100 - (Volume after hardening ÷ Volume before hardening) × 100

<樹脂組成物的硬化物的特性> <Properties of hardened resin compounds>

本發明的樹脂組成物的硬化物的醯亞胺化反應率為70%以上為較佳,80%以上為更佳,90%以上為進一步較佳。在小於70%時,硬化物的機械特性有可能差。 The amide reaction rate of the cured resin composition of this invention is preferably 70% or higher, more preferably 80% or higher, and even more preferably 90% or higher. When it is less than 70%, the mechanical properties of the cured product may be poor.

本發明的樹脂組成物的硬化物的斷裂伸長率為30%以上為較佳,40%以上為更佳,50%以上為進一步較佳。 The elongation at break of the cured resin composition of the present invention is preferably 30% or more, more preferably 40% or more, and even more preferably 50% or more.

本發明的樹脂組成物的硬化物的玻璃轉移溫度(Tg)為180℃以上為較佳,210℃以上為更佳,230℃以上為進一步較佳。 The glass transition temperature (Tg) of the cured resin composition of this invention is preferably 180°C or higher, more preferably 210°C or higher, and even more preferably 230°C or higher.

<樹脂組成物的製備> <Preparation of Resin Components>

本發明的樹脂組成物能夠藉由混合上述各成分來製備。混合方法並無特別限定,能夠藉由先前公知的方法來進行。 The resin composition of this invention can be prepared by mixing the above-mentioned components. The mixing method is not particularly limited and can be carried out using previously known methods.

混合能夠採用基於攪拌葉片之混合、基於球磨機之混合、使罐自身旋轉之混合等。 Mixing can be achieved using methods such as mixing based on agitator blades, mixing based on a ball mill, and mixing by rotating the container itself.

混合中的溫度為10~30℃為較佳,15~25℃為更佳。 The optimal temperature for mixing is 10–30°C, with 15–25°C being even better.

又,為了去除本發明的樹脂組成物中的灰塵或微粒等異物,進行使用過濾器之過濾為較佳。關於過濾器孔徑,例如可以舉出5μm以下 之態樣,1μm以下為較佳,0.5μm以下為更佳,0.1μm以下為進一步較佳。過濾器的材質為聚四氟乙烯、聚乙烯或尼龍為較佳。在過濾器的材質為聚乙烯之情況下,HDPE(高密度聚乙烯)為更佳。過濾器可以使用用有機溶劑預先清洗者。在過濾器的過濾步驟中,亦可以串聯或並聯連接複數種過濾器而使用。在使用複數種過濾器之情況下,可以組合使用孔徑或材質不同之過濾器。作為連接態樣,例如可以舉出將孔徑1μm的HDPE過濾器作為第1級且將孔徑0.2μm的HDPE過濾器作為第2級進行串聯連接之態樣。又,可以將各種材料過濾複數次。在過濾複數次之情況下,可以為循環過濾。又,亦可以在加壓之後進行過濾。在加壓並進行過濾之情況下,進行加壓之壓力例如可以舉出0.01MPa以上且1.0MPa以下之態樣,0.03MPa以上且0.9MPa以下為較佳,0.05MPa以上且0.7MPa以下為更佳,0.05MPa以上且0.5MPa以下為進一步較佳。 Furthermore, to remove foreign matter such as dust or particulate matter from the resin composition of this invention, filtration using a filter is preferable. Regarding the filter pore size, for example, pores of 5 μm or less are preferred, 1 μm or less is preferred, 0.5 μm or less is even better, and 0.1 μm or less is further preferred. The filter material is preferably polytetrafluoroethylene, polyethylene, or nylon. When the filter material is polyethylene, HDPE (high-density polyethylene) is preferred. The filter can be pre-cleaned with an organic solvent. Multiple filters can also be connected in series or parallel during the filtration process. When using multiple filters, filters with different pore sizes or materials can be combined. For example, a connection could be made by connecting a 1μm pore size HDPE filter as the first stage and a 0.2μm pore size HDPE filter as the second stage in series. Furthermore, various materials can be filtered multiple times. Multiple filtrations constitute circulating filtration. Alternatively, filtration can be performed after pressurization. When pressurizing and filtering, the pressure applied can be, for example, 0.01 MPa or higher and 1.0 MPa or lower, preferably 0.03 MPa or higher and 0.9 MPa or lower, even better 0.05 MPa or higher and 0.7 MPa or lower, and further preferably 0.05 MPa or higher and 0.5 MPa or lower.

除了使用過濾器之過濾以外,還可以進行使用吸附材料之雜質去除處理。亦可以組合過濾器過濾與使用吸附材料之雜質去除處理。作為吸附材料,能夠使用公知的吸附材料。例如,可以舉出矽膠、沸石等無機系吸附材料、活性碳等有機系吸附材料。 In addition to filtration using a filter, impurity removal can also be performed using adsorption materials. A combination of filter filtration and impurity removal using adsorption materials can also be used. As the adsorption material, known adsorption materials can be used. Examples include inorganic adsorption materials such as silicone and zeolite, and organic adsorption materials such as activated carbon.

進而,在使用過濾器之過濾之後,還可以實施在減壓狀態下放置填充於瓶中之樹脂組成物並進行脫氣之步驟。 Furthermore, after filtration using a filter, the resin composition filled in the bottle can be placed under reduced pressure and degassed.

(硬化物之製造方法) (Method for manufacturing hardened materials)

本發明的硬化物之製造方法包括將樹脂組成物適用於基材上而形成膜之膜形成步驟為較佳。 The method for manufacturing the cured material of this invention preferably includes a film-forming step of applying a resin composition to a substrate to form a film.

又,本發明的硬化物之製造方法包括上述膜形成步驟、選擇性地曝光 藉由膜形成步驟而形成之膜之曝光步驟及使用顯影液對藉由曝光步驟進行曝光之膜進行顯影而形成圖案之顯影步驟為更佳。 Furthermore, the method for manufacturing the cured material of this invention includes, more preferably, the above-described film formation step, the selective exposure step of the film formed by the film formation step, and the development step of developing the film exposed by the exposure step with a developing solution to form a pattern.

本發明的硬化物之製造方法包括上述膜形成步驟、上述曝光步驟、上述顯影步驟、以及對藉由顯影步驟而獲得之圖案進行加熱之加熱步驟及對藉由顯影步驟而獲得之圖案進行曝光之顯影後曝光步驟中的至少一者為特佳。 The method for manufacturing the cured material of this invention preferably includes at least one of the above-described film formation step, the above-described exposure step, the above-described development step, a heating step for heating the pattern obtained by the development step, and a post-development exposure step for exposing the pattern obtained by the development step.

又,本發明之製造方法包括上述膜形成步驟及對上述膜進行加熱之步驟亦較佳。 Furthermore, the manufacturing method of this invention, including the above-described film formation step and the step of heating the above-described film, is also preferable.

以下,對各步驟的詳細內容進行說明。 The following provides a detailed explanation of each step.

<膜形成步驟> <Membrane Formation Steps>

本發明的樹脂組成物能夠用於適用於基材上而形成膜之膜形成步驟中。 The resin composition of this invention can be used in the film formation process for forming films on a substrate.

本發明的硬化物之製造方法包括將樹脂組成物適用於基材上而形成膜之膜形成步驟為較佳。 The method for manufacturing the cured material of this invention preferably includes a film-forming step of applying a resin composition to a substrate to form a film.

〔基材〕 [Substrate]

基材的種類能夠依據用途適當設定,但是並無特別限制,可以舉出矽、氮化矽、多晶矽、氧化矽、非晶矽等半導體製作基材、石英、玻璃、光學膜、陶瓷材料、蒸鍍膜、磁性膜、反射膜、Ni、Cu、Cr、Fe等金屬基材(例如,可以為由金屬形成之基材及例如藉由電鍍或蒸鍍等而形成金屬層之基材中的任一個)、紙、SOG(Spin On Glass:旋塗式玻璃)、TFT(薄膜晶體管)陣列基材、模具基材、電漿顯示面板(PDP)的電極板等。在本發明中,尤其半導體製作基材為較佳,矽基材、Cu基材及模具基材為更佳。 The type of substrate can be appropriately set according to the application, but there are no particular limitations. Examples include semiconductor substrates such as silicon, silicon nitride, polycrystalline silicon, silicon oxide, and amorphous silicon; quartz; glass; optical films; ceramic materials; vapor-deposited films; magnetic films; reflective films; metal substrates such as Ni, Cu, Cr, and Fe (e.g., any substrate formed of metal and substrates with metal layers formed by electroplating or vapor deposition); paper; SOG (Spin On Glass); TFT (Thin Film Transistor) array substrates; mold substrates; and electrode plates for plasma display panels (PDPs). In this invention, semiconductor substrates are particularly preferred, with silicon substrates, Cu substrates, and mold substrates being even more preferred.

又,在該等基材的表面上可以設置有由六甲基二矽氮烷(HMDS)等製成之密接層和氧化層等層。 Furthermore, a bonding layer and an oxide layer made of hexamethyldisilazane (HMDS) or similar materials may be disposed on the surface of such substrates.

又,基材的形狀並無特別限定,可以為圓形,亦可以為矩形。 Furthermore, the shape of the substrate is not particularly limited; it can be circular or rectangular.

作為基材的尺寸,若為圓形,則例如直徑為100~450mm,較佳為200~450mm。若為矩形,則例如短邊的長度為100~1000mm,較佳為200~700mm。 Regarding the dimensions of the substrate, if it is circular, the diameter is, for example, 100-450 mm, preferably 200-450 mm. If it is rectangular, the length of the shorter side is, for example, 100-1000 mm, preferably 200-700 mm.

又,作為基材,例如可以使用板狀、較佳為面板狀的基材(基板)。 Furthermore, as a substrate, a plate-shaped, preferably panel-shaped, substrate (base plate) can be used.

又,在樹脂層(例如,由硬化物形成之層)的表面或金屬層的表面上適用樹脂組成物而形成膜之情況下,樹脂層或金屬層成為基材。 Furthermore, when a film is formed by applying a resin composition to the surface of a resin layer (e.g., a layer formed from a hardened material) or a metal layer, the resin layer or metal layer becomes the substrate.

作為將本發明的樹脂組成物適用於基材上之方法,塗佈為較佳。 As a method for applying the resin composition of the present invention to a substrate, coating is preferred.

作為所適用之方法,具體而言,可以例示浸塗法、氣刀塗佈法、簾式塗佈法、線棒塗佈法、凹版塗佈法、擠壓塗佈法、噴塗法、旋塗法、狹縫塗佈法、噴墨法等。從膜的厚度的均勻性的觀點考慮,更佳為旋塗法、狹縫塗佈法、噴塗法或噴墨法,從膜的厚度的均勻性的觀點及生產率的觀點考慮,旋塗法及狹縫塗佈法為較佳。依據方法調整樹脂組成物的固體成分濃度或塗佈條件,從而能夠獲得所期望的厚度的膜。又,亦能夠依據基材的形狀適當選擇塗佈方法,若為晶圓等圓形基材,則旋塗法、噴塗法、噴墨法等為較佳,若為矩形基材,則狹縫塗佈法或噴塗法、噴墨法等為較佳。在為旋塗法的情況下,例如能夠以500~3,500rpm的轉速適用10秒鐘~3分鐘左右。 Specifically, applicable methods include dip coating, air knife coating, curtain coating, wire rod coating, gravure coating, extrusion coating, spray coating, spin coating, slit coating, and inkjet coating. From the perspective of film thickness uniformity, spin coating, slit coating, spray coating, or inkjet coating are preferred. From the perspectives of film thickness uniformity and productivity, spin coating and slit coating are more advantageous. By adjusting the solid content concentration of the resin composition or the coating conditions according to the method, a film of the desired thickness can be obtained. Furthermore, the coating method can be appropriately selected according to the shape of the substrate. For circular substrates such as wafers, spin coating, spray coating, and inkjet coating are preferred; for rectangular substrates, slit coating, spray coating, or inkjet coating are preferred. In the case of spin coating, for example, a rotation speed of 500~3,500 rpm can be used for approximately 10 seconds to 3 minutes.

又,亦能夠適用將藉由上述賦予方法預先賦予至偽支撐體上而形成之 塗膜轉印到基材上之方法。 Furthermore, it is also applicable to the method of transferring a coating, formed by pre-applying it to a pseudo-support using the aforementioned application method, onto a substrate.

關於轉印方法,本發明中亦能夠較佳地使用日本特開2006-023696號公報的0023段、0036~0051段或日本特開2006-047592號公報的0096~0108段中所記載的製作方法。 Regarding the transfer method, the present invention can also preferably utilize the manufacturing methods described in paragraphs 0023, 0036-0051 of Japanese Patent Application Publication No. 2006-023696 or paragraphs 0096-0108 of Japanese Patent Application Publication No. 2006-047592.

又,可以進行在基材的端部中去除多餘的膜的步驟。在該種步驟的例子中,可以舉出邊珠沖洗(EBR)、背面沖洗(Back rinse)等。 Furthermore, a step can be performed to remove excess film from the ends of the substrate. Examples of such steps include edge bead rinsing (EBR) and back rinse.

又,亦可以採用預濕步驟,該預濕步驟在將樹脂組成物塗佈於基材上之前,對基材塗佈各種溶劑以提高基材的潤濕性之後,塗佈樹脂組成物。 Alternatively, a pre-wetting step can be used, in which various solvents are applied to the substrate to improve its wettability before the resin composition is applied.

<乾燥步驟> <Drying Steps>

上述膜在膜形成步驟(層形成步驟)之後,為了去除溶劑,可以供於乾燥所形成之膜(層)之步驟(乾燥步驟)中。 The aforementioned membrane, after the membrane formation step (layer formation step), can be used in the drying step (drying step) to remove the solvent.

亦即,本發明的硬化物之製造方法可以包括乾燥步驟,該乾燥步驟乾燥藉由膜形成步驟而形成之膜。 That is, the method for manufacturing the hardened material of this invention may include a drying step, which dries the film formed by the film forming step.

又,上述乾燥步驟在膜形成步驟之後且在曝光步驟之前進行為較佳。 Furthermore, it is preferable to perform the drying step described above after the film formation step and before the exposure step.

乾燥步驟中之膜的乾燥溫度為50~150℃為較佳,70℃~130℃為更佳,90℃~110℃為進一步較佳。又,亦可以藉由減壓來進行乾燥。作為乾燥時間,可以例示30秒鐘~20分鐘,1分鐘~10分鐘為較佳,2分鐘~7分鐘為更佳。 The optimal drying temperature for the membrane during the drying process is 50-150°C, with 70-130°C being even better, and 90-110°C being even more desirable. Alternatively, drying can be achieved by reducing pressure. For drying time, examples include 30 seconds to 20 minutes, 1 minute to 10 minutes, and 2 minutes to 7 minutes, all of which are preferable.

<曝光步驟> <Exposure Steps>

上述膜可以供於選擇性地曝光膜之曝光步驟中。 The aforementioned film can be used in the exposure step of selectively exposing films.

亦即,本發明的硬化物之製造方法可以包括曝光步驟,該曝光步驟選擇性地曝光藉由膜形成步驟而形成之膜。 That is, the method for manufacturing the cured material of this invention may include an exposure step that selectively exposes the film formed by the film formation step.

選擇性地曝光表示對膜的一部分進行曝光。又,藉由選擇性地曝光,在膜上形成經曝光之區域(曝光部)和未經曝光的區域(非曝光部)。 Selective exposure means exposing only a portion of the film. Furthermore, through selective exposure, exposed areas (exposed areas) and unexposed areas (non-exposed areas) are formed on the film.

關於曝光量,只要能夠將本發明的樹脂組成物硬化,則並無特別規定,例如以在波長365nm下的曝光能量換算為50~10,000mJ/cm2為較佳,200~8,000mJ/cm2為更佳。 Regarding the exposure amount, there are no special requirements as long as it can harden the resin composition of this invention. For example, it is preferable to use an exposure energy of 50~10,000mJ/ cm2 at a wavelength of 365nm, and even better to use 200~8,000mJ/ cm2 .

曝光波長能夠在190~1,000nm的範圍內適當設定,240~550nm為較佳。 The exposure wavelength can be appropriately set within the range of 190~1,000nm, with 240~550nm being optimal.

關於曝光波長,若以與光源的關係進行說明,則可以舉出(1)半導體雷射(波長830nm、532nm、488nm、405nm、375nm、355nm etc.)、(2)金屬鹵化物燈、(3)高壓水銀燈、g射線(波長436nm)、h射線(波長405nm)、i射線(波長365nm)、寬(g、h、i射線的3波長)、(4)準分子雷射、KrF準分子雷射(波長248nm)、ArF準分子雷射(波長193nm)、F2準分子雷射(波長157nm)、(5)極紫外線;EUV(波長13.6nm)、(6)電子束、(7)YAG雷射的第二諧波532nm且第三諧波355nm等。關於本發明的樹脂組成物,尤其基於高壓水銀燈之曝光為較佳,其中,基於i射線之曝光為較佳。藉此,可以獲得尤其高的曝光靈敏度。 Regarding the exposure wavelength, if we explain it in terms of its relationship with the light source, we can cite (1) semiconductor lasers (wavelengths 830nm, 532nm, 488nm, 405nm, 375nm, 355nm) as examples. (etc.), (2) metal halide lamps, (3) high-pressure mercury lamps, g-rays (wavelength 436nm), h-rays (wavelength 405nm), i-rays (wavelength 365nm), broadband (three wavelengths of g, h, and i-rays), (4) excimer lasers, KrF excimer lasers (wavelength 248nm), ArF excimer lasers (wavelength 193nm), F2 excimer lasers (wavelength 157nm), (5) extreme ultraviolet; EUV (wavelength 13.6nm), (6) electron beams, (7) YAG lasers with a second harmonic of 532nm and a third harmonic of 355nm, etc. Regarding the resin composition of the present invention, exposure to high-pressure mercury lamps is particularly preferred, and exposure to i-rays is particularly preferred. This allows for exceptionally high exposure sensitivity.

又,曝光的方式並無特別限定,只要為曝光由本發明的樹脂組成物形成之膜的至少一部分之方式即可,但是可以舉出使用了光罩之曝光、基於雷射直接成像法之曝光等。 Furthermore, the exposure method is not particularly limited, as long as it exposes at least a portion of the film formed by the resin composition of this invention. However, examples include exposure using a photomask and exposure based on direct laser imaging.

<曝光後加熱步驟> <Heating steps after exposure>

上述膜可以供於在曝光後進行加熱之步驟(曝光後加熱步驟)中。 The aforementioned film can be used in the post-exposure heating step (post-exposure heating step).

亦即,本發明的硬化物之製造方法可以包括曝光後加熱步驟,該曝光 後加熱步驟加熱藉由曝光步驟進行曝光之膜。 That is, the method for manufacturing the cured material of this invention may include a post-exposure heating step, which heats the film exposed by the exposure step.

曝光後加熱步驟能夠在曝光步驟之後且在顯影步驟之前進行。 The post-exposure heating step can be performed after the exposure step and before the development step.

曝光後加熱步驟中之加熱溫度為50℃~140℃為較佳,60℃~120℃為更佳。 The optimal heating temperature during the post-exposure heating step is 50℃~140℃, with 60℃~120℃ being even better.

曝光後加熱步驟中之加熱時間為30秒鐘~300分鐘為較佳,1分鐘~10分鐘為更佳。 The optimal heating time after exposure is 30 seconds to 300 minutes, with 1 to 10 minutes being even better.

關於曝光後加熱步驟中之升溫速度,從加熱開始時的溫度至最高加熱溫度為1~12℃/分鐘為較佳,2~10℃/分鐘為更佳,3~10℃/分鐘為進一步較佳。 Regarding the heating rate during the post-exposure heating process, a rate of 1-12°C/min from the initial heating temperature to the maximum heating temperature is preferred, 2-10°C/min is even better, and 3-10°C/min is still preferable.

又,升溫速度可以在加熱過程中適當變更。 Furthermore, the heating rate can be appropriately adjusted during the heating process.

作為曝光後加熱步驟中之加熱機構,並無特別限定,能夠使用公知的加熱板、烘箱、紅外線加熱器等。 There are no particular limitations on the heating mechanism used in the post-exposure heating step; commonly known heating plates, ovens, infrared heaters, etc., can be used.

又,藉由在加熱時使氮氣、氦氣、氬氣等非活性氣體流過等而在低氧濃度的環境下進行亦較佳。 Furthermore, it is also preferable to conduct the experiment in a low-oxygen environment by allowing inert gases such as nitrogen, helium, and argon to flow through during heating.

<顯影步驟> <Development Steps>

曝光後的上述膜可以供於使用顯影液進行顯影而形成圖案之顯影步驟中。 The exposed film can then be used in the developing process to create patterns using a developing solution.

亦即,本發明的硬化物之製造方法可以包括顯影步驟,該顯影步驟使用顯影液對藉由曝光步驟進行曝光之膜進行顯影而形成圖案。藉由進行顯影來去除膜的曝光部及非曝光部中的一者,並形成圖案。 That is, the method for manufacturing the cured material of this invention may include a developing step, in which a developing solution is used to develop a film exposed by an exposure step to form a pattern. Development removes either the exposed or unexposed portions of the film, thus forming the pattern.

其中,將藉由顯影步驟去除膜的非曝光部之顯影稱為負型顯影,將藉由顯影步驟去除膜的曝光部之顯影稱為正型顯影。 The process of developing a film to remove the unexposed portions of the film is called negative development, while the process of developing a film to remove the exposed portions of the film is called positive development.

〔顯影液〕 [Developer]

作為在顯影步驟中所使用之顯影液,可以舉出鹼性水溶液或包含有機溶劑之顯影液。 As examples of developing solutions used in the developing process, alkaline aqueous solutions or developing solutions containing organic solvents can be cited.

在顯影液為鹼性水溶液之情況下,作為鹼性水溶液能夠包含之鹼性化合物,可以舉出無機鹼類、一級胺類、二級胺類、三級胺類、四級銨鹽,TMAH(氫氧化四甲銨)、氫氧化鉀、碳酸鈉、氫氧化鈉、矽酸鈉、偏矽酸鈉、氨、乙胺、正丙胺、二乙胺、二正丁胺、三乙胺、甲基二乙胺、二甲基乙醇胺、三乙醇胺、氫氧化四乙基銨、氫氧化四丙銨(Tetrapropylammonium Hydroxide)、氫氧化四丁基銨、氫氧化四戊基銨、氫氧化四己基銨、氫氧化四辛基銨、氫氧化乙基三甲基銨、氫氧化丁基三甲基銨、氫氧化甲基三戊基銨、氫氧化二丁基二戊基銨、氫氧化二甲基雙(2-羥乙基)銨、氫氧化三甲基苯基銨、氫氧化三甲基苄基銨、氫氧化三乙基苄基銨、吡咯、哌啶為較佳,更佳為TMAH。例如在使用TMAH之情況下,顯影液中之鹼性化合物的含量在顯影液總質量中為0.01~10質量%為較佳,0.1~5質量%為更佳,0.3~3質量%為進一步較佳。 When the developing solution is an alkaline aqueous solution, the alkaline compounds that can be contained in an alkaline aqueous solution include inorganic bases, primary amines, secondary amines, tertiary amines, quaternary ammonium salts, TMAH (tetramethylammonium hydroxide), potassium hydroxide, sodium carbonate, sodium hydroxide, sodium silicate, sodium metasilate, ammonia, ethylamine, n-propylamine, diethylamine, di-n-butylamine, triethylamine, methyldiethylamine, dimethylethanolamine, triethanolamine, tetraethylammonium hydroxide, and tetrapropylammonium hydroxide. Hydroxide, tetrabutylammonium hydroxide, tetrapentylammonium hydroxide, tetrahexylammonium hydroxide, tetraoctylammonium hydroxide, ethyltrimethylammonium hydroxide, butyltrimethylammonium hydroxide, methyltripentylammonium hydroxide, dibutyldipentylammonium hydroxide, dimethylbis(2-hydroxyethyl)ammonium hydroxide, trimethylphenylammonium hydroxide, trimethylbenzylammonium hydroxide, triethylbenzylammonium hydroxide, pyrrole, and piperidine are preferred, and TMAH is even more preferred. For example, when using TMAH, the content of alkaline compounds in the developer is preferably 0.01~10% by mass, more preferably 0.1~5% by mass, and even more preferably 0.3~3% by mass.

在顯影液包含有機溶劑之情況下,關於有機溶劑,作為酯類,例如可以較佳地舉出乙酸乙酯、乙酸正丁酯、甲酸戊酯、乙酸異戊酯、乙酸異丁酯、丙酸丁酯、丁酸異丙酯、丁酸乙酯、丁酸丁酯、乳酸甲酯、乳酸乙酯、γ-丁內酯、ε-己內酯、δ-戊內酯、烷氧基乙酸烷基酯(例:烷氧基乙酸甲酯、烷氧基乙酸乙酯、烷氧基乙酸丁酯(例如,甲氧基乙酸甲酯、甲氧基乙酸乙酯、甲氧基乙酸丁酯、乙氧基乙酸甲酯、乙氧基乙酸乙酯等))、3-烷氧基丙酸烷基酯類(例:3-烷氧基丙酸甲酯、3-烷氧基丙酸乙酯等(例 如,3-甲氧基丙酸甲酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸甲酯、3-乙氧基丙酸乙酯等))、2-烷氧基丙酸烷基酯類(例:2-烷氧基丙酸甲酯、2-烷氧基丙酸乙酯、2-烷氧基丙酸丙酯等(例如,2-甲氧基丙酸甲酯、2-甲氧基丙酸乙酯、2-甲氧基丙酸丙酯、2-乙氧基丙酸甲酯、2-乙氧基丙酸乙酯))、2-烷氧基-2-甲基丙酸甲酯及2-烷氧基-2-甲基丙酸乙酯(例如,2-甲氧基-2-甲基丙酸甲酯、2-乙氧基-2-甲基丙酸乙酯等)、丙酮酸甲酯、丙酮酸乙酯、丙酮酸丙酯、乙醯乙酸甲酯、乙醯乙酸乙酯、2-氧代丁酸甲酯、2-氧代丁酸乙酯等,以及作為醚類,例如可以較佳地舉出二乙二醇二甲醚、四氫呋喃、乙二醇單甲醚、乙二醇單乙醚、甲基溶纖劑乙酸酯、乙基溶纖劑乙酸酯、二乙二醇單甲醚、二乙二醇單乙醚、二乙二醇單丁醚、丙二醇單甲醚(PGME)、丙二醇單甲醚乙酸酯(PGMEA)、丙二醇單乙醚乙酸酯、丙二醇單丙醚乙酸酯等,以及作為酮類,例如可以較佳地舉出甲基乙基酮、環己酮、環戊酮、2-庚酮、3-庚酮、N-甲基-2-吡咯啶酮等,以及作為環狀烴類,例如可以較佳地舉出甲苯、二甲苯、苯甲醚等芳香族烴類、檸檬烯等環式萜烯類、作為亞碸類,可以較佳地舉出二甲基亞碸以及作為醇類,可以較佳地舉出甲醇、乙醇、丙醇、異丙醇、丁醇、戊醇、辛醇、二乙二醇、丙二醇、甲基異丁基甲醇、三乙二醇等以及作為醯胺類,可以較佳地舉出N-甲基吡咯啶酮、N-乙基吡咯啶酮、二甲基甲醯胺等。 When the developing solution contains organic solvents, esters are preferably exemplified as follows: ethyl acetate, n-butyl acetate, amyl formate, isoamyl acetate, isobutyl acetate, butyl propionate, isopropyl butyrate, ethyl butyrate, butyl butyrate, methyl lactate, ethyl lactate, γ-butyrolactone, ε-caprolactone, δ-valerate, alkyl alkoxyacetic acid esters (e.g., methyl alkoxyacetate, ethyl alkoxyacetate, butyl alkoxyacetate (e.g., methyl methoxyacetate, ethyl methoxyacetate, butyl methoxyacetate, methyl ethoxyacetate, ethyl ethoxyacetate, etc.)), and alkyl 3-alkoxypropionic acid esters (e.g., 3- Methyl alkoxypropionate, ethyl 3-alkoxypropionate, etc. (e.g., methyl 3-methoxypropionate, ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, etc.)), alkyl 2-alkoxypropionates (e.g., methyl 2-alkoxypropionate, ethyl 2-alkoxypropionate, propyl 2-alkoxypropionate, etc. (e.g., methyl 2-methoxypropionate, ethyl 2-methoxypropionate, propyl 2-methoxypropionate, methyl 2-ethoxypropionate, ethyl 2-ethoxypropionate)), methyl 2-alkoxy-2-methylpropionate and ethyl 2-alkoxy-2-methylpropionate (e.g., 2-methoxy-2-methylpropionate) Methyl ester, ethyl 2-ethoxy-2-methylpropionate, etc.), methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, methyl 2-oxobutyrate, ethyl 2-oxobutyrate, etc., and as ethers, preferably diethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl solvent acetate, ethyl solvent acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether (PGME), propylene glycol monomethyl ether acetate (PGMEA), propylene glycol monoethyl ether acetate, propylene glycol monopropyl ether acetate, etc., and as... Ketones, preferably including methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, N-methyl-2-pyrrolidone, etc., and cyclic hydrocarbons, preferably including aromatic hydrocarbons such as toluene, xylene, and anisole, and cyclic terpenes such as limonene; ionoids, preferably including dimethyl ionoid; and alcohols, preferably including methanol, ethanol, propanol, isopropanol, butanol, pentanol, octanol, diethylene glycol, propylene glycol, methyl isobutyl methanol, triethylene glycol, etc.; and amides, preferably including N-methylpyrrolidone, N-ethylpyrrolidone, dimethylformamide, etc.

在顯影液包含有機溶劑之情況下,有機溶劑能夠使用1種或混合使用2種以上。在本發明中,尤其包含選自包括環戊酮、γ-丁內酯、二甲基亞碸、N-甲基-2-吡咯啶酮及環己酮之群組中的至少1種之顯影液為較佳,包含選自包括環戊酮、γ-丁內酯及二甲基亞碸之群組中的至少1種之顯 影液為更佳,包含環戊酮之顯影液為最佳。 When the developing solution contains an organic solvent, one or more organic solvents may be used. In this invention, it is particularly preferred that the developing solution contains at least one solvent selected from the group consisting of cyclopentanone, γ-butyrolactone, dimethyl sulfoxide, N-methyl-2-pyrrolidone, and cyclohexanone; it is even more preferred that the developing solution contains at least one solvent selected from the group consisting of cyclopentanone, γ-butyrolactone, and dimethyl sulfoxide; and the developing solution containing cyclopentanone is the most preferred.

在顯影液包含有機溶劑之情況下,有機溶劑的含量相對於顯影液的總質量為50質量%以上為較佳,70質量%以上為更佳,80質量%以上為進一步較佳,90質量%以上為特佳。又,上述含量可以為100質量%。 When the developing solution contains organic solvents, the organic solvent content relative to the total mass of the developing solution is preferably 50% by mass or more, more preferably 70% by mass or more, further preferably 80% by mass or more, and especially preferably 90% by mass or more. Furthermore, the above content can be 100% by mass.

顯影液可以進一步包含其他成分。 The developing solution can further contain other ingredients.

作為其他成分,例如可以舉出公知的界面活性劑和公知的消泡劑等。 Other components include, for example, well-known surfactants and well-known defoamers.

〔顯影液的供給方法〕 [Developer supply method]

關於顯影液的供給方法,只要能夠形成所期望的圖案,則並無特別限制,存在將形成有膜之基材浸漬於顯影液中之方法、使用噴嘴向形成於基材上之膜供給顯影液以進行旋覆浸沒顯影或連續供給顯影液之方法。噴嘴的種類並無特別限制,可以舉出直式噴嘴、噴淋噴嘴、噴霧噴嘴等。 Regarding the method of supplying the developer, there are no particular limitations as long as the desired pattern can be formed. Methods include immersing the substrate with the film formed in the developer, using a nozzle to supply the developer to the film formed on the substrate for immersion development, or continuously supplying the developer. There are no particular limitations on the type of nozzle; examples include straight nozzles, spray nozzles, and mist nozzles.

從顯影液的滲透性、非圖像部的去除性、製造上的效率的觀點考慮,使用直式噴嘴供給顯影液之方法或使用噴霧噴嘴連續供給之方法為較佳,從顯影液向圖像部的滲透性的觀點考慮,使用噴霧噴嘴進行供給之方法為更佳。 Considering the penetrability of the developer, the removal of non-image areas, and manufacturing efficiency, a method of supplying the developer using a straight nozzle or a continuous supply method using a spray nozzle is preferable. From the perspective of the developer's penetration into the image area, a spray nozzle method is even better.

又,可以採用在使用直式噴嘴連續供給顯影液之後,旋轉基材以從基材上去除顯影液,在旋轉乾燥之後再次使用直式噴嘴連續供給之後,旋轉基材以從基材上去除顯影液之步驟,亦可以反覆進行複數次該步驟。 Alternatively, after continuously supplying developer using a vertical nozzle, the substrate can be rotated to remove the developer. After drying by rotation, the substrate can be continuously supplied again using the vertical nozzle, and the substrate can be rotated to remove the developer again. This process can be repeated multiple times.

又,作為顯影步驟中之顯影液的供給方法,能夠採用將顯影液連續地供給至基材之步驟、在基材上使顯影液保持大致靜止狀態之步驟、在基材上利用超聲波等使顯影液振動之步驟及組合了該等之步驟等。 Furthermore, as a method for supplying the developer in the developing step, methods can include continuously supplying the developer to the substrate, maintaining the developer in a substantially static state on the substrate, vibrating the developer on the substrate using ultrasound or the like, and combinations thereof.

作為顯影時間,10秒鐘~10分鐘為較佳,20秒鐘~5分鐘 為更佳。顯影時的顯影液的溫度並無特別規定,能夠較佳為在10~45℃下進行,更較佳為在18℃~30℃下進行。 For development time, 10 seconds to 10 minutes is preferred, and 20 seconds to 5 minutes is even better. There are no specific temperature requirements for the developing solution, but it is best performed between 10 and 45°C, and even better between 18 and 30°C.

在顯影步驟中,在使用了顯影液之處理之後,可以進一步進行使用沖洗液之圖案的清洗(沖洗)。又,可以採用與圖案接觸之顯影液沒有完全乾燥之前供給沖洗液等的方法。 In the developing step, after treatment with developer, the pattern can be further cleaned using rinsing solution (rinsing). Alternatively, rinsing solution can be supplied before the developer in contact with the pattern is completely dry.

〔沖洗液〕 [Rinse Solution]

在顯影液為鹼性水溶液之情況下,作為沖洗液,例如能夠使用水。在顯影液為包含有機溶劑之顯影液之情況下,作為沖洗液,例如能夠使用與顯影液中所包含之溶劑不同之溶劑(例如,水、與顯影液中所包含之有機溶劑不同之有機溶劑)。 When the developing solution is an alkaline aqueous solution, water can be used as the rinsing solution. When the developing solution contains an organic solvent, a solvent different from the solvent contained in the developing solution can be used as the rinsing solution (e.g., water, or an organic solvent different from the organic solvent contained in the developing solution).

作為沖洗液包含有機溶劑時的有機溶劑,作為酯類,例如可以較佳地舉出乙酸乙酯、乙酸正丁酯、甲酸戊酯、乙酸異戊酯、乙酸異丁酯、丙酸丁酯、丁酸異丙酯、丁酸乙酯、丁酸丁酯、乳酸甲酯、乳酸乙酯、γ-丁內酯、ε-己內酯、δ-戊內酯、烷氧基乙酸烷基酯(例:烷氧基乙酸甲酯、烷氧基乙酸乙酯、烷氧基乙酸丁酯(例如,甲氧基乙酸甲酯、甲氧基乙酸乙酯、甲氧基乙酸丁酯、乙氧基乙酸甲酯、乙氧基乙酸乙酯等))、3-烷氧基丙酸烷基酯類(例:3-烷氧基丙酸甲酯、3-烷氧基丙酸乙酯等(例如,3-甲氧基丙酸甲酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸甲酯、3-乙氧基丙酸乙酯等))、2-烷氧基丙酸烷基酯類(例:2-烷氧基丙酸甲酯、2-烷氧基丙酸乙酯、2-烷氧基丙酸丙酯等(例如,2-甲氧基丙酸甲酯、2-甲氧基丙酸乙酯、2-甲氧基丙酸丙酯、2-乙氧基丙酸甲酯、2-乙氧基丙酸乙酯))、2-烷氧基-2-甲基丙酸甲酯及2-烷氧基-2-甲基丙酸乙酯(例如,2-甲氧基-2-甲基丙酸甲酯、2 -乙氧基-2-甲基丙酸乙酯等)、丙酮酸甲酯、丙酮酸乙酯、丙酮酸丙酯、乙醯乙酸甲酯、乙醯乙酸乙酯、2-氧代丁酸甲酯、2-氧代丁酸乙酯等,以及作為醚類,例如可以較佳地舉出二乙二醇二甲醚、四氫呋喃、乙二醇單甲醚、乙二醇單乙醚、甲基溶纖劑乙酸酯、乙基溶纖劑乙酸酯、二乙二醇單甲醚、二乙二醇單乙醚、二乙二醇單丁醚、丙二醇單甲醚(PGME)、丙二醇單甲醚乙酸酯(PGMEA)、丙二醇單乙醚乙酸酯、丙二醇單丙醚乙酸酯等,以及作為酮類,例如可以較佳地舉出甲基乙基酮、環己酮、環戊酮、2-庚酮、3-庚酮、N-甲基-2-吡咯啶酮等,以及作為環狀烴類,例如可以較佳地舉出甲苯、二甲苯、苯甲醚等芳香族烴類、檸檬烯等環式萜烯類、作為亞碸類,可以較佳地舉出二甲基亞碸以及作為醇類,可以較佳地舉出甲醇、乙醇、丙醇、異丙醇、丁醇、戊醇、辛醇、二乙二醇、丙二醇、甲基異丁基甲醇、三乙二醇等以及作為醯胺類,可以較佳地舉出N-甲基吡咯啶酮、N-乙基吡咯啶酮、二甲基甲醯胺等。 When the rinsing solution contains organic solvents, the organic solvents that are esters include, for example, ethyl acetate, n-butyl acetate, amyl formate, isoamyl acetate, isobutyl acetate, butyl propionate, isopropyl butyrate, ethyl butyrate, butyl butyrate, methyl lactate, ethyl lactate, γ-butyrolactone, ε-caprolactone, δ-valerolactone, alkyl alkoxyacetic acid esters (e.g., methyl alkoxyacetate, ethyl alkoxyacetate, butyl alkoxyacetate (e.g., methyl methoxyacetate, ethyl methoxyacetate, butyl methoxyacetate, methyl ethoxyacetate, ethyl ethoxyacetate, etc.)), and alkyl 3-alkoxypropionic acid esters (e.g., 3-alkoxy...). Methyl propionate, ethyl 3-alkoxypropionate, etc. (e.g., methyl 3-methoxypropionate, ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, etc.)), alkyl 2-alkoxypropionates (e.g., methyl 2-alkoxypropionate, ethyl 2-alkoxypropionate, propyl 2-alkoxypropionate, etc. (e.g., methyl 2-methoxypropionate, ethyl 2-methoxypropionate, propyl 2-methoxypropionate, methyl 2-ethoxypropionate, ethyl 2-ethoxypropionate)), methyl 2-alkoxy-2-methylpropionate and ethyl 2-alkoxy-2-methylpropionate (e.g., methyl 2-methoxy-2-methylpropionate, etc.) 2-Ethoxy-2-methylpropionate ethyl ester, methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, methyl 2-oxobutyrate, ethyl 2-oxobutyrate, etc., and as ethers, preferably diethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl solvent acetate, ethyl solvent acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether (PGME), propylene glycol monomethyl ether acetate (PGMEA), propylene glycol monoethyl ether acetate, propylene glycol monopropyl ether acetate, etc., and as ketones Examples of preferred cyclic hydrocarbons include methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, and N-methyl-2-pyrrolidone; cyclic hydrocarbons include toluene, xylene, and anisole; cyclic terpenes include limonene; ionoids include dimethyl ionoid; alcohols include methanol, ethanol, propanol, isopropanol, butanol, pentanol, octanol, diethylene glycol, propylene glycol, methyl isobutyl methanol, and triethylene glycol; and amides include N-methylpyrrolidone, N-ethylpyrrolidone, and dimethylformamide.

在沖洗液包含有機溶劑之情況下,有機溶劑能夠使用1種或混合使用2種以上。在本發明中,尤其環戊酮、γ-丁內酯、二甲基亞碸、N-甲基吡咯啶酮、環己酮、PGMEA、PGME為較佳,環戊酮、γ-丁內酯、二甲基亞碸、PGMEA、PGME為更佳,環己酮、PGMEA為進一步較佳。 When the rinsing solution contains organic solvents, one or more organic solvents may be used, or a mixture of two or more may be used. In this invention, cyclopentanone, γ-butyrolactone, dimethyl sulfoxide, N-methylpyrrolidone, cyclohexanone, PGMEA, and PGME are particularly preferred; cyclopentanone, γ-butyrolactone, dimethyl sulfoxide, PGMEA, and PGME are even more preferred; and cyclohexanone and PGMEA are further preferred.

在沖洗液包含有機溶劑之情況下,沖洗液的50質量%以上為有機溶劑為較佳,70質量%以上為有機溶劑為更佳,90質量%以上為有機溶劑為進一步較佳。又,亦可以為沖洗液的100質量%為有機溶劑。 When the rinsing solution contains organic solvents, it is preferable that 50% or more by mass of the rinsing solution is an organic solvent, more preferably 70% or more by mass, and even more preferably 90% or more by mass. Alternatively, 100% by mass of the rinsing solution may also be an organic solvent.

沖洗液可以進一步包含其他成分。 Rinse solutions may further include other ingredients.

作為其他成分,例如可以舉出公知的界面活性劑和公知的消泡劑等。 Other components include, for example, well-known surfactants and well-known defoamers.

〔沖洗液的供給方法〕 [Method for supplying the rinsing solution]

關於沖洗液的供給方法,只要能夠形成所期望的圖案,則並無特別限制,存在將基材浸漬於沖洗液中之方法、藉由液盤將沖洗液供給至基材上之方法、以噴淋形式將沖洗液供給至基材之方法、藉由直式噴嘴等機構將沖洗液連續供給至基材之方法。 Regarding the method of supplying the rinsing solution, there are no particular restrictions as long as the desired pattern can be formed. Methods include immersing the substrate in the rinsing solution, supplying the rinsing solution to the substrate via a liquid tray, supplying the rinsing solution to the substrate by spraying, and continuously supplying the rinsing solution to the substrate via a mechanism such as a straight nozzle.

從沖洗液的滲透性、非圖像部的去除性、製造上的效率的觀點考慮,存在使用噴淋噴嘴、直式噴嘴、噴霧噴嘴等供給沖洗液之方法,使用噴霧噴嘴連續供給之方法為較佳,從沖洗液向圖像部的滲透性的觀點考慮,使用噴霧噴嘴進行供給之方法為更佳。噴嘴的種類並無特別限制,可以舉出直式噴嘴、噴淋噴嘴、噴霧噴嘴等。 From the perspectives of rinse fluid penetration, removal of non-image areas, and manufacturing efficiency, there are various methods for supplying rinse fluid, including spray nozzles, straight nozzles, and mist nozzles. Continuous supply via a mist nozzle is preferable, and from the perspective of rinse fluid penetration into the image area, a mist nozzle is even better. There are no particular limitations on the type of nozzle; examples include straight nozzles, spray nozzles, and mist nozzles.

亦即,沖洗步驟為藉由直式噴嘴將沖洗液供給或連續供給至上述曝光後的膜中之步驟為較佳,藉由噴霧噴嘴供給沖洗液之步驟為更佳。 That is, it is preferable to supply the rinsing solution to the exposed film using a straight nozzle or in a continuous manner, and even better to supply the rinsing solution using a spray nozzle.

又,作為沖洗步驟中之沖洗液的供給方法,能夠採用將沖洗液連續地供給至基材之步驟、在基材上使沖洗液保持大致靜止狀態之步驟、在基材上利用超聲波等使沖洗液振動之步驟及組合了該等之步驟等。 Furthermore, as a method for supplying the rinsing solution in the rinsing step, methods include continuously supplying the rinsing solution to the substrate, maintaining the rinsing solution in a substantially static state on the substrate, vibrating the rinsing solution on the substrate using ultrasound or the like, and combinations of these methods.

作為沖洗時間,10秒鐘~10分鐘為較佳,20秒鐘~5分鐘為更佳。沖洗時的沖洗液的溫度並無特別規定,能夠較佳為在10~45℃下進行,更較佳為在18℃~30℃下進行。 The ideal rinsing time is 10 seconds to 10 minutes, with 20 seconds to 5 minutes being even better. There are no specific temperature requirements for the rinsing solution, but it is best performed between 10 and 45°C, and even better between 18 and 30°C.

<加熱步驟> <Heating Steps>

藉由顯影步驟而獲得之圖案(在進行沖洗步驟之情況下為沖洗後的圖案)可以供於對藉由上述顯影而獲得之圖案進行加熱之加熱步驟中。 The pattern obtained through the developing step (or, in the case of a rinsing step, the rinsed pattern) can be used in the heating step that heats the pattern obtained through the aforementioned developing process.

亦即,本發明的硬化物之製造方法可以包括加熱步驟,該加熱步驟對 藉由顯影步驟而獲得之圖案進行加熱。 That is, the method for manufacturing the hardened material of this invention may include a heating step, which heats the pattern obtained by the developing step.

又,本發明的硬化物之製造方法可以包括加熱步驟,該加熱步驟對在不進行顯影步驟的狀態下藉由其他方法而獲得之圖案或藉由膜形成步驟而獲得之膜進行加熱。 Furthermore, the method for manufacturing the cured material of this invention may include a heating step, which heats a pattern obtained by other methods without a developing step or a film obtained by a film forming step.

在加熱步驟中,使聚醯亞胺前驅物等樹脂環化而成為聚醯亞胺等樹脂。 During the heating step, resins such as polyimide precursors are cyclized to form polyimide resins.

又,亦進行特定樹脂或除了特定樹脂以外的交聯劑中之未反應的交聯性基的交聯等。 Furthermore, cross-linking of unreacted crosslinking groups in specific resins or crosslinking agents other than specific resins is also performed.

作為加熱步驟中之加熱溫度(最高加熱溫度),50~450℃為較佳,150~350℃為更佳,150~250℃為進一步較佳,160~250℃為更進一步較佳,160~230℃為特佳。 The optimal heating temperature (maximum heating temperature) in the heating process is 50-450℃, better is 150-350℃, further better is 150-250℃, even better is 160-250℃, and exceptionally good is 160-230℃.

加熱步驟為藉由加熱並利用從上述鹼產生劑產生之鹼、從上述化合物B產生之鹼等的作用而在上述圖案內促進上述聚醯亞胺前驅物的環化反應之步驟為較佳。 The heating step is preferably a step in which the cyclization reaction of the polyimide precursor is promoted within the above-described pattern by heating and utilizing the action of alkali produced from the aforementioned alkali generator, alkali produced from the aforementioned compound B, etc.

關於加熱步驟中之加熱,從加熱開始時的溫度至最高加熱溫度以1~12℃/分鐘的升溫速度進行為較佳。上述升溫速度為2~10℃/分鐘為更佳,3~10℃/分鐘為進一步較佳。藉由將升溫速度設為1℃/分鐘以上,能夠確保生產率的同時,防止酸或溶劑的過度揮發,藉由將升溫速度設為12℃/分鐘以下,能夠緩和硬化物的殘存應力。 Regarding the heating process, it is preferable to increase the temperature at a rate of 1-12°C/min from the initial temperature to the maximum heating temperature. A heating rate of 2-10°C/min is more preferable, and 3-10°C/min is even better. Setting the heating rate to 1°C/min or higher ensures productivity while preventing excessive volatilization of acid or solvent, while setting the heating rate to 12°C/min or lower helps to mitigate residual stress in the hardened material.

另外,在為能夠急速加熱的烘箱的情況下,從加熱開始時的溫度至最高加熱溫度以1~8℃/秒鐘的升溫速度進行為較佳,2~7℃/秒鐘為更佳,3~6℃/秒鐘為進一步較佳。 Furthermore, in the case of an oven capable of rapid heating, a heating rate of 1-8°C/second from the initial temperature to the maximum heating temperature is preferable, 2-7°C/second is even better, and 3-6°C/second is even more preferable.

加熱開始時的溫度為20℃~150℃為較佳,20℃~130℃為更佳,25℃~120℃為進一步較佳。加熱開始時的溫度是指開始加熱至最高加熱溫度之步驟時的溫度。例如,在將本發明的樹脂組成物適用於基材上之後使其乾燥之情況下,為該乾燥後的膜(層)的溫度,例如從比本發明的樹脂組成物中所包含之溶劑的沸點低20~200℃的溫度開始升溫為較佳。 The initial heating temperature is preferably 20°C to 150°C, more preferably 20°C to 130°C, and even more preferably 25°C to 120°C. The initial heating temperature refers to the temperature at which the heating process begins and reaches the maximum heating temperature. For example, after applying the resin composition of the present invention to a substrate and allowing it to dry, it is the temperature of the dried film (layer), preferably starting at a temperature 20°C to 200°C lower than the boiling point of the solvent contained in the resin composition of the present invention.

加熱時間(在最高加熱溫度下的加熱時間)為5~360分鐘為較佳,10~300分鐘為更佳,15~240分鐘為進一步較佳。 The optimal heating time (heating time at the highest heating temperature) is 5–360 minutes, better is 10–300 minutes, and even better is 15–240 minutes.

尤其,在形成多層積層體之情況下,從層間的密接性的觀點考慮,加熱溫度為30℃以上為較佳,80℃以上為更佳,100℃以上為進一步較佳,120℃以上為特佳。 In particular, when forming multilayered bodies, from the perspective of interlayer adhesion, a heating temperature of 30°C or higher is preferred, 80°C or higher is even better, 100°C or higher is further preferred, and 120°C or higher is exceptionally good.

上述加熱溫度的上限為350℃以下為較佳,250℃以下為更佳,240℃以下為進一步較佳。 The upper limit of the heating temperature mentioned above is preferably below 350℃, even better below 250℃, and further preferably below 240℃.

加熱可以階段性地進行。作為例子,可以進行如下步驟:從25℃以3℃/分鐘升溫至120℃且在120℃下保持60分鐘,並且從120℃以2℃/分鐘升溫至180℃且在180℃下保持120分鐘。又,如美國專利第9159547號說明書中所記載,一邊照射紫外線一邊進行處理亦較佳。藉由該種預處理步驟,能夠提高膜的特性。預處理步驟在10秒鐘~2小時左右的短時間內進行即可,15秒鐘~30分鐘為更佳。預處理可以為2個階段以上的步驟,例如可以在100~150℃的範圍內進行第1階段的預處理步驟,之後在150~200℃的範圍內進行第2階段的預處理步驟。 Heating can be performed in stages. For example, the following steps can be taken: increase the temperature from 25°C to 120°C at a rate of 3°C/min and hold at 120°C for 60 minutes, then increase the temperature from 120°C to 180°C at a rate of 2°C/min and hold at 180°C for 120 minutes. Alternatively, as described in U.S. Patent No. 9159547, it is preferable to perform the treatment while irradiating with ultraviolet light. This pretreatment step can improve the membrane's properties. The pretreatment step can be performed in a short time, approximately 10 seconds to 2 hours, with 15 seconds to 30 minutes being more ideal. Pretreatment can consist of two or more steps. For example, the first pretreatment step can be performed at a temperature range of 100–150°C, followed by a second pretreatment step at a temperature range of 150–200°C.

進而,可以在加熱後進行冷卻,作為此時的冷卻速度,1~5℃/分鐘為 較佳。 Furthermore, cooling can be performed after heating; a cooling rate of 1-5°C/minute is preferable in this case.

在防止特定樹脂分解的方面而言,藉由在加熱步驟中使氮氣、氦氣、氬氣等非活性氣體流過且在減壓狀態下進行等而在低氧濃度的環境下進行為較佳。氧濃度為50ppm(體積比)以下為較佳,20ppm(體積比)以下為更佳。 To prevent the decomposition of certain resins, it is preferable to conduct the heating process in a low-oxygen environment by passing inert gases such as nitrogen, helium, or argon through the heating step and under reduced pressure. An oxygen concentration of 50 ppm (by volume) or lower is preferred, and 20 ppm (by volume) or lower is even better.

作為加熱步驟中之加熱機構,並無特別限定,例如可以舉出加熱板、紅外線爐、電烘箱、熱風式烘箱、紅外線烘箱等。 There are no particular limitations on the heating mechanism used in the heating process; examples include heating plates, infrared furnaces, electric ovens, hot air ovens, and infrared ovens.

<顯影後曝光步驟> <Post-exposure steps>

代替上述加熱步驟或除了上述加熱步驟以外,藉由顯影步驟而獲得之圖案(在進行沖洗步驟之情況下為沖洗後的圖案)亦可以供於曝光顯影步驟之後的圖案之顯影後曝光步驟中。 The pattern obtained by the developing step (or, in the case of a washing step), either in lieu of or excluding the heating step described above, can also be used in the post-exposure step of the pattern after the exposure developing step.

亦即,本發明的硬化物之製造方法可以包括顯影後曝光步驟,該顯影後曝光步驟對藉由顯影步驟而獲得之圖案進行曝光。本發明的硬化物之製造方法可以包括加熱步驟及顯影後曝光步驟,亦可以僅包括加熱步驟及顯影後曝光步驟中的一者。 That is, the method for manufacturing the cured material of the present invention may include a post-development exposure step, which exposes the pattern obtained by the development step. The method for manufacturing the cured material of the present invention may include a heating step and a post-development exposure step, or may include only one of the heating step and the post-development exposure step.

在顯影後曝光步驟中,例如能夠促進藉由光鹼產生劑的感光而進行聚醯亞胺前驅物等的環化之反應或藉由光酸產生劑的感光而進行酸分解性基的脫離之反應等。 In the post-development exposure step, it can, for example, promote cyclization reactions of polyimide precursors by exposure to photoalkali generators, or desorption reactions of acid-degrading groups by exposure to photoacid generators.

在顯影後曝光步驟中,只要曝光在顯影步驟中所獲得之圖案的至少一部分即可,但是曝光上述圖案的全部為較佳。 In the post-development exposure step, it is sufficient to expose at least a portion of the pattern obtained in the development step, but exposing the entire pattern is preferable.

顯影後曝光步驟中之曝光量以在感光性化合物具有靈敏度之波長下之曝光能量換算為50~20,000mJ/cm2為較佳,100~15,000mJ/cm2為更佳。 The exposure amount in the post-development exposure step is preferably 50~20,000mJ/ cm2 , and even better if the exposure energy at the wavelength where the photosensitive compound is sensitive is converted to 100~15,000mJ/ cm2 .

顯影後曝光步驟例如能夠使用上述曝光步驟中之光源來進行,使用寬頻帶光為較佳。 The post-development exposure step can be performed using the same light source as described in the exposure steps above; broadband light is preferred.

<金屬層形成步驟> <Metal Layer Formation Steps>

藉由顯影步驟而獲得之圖案(供於加熱步驟及曝光後顯影步驟中的至少一者之圖案為較佳)可以供於在圖案上形成金屬層之金屬層形成步驟中。 The pattern obtained by the developing step (preferably a pattern used in at least one of the heating step and the post-exposure developing step) can be used in the metal layer formation step where a metal layer is formed on the pattern.

亦即,本發明的硬化物之製造方法包括金屬層形成步驟為較佳,該金屬層形成步驟在藉由顯影步驟而獲得之圖案(供於加熱步驟及顯影後曝光步驟中的至少一者之圖案為較佳)上形成金屬層。 That is, the method for manufacturing the hardened material of the present invention preferably includes a metal layer formation step, which forms a metal layer on a pattern obtained by a developing step (preferably a pattern for at least one of a heating step and a post-developing exposure step).

作為金屬層,並無特別限定,能夠使用現有的金屬種類,可以例示銅、鋁、鎳、釩、鈦、鉻、鈷、金、鎢、錫、銀及包含該等金屬之合金,銅及鋁為更佳,銅為進一步較佳。 As a metal layer, there are no particular limitations; existing metal types can be used, such as copper, aluminum, nickel, vanadium, titanium, chromium, cobalt, gold, tungsten, tin, silver, and alloys containing these metals. Copper and aluminum are preferred, with copper being even more preferred.

金屬層的形成方法並無特別限定,能夠適用現有的方法。例如,能夠使用日本特開2007-157879號公報、日本特表2001-521288號公報、日本特開2004-214501號公報、日本特開2004-101850號公報、美國專利第7888181B2、美國專利第9177926B2中所記載之方法。例如,可以考慮光微影、PVD(物理蒸鍍法)、CVD(化學氣相沉積法)、剝離、電解電鍍、無電解電鍍、蝕刻、印刷及組合了該等之方法等。更具體而言,可以舉出組合了濺射、光微影及蝕刻之圖案化方法、組合了光微影和電解電鍍之圖案化方法。作為電鍍的較佳態樣,可以舉出使用了硫酸銅或氰化銅電鍍液之電解電鍍。 There are no particular limitations on the method for forming the metal layer, and existing methods can be used. For example, methods described in Japanese Patent Application Publication No. 2007-157879, Japanese Patent Application Publication No. 2001-521288, Japanese Patent Application Publication No. 2004-214501, Japanese Patent Application Publication No. 2004-101850, US Patent No. 7888181B2, and US Patent No. 9177926B2 can be used. For example, photolithography, PVD (physical vapor deposition), CVD (chemical vapor deposition), peeling, electrolytic electroplating, electroless electroplating, etching, printing, and combinations thereof can be considered. More specifically, examples include patterning methods combining sputtering, photolithography, and etching, and patterning methods combining photolithography and electroplating. As a preferred example of electroplating, electroplating using copper sulfate or copper cyanide plating solutions can be cited.

作為金屬層的厚度,最厚的壁厚的部分為0.01~50μm為較 佳,1~10μm為更佳。 Regarding the thickness of the metal layer, a thickness of 0.01~50 μm for the thickest portion is preferred, and 1~10 μm is even better.

<用途> <Uses>

作為能夠適用本發明的硬化物之製造方法或本發明的硬化物的領域,可以舉出電子元件的絕緣膜、再配線層用層間絕緣膜、應力緩衝膜等。除此以外,亦可以舉出密封膜、基板材料(柔性印刷電路板的基底膜或覆蓋膜、層間絕緣膜)或藉由對如上述實際安裝用途的絕緣膜進行蝕刻而形成圖案之情況等。關於該等用途,例如能夠參閱Science&Technology Co.,Ltd.“聚醯亞胺的高功能化和應用技術”2008年4月、柿本雅明/監修、CMC技術圖書館“聚醯亞胺材料的基礎和開發”2011年11月發行、日本聚醯亞胺/芳香族系高分子研究會/編“最新聚醯亞胺基礎和應用”NTS,2010年8月等。 Examples of applications applicable to the manufacturing method of the cured material of this invention, or to the cured material of this invention, include insulating films for electronic components, interlayer insulating films for redistribution layers, and stress-relief films. Other examples include sealing films, substrate materials (base films or cover films of flexible printed circuit boards, interlayer insulating films), or patterns formed by etching insulating films used for practical installation purposes as described above. For information on these applications, please refer to, for example, Science & Technology Co., Ltd., “High Functionalization and Application Technology of Polyimide,” April 2008; Masaaki Kakimoto, supervisor; CMC Technical Library, “Basic and Development of Polyimide Materials,” November 2011; and Japan Polyimide/Aromatic Polymer Research Association, ed., “Latest Polyimide Basics and Applications,” NTS, August 2010, etc.

又,本發明的硬化物之製造方法或本發明的硬化物亦能夠用於膠印版面或網版版面等版面的製造、蝕刻成形組件的用途、電子尤其微電子中之保護漆及介電層的製造等中。 Furthermore, the method for manufacturing the cured material of this invention, or the cured material itself, can also be used in the manufacture of offset printing plates or screen printing plates, for etching and forming components, and in the manufacture of protective coatings and dielectric layers in electronics, especially microelectronics.

(積層體及積層體之製造方法) (Laminates and methods for manufacturing laminates)

本發明的積層體是指具有複數層由本發明的硬化物形成之層之結構體。 The laminate of this invention refers to a structure having multiple layers formed by the hardening agent of this invention.

本發明的積層體為包括2層以上的由硬化物形成之層之積層體,並且亦可以設為積層3層以上而成之積層體。 The laminate of this invention comprises two or more layers formed of a hardened material, and may also be a laminate consisting of three or more layers.

上述積層體中所包括之2層以上的由上述硬化物形成之層中的至少1個為由本發明的硬化物形成之層,從抑制硬化物的收縮或上述收縮所伴隨之硬化物的變形等之觀點考慮,上述積層體中所包括之所有由硬化物形成之層為由本發明的硬化物形成之層亦較佳。 At least one of the two or more layers formed by the aforementioned hardened material in the aforementioned laminate is a layer formed by the hardened material of the present invention. From the viewpoint of suppressing shrinkage of the hardened material or deformation of the hardened material accompanying such shrinkage, it is also preferable that all the layers formed by hardened materials in the aforementioned laminate are layers formed by the hardened material of the present invention.

亦即,本發明的積層體之製造方法包括本發明的硬化物之製造方法為較佳,包括重複複數次本發明的硬化物之製造方法之步驟為更佳。 That is, it is preferable that the method for manufacturing the laminate of the present invention includes the method for manufacturing the hardened material of the present invention, and it is even more preferable that it includes repeating the steps of the method for manufacturing the hardened material of the present invention several times.

本發明的積層體包括2層以上的由硬化物形成之層,在由上述硬化物形成之層之間的任一個之間包括金屬層之態樣為較佳。關於上述金屬層,藉由上述金屬層形成步驟而形成為較佳。 The laminate of this invention comprises two or more layers formed of a hardened material, and it is preferable that a metal layer is included between any of the layers formed of the hardened material. Preferably, the metal layer is formed by the aforementioned metal layer formation step.

亦即,本發明的積層體之製造方法在複數次進行之硬化物之製造方法之間,進一步包括在由硬化物形成之層上形成金屬層之金屬層形成步驟為較佳。金屬層形成步驟的較佳態樣如上所述。 That is, the method for manufacturing the laminate of the present invention, between the multiple steps of manufacturing the hardened material, preferably includes a metal layer formation step of forming a metal layer on the layer formed by the hardened material. The preferred form of the metal layer formation step is as described above.

作為上述積層體,例如可以舉出至少包含依次積層有第一個由硬化物形成之層、金屬層、第二個由硬化物形成之層這3個層之層結構之積層體作為較佳者。 As an example of the aforementioned laminate, a preferred example is a laminate consisting of at least three layers sequentially stacked: a first layer formed of a hardener, a metal layer, and a second layer formed of a hardener.

上述第一個由硬化物形成之層及上述第二個由硬化物形成之層均為由本發明的硬化物形成之層為較佳。用於形成上述第一個由硬化物形成之層之本發明的樹脂組成物和用於形成上述第二個由硬化物形成之層之本發明的樹脂組成物可以為組成相同的組成物,亦可以為組成不同之組成物。本發明的積層體中之金屬層可以較佳地用作再配線層等金屬配線。 Preferably, both the first and second layers formed by the cured material are layers formed by the cured material of the present invention. The resin composition of the present invention used to form the first layer and the resin composition of the present invention used to form the second layer can be of the same composition or different compositions. The metal layers in the laminate of the present invention are preferably used as metal wiring such as rewiring layers.

<積層步驟> <Layering Steps>

本發明的積層體之製造方法包括積層步驟為較佳。 The method for manufacturing the laminate of this invention preferably includes a lamination step.

積層步驟為包括在圖案(樹脂層)或金屬層的表面上再次依序進行(a)膜形成步驟(層形成步驟)、(b)曝光步驟、(c)顯影步驟、(d)加熱步驟及顯影後曝光步驟中的至少一者之一系列步驟。其中,亦可以為重複(a) 膜形成步驟及(d)加熱步驟及顯影後曝光步驟中的至少一者之態樣。又,在(d)加熱步驟及顯影後曝光步驟中的至少一者之後,還可以包括(e)金屬層形成步驟。在積層步驟中可以進一步適當包括上述乾燥步驟等,這是不言而喻的。 The lamination step includes a series of steps that sequentially perform at least one of (a) a film formation step (layer formation step), (b) an exposure step, (c) a developing step, (d) a heating step, and a post-development exposure step on the surface of the pattern (resin layer) or metal layer. Alternatively, it may be a repetition of at least one of (a) the film formation step and (d) the heating step and the post-development exposure step. Furthermore, after at least one of (d) the heating step and the post-development exposure step, (e) the metal layer formation step may be included. It is self-evident that the lamination step may further appropriately include the aforementioned drying step, etc.

在積層步驟之後進一步進行積層步驟之情況下,可以在上述曝光步驟之後,上述加熱步驟之後或上述金屬層形成步驟之後,進一步進行表面活化處理步驟。作為表面活化處理,可以例示電漿處理。對表面活性化處理的詳細內容將進行後述。 If a further layering step is performed after the layering step, a surface activation treatment step can be performed after the aforementioned exposure step, heating step, or metal layer formation step. Plasma treatment can be cited as an example of surface activation treatment. Details of the surface activation treatment will be described later.

上述積層步驟進行2~20次為較佳,進行2~9次為更佳。 Performing the above layering steps 2-20 times is preferable, and 2-9 times is even better.

例如,如樹脂層/金屬層/樹脂層/金屬層/樹脂層/金屬層,將樹脂層設為2層以上且20層以下之構成為較佳,並且設為2層以上且9層以下之構成為進一步較佳。 For example, in a resin layer/metal layer/resin layer/metal layer/resin layer/metal layer configuration, it is preferable to have 2 or more but less than 20 resin layers, and it is even more preferable to have 2 or more but less than 9 resin layers.

上述各層的組成、形狀及膜厚等分別可以相同,亦可以不同。 The composition, shape, and film thickness of each of the above layers can be the same or different.

在本發明中,尤其以在設置金屬層之後進一步覆蓋上述金屬層之方式形成上述本發明的樹脂組成物的硬化物(樹脂層)之態樣為較佳。具體而言,可以舉出依序重複(a)膜形成步驟、(b)曝光步驟、(c)顯影步驟、(d)加熱步驟及顯影後曝光步驟中的至少一者、(e)金屬層形成步驟之態樣或依序重複(a)膜形成步驟、(d)加熱步驟及顯影後曝光步驟中的至少一者、(e)金屬層形成步驟之態樣。藉由交替進行積層本發明的樹脂組成物層(樹脂層)之積層步驟和金屬層形成步驟,能夠交替積層本發明的樹脂組成物層(樹脂層)和金屬層。 In this invention, it is particularly preferred that the hardened resin composition (resin layer) of the present invention is formed by further covering the metal layer after the metal layer is applied. Specifically, examples include repeating at least one of (a) film formation step, (b) exposure step, (c) development step, (d) heating step and post-development exposure step, and (e) metal layer formation step in sequence, or repeating at least one of (a) film formation step, (d) heating step and post-development exposure step, and (e) metal layer formation step in sequence. By alternately performing the deposition steps of the resin composition layer (resin layer) and the metal layer formation step of the present invention, the resin composition layer (resin layer) and the metal layer of the present invention can be deposited alternately.

(表面活性化處理步驟) (Surface activation treatment steps)

本發明的積層體之製造方法包括對上述金屬層及樹脂組成物層的至少一部分進行表面活性化處理之表面活性化處理步驟為較佳。 The method for manufacturing the laminate of the present invention preferably includes a surface-activating treatment step of surface-activating at least a portion of the aforementioned metal layer and resin composition layer.

表面活性化處理步驟通常在金屬層形成步驟之後進行,但是亦可以在上述顯影步驟之後,對樹脂組成物層進行表面活性化處理步驟之後進行金屬層形成步驟。 The surface-activation treatment step is usually performed after the metal layer formation step. However, it can also be performed after the above-mentioned development step, specifically after the surface-activation treatment of the resin composition layer, followed by the metal layer formation step.

關於表面活性化處理,可以僅對金屬層的至少一部分進行,亦可以僅對曝光後的樹脂組成物層的至少一部分進行,亦可以分別對金屬層及曝光後的樹脂組成物層這兩者的至少一部分進行。對金屬層的至少一部分進行表面活性化處理為較佳,對金屬層中在表面上形成樹脂組成物層之區域的一部分或全部進行表面活性化處理為較佳。如此,藉由對金屬層的表面進行表面活性化處理,能夠提高與設置於其表面上之樹脂組成物層(膜)的密接性。 Regarding the surface activation treatment, it can be performed on at least a portion of the metal layer, on at least a portion of the exposed resin composition layer, or on at least a portion of both the metal layer and the exposed resin composition layer. It is preferable to perform surface activation treatment on at least a portion of the metal layer, and it is preferable to perform surface activation treatment on a portion or all of the area of the metal layer where the resin composition layer is formed on the surface. Thus, by performing surface activation treatment on the surface of the metal layer, the adhesion to the resin composition layer (film) disposed on its surface can be improved.

又,對曝光後的樹脂組成物層(樹脂層)的一部分或全部亦進行表面活性化處理為較佳。如此,藉由對樹脂組成物層的表面進行表面活性化處理,能夠提高與設置於經表面活性化處理之表面上之金屬層和樹脂層的密接性。尤其,在進行負型顯影之情況等使樹脂組成物層硬化之情況下,不易受到表面處理之損壞,從而容易提高密接性。 Furthermore, it is preferable to perform surface-activation treatment on part or all of the exposed resin composition layer (resin layer). This surface-activation treatment of the resin composition layer improves adhesion to the metal layer and resin layer disposed on the surface-activated surface. In particular, when the resin composition layer hardens due to processes such as negative development, it is less susceptible to damage from the surface treatment, thereby facilitating improved adhesion.

作為表面活性化處理,具體而言,選自各種原料氣體(氧氣、氫氣、氬氣、氮氣、氮氣/氫氣混合氣體、氬氣/氧氣混合氣體等)的電漿處理、電暈放電處理、基於CF4/O2、NF3/O2、SF6、NF3、NF3/O2之蝕刻處理、基於紫外線(UV)臭氧法之表面處理、浸漬於鹽酸水溶液中以去除氧化皮膜之後浸漬於包含具有至少1種胺基和硫醇基之化合物之有機表面處理劑中的 浸漬處理、使用了刷子之機械粗面化處理,電漿處理為較佳,尤其使用氧氣作為原料氣體之氧氣電漿處理為較佳。在進行電暈放電處理之情況下,能量為500~200,000J/m2為較佳,1000~100,000J/m2為更佳,10,000~50,000J/m2為最佳。 As a surface activation treatment, specifically, plasma treatment using various raw material gases (oxygen, hydrogen, argon, nitrogen, nitrogen/hydrogen mixture, argon/oxygen mixture, etc.), corona discharge treatment, etching treatment based on CF4 / O2 , NF3 / O2 , SF6 , NF3 , NF3 / O2 , surface treatment based on ultraviolet (UV) ozone method, immersion treatment after removing the oxide film in hydrochloric acid aqueous solution and then immersion in an organic surface treatment agent containing at least one amine group and a thiol group, and mechanical roughening treatment using a brush are preferred, especially oxygen plasma treatment using oxygen as the raw material gas. When performing corona discharge treatment, an energy of 500~200,000 J/ is preferred, 1000~100,000 J/ is even better, and 10,000~50,000 J/ is optimal.

(半導體元件之製造方法) (Manufacturing method of semiconductor devices)

又,本發明還揭示包含本發明的硬化物或本發明的積層體之半導體元件。 Furthermore, this invention also discloses semiconductor devices comprising the cured material or the laminate of this invention.

又,本發明還揭示包括本發明的硬化物之製造方法或本發明的積層體之製造方法之半導體元件之製造方法。作為將本發明的樹脂組成物用於再配線層用層間絕緣膜的形成中之半導體元件的具體例,能夠參閱日本特開2016-027357號公報的0213~0218段的記載及圖1的記載,並將該等內容編入本說明書中。 Furthermore, this invention also discloses a method for manufacturing a semiconductor device, including a method for manufacturing a cured material of this invention or a method for manufacturing a laminate of this invention. As a specific example of a semiconductor device using the resin composition of this invention in the formation of an interlayer insulating film for a redistribution layer, reference can be made to paragraphs 0213-0218 of Japanese Patent Application Publication No. 2016-027357 and the description in Figure 1, and these contents are incorporated herein by reference.

[實施例] [Implementation Example]

以下,舉出實施例對本發明進行更具體的說明。以下實施例所示之材料、使用量、比例、處理內容、處理步驟等只要不脫離本發明的宗旨,則能夠適當地進行變更。從而,本發明的範圍並不限定於以下所示之具體例。除非另有說明,則“份”、“%”為質量基準。 The following examples provide a more detailed description of the invention. The materials, quantities, proportions, processing methods, and steps shown in the following examples can be appropriately varied, provided they do not depart from the spirit of the invention. Therefore, the scope of the invention is not limited to the specific examples shown below. Unless otherwise stated, "parts" and "%" are based on quality.

<環化樹脂的前驅物之製造方法> <Method for manufacturing precursors of cyclic resins>

〔合成例1:環化樹脂的前驅物A-1(聚合物A-1)的合成〕 [Synthetic Example 1: Synthesis of precursor A-1 (polymer A-1) of cyclic resin]

混合21.2g的4,4’-氧二鄰苯二甲酸酐、18.0g的甲基丙烯酸2-羥乙酯、23.9g的吡啶及250mL的二甘二甲醚(二甘醇二甲醚、二乙二醇二甲醚),並在60℃的溫度下攪拌4小時,從而合成了4,4’-氧二鄰苯二甲酸和甲基丙 烯酸2-羥乙酯的二酯。接著,將反應混合物冷卻至-10℃,一邊將溫度保持在-10±5℃一邊經60分鐘加入了17.0g的硫醯氯。在用50mL的N-甲基吡咯啶酮進行稀釋之後,將使12.6g的4,4’-二胺基二苯醚溶解於100mL的N-甲基吡咯啶酮中而獲得之溶液在-10±5℃下經60分鐘滴加到反應混合物中,並將混合物在室溫下攪拌了2小時。 A diester of 4,4'-oxophthalic anhydride, 18.0 g of 2-hydroxyethyl methacrylate, 23.9 g of pyridine, and 250 mL of diethylene glycol dimethyl ether (or diethylene glycol dimethyl ether) were synthesized by mixing at 60 °C for 4 hours. The mixture was then stirred at 60 °C for 4 hours. Next, the reaction mixture was cooled to -10 °C, and 17.0 g of thiocyanate was added over 60 minutes while maintaining the temperature at -10 ± 5 °C. After dilution with 50 mL of N-methylpyrrolidone, a solution obtained by dissolving 12.6 g of 4,4'-diaminodiphenyl ether in 100 mL of N-methylpyrrolidone was added dropwise to the reaction mixture over 60 minutes at -10±5 °C, and the mixture was stirred at room temperature for 2 hours.

接著,加入6000g的水以使聚醯亞胺前驅物沉澱,並將沉澱物(水-聚醯亞胺前驅物混合物)攪拌了15分鐘。過濾收集攪拌後的沉澱物(聚醯亞胺前驅物的固體),並使其溶解於四氫呋喃500g中。向所獲得之溶液中加入6000g的水(不良溶劑)以使聚醯亞胺前驅物沉澱,並將沉澱物(水-聚醯亞胺前驅物混合物)攪拌了15分鐘。再次過濾攪拌後的沉澱物(聚醯亞胺前驅物的固體),並在減壓狀態下,在45℃下乾燥了3天。 Next, 6000g of water was added to precipitate the polyimide precursor, and the precipitate (water-polyimide precursor mixture) was stirred for 15 minutes. The stirred precipitate (solid polyimide precursor) was collected by filtration and dissolved in 500g of tetrahydrofuran. 6000g of water (a poor solvent) was added to the obtained solution to precipitate the polyimide precursor, and the precipitate (water-polyimide precursor mixture) was stirred for 15 minutes. The stirred precipitate (solid polyimide precursor) was filtered again and dried under reduced pressure at 45°C for 3 days.

使乾燥後的粉體46.6g溶解於四氫呋喃419.6g中之後,添加2.3g的三乙胺,並在室溫下攪拌了35分鐘。之後,將其添加至乙醇3000g中,並過濾收集了沉澱物。將所獲得之沉澱物溶解於四氫呋喃281.8g中。向其中添加水17.1g和離子交換樹脂UP6040(Ambertec Ltd.製)46.6g,並攪拌了4小時。之後,藉由過濾而去除離子交換樹脂,並將所獲得之聚合物溶液加入庚烷4500g和乙酸乙酯500g的混合溶液中,從而獲得了沉澱物。過濾收集沉澱物,在減壓狀態下,在45℃下乾燥24小時,從而獲得了45.1g的聚合物A-1。 46.6 g of dried powder was dissolved in 419.6 g of tetrahydrofuran, followed by the addition of 2.3 g of triethylamine, and stirred at room temperature for 35 minutes. The solution was then added to 3000 g of ethanol, and the precipitate was collected by filtration. The obtained precipitate was dissolved in 281.8 g of tetrahydrofuran. 17.1 g of water and 46.6 g of ion exchange resin UP6040 (manufactured by Ambertec Ltd.) were added, and the mixture was stirred for 4 hours. The ion exchange resin was then removed by filtration, and the resulting polymer solution was added to a mixed solution of 4500 g of heptane and 500 g of ethyl acetate to obtain the precipitate. The precipitate was collected by filtration and dried at 45°C for 24 hours under reduced pressure to obtain 45.1 g of polymer A-1.

藉由凝膠滲透層析法(標準聚苯乙烯換算)測定聚合物A-1的分子量,其結果,重量平均分子量(Mw)為20,000。推測聚合物A-1的結構為下述式(A-1)所表示之結構。 The molecular weight of polymer A-1 was determined by gel osmosis chromatography (standard polystyrene conversion), and the weight-average molecular weight (Mw) was 20,000. The structure of polymer A-1 is presumed to be represented by the following formula (A-1).

〔合成例2:環化樹脂的前驅物A-2(聚合物A-2)的合成〕 [Synthetic Example 2: Synthesis of precursor A-2 (polymer A-2) of cyclic resin]

將4,4’-氧二鄰苯二甲酸二酐(ODPA)23.48g和雙鄰苯二甲酸二酐(BPDA)22.27g加入可分離式燒瓶中,並加入甲基丙烯酸2-羥乙酯(HEMA)39.69g和四氫呋喃136.83g,在室溫(25℃)下進行攪拌,一邊攪拌一邊加入吡啶24.66g,從而獲得了反應混合物。基於反應之發熱結束之後,冷卻至室溫,並放置了16小時。 23.48 g of 4,4'-oxophthalic dianhydride (ODPA) and 22.27 g of bis(phthalic dianhydride) (BPDA) were added to a separable flask, along with 39.69 g of 2-hydroxyethyl methacrylate (HEMA) and 136.83 g of tetrahydrofuran. The mixture was stirred at room temperature (25°C), and 24.66 g of pyridine was added while stirring to obtain the reaction mixture. After the reaction reached thermal equilibrium, it was cooled to room temperature and allowed to stand for 16 hours.

接著,在冰冷卻下,一邊攪拌將二環己基碳二醯亞胺(DCC)62.46g溶解於四氫呋喃61.57g中而獲得之溶液一邊經40分鐘加入反應混合物中,接著一邊攪拌將4,4’-二胺基二苯醚(DADPE)27.42g懸浮於四氫呋喃119.73g中者一邊經60分鐘加入。進而,在室溫下攪拌2小時之後,加入乙醇7.17g,並攪拌1小時,接著加入了四氫呋喃136.83g。藉由過濾而去除在反應混合物中產生之沉澱物,從而獲得了反應液。 Next, while cooling, a solution of 62.46 g of dicyclohexylcarbodiimide (DCC) dissolved in 61.57 g of tetrahydrofuran was added to the reaction mixture over 40 minutes with stirring. Then, 27.42 g of 4,4'-diaminodiphenyl ether (DADPE) suspended in 119.73 g of tetrahydrofuran was added over 60 minutes with stirring. After stirring at room temperature for 2 hours, 7.17 g of ethanol was added and stirred for 1 hour, followed by the addition of 136.83 g of tetrahydrofuran. The precipitate formed in the reaction mixture was removed by filtration, thus obtaining the reaction solution.

將所獲得之反應液加入716.21g的乙醇中,從而生成了由粗聚合物形成之沉澱物。過濾出所生成之粗聚合物並將其溶解於四氫呋喃403.49g中,從而獲得了粗聚合物溶液。將所獲得之粗聚合物溶液滴加到8470.26g的水中以使聚合物沉澱,並過濾出所獲得之沉澱物之後進行真空乾燥,從而獲得了80.3g的粉末狀的聚合物A-2。藉由凝膠滲透層析法(標準聚苯乙烯換算)測定聚合物A-2的分子量,其結果,重量平均分子量(Mw)為20,000。推測聚合物A-2的結構為下述式(A-2)所表示之結構。 The obtained reaction solution was added to 716.21 g of ethanol, thereby generating a precipitate of crude polymer. The crude polymer was filtered off and dissolved in 403.49 g of tetrahydrofuran, thus obtaining a crude polymer solution. The obtained crude polymer solution was added dropwise to 8470.26 g of water to precipitate the polymer. After filtering off the precipitate, it was vacuum dried to obtain 80.3 g of powdered polymer A-2. The molecular weight of polymer A-2 was determined by gel permeation chromatography (standard polystyrene conversion), and the weight average molecular weight (Mw) was 20,000. The structure of polymer A-2 is presumed to be represented by the following formula (A-2).

〔合成例3~7:環化樹脂的前驅物A-3~A-7(聚合物A-3~A-7)的合成〕 [Synthetic Examples 3-7: Synthesis of precursors A-3-A-7 (polymers A-3-A-7) of cyclic resins]

適當變更所使用之化合物,除此以外,藉由與合成例1相同的方法合 成了下述式(A-3)~式(A-7)中的任一個所表示之結構的聚合物A-3~A-7。 By appropriately modifying the compounds used, polymers A-3 to A-7 with structures represented by any one of formulas (A-3) to (A-7) were synthesized using the same method as in Synthesis Example 1.

聚合物A-3的Mw為20500,聚合物A-4的Mw為20000,聚合物A-5的Mw為21000,聚合物A-6的Mw為19000,聚合物A-7的Mw為22000。 The Mw of polymer A-3 is 20,500, the Mw of polymer A-4 is 20,000, the Mw of polymer A-5 is 21,000, the Mw of polymer A-6 is 19,000, and the Mw of polymer A-7 is 22,000.

[化學式62] [Chemical Formula 62]

<實施例及比較例> <Implementation Examples and Comparative Examples>

在各實施例中,分別混合下述表中所記載的成分,從而獲得了各樹脂組成物。又,在各比較例中,分別混合下述表中所記載的成分,從而獲得了各比較用組成物。 In each embodiment, the components listed in the table below were mixed to obtain each resin composition. Furthermore, in each comparative example, the components listed in the table below were mixed to obtain each comparative composition.

具體而言,表中所記載的各成分的含量設為表的各欄括號內所記載的量(質量份)。 Specifically, the content of each component recorded in the table is set to the amount (parts by mass) recorded within the parentheses in each column of the table.

將所獲得之樹脂組成物及比較用組成物使用細孔的寬度為0.8μm的聚四氟乙烯製過濾器進行了加壓過濾。 The obtained resin composition and the comparative composition were pressure filtered using a polytetrafluoroethylene filter with a pore width of 0.8 μm.

又,在表中,“-”的記載表示組成物不含有對應之成分。 Furthermore, in the table, a "-" indicates that the composition does not contain the corresponding ingredient.

又,表中的“抗蝕劑酸值”一欄的記載表示相對於組成物1g之組成物中所包含之酸基的量,單位為mgKOH/g。 Furthermore, the "Anticorrosion Acid Value" column in the table indicates the amount of acid groups contained in 1g of the composition, in mgKOH/g.

表中所記載之各成分的詳細內容如下。 The detailed information for each component listed in the table is as follows.

〔環化樹脂的前驅物〕 [Precursors to cyclic resins]

.A-1~A-7:藉由上述合成例而獲得之聚合物A-1~A-7 A-1 to A-7: Polymers A-1 to A-7 obtained by the above synthesis example.

〔光敏劑(光聚合起始劑)〕 [Photosensitizer (photopolymerization initiator)]

.B-1~B-3:下述結構的化合物 B-1~B-3: Compounds with the following structures

〔有機金屬錯合物〕 [Organometallic complex]

.X-1:雙(η5-2,4-環戊二烯-1-基)雙(2,6-二氟-3-(1H-吡咯-1-基)苯基)鈦 X-1: Bis(η5-2,4-cyclopentadien-1-yl)bis(2,6-difluoro-3-(1H-pyrrolo-1-yl)phenyl)titanium

.X-2:五甲基環戊二烯基三甲醇鈦 X-2: Pentamethylcyclopentadienyltrimethyltitanium

.X-3:雙(η5-2,4-環戊二烯-1-基)雙(2,6-二氟苯基)鈦 X-3: Bis(η5-2,4-cyclopentadien-1-yl)bis(2,6-difluorophenyl)titanium

.X-4:四異丙氧基鈦(Matsumoto Fine Chemical Co.Ltd.製) X-4: Tetraisopropoxytitanium (manufactured by Matsumoto Fine Chemical Co., Ltd.)

.X-5:二異丙氧基雙(乙醯丙酮)鈦(Matsumoto Fine Chemical Co.Ltd.製) X-5: Diisopropoxybis(acetyl acetone)titanium (manufactured by Matsumoto Fine Chemical Co., Ltd.)

.X-6~X-8:下述結構的化合物。 X-6~X-8: Compounds with the following structures.

[化學式65] [Chemical Formula 65]

上述X-1及X-3為具有光自由基聚合起始能之化合物。 X-1 and X-3 mentioned above are compounds with photoradical polymerization initiation energies.

〔聚合性化合物(自由基交聯劑)〕 [Polymerizable compounds (free radical crosslinkers)]

.C-1~C-2:下述結構的化合物 C-1~C-2: Compounds with the following structures

〔聚合抑制劑/遷移抑制劑〕 [Polymerization inhibitors/migration inhibitors]

.D-1~D-5:下述結構的化合物 D-1~D-5: Compounds with the following structures

〔添加劑〕 [Additives]

.E-2~E-3:下述結構的化合物 E-2~E-3: Compounds with the following structures

.I-1~I-2:下述結構的化合物 I-1~I-2: Compounds with the following structures

[化學式68] [Chemical Formula 68]

〔金屬接著性改良劑〕 [Metal adhesion modifier]

.F-1~F-2:下述結構的化合物 F-1~F-2: Compounds with the following structures

在上述結構式中,Et表示乙基。 In the above structural formula, Et represents the ethyl group.

〔其他鹼產生劑〕 [Other alkali-producing agents]

.G-1~G-2:下述結構的化合物 G-1~G-2: Compounds with the following structures

.H-11:下述結構的化合物 H-11: Compounds with the following structure

[化學式70] [Chemical Formula 70]

〔化合物B〕 [Compound B]

.H-1~H-10、H-12~H-26:下述結構的化合物 H-1~H-10, H-12~H-26: Compounds with the following structures

〔溶劑〕 [Soluble]

.NMP:N-甲基-2-吡咯啶酮 NMP: N-methyl-2-pyrrolidone

.EL:乳酸乙酯 EL: Ethyl lactate

.DMSO:二甲基亞碸 DMSO: Dimethyl sulfoxide

.GBL:γ-丁內酯 GBL: γ-Butyrolactone

<評價> <Evaluation>

〔保存穩定性的評價〕 [Evaluation of stability retention]

使用E型黏度計分別測定了在各實施例及比較例中所製備之樹脂組成物及比較用組成物的黏度(0天)。在遮光、密封容器中,將組成物在25℃下靜置14天之後,再次使用E型黏度計測定了黏度(14天)。依據以下式計算出黏度變動率(%)。依據所獲得之黏度變動率(%),按照下述評價基準進行評價,並將評價結果記載於下述表的“保存穩定性”一欄中。黏度變動率越低,表示保存穩定性越高。 The viscosities (0 days) of the resin compositions prepared in each embodiment and comparative example, as well as the comparative composition, were measured using an E-type viscometer. After standing at 25°C for 14 days in a light-proof, sealed container, the viscosity was measured again using an E-type viscometer (14 days). The viscosity change rate (%) was calculated according to the following formula. Based on the obtained viscosity change rate (%), the following evaluation criteria were used to evaluate the composition, and the evaluation results were recorded in the "Storage Stability" column of the table below. A lower viscosity change rate indicates higher storage stability.

黏度變動率(%)=|100×{1-(黏度(14天)/黏度(0天))}| Viscosity change rate (%) = |100×{1-(viscosity (14 days)/viscosity (0 days))}|

黏度的測定在25℃下進行,其他依據JIS Z 8803:2011。 Viscosity was measured at 25°C, and other measurements were performed according to JIS Z 8803:2011.

-評價基準- -Evaluation Criteria- Evaluation Criteria-

A:黏度變動率為5%以下。 A: Viscosity variation rate is below 5%.

B:黏度變動率超過5%且為10%以下。 B: Viscosity variation rate exceeding 5% but below 10%.

C:黏度變動率超過10%且為15%以下。 C: Viscosity variation rate exceeding 10% but below 15%.

D:黏度變動率超過15%且為20%以下。 D: Viscosity variation rate exceeding 15% but below 20%.

E:黏度變動率超過了20%。 E: The viscosity variation rate exceeds 20%.

〔斷裂伸長率的評價〕 [Evaluation of elongation at break]

將各實施例及各比較例中所製備之樹脂組成物或比較用組成物,分別藉由旋塗法適用於矽晶圓上,從而形成了樹脂層。 The resin compositions or comparative compositions prepared in each embodiment and comparative example were applied to a silicon wafer by spin coating, thereby forming a resin layer.

將形成有所獲得之樹脂層之矽晶圓在加熱板上以100℃乾燥5分鐘,從而在矽晶圓上獲得了約15μm的均勻厚度的樹脂組成物層。 The silicon wafer with the obtained resin layer was dried at 100°C for 5 minutes on a heated plate, thereby obtaining a resin composition layer with a uniform thickness of approximately 15 μm on the silicon wafer.

在下述表中的顯影條件一欄中記載為“負”之例子中,以500mJ/cm2的曝光能量對矽晶圓上的樹脂組成物層的整面進行了曝光。曝光波長記載於表 中的“曝光波長(nm)”中。在表中的顯影條件一欄中記載為“正”之例子中,不進行曝光。 In the examples where the developing condition column in the table below is marked "negative," the entire surface of the resin composition layer on the silicon wafer was exposed at an exposure energy of 500 mJ/ cm² . The exposure wavelength is recorded in the "Exposure Wavelength (nm)" column of the table. In the examples where the developing condition column in the table is marked "positive," no exposure was performed.

在曝光條件一欄中記載為“M”之例子中,使用步進機作為光源進行了曝光。 In the example where the exposure condition is marked "M", a stepper motor was used as the light source for the exposure.

在曝光條件一欄中記載為“D”之例子中,使用直接曝光裝置(ADTECDE-6UH III)作為光源進行了曝光。 In the example where the exposure condition is marked "D", a direct exposure apparatus (ADTECDE-6UH III) was used as the light source for the exposure.

在“硬化方法”一欄中記載為“A”之例子中,使用加熱板,在氮氣環境下,以10℃/分鐘的升溫速度對上述曝光後的樹脂組成物層進行升溫,在達到表的“硬化溫度(℃)”一欄中所記載的溫度之後,將上述溫度維持了3小時。 In the example designated as "A" in the "Curing Method" column, a heating plate was used to heat the exposed resin composition layer under a nitrogen atmosphere at a rate of 10°C/min. After reaching the temperature recorded in the "Curing Temperature (°C)" column of the table, this temperature was maintained for 3 hours.

在“硬化方法”一欄中記載為“B”之例子中,使用紅外線燈加熱裝置(ADVANCE RIKO,Inc.製、RTP-6),在氮氣環境下,以10℃/分鐘的升溫速度對在各實施例中所獲得之樹脂膜進行升溫,在達到“硬化溫度(℃)”中所記載的溫度之後,將上述溫度維持了3小時。 In the example designated as "B" under "Curing Method," an infrared lamp heating device (ADVANCE RIKO, Inc., RTP-6) was used to heat the resin films obtained in each embodiment at a rate of 10°C/min under a nitrogen atmosphere. After reaching the temperature specified in "Curing Temperature (°C)," this temperature was maintained for 3 hours.

將硬化後的樹脂組成物層(硬化物)浸漬於4.9質量%氫氟酸水溶液中,並從矽晶圓剝離了硬化物。使用衝孔機對所剝離之硬化物進行沖壓,從而製作出試樣寬度3mm、試樣長度30mm的試驗片。關於所獲得之試驗片的長邊方向的伸長率,使用拉伸試驗機(Tensilon),以十字頭速度300mm/分鐘在25℃、65%RH(相對濕度)的環境下,依據JIS-K6251進行了測定。分別實施5次測定,將5次測定中之試驗片斷裂時的伸長率(斷裂伸長率)的算術平均值用作指標值。 The hardened resin composition layer (hardened material) was immersed in a 4.9% (w/w) hydrofluoric acid aqueous solution and then peeled off from the silicon wafer. The peeled-off hardened material was punched using a punching machine to produce test pieces with a sample width of 3 mm and a sample length of 30 mm. The elongation along the long side of the obtained test pieces was measured using a tensile testing machine (Tensilon) at a crosshead speed of 300 mm/min at 25°C and 65% RH (relative humidity) according to JIS-K6251. Five measurements were performed, and the arithmetic mean of the elongation at break (elongation at break) from the five measurements was used as the index value.

按照下述評價基準進行評價,評價結果記載於表的“斷裂伸長率”一欄中。可以說指標值越大,硬化物的膜強度越優異。 The evaluation was conducted according to the following criteria, and the results are recorded in the "Elongation at Break" column of the table. Generally speaking, the higher the value, the better the film strength of the cured material.

-評價基準- -Evaluation Criteria- Evaluation Criteria-

A:上述指標值為65%以上。 A: The above indicator value is above 65%.

B:上述指標值為60%以上且小於65%。 B: The above indicator value is above 60% and below 65%.

C:上述指標值為55%以上且小於60%。 C: The above indicator value is above 55% and below 60%.

D:上述指標值為50%以上且小於55%。 D: The above indicator value is above 50% and below 55%.

E:上述指標值小於50%。 E: The above indicator value is less than 50%.

〔密接性的評價〕 [Evaluation of close contact]

藉由旋塗法分別將在各實施例及比較例中所製備之樹脂組成物或比較用組成物以層狀適用於銅基板上,從而形成了樹脂組成物層或比較用組成物層。將形成有所獲得之樹脂組成物層或比較用組成物層之銅基板在加熱板上以100℃乾燥5分鐘,從而在銅基板上形成了20μm的厚度均勻的樹脂組成物層或比較用組成物層。在表的“顯影條件”一欄中記載為“負”之例子中使用形成有100μm見方的正方形狀的非遮罩部之光罩且在表的“顯影條件”一欄中記載為“正”之例子中使用形成有100μm見方的正方形狀的遮罩部之光罩,藉由表的“曝光波長nm”一欄中所記載的曝光波長(nm)的光以500mJ/cm2的曝光能量對銅基板上的樹脂組成物層或比較用組成物層進行了曝光。 The resin composition or comparative composition prepared in each embodiment and comparative example was applied in layers onto a copper substrate by spin coating, thereby forming a resin composition layer or a comparative composition layer. The copper substrate with the obtained resin composition layer or comparative composition layer was dried on a heating plate at 100°C for 5 minutes, thereby forming a uniform resin composition layer or comparative composition layer with a thickness of 20 μm on the copper substrate. In the example where "development condition" is marked as "negative" in the table, a photomask with a square non-masking portion of 100 μm was used. In the example where "development condition" is marked as "positive" in the table, a photomask with a square masking portion of 100 μm was used. The resin composition layer or comparison composition layer on the copper substrate was exposed to light with an exposure wavelength (nm) recorded in the table's "exposure wavelength (nm)" column at an exposure energy of 500 mJ/ cm² .

在曝光條件一欄中記載為“M”之例子中,使用步進機作為光源進行了曝光。 In the example where the exposure condition is marked "M", a stepper motor was used as the light source for the exposure.

在曝光條件一欄中記載為“D”之例子中,使用直接曝光裝置(ADTECDE-6UH III)作為光源而不使用光罩,在100μm見方的範圍內進行了雷射直接成像曝光。 In the example marked "D" in the exposure conditions column, direct laser imaging exposure was performed within a 100μm square area using a direct exposure apparatus (ADTECDE-6UH III) as the light source without a photomask.

之後,用環戊酮顯影60秒鐘,從而獲得了100μm見方的正方形狀的樹脂層。 Then, the resin layer was developed with cyclopentanone for 60 seconds, resulting in a square resin layer of 100 μm.

在“硬化方法”一欄中記載為“A”之例子中,使用加熱板,在氮氣環境下,以10℃/分鐘的升溫速度對上述曝光後的樹脂組成物層進行升溫,在達到表的“硬化溫度(℃)”一欄中所記載的溫度之後,將上述溫度維持了3小時。 In the example designated as "A" in the "Curing Method" column, a heating plate was used to heat the exposed resin composition layer under a nitrogen atmosphere at a rate of 10°C/min. After reaching the temperature recorded in the "Curing Temperature (°C)" column of the table, this temperature was maintained for 3 hours.

在“硬化方法”一欄中記載為“B”之例子中,使用紅外線燈加熱裝置(ADVANCE RIKO,Inc.製、RTP-6),在氮氣環境下,以10℃/分鐘的升溫速度對在各實施例中所獲得之樹脂膜進行升溫,在達到“硬化溫度(℃)”中所記載的溫度之後,將上述溫度維持了3小時。 In the example designated as "B" under "Curing Method," an infrared lamp heating device (ADVANCE RIKO, Inc., RTP-6) was used to heat the resin films obtained in each embodiment at a rate of 10°C/min under a nitrogen atmosphere. After reaching the temperature specified in "Curing Temperature (°C)," this temperature was maintained for 3 hours.

在25℃、65%相對濕度(RH)的環境下,使用黏結強度試驗機(XYZ TEC公司製、CondorSigma),測定銅基板上的100μm見方的正方形狀的樹脂層的剪力,並按照下述評價基準進行了評價。評價結果記載於表的“密接性”一欄中。可以說剪力越大,硬化膜的金屬密接性(銅密接性)越優異。 The shear force of a 100 μm square resin layer on a copper substrate was measured using an adhesive strength tester (XYZ TEC, CondorSigma) at 25°C and 65% relative humidity (RH), and evaluated according to the following evaluation criteria. The evaluation results are recorded in the "Adhesion" column of the table. Generally speaking, a higher shear force indicates better metal adhesion (copper adhesion) of the hardened film.

-評價基準- -Evaluation Criteria- Evaluation Criteria-

A:剪力超過了30gf。 A: The shear force exceeded 30gf.

B:剪力超過25gf且為30gf以下。 B: Shear force exceeding 25gf but below 30gf.

C:剪力超過20gf且為25gf以下。 C: Shear force exceeding 20gf but below 25gf.

D:剪力為20gf以下。 D: Shear force is below 20gf.

又,1gf為0.00980665N。 Also, 1 gf is 0.00980665 N.

從以上結果可知,藉由使用本發明的樹脂組成物,可以獲得組成物的保存穩定性及所獲得之硬化物的斷裂伸長率優異之樹脂組成物。 The results above demonstrate that by using the resin composition of this invention, a resin composition with excellent preservation stability and superior elongation at break of the cured product can be obtained.

比較例1中之比較用組成物不包含化合物B而包含大量的“H-11”作為其他鹼產生劑。在該種態樣中,可知組成物的保存穩定性差。 The comparative composition in Comparative Example 1 does not contain compound B but contains a large amount of "H-11" as another alkali generator. In this state, it is evident that the composition exhibits poor storage stability.

比較例2中之比較用組成物不包含化合物B而包含少量的“H-11”作為其他鹼產生劑。在該種態樣中,可知所獲得之硬化物的斷裂伸長率差。 Comparative Example 2 uses a composition that does not contain compound B but contains a small amount of "H-11" as another alkali-generating agent. In this state, the difference in elongation at break of the obtained hardened product is evident.

<實施例101> <Implementation Example 101>

藉由旋塗法將在實施例1中所使用之樹脂組成物以層狀適用於表面上形成有銅薄層之樹脂基材的銅薄層的表面上,並在100℃下乾燥4分鐘而形成膜厚20μm的感光膜之後,使用步進機(Nikon Co.,Ltd.製,NSR1505 i6) 進行了曝光。關於曝光,經由遮罩(圖案為1:1線與空間,線寬為10μm的二元遮罩)在波長365nm下進行。曝光後,在100℃下加熱了4分鐘。上述加熱後,用環己酮顯影2分鐘,並用PGMEA沖洗30秒鐘,從而獲得了層的圖案。 The resin composition used in Example 1 was applied in a layered manner to the surface of a copper thin layer on a resin substrate with a copper thin layer formed thereon by spin coating. After drying at 100°C for 4 minutes to form a photosensitive film with a thickness of 20 μm, exposure was performed using a stepper (Nikon Co., Ltd., NSR1505 i6). Exposure was performed using a mask (a binary mask with a 1:1 line-to-space pattern and a linewidth of 10 μm) at a wavelength of 365 nm. After exposure, heating at 100°C for 4 minutes was performed. Following heating, development with cyclohexanone for 2 minutes and washing with PGMEA for 30 seconds were performed to obtain the layer pattern.

接著,在氮氣環境下,以10℃/分鐘的升溫速度進行升溫,在達到230℃之後,在230℃下維持120分鐘,從而形成了再配線層用層間絕緣膜。該再配線層用層間絕緣膜的絕緣性優異。 Next, under a nitrogen atmosphere, the temperature was increased at a rate of 10°C/min, reaching 230°C, and then maintained at 230°C for 120 minutes, thereby forming the interlayer insulating film for the redistribution layer. This interlayer insulating film for the redistribution layer exhibits excellent insulation properties.

又,使用該等再配線層用層間絕緣膜製造出半導體元件,其結果,確認到正常動作。 Furthermore, semiconductor devices were fabricated using interlayer insulating films for these redistribution layers, and normal operation was confirmed.

Claims (14)

一種樹脂組成物,其係包含:選自包括聚醯亞胺前驅物、聚苯并唑前驅物及聚醯胺醯亞胺前驅物之群組中的至少1種樹脂;以及藉由鹼的作用而產生鹼之化合物B,其中化合物B為下述式(1-1)所表示之化合物: 式(1-1)中,R1表示可以經取代的烴基,R2表示可以經取代的烴基,R1和R2可以鍵結而形成環結構。 A resin composition comprising: selected from polyimide precursors, polyphenylene oxides, etc. At least one resin from the group consisting of azole precursors and polyamide-imide precursors; and compound B, which generates a base by the action of a base, wherein compound B is a compound represented by the following formula (1-1): In equation (1-1), R1 represents a substitutable hydrocarbon, R2 represents a substitutable hydrocarbon, and R1 and R2 can bond together to form a ring structure. 如請求項1所述之樹脂組成物,其中從化合物B產生之鹼為胺。 The resin composition as described in claim 1, wherein the alkali produced from compound B is an amine. 如請求項1或請求項2所述之樹脂組成物,其中化合物B具有胺酯鍵。 The resin composition as described in claim 1 or claim 2, wherein compound B has an amino ester bond. 如請求項1或請求項2所述之樹脂組成物,其係進一步包含熱鹼產生劑或光鹼產生劑。 The resin composition as described in claim 1 or claim 2 further comprises a thermo-alkali generator or a photoalkali generator. 如請求項1或請求項2所述之樹脂組成物,其係進一步包含熱鹼產生劑。 The resin composition as described in claim 1 or claim 2 further comprises a calorific value-generating agent. 如請求項1或請求項2所述之樹脂組成物,其係進一步包含光聚合起始劑。 The resin composition as described in claim 1 or claim 2 further comprises a photopolymerization initiator. 如請求項1或請求項2所述之樹脂組成物,其係進一步包含聚合性化合物。 The resin composition as described in claim 1 or claim 2 further comprises a polymeric compound. 如請求項1或請求項2所述之樹脂組成物,其中化合物B為選自下述化合物中的至少1種: The resin composition as described in claim 1 or claim 2, wherein compound B is selected from at least one of the following compounds: 一種硬化物,其係將請求項1至請求項8之任一項所述之樹脂組成物硬化而成。 A hardened material formed by hardening any of the resin compositions described in claims 1 to 8. 一種積層體,其係包括2層以上的由請求項9所述之硬化物形成之層,並且在由前述硬化物形成之層之間的任一個之間包括金屬層。 A laminate comprising two or more layers formed of the hardened material described in claim 9, and including a metal layer between any of the layers formed of the aforementioned hardened material. 一種硬化物之製造方法,其係包括將請求項1至請求項8之任一項所述之樹脂組成物適用於基材上而形成膜之膜形成步驟。 A method for manufacturing a hardened material, comprising a film formation step of adapting a resin composition described in any one of claims 1 to 8 onto a substrate to form a film. 如請求項11所述之硬化物之製造方法,其係包括選擇性地曝光前述膜之曝光步驟及使用顯影液對前述膜進行顯影而形成圖案之顯影步驟。 The method for manufacturing a hardened material as described in claim 11 includes an exposure step of selectively exposing the aforementioned film and a development step of developing the aforementioned film using a developing solution to form a pattern. 如請求項11所述之硬化物之製造方法,其係包括在50~450℃下對前述膜進行加熱之加熱步驟。 The method for manufacturing the hardened material as described in claim 11 includes a heating step of heating the aforementioned film at a temperature of 50-450°C. 一種半導體元件,其係包含請求項9所述之硬化物。 A semiconductor device comprising the cured material described in claim 9.
TW110134213A 2020-09-16 2021-09-14 Resin compositions, cured materials, laminates, manufacturing methods of cured materials, and semiconductor devices TWI912365B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2020155560 2020-09-16
JP2020-155560 2020-09-16
JP2021092749 2021-06-02
JP2021-092749 2021-06-02

Publications (2)

Publication Number Publication Date
TW202222912A TW202222912A (en) 2022-06-16
TWI912365B true TWI912365B (en) 2026-01-21

Family

ID=

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019156801A (en) 2018-03-16 2019-09-19 日本化薬株式会社 Base proliferation agent, and base reactive resin composition containing the base proliferation agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019156801A (en) 2018-03-16 2019-09-19 日本化薬株式会社 Base proliferation agent, and base reactive resin composition containing the base proliferation agent

Similar Documents

Publication Publication Date Title
TWI894339B (en) Curable resin composition, cured product, laminate, method for manufacturing cured product, and semiconductor device
TWI841777B (en) Method for producing cured film, method for producing laminate, and method for producing electronic component
TWI878598B (en) Curable resin composition, cured product, laminate, method for producing cured product, semiconductor device, polyimide precursor and method for producing the same
TWI890907B (en) Resin composition, cured product, laminate, method for manufacturing cured product, and semiconductor device
TWI890798B (en) Curable resin composition, cured film, laminate, method for producing cured film, and semiconductor device
TWI888627B (en) Method for producing hardened product, method for producing laminate, and method for producing semiconductor element
TWI890841B (en) Curable resin composition, cured product, laminate, method for producing cured product, semiconductor device, polyimide precursor and method for producing the same
TWI898039B (en) Method for producing a cured product, method for producing a laminate, and method for producing a semiconductor device
TWI869552B (en) Curable resin composition, cured film, laminate, method for producing cured film, and semiconductor device
TWI896742B (en) Photosensitive resin composition, cured product, laminate, method for manufacturing cured product, and semiconductor device
KR102793452B1 (en) Curable resin composition, cured product, laminate, method for producing cured product, and semiconductor device, and photobase generator
TWI882163B (en) Curable resin composition, cured product, laminate, method for manufacturing cured product, and semiconductor device
TWI893199B (en) Composite pattern manufacturing method, resin composition, laminate manufacturing method, and semiconductor device manufacturing method
WO2022071226A1 (en) Resin composition, cured product, laminate, cured product production method, and semiconductor device
WO2022059622A1 (en) Resin composition, cured object, layered product, method for producing cured object, and semiconductor device
TWI894341B (en) Curable resin composition, cured product, laminate, method for manufacturing cured product, and semiconductor device
TWI912365B (en) Resin compositions, cured materials, laminates, manufacturing methods of cured materials, and semiconductor devices
TW202219118A (en) Method for producing polyimide precursor and method for producing curable resin composition
TW202222911A (en) Resin composition, cured object, layered product, method for producing cured object, and semiconductor device
TWI902904B (en) Resin composition, cured material, laminate, method for manufacturing cured material and semiconductor device
TWI904246B (en) Resin composition, cured material, laminate, method for manufacturing cured material and semiconductor device
TWI904243B (en) Resin composition, cured material, laminate, method for manufacturing cured material and semiconductor device
TWI912484B (en) Resin composition, cured material, laminate, method for manufacturing cured material and semiconductor device
TWI901645B (en) Photosensitive resin composition, pattern manufacturing method, photosensitive film, cured product, laminate and device
TWI904169B (en) Photosensitive resin compositions, hardened films, laminates, methods for manufacturing hardened films, and semiconductor devices.